Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGRP,Agouti-related protein,42296,0.269351144772686,0.00484306171992115,0.259858743801641,0.278843545743732,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN1,CCN family member 1,42047,0.345900158508319,0.0068258274518196,0.332521536702753,0.359278780313885,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,0.0910197860081615,0.00208626671397345,0.0869307032487736,0.0951088687675495,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LDLR,Low-density lipoprotein receptor,42170,0.39161473151569,0.00410468846521221,0.383569542123874,0.399659920907506,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFGE8,Lactadherin,42137,0.235857809279092,0.00425662340596382,0.227514827403403,0.244200791154781,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPY,Pro-neuropeptide Y,42262,0.34761955500841,0.00588964929092604,0.336075842398195,0.359163267618625,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.139374567437141,0.00312374649680215,0.133252024303409,0.145497110570873,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL27,C-C motif chemokine 27,42145,0.242968861018132,0.00614660774103495,0.230921509845704,0.255016212190561,1.1125369292536e-308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F7,Coagulation factor VII,42194,0.119055944622589,0.00305821140326391,0.113061850272192,0.125050038972986,1.11253798635131e-308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GHR,Growth hormone receptor,39736,0.106808315746286,0.00276168464170545,0.101395413848543,0.112221217644028,3.79359047846679e-307
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PROC,Vitamin K-dependent protein C,42199,0.0942048764022338,0.00254267023687121,0.0892212427379663,0.0991885100665014,2.42105216591772e-286
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCG,Pro-glucagon,41843,0.449958233969329,0.0123154412624881,0.425819969094852,0.474096498843805,1.54497259698106e-278
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPL,Lipoprotein lipase,42145,-0.169697476611111,0.0047798477081411,-0.179065978119068,-0.160328975103155,4.62739070867354e-264
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,42262,0.113877695259851,0.00321350393256388,0.107579227552025,0.120176162967676,3.10733685280782e-263
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,0.269736322841645,0.00759748794621415,0.254845246467065,0.284627399216225,7.02501454335006e-262
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTH,Parathyroid hormone,39649,0.291750122839463,0.00821248118214403,0.275653659722461,0.307846585956465,7.56634001232395e-262
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RARRES2,Retinoic acid receptor responder protein 2,42230,0.169039950856094,0.00481064299144166,0.159611090592868,0.178468811119319,5.17007195019461e-259
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CES1,Liver carboxylesterase 1,42163,0.296062160337742,0.00845780541358608,0.279484861727114,0.312639458948371,4.38240934324149e-257
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,0.148912758516782,0.0042633107050318,0.14055666953492,0.157268847498644,4.51839429071658e-256
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGSF9,Protein turtle homolog A,39958,0.298151555461187,0.0085061083200032,0.28147958315398,0.314823527768393,1.14148630701399e-255
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APCS,Serum amyloid P-component,39870,0.112729139826281,0.00321935419248095,0.106419205609018,0.119039074043543,4.3830708752156e-255
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCHE,Cholinesterase,39806,0.0912956898290938,0.00266270238025911,0.0860767931637859,0.0965145864944016,4.30475156297278e-245
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FURIN,Furin,42181,0.110259727799514,0.00330034470032464,0.103791052186877,0.11672840341215,2.98617858586778e-235
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TTR,Transthyretin,39862,0.081645915458715,0.00246858918740996,0.0768074806513915,0.0864843502660385,5.10139053528902e-229
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMAD1,Mothers against decapentaplegic homolog 1,41843,0.275146000093972,0.00840345177238727,0.258675234620093,0.291616765567851,3.59469870749356e-226
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC39A5,Zinc transporter ZIP5,42119,0.169012912593835,0.0053179684248741,0.158589694481082,0.179436130706588,7.75841350801209e-214
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INHBC,Inhibin beta C chain,42137,0.126364051970068,0.00398841755296424,0.118546753566259,0.134181350373878,1.40437234210936e-212
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,41921,0.463898912552723,0.0146716003603871,0.435142575846364,0.492655249259082,1.21534030264803e-211
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA5,Plasma serine protease inhibitor,39835,0.0951094981055964,0.00300798317528068,0.0892138510820463,0.101005145129147,2.79443371733852e-210
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA4,Kallistatin,39802,0.0738565640172405,0.00233786639189555,0.0692743458891252,0.0784387821453558,6.60284986423902e-210
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,0.255863460255212,0.00820085691367612,0.239789780704407,0.271937139806017,2.66430345862466e-206
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL23,C-C motif chemokine 23,42185,0.131822202176855,0.00424309193172263,0.123505741990679,0.140138662363031,8.84217392646192e-205
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRAP1,Proline-rich acidic protein 1,39966,0.121185644450094,0.00390506406468298,0.113531718883315,0.128839570016872,4.94145062516812e-203
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,0.247905425982443,0.00803410082481592,0.232158588365804,0.263652263599083,4.50927949209018e-202
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB1,DnaJ homolog subfamily B member 1,42070,0.263435721354699,0.00857821065875446,0.24662242846354,0.280249014245858,3.08578678440372e-200
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,0.0595934158033971,0.00194704387175107,0.055777209814765,0.0634096217920292,5.79119605969685e-199
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRP1,Neuropilin-1,42230,-0.0839986900151843,0.00274683700433052,-0.0893824905436721,-0.0786148894866965,1.06935436415283e-198
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C9,Complement component C9,39990,-0.176210054649022,0.00575675671549142,-0.187493297811385,-0.164926811486659,8.26465936154359e-198
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN3,Contactin-3,42137,0.0865071222391953,0.0028516127982098,0.0809179611547041,0.0920962833236865,1.24769123645912e-195
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,42286,-0.183863895827668,0.00608713805582968,-0.195794686417095,-0.171933105238242,4.39353921308481e-194
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD4,T-cell surface glycoprotein CD4,42100,0.0872321094497485,0.00292145493479342,0.0815060577775534,0.0929581611219436,9.19322751525142e-190
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFPI,Tissue factor pathway inhibitor,42152,0.0936489644332668,0.0031382762287106,0.0874979430249941,0.0997999858415396,1.4554787367607e-189
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,42287,-0.381062217450898,0.0127786457001703,-0.406108363023232,-0.356016071878564,2.2744242620311e-189
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,0.316889311552038,0.0107559643358736,0.295807621453726,0.33797100165035,6.12714317789477e-185
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AFM,Afamin,39979,0.0597529205596938,0.00202784085740616,0.0557783524791777,0.0637274886402098,5.68199556891272e-184
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADIPOQ,Adiponectin,39979,-0.200302766813633,0.00691592008746517,-0.213857970185064,-0.186747563442201,5.08714406980488e-178
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,0.0962394495146876,0.00337394715953618,0.0896265130819967,0.102852385947378,6.93679330725863e-174
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLTP,Phospholipid transfer protein,42267,-0.108649036279558,0.00382153733133795,-0.116139249448981,-0.101158823110136,8.57446356407876e-173
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPR37,Prosaposin receptor GPR37,41900,0.186244779280422,0.00658313750756132,0.173341829765602,0.199147728795243,4.8819607442126e-171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSG2,Desmoglein-2,42137,-0.0772526128722362,0.00273393763241318,-0.082611130631766,-0.0718940951127063,1.00379306994661e-170
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHMP6,Charged multivesicular body protein 6,39958,0.162949184642518,0.00576200920579303,0.151655646599164,0.174242722685873,4.38293998915957e-170
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,0.0584509916143131,0.0020839711043718,0.0543664082497444,0.0625355749788819,3.63304275599856e-168
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,0.193202147624434,0.00694012378344134,0.179599505008889,0.206804790239979,7.0386881882434e-166
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLAT,Tissue-type plasminogen activator,42272,0.143680363927937,0.00517611100875136,0.133535186350784,0.15382554150509,4.97746160224725e-165
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL6,C-X-C motif chemokine 6,42296,0.209872846541587,0.00763573143137526,0.194906812936091,0.224838880147082,6.20144386146897e-162
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PROS1,Vitamin K-dependent protein S,39979,0.0690815946731391,0.0025611976610274,0.0640616472575254,0.0741015420887528,2.24847863696818e-155
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,0.162234683602371,0.00607189709299765,0.150333765300095,0.174135601904646,3.14889213409364e-153
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFH,Complement factor H,39418,0.0631620171616726,0.00236583391353233,0.0585249826911493,0.067799051632196,3.98193602391413e-152
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNCA,Alpha-synuclein,39736,0.317061634073309,0.0118899408633056,0.29375734998123,0.340365918165388,6.39861951856659e-152
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.156290622651841,0.00590749713657744,-0.167869317039533,-0.144711928264149,2.15055048113536e-150
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTA3,Glutathione S-transferase A3,41843,0.206599953575821,0.00781963262334344,0.191273473634068,0.221926433517574,5.89356905713294e-150
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,42217,0.0860535524677734,0.00326622087154293,0.0796517595595492,0.0924553453759975,2.99942640837601e-149
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAMR1,Inactive serine protease PAMR1,42137,0.0703844658058072,0.00268179106772161,0.0651281553130728,0.0756407762985416,3.97625560883761e-148
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GH1,Somatotropin,42129,-0.471768980641103,0.018015604187243,-0.507079564848099,-0.436458396434107,1.72904991729174e-147
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,0.0648274952149477,0.00247577889734904,0.0599749685761436,0.0696800218537519,1.76165066737926e-147
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLKB1,Plasma kallikrein,39759,0.0648074859945418,0.00247709921674024,0.0599523715297309,0.0696626004593526,1.74966671417993e-146
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,42310,-0.0882250277340073,0.00339863007728113,-0.0948863426854783,-0.0815637127825362,4.47725222019699e-145
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MXRA8,Matrix remodeling-associated protein 8,39736,-0.0807934653503403,0.00311024789824761,-0.0868895512309056,-0.074697379469775,1.74010883648748e-144
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,0.323743729356049,0.0125794363788297,0.299088034053543,0.348399424658555,1.2184142480844e-142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLI1,Friend leukemia integration 1 transcription factor,41843,0.290993502674711,0.0113313998722408,0.268783958925119,0.313203046424303,5.62595471721394e-142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFP,Properdin,39979,0.0613246896764599,0.00239524868442184,0.0566300022549931,0.0660193770979268,1.30317730876685e-140
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CKB,Creatine kinase B-type,39966,-0.148265820279969,0.00581078091276718,-0.159654950868993,-0.136876689690945,1.08128791156458e-139
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GUSB,Beta-glucuronidase,42211,0.15697701737395,0.00620073097375975,0.144823584665381,0.169130450082519,3.28522065742632e-138
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCS1,Neuronal calcium sensor 1,42262,0.0724586882796971,0.00287214183321105,0.0668292902866035,0.0780880862727908,2.67259027186466e-137
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPM,Carboxypeptidase M,42195,0.0870977848918753,0.00345267894810598,0.0803305341535876,0.093865035630163,2.90007703328565e-137
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRIP2,Cysteine-rich protein 2,42016,0.0933945094349224,0.00370246342582733,0.0861376811203008,0.100651337749544,3.27713124298514e-137
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATRN,"Attractin, Isoform 2",39979,0.0425324111817952,0.00168685437236149,0.0392261766119667,0.0458386457516237,1.51055012303435e-136
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPIND1,Heparin cofactor 2,39959,0.0742113116608764,0.00295393629808045,0.0684215965166387,0.0800010268051141,1.35206665187447e-135
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMPRSS15,Enteropeptidase,42070,0.223270612516709,0.00893157621870486,0.205764723128048,0.240776501905371,7.45515552454328e-135
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KDR,Vascular endothelial growth factor receptor 2,42181,0.0635632757442142,0.00254921374984583,0.0585668167945164,0.068559734693912,3.21227173058266e-134
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFI,Complement factor I,39979,0.0491075877031145,0.00196717297856169,0.0452519286651336,0.0529632467410954,5.88360860134708e-134
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENO3,Beta-enolase,39638,0.15773730461536,0.00637241531052901,0.145247370606723,0.170227238623996,1.07367691813947e-131
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRP,Gastrin-releasing peptide,39638,0.133910039646579,0.00541275621738256,0.123301037460509,0.144519041832648,1.47174365828149e-131
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F10,Coagulation factor X,39990,0.0725076314972472,0.0029360080237915,0.0667530557706158,0.0782622072238785,3.2180061230325e-131
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAT2,Linker for activation of T-cells family member 2,42070,0.316146773752529,0.0128290105040054,0.291001913164679,0.34129163434038,3.43116455368424e-131
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUMB,Protein numb homolog,39657,0.209092674297457,0.00849949149644002,0.192433670964435,0.22575167763048,3.77444749476321e-130
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,0.0488804797139009,0.00199766457112646,0.0449650571544931,0.0527959022733088,1.89298136558491e-129
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMAD2,Mothers against decapentaplegic homolog 2,39919,0.176304863091686,0.0071991935360785,0.162194443760972,0.1904152824224,4.21811484244284e-129
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F9,Coagulation factor IX,42199,0.0454217788964644,0.0018656150279899,0.0417651734416042,0.0490783843513246,3.40913361471532e-128
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTSS1,Protein MTSS 1,39930,0.275141911112845,0.0113010190379528,0.252991913798458,0.297291908427233,1.1584090691633e-127
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTA1,Glutathione S-transferase A1,42119,0.208836900411647,0.00861772418029826,0.191946161018263,0.225727639805032,4.97171904408971e-127
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SORT1,Sortilin,42129,0.093909539119117,0.00388020346150145,0.0863043403345741,0.10151473790366,1.02230130117576e-126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,-0.0951398430528698,0.00393191255842355,-0.10284639166738,-0.0874332944383597,1.11442396233582e-126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACY1,Aminoacylase-1,42145,0.154734298440546,0.00639553822722376,0.142199043515188,0.167269553365905,1.22581283926504e-126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,0.180092539024193,0.00745091732557239,0.165488741066071,0.194696336982315,2.24484497812395e-126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOC1,Apolipoprotein C-I,39959,0.0947514763803767,0.00391253259879214,0.0870829124867442,0.102420040274009,2.25645536743689e-126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHBG,Sex hormone-binding globulin,39990,-0.114681316746448,0.00475020329975377,-0.123991715213966,-0.105370918278931,1.24653688190479e-125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL16,C-C motif chemokine 16,42310,0.125056863326587,0.00522395328328577,0.114817914891347,0.135295811761827,4.15396448726488e-124
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELN,Elastin,39958,0.083978245045152,0.00352647197468334,0.0770663599747727,0.0908901301155313,2.33461539248057e-122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASGR1,Asialoglycoprotein receptor 1,42016,0.073461897644392,0.00309451911900855,0.0673966401711352,0.0795271551176487,4.57333166769073e-122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,0.164886616364863,0.0069546077223718,0.151255585229014,0.178517647500712,9.83870750654271e-122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KYNU,Kynureninase,42296,0.109006563245211,0.00462958484815005,0.0999325769428374,0.118080549547586,3.34739596180755e-120
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LATS1,Serine/threonine-protein kinase LATS1,39657,0.206962052560642,0.00880931999988546,0.189695785360867,0.224228319760418,3.82538718508307e-119
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINF2,Alpha-2-antiplasmin,39786,0.0320208641005261,0.00136363889448758,0.0293481318673304,0.0346935963337218,4.60558890137848e-119
NMR metabolomics,X23508.Triglycerides in Medium VLDL,P4HB,Protein disulfide-isomerase,42073,0.0919670846392756,0.0039347610521705,0.0842549529770214,0.0996792163015297,1.80415489352947e-118
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,0.0524416396029364,0.00223966443110375,0.0480518973179731,0.0568313818878997,2.12240857230173e-118
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,0.124012524471836,0.00530851657908726,0.113607831976825,0.134417216966847,2.20468576800414e-118
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINF1,Pigment epithelium-derived factor,39815,0.0622858887315061,0.00267003069337057,0.0570526285724998,0.0675191488905125,1.42121070833347e-117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YES1,Tyrosine-protein kinase Yes,42070,0.270108098304446,0.0116328327055092,0.247307746201648,0.292908450407244,5.65682589335843e-117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNAPIN,SNARE-associated protein Snapin,39934,0.137870989027074,0.00592816364510785,0.126251788282663,0.149490189771486,6.44673156638668e-117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FN1,Fibronectin,39979,0.0644027841742125,0.00277014571818829,0.0589732985665635,0.0698322697818615,7.53017572044372e-117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,0.330512280816664,0.0142503145513768,0.302581664295966,0.358442897337363,2.65398696376487e-116
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UPB1,Beta-ureidopropionase,39958,0.212356067278528,0.0092148991132837,0.194294865016492,0.230417269540565,6.97959715803139e-115
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EEF1D,Elongation factor 1-delta,39958,0.213053010272413,0.00927482408674919,0.194874355062384,0.231231665482441,3.54215524680788e-114
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNAP29,Synaptosomal-associated protein 29,42181,0.212647218272103,0.0093348917730628,0.1943508303969,0.230943606147306,9.31054908479582e-113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL13,C-X-C motif chemokine 13,42249,0.133301965773837,0.00586268627857797,0.121811100667824,0.14479283087985,2.31192399456999e-112
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOM,Apolipoprotein M,42199,0.0657726592775121,0.00289414690687993,0.0601001313400275,0.0714451872149968,3.01100757220871e-112
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SYAP1,Synapse-associated protein 1,39736,0.135330316770501,0.0059551194558155,0.123658282637102,0.147002350903899,8.63382871581947e-112
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYH9,Myosin-9,39966,0.262543591441777,0.0115614820856822,0.23988308655384,0.285204096329715,1.1043191165717e-111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SARG,Specifically androgen-regulated gene protein,39915,0.253931111933407,0.0111969222299084,0.231985144362786,0.275877079504027,2.1655277460341e-111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,0.0754169320412074,0.00334594496613524,0.0688588799075823,0.0819749841748325,1.84371533795552e-110
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FYB1,FYN-binding protein 1,42115,0.212089250396817,0.00944935257577652,0.193568519348295,0.230609981445339,1.42863914714281e-109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERP44,Endoplasmic reticulum resident protein 44,42047,0.0595207075861097,0.0026528357714567,0.0543211494740546,0.0647202656981648,1.74604184744878e-109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTYMK,Thymidylate kinase,39958,0.153892651565926,0.00684761607712889,0.140471324054753,0.167313979077098,1.78458912099884e-109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,0.0947176068690731,0.00422464500037905,0.0864373026683301,0.102997911069816,2.4708683412489e-109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAA80,N-alpha-acetyltransferase 80,39649,0.280411499851315,0.0125422967385448,0.255828598243767,0.304994401458863,2.53673772905934e-108
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F13B,Coagulation factor XIII B chain,39925,0.0581342605090682,0.00260857162303332,0.0530214601279228,0.0632470608902135,1.02804331670628e-107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOST,Sclerostin,42129,0.0878554537478803,0.00395454759318878,0.0801045404652303,0.0956063670305304,1.97119235676094e-107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL2,Angiopoietin-related protein 2,42140,0.0896559857611374,0.00403851910516815,0.0817404883150078,0.097571483207267,2.77525070620137e-107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,0.0673552533851772,0.00303074540582322,0.0614149923897637,0.0732955143805907,3.79882040282879e-107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SKAP1,Src kinase-associated phosphoprotein 1,41997,0.163523130539108,0.00739324051037819,0.149032379138767,0.178013881939449,1.69304315347208e-106
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGR3,Anterior gradient protein 3,41827,0.133264410455359,0.00604602137968976,0.121414208551167,0.14511461235955,9.1027658904532e-106
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,39958,0.148414661282877,0.00672451241315521,0.135234616953093,0.161594705612661,9.90685343216469e-106
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300LG,CMRF35-like molecule 9,42137,-0.0839418748826183,0.00381311847248231,-0.0914155870886836,-0.076468162676553,1.48951973170841e-105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MLN,Promotilin,42119,0.2007391872886,0.00912200166152389,0.182860064032013,0.218618310545186,1.7730549877228e-105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMP4,Metalloproteinase inhibitor 4,42137,-0.0895189661862666,0.00406999798693649,-0.0974961622406621,-0.0815417701318711,2.23811056801448e-105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOMO1,Nodal modulator 1,42137,0.0522102528213509,0.00237801417965888,0.0475493450292195,0.0568711606134823,5.1771864932562e-105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCN2,Ficolin-2,42116,0.090777756263185,0.00413957459660994,0.0826641900538295,0.0988913224725404,9.07847421921202e-105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YTHDF3,YTH domain-containing family protein 3,41913,0.190985257597148,0.00874696084848697,0.173841214334114,0.208129300860182,7.18412513902908e-104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TJAP1,Tight junction-associated protein 1,42181,0.185259169752361,0.00848945400078195,0.168619839910829,0.201898499593894,8.57569346704661e-104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEG1,Protein HEG homolog 1,39736,0.0611347754621519,0.00280880706453951,0.0556295136156545,0.0666400373086494,6.77025908628972e-103
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AP1G2,AP-1 complex subunit gamma-like 2,39919,0.175295194506458,0.0080989927772133,0.159421168663119,0.191169220349796,7.89140535415798e-102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTD,Biotinidase,39979,0.0451033637813486,0.00209211153881333,0.0410028251652745,0.0492039023974227,4.53857777091703e-101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDHR5,Cadherin-related family member 5,42145,0.0851486672679059,0.00395701048907282,0.0773929267093232,0.0929044078264886,5.09850135560064e-101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPPC,C-type natriuretic peptide,42119,0.115575129013483,0.0053776845518822,0.105034867291794,0.126115390735172,8.98090404410115e-101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF21,Fibroblast growth factor 21,42247,0.263579180617451,0.012268452374264,0.239533013963893,0.287625347271008,1.0092779068555e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADH1B,All-trans-retinol dehydrogenase,39736,0.16733440013461,0.0077745794058433,0.152096224499157,0.182572575770063,1.04530678980692e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PON3,Serum paraoxonase/lactonase 3,42185,-0.0643819989819127,0.00299960656179596,-0.0702612278430328,-0.0585027701207926,1.583728526343e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,42119,0.233220020908915,0.0108704899531328,0.211913860600775,0.254526181217056,1.94762469478988e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTSS2,Protein MTSS 2,39919,0.219266585482757,0.0102445880264801,0.199187192950856,0.239345978014658,1.16195909619056e-99
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAMDC4,Apical endosomal glycoprotein,39919,0.123444471311685,0.00576898844236442,0.112137253964651,0.134751688658719,1.29402254509344e-99
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOS3,"Nitric oxide synthase, endothelial",41839,0.110424505986296,0.00517253075102176,0.100286345714293,0.120562666258298,1.90479775234164e-99
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDHR2,Cadherin-related family member 2,42070,0.143573526739746,0.00673048876958515,0.130381768751359,0.156765284728133,2.50909104429359e-99
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,0.248181607503653,0.0116254058521436,0.225395812033452,0.270967402973854,3.83852002932941e-99
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGSF8,Immunoglobulin superfamily member 8,42145,0.0673905493465014,0.0031718767312077,0.0611736709533343,0.0736074277396685,1.43751976776423e-98
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,39910,0.187888738040954,0.00883339254184118,0.170575288658945,0.205202187422963,1.79060705978376e-98
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,0.215648144256689,0.0101763714806452,0.195702456154625,0.235593832358754,8.97532754426373e-98
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABL1,Tyrosine-protein kinase ABL1,42070,0.145892050613501,0.00689886383889182,0.132370277489273,0.159413823737729,1.12295229157484e-97
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,0.216197212202844,0.0102283360200971,0.196149673603454,0.236244750802234,1.36569617847342e-97
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,0.0890445217658788,0.00421054137891256,0.0807918606632101,0.0972971828685474,2.1656360994322e-97
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,0.210076344765751,0.0099937215356566,0.190488650555864,0.229664038975637,1.49115469120798e-96
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL4A1,Collagen alpha-1(IV) chain,42145,-0.0840520748778698,0.00401895552358777,-0.0919292277041018,-0.0761749220516377,1.28913452205231e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLA,Alpha-galactosidase A,39713,0.083439815321163,0.00399651957704105,0.0756066369501625,0.0912729936921635,5.56159060427178e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEP,Leptin,42145,0.148240643270151,0.00711749201470963,0.134290358921321,0.162190927618982,7.40497005276668e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,42238,0.0675064335125787,0.00325082076133487,0.0611348248203624,0.0738780422047951,2.51692635964604e-94
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELPLG,P-selectin glycoprotein ligand 1,42119,0.0591136149639392,0.0028469230859067,0.0535336457155621,0.0646935842123164,2.69357491475608e-94
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,0.14458159301397,0.00699332150973049,0.130874682854899,0.158288503173042,3.47981227640499e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPB2,Carboxypeptidase B2,39959,0.0474295551618942,0.00229583410506746,0.042929720315962,0.0519293900078265,4.12665590679856e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,0.190144220081229,0.00922424001316852,0.172064709655419,0.208223730507039,5.71961891312654e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HJV,Hemojuvelin,39934,0.0887283224154267,0.00429884886802872,0.0803025786340904,0.097154066196763,6.07288424290991e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AXIN1,Axin-1,42119,0.202765079775712,0.00987835336145002,0.18340350718727,0.222126652364154,3.17990789366759e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBP5,Retinol-binding protein 5,42070,0.11815098959562,0.0057607844848286,0.106859852005356,0.129442127185884,4.48545728959849e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPY,Pancreatic prohormone,42089,0.215919765488057,0.0105305583305676,0.195279871160145,0.23655965981597,4.97473781674352e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KAZN,Kazrin,39930,0.219671716540592,0.0107073692439363,0.198685272822477,0.240658160258708,7.1688265611003e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,0.136845073040275,0.00667929760983709,0.123753649724995,0.149936496355556,7.27928750865493e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXLNA,Alpha-taxilin,42016,0.184700933671659,0.00902484780365094,0.167012231976503,0.202389635366815,1.08478676728258e-91
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHA1,Ephrin type-A receptor 1,42162,0.0675173568995661,0.00330086936848614,0.0610476529373333,0.073987060861799,1.31568097119058e-91
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,0.120126649377065,0.00587491107058151,0.108611823678726,0.131641475075405,3.06993814608597e-91
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,0.0626860178831841,0.00306698271159146,0.0566747317684648,0.0686973039979033,3.28801862859736e-91
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HBEGF,Proheparin-binding EGF-like growth factor,42224,0.151651155104428,0.00746411848435746,0.137021482875087,0.166280827333768,1.96496805969618e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SORD,Sorbitol dehydrogenase,42204,0.142850265923765,0.00703317570693224,0.129065241538178,0.156635290309352,2.24146435601205e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,0.162759155992514,0.00801312989600838,0.147053421396337,0.17846489058869,4.07548467076111e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,0.0762722370208754,0.0037682636394933,0.0688864402874686,0.0836580337542823,9.22943466745207e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F11R,Junctional adhesion molecule A,42137,0.114917005459573,0.00571026592443351,0.103724884247684,0.126109126671463,8.88439153688057e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MME,Neprilysin,42070,0.160025058963489,0.00797399635660168,0.144396026104549,0.175654091822428,2.70978172798828e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OXT,Oxytocin-neurophysin 1,42249,0.29779669945675,0.0148432951785516,0.268703840906789,0.326889558006711,2.91308631908182e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KHK,Ketohexokinase,39638,0.129463655517861,0.00644371417569936,0.11683397573349,0.142093335302232,3.27530822353655e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMAD5,Mothers against decapentaplegic homolog 5,42070,0.0409502857511754,0.00204153951571294,0.0369488683003781,0.0449517032019728,3.28338478367003e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFC,Platelet-derived growth factor C,41843,0.0573408848940411,0.00286190695082261,0.0517315472704288,0.0629502225176534,5.36574384394541e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP10,Stromelysin-2,42124,-0.11804399824318,0.00590251535344163,-0.129612928335926,-0.106475068150435,1.03760285839409e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,0.149574313560107,0.00750424579661253,0.134865991798746,0.164282635321467,4.05056366373678e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CES3,Carboxylesterase 3,42070,0.144929928696265,0.00727842344273001,0.130664218748514,0.159195638644016,5.65361767651158e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAK4,Serine/threonine-protein kinase PAK 4,41839,0.124996872163673,0.00628078282959231,0.112686537817672,0.137307206509674,7.31974900173636e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGT1,Glutathione hydrolase 1 proenzyme,42113,0.105724281692481,0.00531510953759282,0.0953066669987994,0.116141896386163,8.41783117051174e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSNK2A1,Casein kinase II subunit alpha,39934,-0.0906330987119507,0.00455585686401279,-0.0995625781654158,-0.0817036192584857,1.37224068005075e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANG,Angiogenin,42152,0.0667145127685409,0.00335912294115334,0.0601306318038803,0.0732983937332014,1.50940806005327e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EHBP1,EH domain-binding protein 1,39958,0.152397808336892,0.00766395036777409,0.137376465616055,0.167419151057729,1.61241479083553e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFX1,Transcriptional repressor NF-X1,39575,0.137357215284403,0.00690849642722602,0.12381656228704,0.150897868281766,1.90435155869442e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AP3S2,AP-3 complex subunit sigma-2,39929,0.0979385916866668,0.00493097544158878,0.0882738798211528,0.107603303552181,2.5373320880691e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJA2,DnaJ homolog subfamily A member 2,42259,0.165495935643472,0.00834848578821818,0.149132903498565,0.18185896778838,3.03356111239131e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD2AP,CD2-associated protein,42145,0.128058733088855,0.00646430677345663,0.11538869181288,0.14072877436483,4.01620109085964e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP85,Centrosomal protein of 85 kDa,41843,0.132166775328506,0.00667261458738116,0.119088450737239,0.145245099919773,4.51173709016762e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFR2,Fibroblast growth factor receptor 2,42181,0.0455696129382228,0.00230470814000401,0.0410523849838149,0.0500868408926307,8.25313705267575e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP20,Centrosomal protein 20,41843,0.152114482154925,0.00770643786372964,0.137009863942015,0.167219100367835,1.69433560331503e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARF6,ADP-ribosylation factor 6,39930,0.219194642182812,0.0111108127679161,0.197417449157696,0.240971835207927,3.30676361439516e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,0.21945863462485,0.0111392512664986,0.197625702142513,0.241291567107187,5.50599023019959e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,0.105354627707036,0.00539529061188541,0.0947798581077409,0.115929397306332,9.34974787527503e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,0.132964161791602,0.00681066344425824,0.119615261440856,0.146313062142348,1.048224477611e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL16,Pro-interleukin-16,42296,0.0846143901134518,0.00433521546308754,0.0761173678058002,0.0931114124211034,1.05632409288624e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAB2,Stabilin-2,39966,0.0561964856840745,0.00287597540941882,0.0505595738816136,0.0618333974865354,1.17508271557774e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDLIM7,PDZ and LIM domain protein 7,42185,0.250459245917539,0.012848842429969,0.225275514754799,0.275642977080278,1.74131145879518e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,0.16936728858312,0.00868033991810502,0.152353822343634,0.186380754822606,2.2032465092919e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXNA4,Plexin-A4,42119,0.160552109392353,0.00824684918920188,0.144388284981518,0.176715933803189,2.80591631018953e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,0.165159746164008,0.00848256104177383,0.148533926522131,0.181785565805884,4.65849558312703e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMOT,Angiomotin,39736,0.0762377114246909,0.00391938020496009,0.0685557262229691,0.0839196966264126,6.67162271831761e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TARBP2,RISC-loading complex subunit TARBP2,41839,0.156957158438905,0.00810980701143252,0.141061936696497,0.172852380181312,2.57693672504963e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,0.104557544641644,0.00540938539227826,0.0939551492727791,0.11515994001051,4.13553011192693e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD63,CD63 antigen,41992,0.100110560338917,0.00517981651764475,0.0899581199643337,0.110263000713501,4.16045552387361e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MASP1,Mannan-binding lectin serine protease 1,41997,0.0457387422446576,0.00236813967263999,0.0410971884862832,0.050380296003032,5.29450467229247e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.0505157374158805,0.00261682454647937,0.0453867613047809,0.05564471352698,6.0502000240413e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPK9,Mitogen-activated protein kinase 9,42119,0.0847039819234202,0.0043917272769633,0.0760961964605722,0.0933117673862683,8.61240842865488e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPY30,Protein dpy-30 homolog,42216,0.118716068086325,0.00616035884828227,0.106641764743692,0.130790371428959,1.14775378668025e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASAH2,Neutral ceramidase,42016,0.104966506637764,0.00546378343852586,0.0942574910982538,0.115675522177275,3.64810030962207e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCLY,Selenocysteine lyase,42224,0.0955969816073336,0.00498862741089362,0.0858192718819821,0.105374691332685,8.68986350750343e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,0.204458375002099,0.0106698845620521,0.183545401260477,0.225371348743721,8.98541112129584e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCR,Breakpoint cluster region protein,42119,0.181444408561934,0.00946887575705995,0.162885412078096,0.200003405045771,8.98550528350731e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1R2,Interleukin-1 receptor type 2,42100,0.0393168094583174,0.00205292426681914,0.0352930778953518,0.0433405410212829,1.09885151408351e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERBIN,Erbin,42070,0.201206213439519,0.01050791712611,0.180610695872343,0.221801731006695,1.18066105749497e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DKK1,Dickkopf-related protein 1,42249,0.115623930334602,0.00604644858717765,0.103772891103734,0.12747496956547,1.83987562822123e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IKBKG,NF-kappa-B essential modulator,42119,0.17890026469945,0.00937191862494853,0.160531304194551,0.197269225204349,3.52633395402036e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YOD1,Ubiquitin thioesterase OTU1,39575,0.118888673108946,0.00622139021621177,0.106694748285171,0.131082597932721,4.16535167326018e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RTN4R,Reticulon-4 receptor,42262,0.0659215462759277,0.00345830265379667,0.0591432730744862,0.0726998194773691,5.70370412691794e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL10,C-X-C motif chemokine 10,42185,0.128784108920721,0.00675934646878456,0.115535789841903,0.142032427999539,6.84364377444754e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTN1,Dynactin subunit 1,42262,0.12462330933083,0.00655319021928818,0.111779056501026,0.137467562160635,1.30794887838905e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB11FIP3,Rab11 family-interacting protein 3,39958,0.209694416994925,0.0110301257992653,0.188075370428365,0.231313463561485,2.3434901890845e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,0.0522756345938345,0.0027540376433737,0.046877720812822,0.0576735483748469,2.60435584755053e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCXR,L-xylulose reductase,42181,0.105468891797928,0.00556451741367363,0.0945624376671278,0.116375345928728,4.29558859929837e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BECN1,Beclin-1,39638,0.11553624821431,0.00609236360247621,0.103595215553457,0.127477280875163,6.03576685805538e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ISM1,Isthmin-1,42119,0.0764808665196884,0.00405143009987361,0.0685400635239361,0.0844216695154407,1.77897412271691e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAB2,Disabled homolog 2,42262,0.214322792480416,0.0113731309143564,0.192031455888278,0.236614129072555,3.18192830196393e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A4,Protein S100-A4,42181,0.108058703128328,0.00574864265862661,0.09679136351742,0.119326042739236,7.71246795242535e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC1B,C-type lectin domain family 1 member B,42249,0.18383125376747,0.00980097125262052,0.164621350112334,0.203041157422606,1.613581275599e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R9B,Neurabin-2,42296,0.182285968845409,0.00972328954400358,0.163228321339162,0.201343616351656,1.89137295690172e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,0.094373831508392,0.0050400351682846,0.0844953625785542,0.10425230043823,3.01532985798305e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNAP23,Synaptosomal-associated protein 23,42145,0.166643608952869,0.00891496845740835,0.149170270776349,0.184116947129389,5.2826471606039e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,0.143285646386615,0.0076601718242542,0.128271709611076,0.158299583162153,6.98886562199881e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE4,Ribonuclease 4,39645,0.0529865311216045,0.00284011085965828,0.0474199138366743,0.0585531484065347,1.66611949545862e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATG16L1,Autophagy-related protein 16-1,39930,0.164523979645509,0.00882945219785825,0.147218253337706,0.181829705953311,2.36408903521234e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.211102045710476,0.0113562389434926,-0.233360274039721,-0.18884381738123,3.48324020277567e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNIP1,TNFAIP3-interacting protein 1,39929,0.168322525102539,0.00905421458265774,0.15057626452053,0.186068785684549,5.15468578309642e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL5,C-X-C motif chemokine 5,42101,0.214358346714531,0.0115558402976937,0.191708899731051,0.23700779369801,7.16022258939354e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLA2,Src-like-adapter 2,39934,0.202686445553088,0.0109346618577204,0.181254508311956,0.22411838279422,1.37521464461836e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CMIP,C-Maf-inducing protein,39919,0.159156691967224,0.00859501032319009,0.142310471733771,0.176002912200676,1.93690121217971e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM20A,Pseudokinase FAM20A,39958,0.0534288341010553,0.00288658176089234,0.0477711338497063,0.0590865343524043,2.21640527025663e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MVK,Mevalonate kinase,41913,0.156729312512967,0.00848995983443811,0.140088991237469,0.173369633788466,3.70860878328633e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,0.179515906232661,0.00974512066080437,0.160415469737484,0.198616342727837,7.24585889035572e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,0.105304136816377,0.0057220289686731,0.0940889600377777,0.116519313594976,1.04322303437927e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLUL1,Clusterin-like protein 1,42123,-0.0843852672150934,0.00458655970635775,-0.0933749242395546,-0.0753956101906322,1.10082051051337e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFAP5,Microfibrillar-associated protein 5,42310,0.0762950695446813,0.00415148827664248,0.0681581525224621,0.0844319865669006,1.55113279774781e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,42119,0.212929289014125,0.0116037725788171,0.190185894759643,0.235672683268606,2.62847309483198e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,39919,0.214844042405023,0.0116958812047708,0.191920115243672,0.237767969566373,2.76920122218507e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NT5E,5'-nucleotidase,42181,0.101296054807136,0.00552204227342123,0.09047285195123,0.112119257663041,2.90332252321769e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAT5B,Signal transducer and activator of transcription 5B,42070,0.257703223656937,0.0140738986169144,0.230118382367785,0.28528806494609,5.3574422049294e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FETUB,Fetuin-B,42199,0.060375562264584,0.00330320873355565,0.0539012731468149,0.0668498513823531,9.46699061315281e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,0.206089097566481,0.0112863378655342,0.183967875350034,0.228210319782928,1.94654078744659e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,0.0526370939564004,0.00289478628145044,0.0469633128447576,0.0583108750680433,7.55178898172448e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,0.167267445765174,0.00920224210601933,0.149231051237376,0.185303840292972,8.49011456508925e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL22,C-C motif chemokine 22,41991,0.0966758453691882,0.00532585533421939,0.0862371689141182,0.107114521824258,9.17848993553812e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VEGFC,Vascular endothelial growth factor C,42181,0.103017470480093,0.00568861970558091,0.0918677758571545,0.114167165103032,1.90822752860753e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOE,Apolipoprotein E,39979,0.129818905848375,0.0071605054247546,0.115784315215856,0.143853496480894,1.9291672157774e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCK2,Cytoplasmic protein NCK2,42185,0.197996290339766,0.010973504142863,0.176488222219755,0.219504358459778,6.16567650530007e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,0.101368729062038,0.00562382604700346,0.0903460300099108,0.112391428114164,9.01784087763148e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOXO1,Forkhead box protein O1,42119,0.159881123435982,0.00890009100037225,0.142436945075253,0.177325301796712,2.51263178366006e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,0.0443107763574552,0.00246963766762858,0.0394702865289032,0.0491512661860072,3.78060111619672e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MINK1,Misshapen-like kinase 1,39929,0.171523291296076,0.00955767431140935,0.152790249645714,0.190256332946438,4.93277039047972e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL18R1,Interleukin-18 receptor 1,42296,0.060745044297299,0.00339234504078504,0.0540960480173603,0.0673940405772377,6.73603079168281e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINC1,Antithrombin-III,39959,0.0265614548224963,0.0014844524112519,0.0236519280964425,0.02947098154855,1.23926888241859e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STC1,Stanniocalcin-1,42249,0.0841353565294907,0.00470765355697219,0.0749083555578252,0.0933623575011562,1.24054939344361e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,0.128166206371229,0.00716384120173967,0.114125077615819,0.142207335126638,1.29955269482459e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BPIFB1,BPI fold-containing family B member 1,42098,-0.118714283553784,0.00664970092523467,-0.131747697367244,-0.105680869740324,1.77999212185545e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL17,C-X-C motif chemokine 17,42296,0.0779631582519583,0.00437486612953332,0.0693884206380729,0.0865378958658436,3.02682788806181e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEFTY2,Left-right determination factor 2,42247,0.0942958533836697,0.00529405323315227,0.0839195090466912,0.104672197720648,3.56747292061299e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TANK,TRAF family member-associated NF-kappa-B activator,41913,0.129614860884136,0.00728356080156638,0.115339081713066,0.143890640055206,4.94411162679342e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL5,C-C motif chemokine 5,42217,0.184299837650336,0.0103636135759213,0.16398715504153,0.204612520259142,5.86831003112177e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,0.196901238541947,0.0111031951468265,0.175138976054167,0.218663501029727,1.98870585025309e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,0.13483734550887,0.00761881249006058,0.119904473028352,0.149770217989389,3.90430828317694e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD6,T-cell differentiation antigen CD6,42284,0.0943744717093577,0.00535245357926472,0.0838836626939989,0.104865280724717,8.05757603191191e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPD52L2,Tumor protein D54,39736,0.196861853343468,0.0111670355353943,0.174974463694095,0.218749242992841,1.26083050403809e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,0.15240336030327,0.0086535043157467,0.135442491844407,0.169364228762134,1.63067466312075e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLIN1,Perilipin-1,41839,0.0613020958223314,0.0034873180807124,0.0544669523841351,0.0681372392605277,2.14669553170148e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH2B3,SH2B adapter protein 3,41843,0.177488502454411,0.0101319215936595,0.157629936130838,0.197347068777984,6.10974643240349e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BACH1,Transcription regulator protein BACH1,42119,0.134840507154919,0.00770741028333063,0.119733982999591,0.149947031310247,8.72871415830718e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,0.183461740713007,0.0105241987222602,0.162834311217377,0.204089170208637,2.52009191579615e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4B,Eukaryotic translation initiation factor 4B,42016,0.100768851667398,0.00578156879995853,0.0894369768194793,0.112100726515317,2.71984225418477e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMBP,Protein AMBP,42239,0.0360860871387833,0.00207074115130756,0.0320274344822205,0.0401447397953461,2.76995907759625e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELP,P-selectin,42217,0.0999319064972384,0.00573508183943774,0.0886911460919404,0.111172666902536,2.87317303838006e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL18A1,Collagen alpha-1(XVIII) chain,42194,0.0423803889914817,0.00243365677320465,0.0376104217160006,0.0471503562669628,3.44101432377039e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUGP1,SURP and G-patch domain-containing protein 1,39930,0.0727140670469589,0.00417262350551651,0.0645357249761466,0.0808924091177713,3.88775681173004e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,39638,0.130262167386289,0.00748833282471256,0.115585035049852,0.144939299722725,6.95227904468826e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,39638,0.18360008686042,0.0105580873894801,0.162906235577039,0.204293938143801,7.67567150528055e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DOK2,Docking protein 2,42145,0.219325080678764,0.0126306298092335,0.194569046252667,0.244081115104862,8.09009644010918e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,0.12473349072399,0.0071898040104253,0.110641474863556,0.138825506584423,1.09088813640726e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,0.122269811108771,0.007049400376373,0.10845298637108,0.136086635846462,1.64131261044328e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OPHN1,Oligophrenin-1,39929,0.192777441291353,0.011137562035284,0.170947819702197,0.21460706288051,2.86650534001007e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CANT1,Soluble calcium-activated nucleotidase 1,42084,0.0355672268076157,0.00205891768324972,0.0315317481484462,0.0396027054667851,3.75208818947951e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,39919,0.0942118289716338,0.0054635005584148,0.0835033678771408,0.104920290066127,8.59316542934801e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINH1,Serpin H1,39757,0.227170730746848,0.013220356015329,0.201258832956803,0.253082628536893,2.44256296297211e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SRPK2,SRSF protein kinase 2,42119,0.150161327725487,0.00875222813440768,0.133006960582048,0.167315694868926,2.73633792861901e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLSCR3,Phospholipid scramblase 3,39911,0.101622496623703,0.00592295098290744,0.0900135126972043,0.113231480550201,3.68273445651547e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM5,Tripartite motif-containing protein 5,42119,0.152811897992775,0.00892331948415779,0.135322191803826,0.170301604181724,4.68295840209367e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCBP2,Poly(rC)-binding protein 2,39934,0.128406188366529,0.00749695605704333,0.113712154494724,0.143100222238334,6.02970155378483e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCTN3,Tectonic-3,39958,0.0533918591763498,0.00312338042620179,0.0472700335409943,0.0595136848117053,1.05263001921875e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESM1,Endothelial cell-specific molecule 1,42123,-0.0609544751574069,0.00356956243992112,-0.0679508175396523,-0.0539581327751615,1.06290994428579e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,0.135975518457793,0.00797552931135491,0.120343481007537,0.151607555908049,1.6836731334198e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,41843,0.0865173724277569,0.00507625628629384,0.076567910106621,0.0964668347488929,1.89683521082874e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA3F,Semaphorin-3F,42145,0.0467118548371018,0.002741795330849,0.0413379359886377,0.0520857736855658,2.045376881931e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACE2,Angiotensin-converting enzyme 2,41900,0.0952754158840941,0.0056136702883445,0.0842726221189389,0.106278209649249,6.22026473610464e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIT1,ARF GTPase-activating protein GIT1,39657,0.169078672692113,0.00995927354433447,0.149558496545217,0.188598848839008,7.79901951957427e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,0.170286193277533,0.010053237454909,0.150581847865912,0.189990538689155,1.04172018318373e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,0.195086807939137,0.0115174035462848,0.172512696988418,0.217660918889855,1.07662105729837e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINE1,Plasminogen activator inhibitor 1,42310,0.115721782369624,0.0068346393765794,0.102325889191529,0.12911767554772,1.16451156903885e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEC31A,Protein transport protein Sec31A,39638,0.134827074811044,0.00795953986269045,0.119226376680171,0.150427772941917,1.46817268697651e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGRN,Agrin,42185,0.0623428883449418,0.0036868263754613,0.0551167086490377,0.069569068040846,1.70240160240199e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAT,Linker for activation of T-cells family member 1,42296,0.131661035601762,0.0077948389988347,0.116383151164046,0.146938920039478,2.30034396119124e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN2,CCN family member 2,42146,0.0980305108040475,0.00580822268163739,0.0866463943480382,0.109414627260057,2.89628811714106e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUOM,Fucose mutarotase,39736,0.111691183663377,0.00662012195860799,0.0987157446245049,0.124666622702248,4.4187968446079e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,0.0863819934266562,0.0051297143541607,0.0763277532925012,0.0964362335608111,7.48284410486403e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,0.177072888377499,0.0105427955539713,0.156409009091716,0.197736767663283,1.49602426020205e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL32,Interleukin-32,42119,-0.076669166270607,0.00457247705364989,-0.0856312212957608,-0.0677071112454532,1.80123904546795e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAXX,Protein PAXX,39736,0.0797619641909082,0.00475335293283383,0.0704453924425539,0.0890785359392625,1.98774435741383e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRAP,BRCA1-associated protein,39813,0.189607234112418,0.0113036961128723,0.167451989731188,0.211762478493648,2.17594530002068e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,0.0835419206237098,0.00498682048092163,0.0737677524811034,0.0933160887663162,3.13077351194127e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PYY,Peptide YY,39575,0.171877164021625,0.0102807675420996,0.15172685963911,0.19202746840414,5.61675801436145e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,41843,0.1092732721817,0.00655898059020069,0.0964176702249071,0.122128874138494,1.08385740362062e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USO1,General vesicular transport factor p115,42070,0.152386148781954,0.00915955301590767,0.134433424870775,0.170338872693133,1.54816257448489e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP43,Centrosomal protein 43,41797,0.119923122148125,0.00724215511623579,0.105728498120303,0.134117746175947,5.67251053907588e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OTUD7B,OTU domain-containing protein 7B,39934,0.10763425890076,0.00649571491979729,0.0949026576579575,0.120365860143563,5.96546024163954e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,0.107681160522524,0.00650442883210435,0.0949324800115994,0.120429841033448,6.02349874221528e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SKAP2,Src kinase-associated phosphoprotein 2,42185,0.176824135707498,0.0106989932995534,0.155854108840374,0.197794162574623,9.15522626828433e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,0.161616902579793,0.00977938267244442,0.142449312541802,0.180784492617784,9.44698397164567e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT5,"Keratin, type II cytoskeletal 5",41839,0.0907007192012075,0.0054904395669959,0.0799394576498955,0.101461980752519,1.06981410876581e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFB,Platelet-derived growth factor subunit B,42185,0.145289832741983,0.00881723355421946,0.128008054975713,0.162571610508253,2.03644109368247e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.103924435732093,0.00630992919216222,0.0915569745154554,0.116291896948731,2.33177215869964e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRELD1,Protein disulfide isomerase CRELD1,39736,0.0634264869410935,0.0038476263860847,0.0558851392243675,0.0709678346578195,2.44963687734083e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFB1,Transforming growth factor beta-1 proprotein,42284,0.0657656629582806,0.00399579982312459,0.0579338953049564,0.0735974306116048,2.7549784972544e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL17,C-C motif chemokine 17,42107,0.154864715178598,0.00941261792087772,0.136415984053677,0.173313446303518,3.07953791913021e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GASK1A,Golgi-associated kinase 1A,39575,0.0723188434140263,0.00439467552927534,0.0637052793766466,0.0809324074514059,3.97648623841206e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,0.177804132633419,0.0108356298183489,0.156566298189455,0.199041967077382,8.2277261524677e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GMPR,GMP reductase 1,42296,0.0802879245414279,0.00489961919000122,0.0706846709290255,0.0898911781538303,8.83113020524521e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOP2B,DNA topoisomerase 2-beta,39657,0.135554545560894,0.0082688460387372,0.119347607324969,0.151761483796819,1.07601591246235e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC27,Cell division cycle protein 27 homolog,41843,0.102706792135925,0.00627319729360277,0.0904113254404632,0.115002258831386,1.16114323655929e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNST,Consortin,42145,0.183454248577757,0.0112097527239069,0.1614831332389,0.205425363916615,1.2562212629987e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDLIM5,PDZ and LIM domain protein 5,39934,0.199521185406196,0.0121995066025722,0.175610152465154,0.223432218347237,1.92168854860058e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EZR,Ezrin,42249,0.0408552316099446,0.00250224619936058,0.0359508290591978,0.0457596341606913,2.29893147837286e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,0.17728205818257,0.0108579668492523,0.156000443158035,0.198563673207105,2.34338707333093e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,0.136108469012548,0.0083340753636276,0.119773681299838,0.152443256725258,2.79137477124468e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AP3B1,AP-3 complex subunit beta-1,39930,0.129167516831985,0.00792157248137637,0.113641234768487,0.144693798895483,4.21848195169541e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,0.159502003061029,0.00979054914807043,0.140312526730811,0.178691479391247,4.23634287168019e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUCB2,Nucleobindin-2,42231,0.0628332488320323,0.00385755108729282,0.0552724487009384,0.0703940489631262,4.31036225464997e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GHRL,Appetite-regulating hormone,42145,0.139209419073026,0.00855314969280287,0.122445245675133,0.15597359247092,5.31513715019724e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,0.0428488658349647,0.00263117702691297,0.0376917588622153,0.0480059728077141,6.11636910025294e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPC5,Glypican-5,42016,0.0944299350163013,0.00580795676719129,0.0830463397526064,0.105813530279996,7.07396769618999e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,0.170289404015264,0.0104754979021683,0.149757428127014,0.190821379903514,7.32019753636456e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,0.0401962041155058,0.00247277986623151,0.0353495555776921,0.0450428526533196,7.36660631671297e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL3,C-X-C motif chemokine 3,42129,0.159537010916734,0.00981552887291123,0.140298574325828,0.17877544750764,7.60462089670669e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AAMDC,Mth938 domain-containing protein,39638,0.0885758256695391,0.00545007104907323,0.0778936864133556,0.0992579649257226,1.03233265539959e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AZI2,5-azacytidine-induced protein 2,39934,0.0928739766473519,0.00571822960366205,0.0816662466241742,0.104081706670529,1.17210866641679e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGCC,Regulator of cell cycle RGCC,39934,0.127853135865158,0.00787299269303679,0.112422070186806,0.14328420154351,1.21542598005722e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,0.158964568806224,0.0098001038723039,0.139756365216509,0.17817277239594,1.31341523576133e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAS6,Growth arrest-specific protein 6,42236,-0.0419705009876569,0.002598001986506,-0.0470625848812087,-0.0368784170941052,3.63271012064512e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F2,Prothrombin,39979,0.0247108677673818,0.00152948547668976,0.0217130762330698,0.0277086593016937,4.52828583021805e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHACTR2,Phosphatase and actin regulator 2,39934,0.189723198173763,0.0117474085866155,0.166698277343996,0.212748119003529,5.01783432377477e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RABEP1,Rab GTPase-binding effector protein 1,39736,0.127906079173062,0.00791922998060079,0.112384388411085,0.14342776993504,5.06056804626883e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYN,Tyrosine-protein kinase Lyn,42070,0.14083944204377,0.00873646269610791,0.123715975159399,0.157962908928142,6.33461142737425e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RTBDN,Retbindin,42070,0.0496862164731181,0.00308568105873312,0.0436382815980012,0.055734151348235,8.52136175295314e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUSD1,Sushi domain-containing protein 1,41900,0.0806882250985312,0.00501152361477356,0.070865638813575,0.0905108113834873,8.88535578323237e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKT1S1,Proline-rich AKT1 substrate 1,41839,0.110092037382023,0.00684424484310155,0.0966773174895442,0.123506757274502,1.13685275605553e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SYTL4,Synaptotagmin-like protein 4,39958,0.120446099292601,0.00748334325194564,0.105778746518787,0.135113452066414,1.19410077689982e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSTN,Growth/differentiation factor 8,41900,0.0893864466110783,0.00556044081400781,0.078487982615623,0.100284910606534,1.32266342266511e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,0.12741478539844,0.00792986253992752,0.111872254820183,0.142957315976698,1.84335948677091e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH2,Cadherin-2,42145,0.0583139278136246,0.00363278630972019,0.051193666646573,0.0654341889806762,1.87027784760488e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNDP1,Beta-Ala-His dipeptidase,42217,0.0762862950605167,0.0047552612676548,0.0669659829759133,0.0856066071451201,2.16362462145585e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,0.129000521537916,0.00804475828041642,0.1132327953083,0.144768247767533,3.07885960907676e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTBS,Di-N-acetylchitobiase,39860,0.0452458925972101,0.00283234888441496,0.0396944887837568,0.0507972964106635,8.05995024336092e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEXIM1,Protein HEXIM1,42119,0.132570113198399,0.00831053456481089,0.11628146545137,0.148858760945428,9.07918767731357e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOA2,Apolipoprotein A-II,39990,-0.0809077982152811,0.00507869550556633,-0.0908620414061911,-0.0709535550243711,1.57670686811865e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB6,DnaJ homolog subfamily B member 6,39639,0.139380531035102,0.00875259744592938,0.122225440041081,0.156535622029124,1.81941073895203e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,42070,0.137031028058096,0.00861959572853675,0.120136620430164,0.153925435686029,2.14240714858263e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEP1A,Meprin A subunit alpha,39930,0.124288253624252,0.00781899814230261,0.108963017265339,0.139613489983165,2.75081159131088e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,42117,0.0545095697942498,0.00343294857305868,0.0477809905910548,0.0612381489974448,2.88493979919074e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CMC1,COX assembly mitochondrial protein homolog,39958,0.149397677239302,0.00940325422838756,0.130967298951662,0.167828055526941,3.09663919899725e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,0.108079806907816,0.00680634218638706,0.0947393762224975,0.121420237593135,3.55099188130633e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMN,Protein amnionless,41913,0.0771392144606968,0.00486497316832229,0.0676038670507852,0.0866745618706085,4.16220521842602e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,0.178324515554366,0.0112534621143993,0.156267729810143,0.200381301298589,4.74253361697145e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPL,N-acetylneuraminate lyase,39958,0.0757072275637368,0.00477826067051772,0.0663418366495221,0.0850726184779516,6.12528735212506e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT18,"Keratin, type I cytoskeletal 18",42070,0.138048479177437,0.00874552757212353,0.120907245136075,0.155189713218799,1.24241029873177e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL3,Angiopoietin-related protein 3,42189,0.0558370172669998,0.00354644656975873,0.0488859819902727,0.062788052543727,2.31003310738248e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4A,C-type lectin domain family 4 member A,42119,-0.0578155086723692,0.00367502088137903,-0.0650185495998721,-0.0506124677448663,2.81961026337816e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,0.0873499645323179,0.0055481992608891,0.0764754939809752,0.0982244350836605,2.97214326094239e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,0.126714141413357,0.00805105555383549,0.11093407252784,0.142494210298875,3.14504377907092e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM13A,Protein FAM13A,39930,0.109763611528699,0.00698855630896993,0.0960660411631175,0.12346118189428,5.20902900577387e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MITD1,MIT domain-containing protein 1,42016,0.156222197247288,0.00996845698984643,0.136684021547189,0.175760372947387,7.24055966366385e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,0.116432365536731,0.00742620670388947,0.101877000397107,0.130987730676354,7.98434811036451e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBC1D23,TBC1 domain family member 23,42070,0.145176609871342,0.00927838716673013,0.126990971024551,0.163362248718133,1.05887337606908e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,0.171160735474458,0.0109574733666079,0.149684087675906,0.192637383273009,1.94861376067082e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP45,Rho GTPase-activating protein 45,39736,0.133447435727399,0.0085517266683728,0.116686051457388,0.150208819997409,2.53743410292353e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F11,Coagulation factor XI,39822,0.0505117756906979,0.003237633771205,0.0441660134991362,0.0568575378822597,2.64209315096857e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNMBP,Dynamin-binding protein,42016,0.0974780445172653,0.00625704481629335,0.0852142366773304,0.1097418523572,3.02183987614027e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,39657,0.145704003937961,0.00934481435722386,0.127388167797802,0.164019840078119,3.11491664162957e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,0.187160368980077,0.0120373840306039,0.163567096280094,0.210753641680061,4.81781653910574e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DBNL,Drebrin-like protein,42185,0.148418949091053,0.00954821969284408,0.129704438493079,0.167133459689027,5.0851313550092e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,0.100225749364031,0.00644454635983641,0.0875944384987514,0.11285706022931,5.54506347084163e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGB3A2,Secretoglobin family 3A member 2,42166,-0.125613781896987,0.00809343735850166,-0.14147691911965,-0.109750644674324,7.3226475416803e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C19orf12,Protein C19orf12,41839,0.106665644277978,0.00688016397334916,0.0931805228902136,0.120150765665742,9.76139357706605e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCD5,Programmed cell death protein 5,42249,0.0914230163281531,0.00590089355122048,0.079857264967761,0.102988767688545,1.10600909145967e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSO,Cathepsin O,42296,0.0487522970967961,0.00315203165872727,0.0425743150456906,0.0549302791479015,1.64290438529935e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSIP1,PC4 and SFRS1-interacting protein,42119,0.104674475071403,0.00677482638886421,0.0913958153492287,0.117953134793576,2.1398155270779e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,METAP2,Methionine aminopeptidase 2,42247,0.088727125887173,0.00574298983936673,0.0774708658020142,0.0999833859723318,2.1471433433186e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HCLS1,Hematopoietic lineage cell-specific protein,42296,0.0878411068307127,0.00569433456621044,0.0766802110809402,0.0990020025804851,3.06440484451005e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,0.135306266592794,0.00878204421814419,0.118093459925231,0.152519073260356,4.22987322680164e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRHBP,Corticotropin-releasing factor-binding protein,42123,0.0434381154623394,0.00282105609702173,0.0379088455121768,0.048967385412502,4.76965913859289e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NIT2,Omega-amidase NIT2,39903,0.115788007635326,0.00751584885064565,0.10105694388806,0.130519071382591,5.16225726254235e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL13,C-C motif chemokine 13,42275,0.107738904926214,0.00701825580893016,0.0939831235407111,0.121494686311717,9.5628176395597e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB27B,Ras-related protein Rab-27B,39958,0.130545358533118,0.00849768044858694,0.113889904853888,0.147200812212349,9.89348083918082e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THOP1,Thimet oligopeptidase,42081,0.0493705492324455,0.00322930837914669,0.043041104809318,0.055699993655573,2.51375632440151e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STK11,Serine/threonine-protein kinase STK11,41900,0.11490760790435,0.00752063914447813,0.100167155181173,0.129648060627527,2.93209817282498e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GOLGA3,Golgin subfamily A member 3,39934,0.122233357940738,0.00799563244557753,0.106561918347406,0.13790479753407,3.07079732498086e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GTPBP2,GTP-binding protein 2,39649,0.129280859185789,0.00845868621354229,0.112701834207246,0.145859884164332,3.34779998136426e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPON2,Spondin-2,42070,-0.0548734281636617,0.00359704767830794,-0.0619236416131452,-0.0478232147141781,4.14646836218106e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,0.0803593083797721,0.00526807685229685,0.0700338777492702,0.0906847390102739,5.2638008843172e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,0.0677606203932966,0.00444342770062976,0.0590515021000623,0.076469738686531,5.43430166227379e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1S,Complement C1s subcomponent,39979,0.0331231977495174,0.00217290284451745,0.0288643081742632,0.0373820873247716,5.89840757179342e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,0.0465788707563935,0.00305875867384356,0.0405837037556601,0.0525740377571269,6.12750825250829e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HGF,Hepatocyte growth factor,42296,0.0540179981085056,0.0035567025261199,0.0470468611573106,0.0609891350597006,1.12467584160837e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,0.048076159551154,0.00316230985913854,0.0418780322272424,0.0542742868750655,1.14691965128577e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,0.141508052773744,0.00931034115278026,0.123259784114295,0.159756321433194,1.15867919331693e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRKL,Crk-like protein,42143,0.164750681029932,0.0108675138053143,0.143450353971516,0.186051008088348,1.72282722367908e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,0.143284579161983,0.00945281077903014,0.124757070035084,0.161812088288882,1.80779613475061e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,0.138557586529566,0.00913519429923477,0.120652605703066,0.156462567356066,1.85723682312926e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,-0.050122702213541,0.00330744069099263,-0.0566052859678866,-0.0436401184591954,1.85985782275236e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,0.0998222222233318,0.00659129837333861,0.0869032774115882,0.112741167035076,2.61395765854576e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PXN,Paxillin,41839,0.0797864150434546,0.00528654869631762,0.0694247795986721,0.0901480504882372,4.83191201472059e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBCC,Tubulin-specific chaperone C,42016,0.125213607221033,0.00830104457931752,0.108943559845571,0.141483654596495,5.3960659447196e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAX1BP1,Tax1-binding protein 1,39929,0.0964685677255925,0.00639306424460789,0.083938161806161,0.108998973645024,5.92449964304976e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMP3,Metalloproteinase inhibitor 3,42185,0.198425987446342,0.0131647704989362,0.172623037268427,0.224228937624257,6.33636742007704e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXNB3,Plexin-B3,42099,0.0745190436659242,0.00495352785693578,0.06481012906633,0.0842279582655183,9.79293891444147e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,0.129545057925554,0.00863024008136138,0.112629787366086,0.146460328485022,1.91129199326398e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RLN2,Prorelaxin H2,39709,0.0795883292770978,0.00530229747966768,0.0691958262169492,0.0899808323372465,1.96418548785024e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MGLL,Monoglyceride lipase,42166,0.134679891032596,0.00899392159079668,0.117051804714634,0.152307977350557,2.71530683096663e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,42211,0.0511070752593334,0.00341806707720287,0.0444076637880157,0.057806486730651,3.77598140652201e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAG1,Dystroglycan,42185,0.0730992637086835,0.00489250176806473,0.0635099602432766,0.0826885671740903,4.44714339908843e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,0.0579246689111575,0.00387784720950632,0.0503240883805251,0.0655252494417899,4.7370307932014e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DOK1,Docking protein 1,39929,0.211296130706156,0.014137734090808,0.183586171888173,0.23900608952414,4.98520941823532e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDHD2,Phospholipase DDHD2,39934,0.102069815652751,0.00683257837360588,0.0886779620404838,0.115461669265019,5.51121264499734e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFRP4,Secreted frizzled-related protein 4,39736,0.0615251763802759,0.00412007467085201,0.053449830025406,0.0696005227351459,6.10680706193378e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAMBP,STAM-binding protein,41997,0.0970381763108275,0.00650675576694535,0.0842849350076147,0.10979141761404,6.76981845136948e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GOLM2,Protein GOLM2,42249,0.0349345290053088,0.00234534017972729,0.0303376622530433,0.0395313957575743,8.69823883016497e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EREG,Proepiregulin,41997,0.123262337357829,0.00828580122235121,0.107022166962021,0.139502507753638,1.16902057726059e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,0.131900194674242,0.00887889240772911,0.114497565555093,0.149302823793391,1.87185602704963e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLK1,Protein delta homolog 1,42310,0.0882603669145321,0.00596676023948629,0.076565516845139,0.0999552169839253,3.94414269777392e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPP,Lipoma-preferred partner,39575,0.100588305850784,0.00680526373495003,0.0872499889302817,0.113926622771286,5.74072076135128e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CIRBP,Cold-inducible RNA-binding protein,39930,0.146716104869039,0.00993209215195514,0.127249204251207,0.166183005486871,6.33206747494561e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPHOSPH8,M-phase phosphoprotein 8,41900,0.117043697647491,0.00792962784033341,0.101501627080438,0.132585768214545,6.43559007889893e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS8,Galectin-8,42249,0.0926261235525384,0.00627629382268734,0.0803245876600712,0.104927659445006,6.4983419878243e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRAF2,TNF receptor-associated factor 2,42119,0.105255485130843,0.00715301182271033,0.0912355819583306,0.119275388303355,1.23030883483795e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NIT1,Deaminated glutathione amidase,39638,0.0674000080449492,0.00457777317691021,0.0584275726182051,0.0763724434716932,1.31857308308326e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,0.116812652678696,0.00797748061776735,0.101176790667872,0.13244851468952,3.56283535917137e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IST1,IST1 homolog,39850,0.148577837138309,0.01014591244998,0.128691848736348,0.16846382554027,4.0685400700539e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NHLRC3,NHL repeat-containing protein 3,39481,0.0487291218821472,0.0033277856664098,0.042206661975984,0.0552515817883104,4.27088346373197e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,0.0561862731096374,0.00384105655734898,0.0486578022572334,0.0637147439620414,4.33223323583853e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATXN2L,Ataxin-2-like protein,39934,0.072454062375528,0.00495646542444505,0.0627393901436157,0.0821687346074403,5.87765915458161e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,0.0942140873764845,0.00646129780229188,0.0815499436839925,0.106878231068977,1.0308939936344e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAGK,N-acetyl-D-glucosamine kinase,39627,0.0855222466274125,0.00586611747876399,0.0740246563690351,0.0970198368857899,1.06006660294113e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH3GLB2,Endophilin-B2,39929,0.0986354563295432,0.00677763899494328,0.0853512838994543,0.111919628759632,1.49814893693672e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,0.113332262637986,0.00780115203128573,0.0980420046566657,0.128622520619306,1.85198518856167e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGL1,Fibrinogen-like protein 1,39990,-0.0969715181594002,0.00667647279343423,-0.110057404834531,-0.0838856314842692,2.24944490942274e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIA1,Nucleolysin TIA-1 isoform p40,41728,0.185005469070022,0.0127646134047628,0.159986826796687,0.210024111343357,3.0776264264083e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRELD2,Protein disulfide isomerase CRELD2,42166,0.0779019829927758,0.00538376028108565,0.0673498128418479,0.0884541531437037,4.21447929055425e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GYS1,"Glycogen [starch] synthase, muscle",41900,0.138534109440746,0.00957617182077561,0.119764812672026,0.157303406209466,4.48722307769368e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAVS,Mitochondrial antiviral-signaling protein,41843,0.135001814731407,0.00935488163014424,0.116666246736324,0.153337382726489,7.46641190299698e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,42119,0.0565546933390486,0.00392111453948546,0.0488693088416572,0.0642400778364401,8.23783709248146e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,-0.0290797298911413,0.00201735082714293,-0.0330337375123414,-0.0251257222699411,9.30106116473277e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,0.107190466523139,0.00743630536821659,0.092615308001435,0.121765625044844,1.10301801816416e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSD,Cathepsin D,41225,0.0614862038969271,0.00426853167853824,0.0531198818069922,0.0698525259868621,1.1353748443605e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OGA,Protein O-GlcNAcase,39930,0.105896036276816,0.00735713500473321,0.0914760516675389,0.120316020886093,1.4589421431123e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GORASP2,Golgi reassembly-stacking protein 2,39930,0.0707970273331667,0.00492347559054139,0.0611470151757055,0.0804470394906278,1.7840119195882e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,0.10758612578606,0.00749694585297617,0.0928921119142271,0.122280139657894,2.31119827017912e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,0.125394126108545,0.00874184771897611,0.108260104579351,0.142528147637738,2.5292898590056e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX15,Sorting nexin-15,39736,0.079781453332629,0.00556014986782758,0.0688835595916869,0.090679347073571,2.80078630053354e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HS1BP3,HCLS1-binding protein 3,39638,0.13510159694418,0.00941642404932659,0.1166454058075,0.15355778808086,2.87882519294422e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK10,Kallikrein-10,42138,0.060372220883223,0.00421632345088813,0.0521082269194822,0.0686362148469637,3.63393011344514e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LSP1,Lymphocyte-specific protein 1,42119,0.0597598948112731,0.00417609274983715,0.0515747530215923,0.0679450366009539,4.11430594468018e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F12,Coagulation factor XII,39979,0.060888160370543,0.00425374489432926,0.0525508203776576,0.0692255003634283,4.49008953376456e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,0.153794296000251,0.0107563104566052,0.132711927505305,0.174876664495197,4.87272976611499e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTDH,Protein LYRIC,39657,0.140560811160467,0.00982481236115127,0.12130417893261,0.159817443388323,5.11079101606379e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,39892,0.0669067298143341,0.00468081027251427,0.0577323416802061,0.076081117948462,6.01189958451539e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA11,Annexin A11,42087,0.0975675200840194,0.00683091141621756,0.084178933708233,0.110956106459806,6.0198658910853e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COMMD1,COMM domain-containing protein 1,39638,0.0899281224842807,0.0062936673071405,0.0775925345622853,0.102263710406276,6.60321675781521e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RILPL2,RILP-like protein 2,39958,0.145584751940358,0.0101909470381445,0.125610495745595,0.165559008135121,6.70784067111937e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,0.0805593121505726,0.00564352905519265,0.069497995202395,0.0916206290987502,6.86616610526119e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17RB,Interleukin-17 receptor B,41934,-0.0795095181938636,0.00557880565688678,-0.0904439772813617,-0.0685750591063655,9.43063134769138e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,39934,0.0978711906002659,0.00686447480283549,0.0844168199867084,0.111325561213824,9.97872149605568e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PENK,Proenkephalin-A,39736,0.0454689458180656,0.00319556456879267,0.039205639263232,0.0517322523728992,1.52143898434868e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,0.0716678632253245,0.00504158663347641,0.0617863534237107,0.0815493730269382,1.81037573160008e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1RL2,Interleukin-1 receptor-like 2,41913,0.0552899531814424,0.00389327474172749,0.0476591346876566,0.0629207716752283,1.92726429051431e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.0598634442816293,0.00422018148667516,0.051591888567746,0.0681349999955126,2.41674479613971e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TWF2,Twinfilin-2,39966,0.124631427930609,0.00878523533353614,0.107412366676878,0.14185048918434,2.70399824720566e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM40,E3 ubiquitin ligase TRIM40,39649,0.106588506168057,0.00751786989901766,0.091853481165982,0.121323531170131,3.12097432105318e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HYOU1,Hypoxia up-regulated protein 1,42310,0.0334668225761807,0.00236425282139982,0.028832887046237,0.0381007581061243,3.59978988059412e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.0484826037329177,0.0034270406627628,0.0417656040339026,0.0551996034319328,4.07024333257877e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BID,BH3-interacting domain death agonist,42119,0.0966553628130889,0.00683276554015936,0.0832631423543765,0.110047583271801,4.15389351967994e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GDF2,Growth/differentiation factor 2,42145,0.0515395856357749,0.00364725939392707,0.0443909572236778,0.0586882140478719,5.10446913451414e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,-0.0467476060155564,0.00331102368546313,-0.0532372124390641,-0.0402579995920487,6.00733214802563e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHSG,Alpha-2-HS-glycoprotein,39990,0.0387722446713751,0.00275503769728931,0.033372370784688,0.0441721185580621,1.31086476919705e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,0.110426278607353,0.00785716643157081,0.0950262324014741,0.125826324813232,1.51627061491552e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGA5,Integrin alpha-5,42137,0.036054582106561,0.00256756369983503,0.0310221572548843,0.0410870069582377,1.76071566336523e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,0.0707093767444922,0.005035411093812,0.0608399710006207,0.0805787824883637,1.78646211156804e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,41839,0.042515411019304,0.00303016385616571,0.0365762898612192,0.0484545321773888,2.10223998323218e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBPL,FK506-binding protein-like,39930,0.0857172691330595,0.00611800255517092,0.0737259841249245,0.0977085541411945,3.13581741687476e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,0.124306144172345,0.00887724952083135,0.106906735111516,0.141705553233175,3.55502556594694e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,0.210508120802581,0.0150530428624606,0.181004156792158,0.240012084813004,4.50756634482982e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,0.0883351709849096,0.00632468909552189,0.0759387803576867,0.100731561612132,5.03132985742948e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TDRKH,Tudor and KH domain-containing protein,41839,0.122537826931829,0.00877827177409827,0.105332414254597,0.139743239609062,5.66427510884218e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYDGF,Myeloid-derived growth factor,39958,0.14337087460359,0.0102654424595361,0.123250607382899,0.163491141824281,5.7725827366946e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,0.1031338475337,0.00741653546267757,0.0885974380268519,0.117670257040548,1.16112677467553e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EHD3,EH domain-containing protein 3,39638,0.16937144154017,0.0121864607779625,0.145485978415364,0.193256904664976,1.50789953101745e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAT2,Signal transducer and activator of transcription 2,39657,0.112411936845869,0.00810789951178324,0.096520453802774,0.128303419888964,2.39472012157621e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBM17,Splicing factor 45,39934,0.109803950180617,0.0079288674493701,0.0942633699798519,0.125344530381383,2.91653238412634e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGF,Placenta growth factor,42296,0.0373740682378009,0.00270226021247376,0.0320776382213523,0.0426704982542494,3.24878643714318e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PON2,Serum paraoxonase/arylesterase 2,41900,0.0502064911202141,0.00363005304348707,0.0430915871549794,0.0573213950854487,3.30815808200633e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NSFL1C,NSFL1 cofactor p47,42249,0.0896999671655387,0.00648957303519725,0.0769804040165521,0.102419530314525,3.6586334446262e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIGYF2,GRB10-interacting GYF protein 2,39934,0.108823946191399,0.00787823871400197,0.0933825983119552,0.124265294070843,4.73192730137808e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT5,ADP-sugar pyrophosphatase,42137,0.0711314990250514,0.0051553139546773,0.0610270836738839,0.081235914376219,5.14202051619625e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KITLG,Kit ligand,42145,-0.0543652173487605,0.00394075731039936,-0.0620891016771432,-0.0466413330203778,5.2881562106352e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNPY4,Protein canopy homolog 4,42070,0.106976579896236,0.00775670963128232,0.091773429018923,0.12217973077355,5.61660513900682e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMAD3,Mothers against decapentaplegic homolog 3,39919,0.0740441754656417,0.00537405516878777,0.0635110273348177,0.0845773235964658,7.65047764670521e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LBR,Delta(14)-sterol reductase LBR,42249,0.0966659439003633,0.00702527325577783,0.0828964083190387,0.110435479481688,8.58995911801283e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSME1,Proteasome activator complex subunit 1,42002,0.0516226628254018,0.00375346438850722,0.0442658726239277,0.058979453026876,9.48698869614627e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLG,Plasminogen,39742,0.0310351905715717,0.00225536245932636,0.0266146801512921,0.0354557009918514,9.82463132214823e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PMVK,Phosphomevalonate kinase,41832,0.154215262687657,0.0112189543963294,0.132226112070852,0.176204413304463,1.05803916102194e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELE,E-selectin,42310,0.0716391994913564,0.0052123692115365,0.0614229558367448,0.0818554431459679,1.06047727040935e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,0.117014097349503,0.00851567030483508,0.100323383552027,0.13370481114698,1.1308222625648e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPART,Spartin,39736,0.110279286328066,0.00802214977860364,0.094555872762003,0.126002699894129,1.1852695516084e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DGKA,Diacylglycerol kinase alpha,39657,0.0785220504080942,0.00571186597641523,0.0673267930943203,0.089717307721868,1.18665593574386e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAX,Protein max,41839,0.150490922931721,0.0109601228001468,0.129009082243434,0.171972763620009,1.30063740556384e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD207,C-type lectin domain family 4 member K,41832,0.0552790093097039,0.00402595333345803,0.0473881407761262,0.0631698778432816,1.3029839115391e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APPL2,DCC-interacting protein 13-beta,39736,0.15995865216765,0.0116457787497236,0.137132925818192,0.182784378517108,1.38596149747811e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COCH,Cochlin,39958,0.0650514687776275,0.00473818754739015,0.0557646211847428,0.0743383163705122,1.48349253145821e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,0.133582916508335,0.00973523508261685,0.114501855746406,0.152663977270264,1.64730722103497e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,0.116749577768609,0.00851640444113383,0.100057425063986,0.133441730473231,1.72777811460622e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGBP1,Immunoglobulin-binding protein 1,39934,0.0848097367792725,0.00618727494679528,0.0726826778835537,0.0969367956749912,2.00442408804353e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD226,CD226 antigen,39657,0.060207714287266,0.00439215485576934,0.0515990907699581,0.0688163378045739,2.01895544562466e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLG4,Disks large homolog 4,39929,0.101975012479979,0.00744176185929204,0.0873891592357668,0.116560865724192,2.1182039284386e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4G,C-type lectin domain family 4 member G,42119,0.047228633855663,0.00345245296884217,0.0404618260367323,0.0539954416745936,2.56661793870902e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDC,Nuclear migration protein nudC,42296,0.0896346526956206,0.00655308874163766,0.0767905987620108,0.10247870662923,2.5978227178776e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,0.0833541387665077,0.00609395127275563,0.0714099942719067,0.0952982832611088,2.65907714712294e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOXJ3,Forkhead box protein J3,39657,0.063919163903656,0.00466984107981335,0.0547662753872218,0.0730720524200901,2.65981582773288e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ST13,Hsc70-interacting protein,39736,0.07672029697738,0.00560664036183472,0.065731281868184,0.087709312086576,2.78558580252332e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL7,Interleukin-7,42119,0.09108396424391,0.00666575633184598,0.0780190818334918,0.104148846654328,3.15703882378487e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,0.124915439271918,0.00915056328326781,0.106980335236713,0.142850543307122,4.2689319548301e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THPO,Thrombopoietin,41900,0.0548973863984166,0.00402525963913074,0.0470078775057204,0.0627868952911129,4.55069001452879e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,0.0629798114802303,0.00462032145319005,0.0539239814319778,0.0720356415284828,5.02824728566048e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,0.0406635616289789,0.00298410339040223,0.0348147189837905,0.0465124042741673,6.02191787500898e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD36,Platelet glycoprotein 4,39657,0.0653109289631199,0.00480190787774302,0.0558991895227436,0.0747226684034962,8.55636622851177e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRAP2,GRB2-related adapter protein 2,42145,0.181084058526222,0.0133289685599333,0.154959280148753,0.207208836903691,9.13359689454811e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEXN,Nexilin,39990,0.0977314462167216,0.00719419734938865,0.0836308194119199,0.111832073021523,1.04144181998013e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,A1BG,Alpha-1B-glycoprotein,39979,0.0231532518201526,0.0017059187845443,0.0198096510024458,0.0264968526378595,1.23198603672498e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YJU2,Splicing factor YJU2,39919,0.0462022593375823,0.00341190267422996,0.0395149300960916,0.052889588579073,1.86972687088452e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0513620356309055,0.00380326869818769,0.0439076289824576,0.0588164422793533,3.05671414139811e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL4,C-C motif chemokine 4,42148,0.0865552416559704,0.00642437589452138,0.0739634649027085,0.0991470184092323,4.15069520473029e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VAMP8,Vesicle-associated membrane protein 8,39657,0.122335012031231,0.00907974285277646,0.104538716039789,0.140131308022673,4.72536082805463e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGF,Pro-epidermal growth factor,42081,0.144387312804848,0.0107423702992602,0.123332267018298,0.165442358591398,6.38425426291351e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,0.0405622041111011,0.00301696762913286,0.0346489475580007,0.0464754606642015,6.83363436809157e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STIP1,Stress-induced-phosphoprotein 1,42105,0.0886435511461883,0.00660453899273182,0.0756986547204339,0.101588447571943,8.24878338535777e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FIS1,Mitochondrial fission 1 protein,42125,0.106230925027197,0.00792014436865162,0.0907074420646401,0.121754407989754,9.27328044520486e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CREG1,Protein CREG1,41960,0.0559527283582787,0.00417160146982414,0.0477763894774234,0.064129067239134,9.33932071227131e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DIABLO,"Diablo homolog, mitochondrial",42107,0.151694503114718,0.011310384467118,0.129526149559166,0.173862856670269,9.37798300598602e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,QDPR,Dihydropteridine reductase,42081,0.0583424132002093,0.0043521317563145,0.0498122349578329,0.0668725914425857,1.02351510306198e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TREH,Trehalase,39966,0.104167342127342,0.00777187991880936,0.0889344574864755,0.119400226768208,1.17968458193941e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICA1,Islet cell autoantigen 1,41913,0.110476090206365,0.00825723149694309,0.094291916472357,0.126660263940374,1.45997910554463e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WASHC3,WASH complex subunit 3,39929,0.104870373370054,0.00783938161775979,0.089505185399245,0.120235561340863,1.66290556286119e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,0.0966922747164259,0.00723705839524698,0.0825076402617418,0.11087690917111,2.11009989607788e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,0.100277939587251,0.00751307973444148,0.0855523033077455,0.115003575866756,2.2173933171233e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASC3,Protein CASC3,39649,0.0594439666944959,0.00445684989031806,0.0507085409094725,0.0681793924795193,2.86120517634702e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSC22D1,TSC22 domain family protein 1,39934,0.090838998906817,0.00681254874554564,0.0774864033655476,0.104191594448086,2.94724777728996e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TADA3,Transcriptional adapter 3,39919,0.0556452584733999,0.00417449585729292,0.0474632465931058,0.0638272703536941,3.12033184987801e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKG1,cGMP-dependent protein kinase 1,39736,0.173538773164535,0.0130304470567712,0.147999096933264,0.199078449395807,3.6907681883054e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CETN2,Centrin-2,41839,0.0934527492236492,0.00703090937049565,0.0796721668574777,0.107233331589821,4.66943978088738e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,39966,0.0705027701468199,0.00530809187243749,0.0600989100768424,0.0809066302167974,5.83182170262285e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VNN1,Pantetheinase,39990,0.100258562333371,0.00755051033792288,0.0854595620710424,0.1150575625957,6.11776563899364e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIAE,Sialate O-acetylesterase,42147,0.0635240082986735,0.0047994205218191,0.0541171440759081,0.0729308725214389,9.62378828960501e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP53,Cellular tumor antigen p53,41843,0.0607757715181033,0.00459513602726062,0.0517693049046725,0.0697822381315341,1.1067107545635e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CETN3,Centrin-3,39930,0.107389784419703,0.0081162952112614,0.0914818458056303,0.123297723033775,1.13785291017916e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,0.0384500914056055,0.00290818696209073,0.0327500449599077,0.0441501378513034,1.16706880878315e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARSB,Arylsulfatase B,42070,0.0758001917298329,0.00573493808623381,0.0645597130808146,0.0870406703788512,1.23098889215352e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,0.133468679470122,0.0100993864717105,0.113673881985569,0.153263476954674,1.27163526827867e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,0.152209604311767,0.0115216680089623,0.129627135014201,0.174792073609333,1.35444288358354e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDC4,Syndecan-4,42145,0.0645924948235798,0.0048909624864289,0.0550062083501791,0.0741787812969804,1.41326659394203e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,39657,0.0795804064548982,0.00602201243529963,0.0677772620817109,0.0913835508280854,1.43501117642083e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,0.0679188171657789,0.00513998830051381,0.0578444400967719,0.077993194234786,1.44714134822761e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6AP2,Renin receptor,41843,0.0536569354250674,0.00406523266867417,0.045689079394466,0.0616247914556688,1.5795585200046e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SULT2A1,Bile salt sulfotransferase,42119,0.0801388579077185,0.00607220688722421,0.068237332408759,0.0920403834066779,1.58881233263562e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,0.10819200233119,0.00820116951408246,0.0921177100835888,0.124266294578792,1.72528389286681e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS8,Prostasin,42080,0.0568632601290792,0.00431136578212651,0.0484129831961112,0.0653135370620471,1.77874123906108e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",42181,0.0828509640681247,0.00628300230666264,0.0705362795470659,0.0951656485891834,1.8333908325191e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HPSE,Heparanase,39866,0.129972383960979,0.00986072657435414,0.110645359875245,0.149299408046713,2.21289110653595e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHMP1A,Charged multivesicular body protein 1a,42016,0.108113735777903,0.00820790564404612,0.0920262407155725,0.124201230840233,2.23512287896169e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,0.0840735373812222,0.00638018672171644,0.071568371406658,0.0965787033557864,2.30849335230181e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLT4,Vascular endothelial growth factor receptor 3,42181,0.0462606316638201,0.00351462492514384,0.0393719668105382,0.0531492965171021,2.51624194787025e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,0.0665567500548512,0.00505624008888532,0.056646519480636,0.0764669806290664,2.81946000661055e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,0.0601623203542374,0.00457416719510242,0.0511969526518367,0.0691276880566381,2.86900792184258e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM24,Transcription intermediary factor 1-alpha,39735,0.0895650210274899,0.00681095242088617,0.076215554282553,0.102914487772427,3.32648791878539e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RRAS,Ras-related protein R-Ras,39649,0.178519996205141,0.0135836467765866,0.151896048523032,0.205143943887251,3.70464335395874e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AP2B1,AP-2 complex subunit beta,39649,0.0660142566975545,0.00502338525292535,0.0561684216018208,0.0758600917932882,3.74754399716677e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,0.0627567168856255,0.00478340039196108,0.0533812521173818,0.0721321816538693,4.39712784144129e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,-0.0631454585317386,0.00481392000917662,-0.0725807417497248,-0.0537101753137524,4.51796322464271e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAG4,BAG family molecular chaperone regulator 4,39657,0.0684621764645704,0.0052240469573865,0.0582230444280929,0.078701308501048,5.99507126487507e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R2,Protein phosphatase inhibitor 2,42145,0.108790851815962,0.00832142792482699,0.0924808530833011,0.125100850548623,8.00741283033635e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOXO3,Forkhead box protein O3,41843,0.129648231888434,0.00992822729871413,0.110188906382954,0.149107557393914,9.85155381183765e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,0.10262412699138,0.00786271965822687,0.0872131964612556,0.118035057521505,1.05876552989329e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,0.11709645194542,0.00899351607762329,0.0994691604332784,0.134723743457562,1.60615592749671e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,42239,0.0870685646445847,0.00668774137135051,0.0739605915567377,0.100176537732432,1.61574090702128e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.0374833629714959,0.00287982055674047,0.0318389146802846,0.0431278112627072,1.68167105430885e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SRP14,Signal recognition particle 14 kDa protein,42070,0.0803295433773369,0.00617556334596808,0.0682254392192395,0.0924336475354343,1.88664187535448e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,39736,0.0550612146558054,0.00423625338770002,0.0467581580159133,0.0633642712956974,2.39788383415534e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRY2,Protein sprouty homolog 2,41913,0.124578914454267,0.00959288551419001,0.105776858846454,0.143380970062079,2.49128252643746e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,0.0343941102205004,0.00265322372044795,0.0291937917284224,0.0395944287125784,3.34036871526227e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP5,Fatty acid-binding protein 5,42218,0.08917498166965,0.00687979939933922,0.0756905748469452,0.102659388492355,3.38642349982464e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,39638,0.098489422051567,0.00759487350429109,0.0836034699831565,0.113375374119978,3.53510399702542e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALDH1A1,Retinal dehydrogenase 1,42137,0.0712539661588986,0.00550332570554103,0.0604674477760382,0.082040484541759,4.08968892635602e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADD1,Alpha-adducin,39736,0.0931196236480479,0.00719802766217759,0.0790114894301798,0.107227757865916,5.23714525963193e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIFBP,KIF-binding protein,42070,0.110261352709744,0.0085286637797055,0.0935451717015216,0.126977533717967,5.24197582771133e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCAM,Cell surface glycoprotein MUC18,42217,-0.0427680922371661,0.00330871999187456,-0.0492531834212402,-0.0362830010530919,5.37982622420388e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLB,Beta-klotho,41839,-0.0997313247008351,0.00772355810225564,-0.114869498581256,-0.084593150820414,6.47130979604015e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC3B,Tetranectin,39726,0.0280261766646432,0.00216963340208408,0.0237736951965584,0.032278658132728,6.71459107409707e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,0.122022410655095,0.00945998606515669,0.103480837967388,0.140563983342803,7.64298432094107e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUS,RNA-binding protein FUS,41831,0.0529144816486705,0.00410286171902196,0.0448728726793875,0.0609560906179535,7.91104523465183e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,0.127454555022807,0.00989271202214299,0.108064839459407,0.146844270586207,9.27552369743796e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTF1,Cardiotrophin-1,41900,0.112510759294535,0.0087348127792474,0.0953905262472105,0.12963099234186,9.71355571949773e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP7,Caspase-7,39929,0.112374290040983,0.00872945385629767,0.0952645604826398,0.129484019599327,1.17240477039645e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RWDD1,RWD domain-containing protein 1,42249,0.0827562915946438,0.0064348449150371,0.0701439955611711,0.0953685876281165,1.23938659569352e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,0.0884682477800332,0.00688616719806138,0.0749713600718329,0.101965135488233,1.64337610352452e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,0.131211318720009,0.0102185481897215,0.111182964268155,0.151239673171863,1.77417545887388e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1RN,Interleukin-1 receptor antagonist protein,42092,0.0698403923005191,0.00544301874297998,0.0591720755642783,0.0805087090367598,1.8158842484693e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OGFR,Opioid growth factor receptor,42070,0.042540821903983,0.00331666491005618,0.0360401586802729,0.0490414851276931,1.93211277232318e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMED8,Protein TMED8,39930,0.136676190569911,0.0106667974469258,0.115769267573936,0.157583113565885,2.50960517694988e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP2,Microtubule-associated protein 2,39929,0.0618043620685888,0.00483693302406219,0.0523239733414269,0.0712847507957507,3.94502809738458e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RFC4,Replication factor C subunit 4,39919,0.0292211601736348,0.00228854950495719,0.0247356031439187,0.0337067172033509,4.43346295539769e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VASP,Vasodilator-stimulated phosphoprotein,39990,0.0965292352720973,0.00756546641475252,0.0817009210991823,0.111357549445012,4.96480195339072e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STK24,Serine/threonine-protein kinase 24,41839,0.0819344088299018,0.00642528776383046,0.0693408448127941,0.0945279728470095,5.0250397278052e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,0.0955530414638205,0.00749972826311162,0.0808535740681217,0.110252508859519,6.26977932987538e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD69,Early activation antigen CD69,42082,0.115178388805054,0.00905033935744293,0.0974397236644659,0.132917053945642,6.87414274491549e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,0.097542060060994,0.00766159544105335,0.0825253329965294,0.112558787125459,7.1489747813599e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,0.0464858837382986,0.00365279241587496,0.0393264106031836,0.0536453568734135,7.56818635885542e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,41913,0.0781566523247823,0.00614777352954604,0.0661070162068721,0.0902062884426926,8.19511854266762e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEP1B,Meprin A subunit beta,42145,0.150553263327591,0.0118480141069267,0.127331155678015,0.173775370977168,8.76196788259112e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNDC5,Thioredoxin domain-containing protein 5,42249,0.0902349760340904,0.00710925488977009,0.076300836450141,0.10416911561804,1.04762947102007e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,0.0674454063632743,0.00531127049396179,0.0570353161951092,0.0778554965314394,1.07097466646109e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFA,Platelet-derived growth factor subunit A,42310,0.0941131678594926,0.00742637616193415,0.0795574705821016,0.108668865136884,1.34167186664357e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VAV3,Guanine nucleotide exchange factor VAV3,39586,0.129598095339349,0.0102191763917881,0.109568509611444,0.149627681067253,1.3450788797191e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GDNF,Glial cell line-derived neurotrophic factor,41839,0.0500810219560855,0.00395780360379493,0.0423237268926474,0.0578383170195236,1.73470934987148e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNLR1,Interferon lambda receptor 1,42119,0.0475497952630407,0.00376077901821604,0.0401786683873372,0.0549209221387441,1.95105113140796e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GET3,ATPase GET3,39958,0.0706029691528932,0.00558448637183331,0.0596573758640999,0.0815485624416865,2.15808278410643e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK13,Kallikrein-13,41839,0.058596345683952,0.00463716908086647,0.0495074942854538,0.0676851970824503,2.16181303244469e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HAO1,Hydroxyacid oxidase 1,42262,0.16118597292396,0.0127705005815696,0.136155791784083,0.186216154063836,2.5550875274811e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BIN2,Bridging integrator 2,42137,0.116321287860956,0.00922688334386649,0.0982365965069781,0.134405979214935,3.09587780026565e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,42070,0.0738835629312476,0.00586965239255656,0.0623790442418367,0.0853880816206584,3.956607854147e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MUC13,Mucin-13,41839,0.06852873679766,0.00544524962787112,0.0578560475270326,0.0792014260682874,4.10700189414903e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGLN1,Egl nine homolog 1,42119,0.072660078884539,0.00577513342099081,0.061340817379397,0.083979340389681,4.24958795571293e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERMAP,Erythroid membrane-associated protein,39657,0.0579788759699549,0.00460580142718135,0.0489515051726795,0.0670062467672303,4.33205616081152e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPT1,Angiopoietin-1,42085,0.108553062211323,0.00863281484519841,0.0916327451147346,0.125473379307912,4.64810034058056e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,42129,0.0655386659393081,0.00522196765443624,0.0553036093366131,0.0757737225420032,6.25632520175962e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRG2,Bone marrow proteoglycan,39966,-0.0663427186303319,0.005297471738455,-0.0767257632377037,-0.0559596740229601,9.56116667914312e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX6,Peroxiredoxin-6,42262,-0.0776639965242104,0.0062059072392219,-0.0898275747130853,-0.0655004183353354,9.76211797156119e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,0.0743979087167549,0.00594384731822868,0.0627479679730267,0.0860478494604831,1.05039165276079e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINE2,Glia-derived nexin,39958,0.0838546331259716,0.00670264675603094,0.0707174454841509,0.0969918207677922,1.12126437282792e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,0.0744452632667888,0.00595613363177871,0.0627712413485026,0.0861192851850751,1.18718270231717e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COMT,Catechol O-methyltransferase,41740,0.107438554950468,0.00860836191057356,0.090566165605744,0.124310944295192,1.5126960946025e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB9,Serpin B9,42016,0.0424014775507999,0.00339833967338438,0.0357407317909665,0.0490622233106332,1.56700482751889e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP25,Rho GTPase-activating protein 25,41843,0.0783015856911514,0.00628276061215808,0.0659873748913216,0.0906157964909812,1.87957073793223e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH2D1A,SH2 domain-containing protein 1A,42119,0.0770594788656415,0.00618420279053702,0.064938441396189,0.0891805163350941,1.91441575746636e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PF4,Platelet factor 4,39914,0.125548453737058,0.010081968385138,0.105787795702187,0.145309111771928,2.30243897017582e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,0.0988203990666352,0.00794355851630538,0.0832510243746766,0.114389773758594,2.46273054597133e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,0.109418143045288,0.00879915190988841,0.0921718053019068,0.126664480788669,2.86232060923881e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,42185,0.0501074111643738,0.0040358920219572,0.0421970628013377,0.05801775952741,3.34433756316456e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRC59,Leucine-rich repeat-containing protein 59,39958,0.0620565386330202,0.00499750810295432,0.0522614227512297,0.0718516545148107,3.55178482851188e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOL1,Apolipoprotein L1,39990,0.0684743989114647,0.00551465273221398,0.0576656795563254,0.0792831182666041,3.57670365062897e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,0.10812698448375,0.00871257516510842,0.0910503371601375,0.125203631807362,3.59756091414326e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,0.134302008037911,0.0108209319038701,0.113092981506325,0.155511034569496,3.87283925121551e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NID1,Nidogen-1,42189,0.0461545025958044,0.00372447208842517,0.0388545373024911,0.0534544678891178,4.45393087078269e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ORM1,Alpha-1-acid glycoprotein 1,39922,0.0257053502978148,0.00207404715525541,0.0216402178735142,0.0297704827221154,4.76284953485718e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VEGFA,Vascular endothelial growth factor A,42253,0.0723788587207353,0.00585304166848215,0.0609068970505103,0.0838508203909604,6.13849729807487e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,0.0561666107184165,0.00454654976924799,0.0472553731706905,0.0650778482661426,7.22353938787007e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,0.0685004037682431,0.00554609100453321,0.057630065399358,0.0793707421371282,7.41697187633383e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MOCS2,Molybdopterin synthase catalytic subunit,39736,0.0857985925700883,0.00694316260719612,0.072189993859984,0.0994071912801927,7.52602801826244e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,0.126682266163299,0.0102650588158071,0.106562750884317,0.146801781442281,8.37357571776694e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA4D,Semaphorin-4D,42249,0.0382986642398898,0.00311008174256706,0.0322029040244583,0.0443944244553212,1.15804666817035e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,0.0714131779633259,0.00580199208331364,0.0600412734800312,0.0827850824466207,1.24595104011658e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPARC,SPARC,42181,0.0888938213453463,0.00722496281886142,0.0747328942203779,0.103054748470315,1.32229096498217e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,39979,-0.0338212713948937,0.00275004500694165,-0.0392113596084993,-0.028431183181288,1.52968628309241e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF19,Fibroblast growth factor 19,42185,0.0986366681489496,0.00802919505216868,0.082899445846699,0.1143738904512,1.66731621609731e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBCB,Tubulin-folding cofactor B,42016,0.127213599861985,0.0103558498084233,0.106916134237476,0.147511065486495,1.68693715897975e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GMPR2,GMP reductase 2,39736,0.0841831900784275,0.00686416624854047,0.0707294242312882,0.0976369559255668,2.34946072548166e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATXN3,Ataxin-3,39929,0.07736605002787,0.00630892765717379,0.0650005518198094,0.0897315482359306,2.3637860528954e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNRD2,Protein ZNRD2,39930,0.0882953176742332,0.00720739233093482,0.0741688287056009,0.102421806642865,2.74512481152087e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIP,Gastric inhibitory polypeptide,39638,0.0640724692541965,0.0052331281109278,0.053815538156778,0.0743294003516149,3.02968795131968e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERP29,Endoplasmic reticulum resident protein 29,39736,0.151379740320114,0.0123719525467077,0.127130713328567,0.175628767311661,3.32055878613115e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,0.109825758833243,0.00898455329587653,0.0922160343733247,0.127435483293161,3.83593693698547e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPB1,Heat shock protein beta-1,41949,0.0885409490506881,0.0072497676604226,0.0743314044362598,0.102750493665116,4.03181644592448e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,0.0350624219508215,0.00287235112903745,0.0294326137379081,0.0406922301637349,4.3142330053573e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH9,Protocadherin-9,39930,0.0425987816983827,0.00349687804252055,0.0357449007350424,0.049452662661723,6.32065826965846e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,0.0952973483641602,0.00782432869247826,0.0799616641269028,0.110633032601418,6.58489097757608e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM172A,Cotranscriptional regulator FAM172A,39638,0.0769255336716743,0.00632090651608984,0.0645365569001383,0.0893145104432104,7.39585797430155e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,0.0824628735372619,0.00677945725262005,0.0691751373221266,0.0957506097523972,8.01103883992605e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWA1,von Willebrand factor A domain-containing protein 1,42247,0.0530398803525047,0.00436484058942826,0.0444847927972253,0.0615949679077841,8.40636329289453e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPBP,Platelet basic protein,39908,0.107655979098499,0.00885984987541705,0.0902906733426818,0.125021284854317,9.19781812958771e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NACC1,Nucleus accumbens-associated protein 1,39919,0.0695313578535933,0.00572352975012889,0.0583132395433407,0.0807494761638459,9.49339059745961e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGSF3,Immunoglobulin superfamily member 3,42070,0.046429757753201,0.00382712323672904,0.0389285962092121,0.0539309192971899,1.07433561137731e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,0.0842787984053236,0.00694736077447396,0.0706619712873546,0.0978956255232925,1.09109920886949e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AFP,Alpha-fetoprotein,41976,0.0817773096352031,0.00674875143547781,0.0685497568216666,0.0950048624487396,1.28142255119178e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCG2,Secretogranin-2,42193,0.0413264976148164,0.00341101170290101,0.0346409146771304,0.0480120805525023,1.30094314851155e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP10,Caspase-10,41839,0.0892497494746862,0.00737284439840052,0.0747989744538211,0.103700524495551,1.49070437003542e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,42185,-0.0254640739470316,0.00210672874229447,-0.0295932622819288,-0.0213348856121344,1.83664928426399e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNM3,Dynamin-3,39934,0.0688433459139218,0.00569525830813719,0.0576806396299729,0.0800060521978707,1.96600105365938e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FNDC1,Fibronectin type III domain-containing protein 1,39929,0.0591365226624788,0.00489304489534323,0.0495461546676061,0.0687268906573516,2.01429349842384e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEPR,Leptin receptor,42145,-0.0392658729290768,0.00325064223384871,-0.0456371317074203,-0.0328946141507333,2.0149155061207e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,0.0986994577484099,0.00817655228208889,0.0826734152755157,0.114725500221304,2.23709919362767e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PARP1,Poly [ADP-ribose] polymerase 1,42119,0.0734329134845433,0.00608585388943387,0.0615046398612529,0.0853611871078337,2.36488614240494e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C2,Complement C2,42199,0.0281864455533968,0.00233644712149094,0.0236070091952746,0.0327658819115191,2.42726431016795e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LARP1,La-related protein 1,39919,0.0775439350367123,0.00643424443342776,0.0649328159471939,0.0901550541262307,3.03281454200188e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNMA1,Paraneoplastic antigen Ma1,39638,0.0713709251846253,0.00592353261456592,0.0597608012600761,0.0829810491091745,3.18283361998877e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL1,Growth-regulated alpha protein,42117,0.115549581716823,0.00961691565569392,0.0967004270316631,0.134398736401983,4.3559145448614e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPA1A,Heat shock 70 kDa protein 1A,42162,0.0872619853175974,0.00726274528225312,0.0730270045643812,0.101496966070813,4.36231403843035e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TTF2,Transcription termination factor 2,39649,0.0618409888371119,0.0051473836645604,0.0517521168545735,0.0719298608196502,4.81418518480743e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C4BPB,C4b-binding protein beta chain,42181,0.0474105192394974,0.00394980763733607,0.0396688962703187,0.0551521422086761,5.01904211727169e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IMPACT,Protein IMPACT,39929,0.0671496538143333,0.00560418449326077,0.0561654522075421,0.0781338554211244,6.97092195413308e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACYBP,Calcyclin-binding protein,39713,0.12842897491402,0.0107211262440346,0.107415567475713,0.149442382352328,7.28842462312985e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYO9B,Unconventional myosin-IXb,41913,0.0813873093061533,0.00681794787757455,0.0680241314661072,0.0947504871461995,1.11152878192241e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,0.0559578400951581,0.00468870545652513,0.0467679774003689,0.0651477027899474,1.1415092036076e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRADD,Death domain-containing protein CRADD,41997,0.0922621927378172,0.00773282535476811,0.0771058550424717,0.107418530433163,1.19052533989141e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST3,Cystatin-C,42184,0.0353455201353319,0.00296475331968454,0.0295346036287502,0.0411564366419135,1.32323459305279e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP2,Caspase-2,42119,0.0841860222490325,0.00706469159737777,0.0703392267181721,0.0980328177798929,1.41445500128888e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESYT2,Extended synaptotagmin-2,39929,0.102686939451443,0.00861937780288988,0.0857929589577792,0.119580919945108,1.57409158419558e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,0.0974461744837921,0.00818014250649399,0.0814130951710639,0.11347925379652,1.61173089654616e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,0.0696553535911977,0.00585708188862443,0.0581754730894938,0.0811352340929016,1.8936763831548e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,0.0801801730444723,0.0067469922790708,0.0669560681774936,0.0934042779114511,2.09827686397522e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUB1,NEDD8 ultimate buster 1,42119,0.103343592992573,0.00869873395176268,0.0862940744471183,0.120393111538028,2.1712621422737e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STXBP1,Syntaxin-binding protein 1,39934,0.0957917545701182,0.00806003720353726,0.0799940816511851,0.111589427489051,2.21080508494555e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,39958,0.0328985411275967,0.00277303746993216,0.0274633876865296,0.0383336945686637,2.83243433979527e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,0.132189246213054,0.0111523245055358,0.110330690182204,0.154047802243904,3.21650585385921e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,0.0573963102601753,0.00484389349651475,0.0479022790070064,0.0668903415133442,3.36418653522218e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IDUA,Alpha-L-iduronidase,42262,0.057671583062677,0.00487372222831808,0.0481190874951736,0.0672240786301805,3.77530781884488e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEMIP2,Cell surface hyaluronidase,39657,0.0396483825158639,0.00334881234512265,0.0330847103194235,0.0462120547123043,3.81140760370248e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBXN1,UBX domain-containing protein 1,39736,0.0842424666666807,0.00711571004204683,0.0702956749842689,0.0981892583490925,3.82616177043204e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSPN,Persephin,42119,0.105631026860074,0.00893834041613279,0.0881118796444539,0.123150174075694,4.54529147665691e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCT5,T-complex protein 1 subunit epsilon,41843,0.0552827065766145,0.00468062386490329,0.046108683801404,0.0644567293518249,4.95987890522453e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BMP6,Bone morphogenetic protein 6,41886,0.0488858076412897,0.00414327879809544,0.0407649811970226,0.0570066340855567,5.71511097105743e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATOX1,Copper transport protein ATOX1,42181,0.0866542069745421,0.0073484588366442,0.0722512276547195,0.101057186294365,6.13195138476576e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VCAM1,Vascular cell adhesion protein 1,42199,-0.0338136897893098,0.00286869039902335,-0.0394363229713956,-0.0281910566072241,6.50069242798081e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,0.116836411566234,0.0099242559893483,0.0973848698271112,0.136287953305357,7.70176079922883e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX1,Peroxiredoxin-1,41742,-0.111809763667229,0.00951159756187905,-0.130452494888512,-0.0931670324459457,9.58581346932023e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA12,Serpin A12,41751,0.13178063475272,0.0112151128111648,0.109799013642837,0.153762255862603,1.01407170666334e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1R,Complement C1r subcomponent,39979,0.0228432173203564,0.00194431226001436,0.0190323652907282,0.0266540693499845,1.09231939501486e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,0.114820300162335,0.00978719793900858,0.0956373922018782,0.134003208122792,1.33611992671418e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBC1D5,TBC1 domain family member 5,42119,0.0942990479921723,0.0080641403317729,0.0784933329418974,0.110104763042447,1.94670546444457e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUGT1,Protein SGT1 homolog,41843,0.0965838793129904,0.00826286132752398,0.0803886711110434,0.112779087514937,2.07150617450486e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSNL1,Visinin-like protein 1,39929,0.0468293733505035,0.00400820609392763,0.0389732894064053,0.0546854572946017,2.34486217217249e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UROD,Uroporphyrinogen decarboxylase,39736,0.0817330632471764,0.00700810265691267,0.0679971820396275,0.0954689444547252,3.00428714899208e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MESD,LRP chaperone MESD,42137,0.146965588269694,0.0126099026998356,0.122250178978017,0.171680997561372,3.05861025462635e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,0.0768592858574972,0.00660477940292572,0.0639139182277628,0.0898046534872316,4.04856182223781e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB33A,Ras-related protein Rab-33A,39575,0.0798319914607103,0.00687524827829906,0.0663565048352442,0.0933074780861765,5.46481504809016e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL2L1,Bcl-2-like protein 1,39929,0.11954788459728,0.0103062630195751,0.0993476090789127,0.139748160115647,6.19466908525218e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB6,Serpin B6,42216,0.0702130376393593,0.0060562554665528,0.0583427769249158,0.0820832983538028,6.21341037574966e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,41791,0.0695669573020543,0.00601368434844388,0.0577801359791043,0.0813537786250043,8.41766079964886e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,0.145359394848784,0.0125752408297591,0.120711922822456,0.170006866875112,9.25489137527792e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,0.0672634357337833,0.00581843253538312,0.0558593079644324,0.0786675635031342,9.72969279592623e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS2,Trypsin-2,42217,0.0682565096733422,0.0059123028379305,0.0566683961109984,0.0798446232356859,1.08929684540108e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,0.0654183412241448,0.0056682482775886,0.0543085746000711,0.0765281078482184,1.14434993861654e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP1BB,Platelet glycoprotein Ib beta chain,39575,0.0827495877613927,0.00717677227971425,0.0686831140931528,0.0968160614296326,1.39387363956299e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMOX2,Heme oxygenase 2,41839,0.0569829775832529,0.00494480089013726,0.0472911678385839,0.0666747873279219,1.40012573590423e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,0.111684783485942,0.00969583332572411,0.0926809501675223,0.130688616804361,1.47597512580353e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,39638,-0.0673580129821449,0.00584907239986153,-0.0788221948858735,-0.0558938310784163,1.63629783196998e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMEM106A,Transmembrane protein 106A,39919,0.0853021350126311,0.00741046551801203,0.0707776225973275,0.0998266474279347,1.71541204865657e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKT2,RAC-beta serine/threonine-protein kinase,39934,0.15191164851627,0.0132122963089101,0.126015547750806,0.177807749281734,1.99645848307332e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBP2,Retinol-binding protein 2,42070,-0.0926197236217841,0.00806170139825102,-0.108420658362356,-0.0768187888812121,2.07956839225872e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DFFA,DNA fragmentation factor subunit alpha,42296,0.0792623326703042,0.00690780245820263,0.0657230398522271,0.0928016254883814,2.44331382839968e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,0.111296083466679,0.00970130034224312,0.0922815347958828,0.130310632137476,2.51422442092435e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,0.128497751449551,0.0112036510553774,0.106538595381011,0.150456907518091,2.81502271906763e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELOA,Elongin-A,42070,0.0637318231269713,0.00556380331876391,0.0528267686221941,0.0746368776317486,3.07357964392521e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HNMT,Histamine N-methyltransferase,41961,0.0568299586886094,0.0049613944683208,0.0471056255307007,0.0665542918465182,3.09184526944365e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB14,DnaJ homolog subfamily B member 14,39930,0.0762369202251499,0.00665740864614563,0.0631883992787045,0.0892854411715954,3.38952719420629e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,0.134459606475549,0.0117609903560282,0.111408065377734,0.157511147573364,3.94121371577107e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CERT,Ceramide transfer protein,41839,0.0725907186553983,0.00635118627576817,0.0601423935548927,0.085039043755904,4.12327970659819e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THTPA,Thiamine-triphosphatase,39897,0.103693160409977,0.00907385293974969,0.0859084086480672,0.121477912171886,4.44788786450864e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,0.0669678339433814,0.00586541141496042,0.055471627570059,0.0784640403167038,4.69818794120353e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TALDO1,Transaldolase,39948,0.0521074514287879,0.00457304098238441,0.0431442911033144,0.0610706117542613,6.4762388455052e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,0.141817336378217,0.0124542992898193,0.117406909770171,0.166227762986263,6.63130194978042e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,0.072128928457367,0.00633156384674763,0.0597190633177417,0.0845387935969923,6.73176961627954e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAP,Prolyl endopeptidase FAP,42310,0.0323837863493913,0.00284811186049416,0.0268014871028228,0.0379660855959599,7.9985392577234e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,0.0780032653518899,0.0068690270577832,0.0645399723186348,0.091466558385145,1.01660514330457e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,0.0948431386471101,0.00835735405914416,0.0784627246911875,0.111223552603033,1.10136086455494e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,0.0466442252456477,0.00411535791350103,0.0385781237351856,0.0547103267561097,1.20388685504418e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DYNLT1,Dynein light chain Tctex-type 1,39649,0.0931033131879663,0.0082140476112501,0.0770037798699161,0.109202846506016,1.28780561309802e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL8,C-C motif chemokine 8,42239,0.0709361648534883,0.00626587350025775,0.0586550527929831,0.0832172769139935,1.39911040268459e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REEP4,Receptor expression-enhancing protein 4,39934,0.0730476475194908,0.00645165430895133,0.0604024050739462,0.0856928899650354,1.46630858778656e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,39575,0.0809026259295364,0.00715091232552076,0.0668868377715157,0.0949184140875571,1.6367762728795e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,0.0843195760519251,0.00745969386978611,0.0696985760671443,0.0989405760367058,1.72381794058003e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YWHAQ,14-3-3 protein theta,39736,0.0865943105519504,0.00766778972124137,0.0715654426983173,0.101623178405584,2.04733057878021e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP2,"Fatty acid-binding protein, intestinal",42145,-0.093311505381734,0.00827639148752784,-0.109533232697289,-0.0770897780661794,2.37187564781011e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GMFG,Glia maturation factor gamma,39958,0.0839343563967025,0.00745049530821265,0.0693313855926057,0.0985373272007993,2.77370536677975e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,41900,0.130201633729852,0.0115834602553167,0.107498051629431,0.152905215830273,3.49924974103802e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB1,Leukocyte elastase inhibitor,42093,0.104160953319379,0.00927240820828811,0.0859870332311345,0.122334873407624,3.76360992978e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G4A,Cytosolic phospholipase A2,42185,0.102474656658887,0.00912553030749122,0.0845886172562045,0.12036069606157,3.92769061090036e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD99L2,CD99 antigen-like protein 2,42137,0.0285688683309227,0.00254610679942378,0.0235784990040521,0.0335592376577933,4.3412063698035e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPI,Mannose-6-phosphate isomerase,42070,0.0986548525950045,0.0088086507657176,0.081389897094198,0.115919808095811,5.48977196545753e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNDC9,Thioredoxin domain-containing protein 9,39929,0.0620909011308564,0.00554165112947609,0.0512292649170833,0.0729525373446296,5.50929281414837e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,0.0746267101073488,0.00666351160614106,0.0615662273593123,0.0876871928553853,5.54649849051442e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGFR,Epidermal growth factor receptor,42310,0.0184925685281666,0.00165260322724666,0.0152534662027632,0.0217316708535701,6.094551072908e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MICALL2,MICAL-like protein 2,39649,0.0793810185641801,0.00709003765345056,0.065484544763417,0.0932774923649432,6.09554427535881e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OTUD6B,Deubiquitinase OTUD6B,39930,0.067064598393406,0.00599505664153297,0.0553142873760014,0.0788149094108107,6.71638501274801e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,0.0368826646804015,0.00330195906563716,0.0304108249117527,0.0433545044490503,8.16549754628013e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL18,C-C motif chemokine 18,42020,0.0810303046098459,0.00726461169031779,0.066791665696823,0.0952689435228688,9.14805823115152e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARA5,Scavenger receptor class A member 5,42249,0.0351876065120618,0.00315812734522695,0.0289976769154169,0.0413775361087066,1.0427497004095e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PKD2,Polycystin-2,39575,0.0673795737820373,0.00605442379046126,0.0555129031527333,0.0792462444113414,1.289701540417e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,0.0665452633861682,0.00598376584055592,0.0548170823386786,0.0782734444336578,1.32277807960266e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C3,Complement C3,39445,0.0529629823548505,0.00476205422789909,0.0436293560681683,0.0622966086415327,1.40126814013428e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,39638,0.104488469863576,0.00939817654122642,0.0860680438427718,0.122908895884379,1.45458233594117e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL11,Eotaxin,42296,0.0429554224639138,0.00386606340535532,0.0353779381894174,0.0505329067384102,1.4706940516509e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF23,Fibroblast growth factor 23,42250,0.0579113733030922,0.00522885789761021,0.0476628118237762,0.0681599347824082,2.18300001450259e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTD,Deoxycytidylate deaminase,39736,0.109542808546377,0.00990803659150655,0.0901230568270238,0.12896256026573,2.8776026040743e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC37,Hsp90 co-chaperone Cdc37,42181,0.0953018804500611,0.00865712710908393,0.0783339113162566,0.112269849583866,4.57041616949785e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEBPB,CCAAT/enhancer-binding protein beta,41900,0.042883204787593,0.003895348714859,0.0352483213064694,0.0505180882687167,4.5798069177296e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,0.063098509755412,0.00573303232196677,0.0518617664043571,0.0743352531064668,4.98969400420358e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP3,Caspase-3,42310,0.10016452197025,0.00911205546142813,0.0823048932658504,0.118024150674649,5.43304715595167e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,0.0558325559904783,0.005077439882668,0.045880773820449,0.0657843381605076,5.56394558129246e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRGN,Neurogranin,39990,0.104798723468683,0.00955611656218926,0.0860687350067924,0.123528711930574,7.61569182239388e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CIAPIN1,Anamorsin,42181,0.0695312946517072,0.00634318529277166,0.0570986514778748,0.0819639378255397,7.64906684894528e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPP4,Dipeptidyl peptidase 4,41948,0.0316641214197151,0.00288900790706106,0.0260016659218754,0.0373265769175547,7.80081099002074e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,0.101510151580593,0.00927099622926236,0.0833389989712384,0.119681304189947,9.22431402555696e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,0.0420772906111953,0.00384313517898924,0.0345447456603764,0.0496098355620142,9.28786721749923e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLOD4,Glyoxalase domain-containing protein 4,42106,0.0387912761287762,0.00355016193455734,0.0318329587370438,0.0457495935205086,1.12272086504378e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,0.115249727658347,0.0105482127051595,0.0945752307562347,0.13592422456046,1.19935060652497e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,39736,0.0987742981151657,0.00904644966892298,0.0810432567640767,0.116505339466255,1.29671853282198e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBKS,Ribokinase,41830,0.0560032061432368,0.00513176005583883,0.0459449564337927,0.0660614558526809,1.30899889044112e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGCT,Gamma-glutamylcyclotransferase,39952,0.0534931739957631,0.00491956328217209,0.0438508299627058,0.0631355180288204,2.10247658829591e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,0.072807636744863,0.00670474559010392,0.0596663353882594,0.0859489381014667,2.3349020389608e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPA1,Carboxypeptidase A1,42310,0.0725468848146427,0.0066981510483035,0.0594185087599679,0.0856752608693176,3.16769400609796e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FRMD4B,FERM domain-containing protein 4B,39575,0.0788585273212872,0.00727927688664438,0.0645911446234642,0.0931259100191102,3.28628719364228e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JPT2,Jupiter microtubule associated homolog 2,39930,0.0984304545729741,0.00909295405760721,0.080608264620064,0.116252644525884,3.56238907189504e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DBN1,Drebrin,39657,0.0570742920759474,0.0052793316938628,0.0467268019559763,0.0674217821959185,4.17573990473168e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.0424692627862799,0.00393745028709542,0.0347518602235728,0.0501866653489869,5.19148906063179e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLMAP,Sarcolemmal membrane-associated protein,39930,0.0930558942464353,0.008633777852384,0.0761336896557626,0.109978098837108,5.90000031905546e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCRG1,Scrapie-responsive protein 1,39958,0.030476163285241,0.0028289882233647,0.0249313463674462,0.0360209802030358,6.2419600393529e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,0.0516358085276058,0.00479537407855133,0.0422368753336452,0.0610347417215664,6.26449734862369e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNCG,Gamma-synuclein,42016,0.0745185738785898,0.00692533150035733,0.0609449241378894,0.0880922236192902,6.82389555200093e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.03992209357823,0.00371005591603247,-0.0471938031736536,-0.0326503839828063,7.12971464255856e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4E,Eukaryotic translation initiation factor 4E,39657,0.10065196965637,0.0093541538823131,0.0823178280470364,0.118986111265704,7.21104577523546e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AIF1,Allograft inflammatory factor 1,41843,0.0581929905144665,0.00541105858310726,0.0475873156915763,0.0687986653373568,7.28964832904968e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASEH2A,Ribonuclease H2 subunit A,39934,0.0533075907357118,0.0049554198970448,0.043594967737504,0.0630202137339196,7.36861369298025e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JAM3,Junctional adhesion molecule C,39736,0.0565672540029992,0.00526183295033629,0.0462540614203401,0.0668804465856583,7.98104069145055e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUOX,"Sulfite oxidase, mitochondrial",39934,0.0703097916693173,0.00656987487022826,0.0574328369236699,0.0831867464149647,1.33655982643058e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,42145,0.0742490619507944,0.00695215564036003,0.0606228368956887,0.0878752870059,1.60989695849116e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APP,Amyloid-beta precursor protein,42112,0.0731302019645301,0.00685156779263384,0.0597011290909678,0.0865592748380924,1.7267546923036e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,0.0515096172858187,0.00483100819276993,0.0420408412279897,0.0609783933436478,2.05380656713348e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA3,Annexin A3,42224,0.076505545928964,0.00719290240654056,0.0624074572121445,0.0906036346457835,2.56308898372616e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAG3,BAG family molecular chaperone regulator 3,41992,0.0447456946895212,0.00420687810820366,0.0365002135974421,0.0529911757816004,2.57187860782217e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STXBP3,Syntaxin-binding protein 3,41843,0.0478388410776634,0.00450091056371457,0.0390170563727828,0.056660625782544,2.79637924472219e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD22,B-cell receptor CD22,42296,0.0469083816353275,0.00441368802892658,0.0382575530986314,0.0555592101720236,2.79683872102655e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WDR46,WD repeat-containing protein 46,39919,0.040243224277354,0.00378897451929614,0.0328168342195335,0.0476696143351744,3.15743279668306e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,0.0637570362128217,0.00600692847066449,0.0519834564103193,0.0755306160153241,3.27202195204316e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,0.131155415422676,0.0123621088239084,0.106925682127815,0.155385148717537,3.41055989080654e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP53I3,Quinone oxidoreductase PIG3,39513,0.0583274855357834,0.00549708408785522,0.0475532007235872,0.0691017703479796,3.56697703847902e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,0.0907523081892751,0.00856561778077561,0.0739636973389549,0.107540919039595,3.98157277949784e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNAP25,Synaptosomal-associated protein 25,39586,0.0527880318750965,0.00498064785862092,0.0430259620721995,0.0625501016779935,4.0422317292737e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDIA4,Protein disulfide-isomerase A4,39966,0.0671397013720378,0.00634537875152207,0.0547027590190545,0.079576643725021,4.83014250760463e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP3,Stromelysin-1,42137,-0.0544273239729401,0.00514761138908559,-0.0645166422955479,-0.0443380056503324,5.00516638912564e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB2,DnaJ homolog subfamily B member 2,39736,0.0573411587284529,0.00542215541820736,0.0467137341087665,0.0679685833481393,5.15053061250303e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPB1,Carboxypeptidase B,42310,0.0678603432180894,0.00642458588991516,0.0552681548738557,0.0804525315623231,5.58923234858249e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PQBP1,Polyglutamine-binding protein 1,41843,0.0618350645436182,0.0058557796365585,0.0503577364559635,0.0733123926312728,5.81209732569672e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.0441879888011148,0.0041889134242576,0.0359777184895699,0.0523982591126596,6.51080860700061e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,0.0916192547346435,0.00869457206219468,0.074577893492742,0.108660615976545,7.35167466220625e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LACTB2,Endoribonuclease LACTB2,42145,0.0716399875801237,0.00682344906866436,0.0582660274055415,0.0850139477547058,1.09455683299369e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPPB,Natriuretic peptides B,41900,-0.1523919187876,0.0145248908940247,-0.180860704939889,-0.123923132635312,1.18682486099901e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,0.108644454829114,0.010358077966523,0.0883426220147285,0.128946287643499,1.27326165860213e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,0.0467630839246115,0.00446017692836625,0.0380211371450136,0.0555050307042093,1.27740855185198e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYBB1,Beta-crystallin B1,39958,0.0718224687700832,0.0068486867930005,0.0583990426558023,0.0852458948843642,1.29704549410276e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD5,T-cell surface glycoprotein CD5,42239,0.0385715731550923,0.00368207081830281,0.0313547143512188,0.0457884319589659,1.3997005958347e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS1,Galectin-1,42145,0.0379097666151956,0.00362456399574815,0.0308056211835292,0.045013912046862,1.664410959796e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFB,Complement factor B,39794,0.0355007325145958,0.00339356926479787,0.028849336755592,0.0421521282735996,1.70691489749876e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRI1,Methylthioribose-1-phosphate isomerase,39649,0.0726056979571927,0.00694148521297535,0.059000386939761,0.0862110089746244,1.74001924225007e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,0.0529553307622634,0.00506485606856422,0.0430282128678776,0.0628824486566493,1.80628387874737e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,0.0571950187909344,0.00548108633681597,0.0464520895707751,0.0679379480110937,2.23674572889128e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MIA,Melanoma-derived growth regulatory protein,42181,0.0399150101432438,0.00382786420585624,0.0324123962997656,0.0474176239867221,2.31541049298828e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,0.0497344873189179,0.00477020583470634,0.0403848838828934,0.0590840907549423,2.46554585103162e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIPC3,PDZ domain-containing protein GIPC3,39930,0.106650504995539,0.0102356162107649,0.0865886972224394,0.126712312768638,2.62694302891848e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL16,C-X-C motif chemokine 16,42295,0.0251472919021762,0.00241514723452814,0.020413603322501,0.0298809804818513,2.70733723442256e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT16,U8 snoRNA-decapping enzyme,39915,0.0944928459615553,0.00907179169891769,0.0767121342316767,0.112273557691434,2.72345178422634e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL3,C-C motif chemokine 3,42119,0.0638432763058347,0.00614266393653018,0.0518036549902355,0.0758828976214338,3.30569414365608e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,0.106070738818309,0.0102018215930636,0.0860751684959043,0.126066309140714,3.31122557124398e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,0.128810219159617,0.0124286178315166,0.104450128209845,0.15317031010939,4.48751709620442e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FMNL1,Formin-like protein 1,41839,0.0678127849922007,0.0065459848064867,0.0549826547714868,0.0806429152129147,4.72604568062352e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POMC,Pro-opiomelanocortin,39638,0.0788072422504566,0.00760460325149135,0.0639022198775335,0.0937122646233796,4.75381961692837e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMTN,Smoothelin,39897,0.0993974038151058,0.0095930336196113,0.0805950579206676,0.118199749709544,4.80832452479765e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MIF,Macrophage migration inhibitory factor,42105,0.0717991145170302,0.00693881933391426,0.0581990286225582,0.0853992004115021,5.32862989497122e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX8,Syntaxin-8,42119,0.0511516412976097,0.00495259456786373,0.0414445559445968,0.0608587266506226,6.49895213703491e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPI,Glucose-6-phosphate isomerase,39990,0.0510928505900006,0.00494938067721306,0.041392064462663,0.0607936367173382,7.13239457764756e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,42272,0.0355112445637731,0.00344403091288357,0.0287609439745213,0.0422615451530249,7.75254318883389e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBLN4,Cerebellin-4,42262,0.033862791551751,0.00328619496481341,0.0274218494207167,0.0403037336827853,8.28281513597844e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAG6,Large proline-rich protein BAG6,41900,0.0393213506734425,0.00382371244389038,0.0318268742834174,0.0468158270634677,1.03435397247333e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,0.0633574436637466,0.00616301343446672,0.0512779373321919,0.0754369499953014,1.11479187611388e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD164,Sialomucin core protein 24,42137,0.0286780175059348,0.00279860055902088,0.0231927604102538,0.0341632746016157,1.4964387064987e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RILP,Rab-interacting lysosomal protein,42224,0.0620894271441744,0.00606611507991157,0.0501998415875477,0.0739790127008011,1.68711495384178e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,39934,0.0394475156361974,0.00386059132325837,0.031880756642611,0.0470142746297838,2.10127011587469e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,0.0394631316313959,0.00386329416240807,0.0318910750730761,0.0470351881897158,2.17838688809431e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFAT5,Nuclear factor of activated T-cells 5,39657,0.0902003947942427,0.00883287467052653,0.0728879604400107,0.107512829148475,2.25002523164075e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DYNLT3,Dynein light chain Tctex-type 3,39919,0.0463119323575141,0.00454018743507337,0.0374131649847703,0.0552106997302579,2.51457849200144e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNAS,Neuroendocrine secretory protein 55,39934,0.0909593438137998,0.00895224963905027,0.0734129345212613,0.108505753106338,3.77561715981868e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,0.0422253526971982,0.00416190222784099,0.0340680243306299,0.0503826810637665,4.38658772452895e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,0.0449765757429013,0.0044355459430213,0.0362829056945796,0.0536702457912231,4.4683018652889e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTRB1,Chymotrypsinogen B,42137,0.061301359615289,0.00605248384840875,0.0494384912724078,0.0731642279581701,5.03950884080329e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAD23B,UV excision repair protein RAD23 homolog B,41843,0.0484159390617674,0.00479151243212886,0.0390245746947949,0.05780730342874,6.44072554584055e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,0.0243949877427053,0.00241850787665604,0.0196547123044595,0.0291352631809511,7.65412835790273e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,0.0791434768852129,0.00784370870033151,0.0637698078325632,0.0945171459378627,7.70810823571399e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLMH,Bleomycin hydrolase,42310,0.032269304593402,0.00320143156262925,0.0259944987306487,0.0385441104561554,8.22717627230969e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRLF1,Cytokine receptor-like factor 1,42185,0.0259391692954878,0.00257571376079984,0.0208907703243202,0.0309875682666555,9.02342376077657e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,0.053784087685287,0.00533989426633759,0.0433178949232654,0.0642502804473087,9.28889949754597e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTX3,Pentraxin-related protein PTX3,42119,-0.051822358408065,0.00514879746877617,-0.0619140014468663,-0.0417307153692637,9.56923163783933e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PKN3,Serine/threonine-protein kinase N3,39757,0.0766842613769671,0.00761883293952029,0.0617513488155073,0.0916171739384269,9.95001014888003e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TF,Serotransferrin,39979,0.0223147381025488,0.00221982679236506,0.0179638775895133,0.0266655986155843,1.12474769523731e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGA11,Integrin alpha-11,42119,-0.0351898799846983,0.0035062221989247,-0.0420620754945907,-0.0283176844748059,1.27558104126731e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDNF,Cerebral dopamine neurotrophic factor,42070,0.0340660836077717,0.003395139682306,0.0274116098304519,0.0407205573850915,1.31066611014865e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFT20,Intraflagellar transport protein 20 homolog,39649,0.0453499292065493,0.0045199029292671,0.0364909194651858,0.0542089389479128,1.37172337887724e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATG4A,Cysteine protease ATG4A,41843,0.0603549608549178,0.006028112715583,0.0485398599323751,0.0721700617774605,1.63242696583583e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP170,Centrosomal protein of 170 kDa,39638,0.0801786750904052,0.00800511010561115,0.0644886592834073,0.095868690897403,1.63449345485553e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,0.0598967228617965,0.00598717899776099,0.048161852026185,0.0716315936974081,1.76595092918258e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,0.0637243006794074,0.00637538415311947,0.0512285477392932,0.0762200536195216,1.99546864791344e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRK5,G protein-coupled receptor kinase 5,41900,0.0531654252581579,0.005329137450448,0.0427203158552799,0.063610534661036,2.33657793902055e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,0.0750609839889124,0.00752399673524439,0.0603139503878334,0.0898080175899914,2.41658277502626e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALCA,Calcitonin,41997,0.0718080800465328,0.00720707778543177,0.0576822075870865,0.0859339525059791,2.65225456950131e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA13,Carbonic anhydrase 13,41967,0.10820908723445,0.0109051754997275,0.0868349432549836,0.129583231213916,3.98582761905086e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RP2,Protein XRP2,42070,0.0436950093958436,0.00441147221704629,0.0350485238504328,0.0523414949412543,4.75389474850747e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,-0.0441084138142993,0.00445483721789885,-0.0528398947613811,-0.0353769328672176,4.91823138618362e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BGLAP,Osteocalcin,39966,0.0863558952342184,0.00872321600849295,0.0692583918575722,0.103453398610865,5.18106336595614e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD244,Natural killer cell receptor 2B4,42296,0.028188612713226,0.00285005591107406,0.0226025031275208,0.0337747222989312,5.46321870231397e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PARK7,Parkinson disease protein 7,42137,0.0518716210444119,0.00524633385498426,0.0415888066886427,0.062154435400181,5.65858700620952e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OPLAH,5-oxoprolinase,39638,0.0710253463009918,0.00719434380783138,0.0569244324376423,0.0851262601643413,6.82209811441201e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,0.0588284034209528,0.00597048645488502,0.0471262499693781,0.0705305568725274,7.95453255615773e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP5,Platelet glycoprotein V,39736,0.0373249848281275,0.00378773854110706,0.0299010172875577,0.0447489523686974,8.15202006766779e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL18,Interleukin-18,42069,0.0452035806877183,0.0045891895000423,0.0362087692676354,0.0541983921078012,8.18425599607802e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,0.0288527865739255,0.00293371151691858,0.0231027120007651,0.0346028611470859,9.47857976288611e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TST,Thiosulfate sulfurtransferase,41809,0.0768561183855905,0.00782073723274184,0.0615274734094165,0.0921847633617645,1.02836582440842e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F2R,Proteinase-activated receptor 1,42166,0.0583050925859315,0.005935096577083,0.0466723032948488,0.0699378818770142,1.05884343212212e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MZT1,Mitotic-spindle organizing protein 1,41843,0.0534760761830468,0.00544487386489533,0.0428041234078519,0.0641480289582416,1.08898467147911e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP7,Matrilysin,41881,0.0527088433663163,0.00537265958697556,0.0421784305758442,0.0632392561567884,1.21045223841863e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP6,Platelet glycoprotein VI,42115,0.0895623852152918,0.00913190261086097,0.0716638560980043,0.107460914332579,1.24207388865131e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCRIB,Protein scribble homolog,39638,0.0890181211368674,0.00907655740759195,0.0712280686179872,0.106808173655748,1.29324549111509e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CES2,Cocaine esterase,42070,0.0563895943184798,0.00576621269460498,0.0450878174370541,0.0676913711999056,1.64150075677961e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSNAX,Translin-associated protein X,39575,0.0397557226888738,0.00407230973611641,0.0317739956060856,0.0477374497716619,2.01295273007157e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,0.0648177740826636,0.00664560775324191,0.0517923828863095,0.0778431652790178,2.18321582511741e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPING1,Plasma protease C1 inhibitor,39959,0.0186994539555693,0.00191777864334396,0.0149406078146151,0.0224583000965234,2.24471459307738e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HRG,Histidine-rich glycoprotein,39925,0.031430845304609,0.00322357252866987,0.0251126431484161,0.037749047460802,2.2519047946945e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,0.0276442499556608,0.00283546417932928,0.0220867401641754,0.0332017597471462,2.28167263263839e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLB1,Beta-galactosidase,42016,0.0434781104684534,0.0044723039259908,0.0347123947735115,0.0522438261633954,2.8877317611559e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,0.0283571091428123,0.002917637432877,0.0226385397743734,0.0340756785112512,3.06969018800545e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,0.0584038436367316,0.00601573673909084,0.0466129996281136,0.0701946876453497,3.28185471460349e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHRDL2,Chordin-like protein 2,42145,0.0458129136948239,0.004735994917818,0.0365303636559006,0.0550954637337471,4.6125564009665e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,0.0429786923929498,0.0044420694904916,0.0342722361915863,0.0516851485943133,4.68534743412447e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UNC79,Protein unc-79 homolog,39560,0.055899726627414,0.00577926692868683,0.0445723634471878,0.0672270898076402,4.83507164411271e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,-0.112883976852953,0.011694919664703,-0.135806019395771,-0.0899619343101352,5.66048509442096e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POSTN,Periostin,39966,-0.0378411916956222,0.00392082132082723,-0.0455260014844436,-0.0301563819068009,5.88955805790349e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTGR1,Prostaglandin reductase 1,39958,0.0835813716979382,0.00866669185989976,0.0665946556525346,0.100568087743342,6.32526605379964e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARFIP1,Arfaptin-1,39934,0.0691444346526993,0.00717085426700627,0.055089560289367,0.0831993090160316,6.42335549112542e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPP1,Osteopontin,42286,-0.0438846429248234,0.00455952384226883,-0.0528213096556703,-0.0349479761939765,7.36655829636517e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,39958,0.0253795426065323,0.00263771999447064,0.0202096114173698,0.0305494737956947,7.83767318465185e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH3BP1,SH3 domain-binding protein 1,39930,0.0489086460277538,0.00511721335126331,0.0388789078592777,0.0589383841962299,1.4522032455372e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB10,Ras-related protein Rab-10,39958,0.0529364426872113,0.00553920683910241,0.0420795972825706,0.063793288091852,1.46535969523871e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINT2,Kunitz-type protease inhibitor 2,42185,0.0390237744019826,0.00408988105823816,0.0310076075278358,0.0470399412761294,1.64345306395894e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C7,Complement component C7,39722,-0.0329252875076183,0.00345811871702479,-0.0397032001929869,-0.0261473748222497,2.06636978108064e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DBI,Acyl-CoA-binding protein,42085,0.0768104563817336,0.00807095459962824,0.0609913853664623,0.092629527397005,2.08283007976344e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BDNF,Brain-derived neurotrophic factor,39966,0.0828286018029254,0.00870152899806431,0.0657736049667194,0.0998835986391315,2.10378924936794e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEPH,Hephaestin,39958,0.0274274383016386,0.00289191383512064,0.0217592871848022,0.0330955894184751,2.92784522230689e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,0.0610999036825572,0.00644465613905031,0.0484683776500186,0.0737314297150958,2.93570432576252e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,0.0359952441136896,0.00379902144141637,0.0285491620885135,0.0434413261388657,3.11189717741849e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFHR5,Complement factor H-related protein 5,39864,0.0409241885734751,0.00431834878664241,0.0324602249516559,0.0493881521952942,3.14504110499102e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB2B,Ras-related protein Rab-2B,39919,0.0611644803346595,0.00645622562254916,0.0485102781144631,0.0738186825548559,3.2360099898452e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RASSF2,Ras association domain-containing protein 2,41843,0.0560221039241609,0.00591570307011205,0.0444273259067413,0.0676168819415805,3.26391880835929e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPAG1,Sperm-associated antigen 1,39934,0.0573166049746498,0.00605183498942082,0.0454550083953849,0.0691782015539146,3.32165346321032e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,0.0644371560318791,0.00681060791124975,0.0510883645258296,0.0777859475379287,3.64048856109906e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD40LG,CD40 ligand,42296,0.0774861450141202,0.00820832920578545,0.0613978197707808,0.0935744702574597,4.32291454553442e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,0.0414645129260419,0.004393920520889,0.0328524287050995,0.0500765971469843,4.61394665848234e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGACT,Gamma-glutamylaminecyclotransferase,39958,0.069271231616371,0.00736115120196047,0.0548433752605285,0.0836990879722135,5.8922960471471e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX4,Syntaxin-4,42070,0.0574535837564175,0.00611233959921797,0.0454733981419503,0.0694337693708847,6.34723565022301e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,0.0237705069185905,0.00252890258308445,0.018813857855745,0.028727155981436,6.34945112650763e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",39950,0.0381941579688522,0.00406314625418761,0.0302303913106444,0.0461579246270599,6.49063036286869e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTN6,Dynactin subunit 6,41839,0.070304847308777,0.00748486259054444,0.0556345166313099,0.0849751779862441,6.77686163109419e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEPTIN9,Septin-9,42070,0.0279786647209244,0.00298001440826523,0.0221378364807245,0.0338194929611242,7.03072202558045e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLNK,B-cell linker protein,39657,0.0406978659600231,0.00433399288554701,0.032203239904351,0.0491924920156953,7.1486832634347e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC5A,C-type lectin domain family 5 member A,42107,-0.0295617508408868,0.00315339401033519,-0.0357424031011438,-0.0233810985806298,8.03323808189282e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LBP,Lipopolysaccharide-binding protein,42217,-0.056864629328193,0.00607506166452012,-0.0687717501906524,-0.0449575084657335,9.17491252615178e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLTA,Clathrin light chain A,41900,0.0452081384922145,0.00484959245365548,0.0357029372830498,0.0547133397013792,1.31865043881952e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ING1,Inhibitor of growth protein 1,41820,0.0459940218866323,0.0049405616864764,0.0363105209811385,0.055677522792126,1.48466575621893e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCS,Copper chaperone for superoxide dismutase,42016,0.0447533279565921,0.00480830212483945,0.0353290557919068,0.0541776001212774,1.50896350890065e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGA2,Integrin alpha-2,39736,0.0333533835101148,0.00358543804164063,0.0263259249484992,0.0403808420717305,1.62846099643693e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL24,C-C motif chemokine 24,42166,0.0793306422723608,0.00853290913120752,0.062606140375194,0.0960551441695275,1.6618161784263e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PVR,Poliovirus receptor,42249,0.0359771723840298,0.00387539610544505,0.0283813960173575,0.0435729487507021,1.88413737811849e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PARD3,Partitioning defective 3 homolog,39757,0.0713113543191342,0.00768359492556652,0.0562515082650239,0.0863712003732446,1.98875271470736e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFASC,Neurofascin,42296,0.0279864304527984,0.00301927614420407,0.0220686492101584,0.0339042116954384,2.15044422095228e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VGF,Neurosecretory protein VGF,39934,0.0289754060053876,0.00312614881948206,0.0228481543192027,0.0351026576915724,2.22346651337661e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,0.0633271314591692,0.00684100555564645,0.0499187605701021,0.0767355023482362,2.41046423598326e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GZMA,Granzyme A,42296,0.032494795465271,0.00351457429444105,0.0256062298481665,0.0393833610823754,2.67665035996414e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,42145,0.0354654100190056,0.00383660363531874,0.0279456668937809,0.0429851531442304,2.72508068528932e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BPIFB2,BPI fold-containing family B member 2,39927,0.0586784554024304,0.00635256142664689,0.0462274350062025,0.0711294757986583,2.98632653289844e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.0826071242576516,0.00895100424165589,0.0650631559440061,0.100151092571297,3.13843131760246e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,-0.0234311107071681,0.00254073095322513,-0.0284109433754894,-0.0184512780388469,3.32968476846697e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMB1,Laminin subunit beta-1,39638,0.0299960555570635,0.00325414031517772,0.0236179405393152,0.0363741705748118,3.58153804269899e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP4,"Fatty acid-binding protein, adipocyte",42310,0.0480483521569697,0.00521538364716347,0.0378262002085293,0.0582705041054101,3.63204525566176e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL2,C-C motif chemokine 2,41992,0.0495803960189293,0.00538266009108793,0.0390303822403969,0.0601304097974616,3.70068318537232e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,41843,0.0708575146391125,0.00769399321727595,0.0557772879332517,0.0859377413449734,3.76423812306712e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,0.0283371967607684,0.00307957884882626,0.022301222217069,0.0343731713044679,4.04087864008072e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLC,Galectin-10,42119,-0.0639260757211772,0.00696053331453162,-0.0775687210176592,-0.0502834304246952,4.7464209312103e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH7,Protocadherin-7,39930,0.0331475815146417,0.00361397779226269,0.0260641850418068,0.0402309779874765,5.44135088546585e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INPP1,Inositol polyphosphate 1-phosphatase,42070,0.0504448990210128,0.00551232794138269,0.0396407362559028,0.0612490617861229,6.42431983898273e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDT,D-dopachrome decarboxylase,39966,0.0385643975081383,0.00421720789298993,0.030298670037878,0.0468301249783985,7.00478123095265e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,41913,0.0616034045701872,0.00674682380179211,0.0483796299186746,0.0748271792216997,7.7726369325019e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK7,Kallikrein-7,39475,0.0374079947139692,0.00410189101926795,0.029368288316204,0.0454477011117344,8.85842783559181e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,0.078886502339884,0.0086557483239676,0.0619212356249076,0.0958517690548605,9.29204572820319e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSC2,Desmocollin-2,41984,-0.0331591591218645,0.0036473467585812,-0.0403079587686836,-0.0260103594750453,1.11453567785421e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,0.0297093676767675,0.00327022933038635,0.0232997181892103,0.0361190171643248,1.18108957137316e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLAMF7,SLAM family member 7,42119,-0.0561626611322289,0.00618497009395209,-0.068285202516375,-0.0440401197480828,1.22858077978629e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGFL7,Epidermal growth factor-like protein 7,41843,0.0364902114484025,0.00402031787700838,0.0286103884094661,0.044370034487339,1.27833770116644e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,0.0816556159062312,0.00900265308618016,0.0640104158573181,0.0993008159551443,1.38367643061665e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGS10,Regulator of G-protein signaling 10,39934,0.0558911707681474,0.006167723357372,0.0438024329876983,0.0679799085485965,1.4921227722137e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN4,CCN family member 4,42262,0.0366728138154958,0.00405340098877371,0.0287281478774993,0.0446174797534923,1.65895191608847e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DXO,Decapping and exoribonuclease protein,39929,0.0424874967804357,0.00469707073051328,0.0332812381486296,0.0516937554122417,1.73148628295622e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPOCK1,Testican-1,42016,0.0245158050192951,0.00271128225342897,0.0192016918025743,0.0298299182360158,1.74446835078255e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MANSC1,MANSC domain-containing protein 1,42181,-0.0260401830557628,0.00288026036510684,-0.0316854933713722,-0.0203948727401533,1.76140231197505e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNM1,Dynamin-1,39930,0.108359750022589,0.0119851109376221,0.0848689325848502,0.131850567460329,1.80099610370137e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MATN2,Matrilin-2,42144,0.027728995048476,0.00307139506859717,0.0217090607140256,0.0337489293829265,1.9788173344091e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASS1,Argininosuccinate synthase,39575,0.0722689341049096,0.00801683068499744,0.0565559459623146,0.0879819222475046,2.30231290934629e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB103A_DEFB103B,Beta-defensin 103,39596,0.0388430172626031,0.0043107896891966,0.0303938694717778,0.0472921650534285,2.38655715921674e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AK2,"Adenylate kinase 2, mitochondrial",39929,0.0999945444258102,0.0111005831736432,0.0782374014054696,0.121751687446151,2.43262657283737e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XCL1,Lymphotactin,42262,0.0509016248741232,0.00565251422446062,0.0398226969941804,0.061980552754066,2.4355620622963e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,0.0520797355882599,0.00578342577199298,0.0407442210751537,0.0634152501013662,2.44123724706701e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJC9,DnaJ homolog subfamily C member 9,39930,0.0703724579994839,0.00782370697937673,0.0550379923199055,0.0857069236790623,2.74288890796793e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,0.0496894088107262,0.00552584307151464,0.0388587563905575,0.0605200612308949,2.74893374910644e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF2,Fibroblast growth factor 2,42119,0.0643793087245976,0.00715989969825619,0.0503459053160154,0.0784127121331797,2.75524161652919e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NBN,Nibrin,41913,0.0503652797610021,0.00563312787112501,0.039324349133597,0.0614062103884071,4.36286009625293e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RARRES1,Retinoic acid receptor responder protein 1,41843,0.0292997437707561,0.00327785149162393,0.0228751548471732,0.035724332694339,4.4531030593727e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC26,Anaphase-promoting complex subunit CDC26,39911,0.064954257031209,0.00727230511486504,0.0507005390060735,0.0792079750563445,4.84119030868525e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTC,Probetacellulin,41843,0.0678845454361767,0.00760592119016889,0.0529769399034456,0.0827921509689077,5.02664142177505e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITPA,Inosine triphosphate pyrophosphatase,39575,0.0622225651384411,0.0069698290197166,0.0485617002597966,0.0758834300170857,5.05426260171344e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCN1,Ficolin-1,39978,0.0515266277827448,0.00577624896976237,0.0402051798020106,0.0628480757634791,5.35319889287502e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX16,Syntaxin-16,41843,0.0527107456832194,0.00591695512533882,0.0411135136375553,0.0643079777288835,5.84438911167314e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,41839,0.0459136713229171,0.00515828131922842,0.0358034399372294,0.0560239027086048,6.24870748278991e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,0.0281176723388831,0.00316097505478597,0.0219221612315026,0.0343131834462636,6.55381093314683e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACYP1,Acylphosphatase-1,39701,0.0599687668199722,0.00674260363887811,0.0467532636877711,0.0731842699521733,6.80583948247434e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLIT2,Slit homolog 2 protein,41839,0.0475363770126054,0.00535635032036475,0.0370379303846905,0.0580348236405203,7.89834675163536e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOD1,Superoxide dismutase [Cu-Zn],41874,0.043575161671549,0.0049111313004832,0.033949344322602,0.0532009790204961,8.04074773289569e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BMPER,BMP-binding endothelial regulator protein,39736,0.021248349805033,0.00239471032353875,0.016554717570897,0.0259419820391689,8.20392105452428e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJC21,DnaJ homolog subfamily C member 21,39929,0.0362227165097421,0.00408429618484983,0.0282174959874365,0.0442279370320478,8.50093502047126e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,0.0209986697835347,0.00237055779158398,0.0163523765120301,0.0256449630550393,9.1385053487954e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PROK1,Prokineticin-1,42119,0.0456386031238546,0.00515245002105435,0.0355398010825881,0.0557374051651212,9.1794137063438e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BOLA2_BOLA2B,BolA-like protein 2,39638,0.0484307449482836,0.00547226221426081,0.0377051110083324,0.0591563788882348,1.00651916454921e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FEN1,Flap endonuclease 1,41843,0.0589797766653824,0.0066683262980594,0.0459098571211859,0.0720496962095788,1.03209604067176e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFRP1,Secreted frizzled-related protein 1,41968,0.0394919973539054,0.00446597871546563,0.0307386790715928,0.0482453156362181,1.04864828608636e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLITRK2,SLIT and NTRK-like protein 2,42262,0.037161815310886,0.00420349177168302,0.0289229714383873,0.0454006591833848,1.06626125554015e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL5RA,Interleukin-5 receptor subunit alpha,42119,-0.0520363063383047,0.00589816385611074,-0.0635967074962818,-0.0404759051803277,1.25552487542327e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPPK1,Epiplakin,39638,0.0676418606067805,0.00768072456888246,0.0525876404517708,0.0826960807617901,1.48112300934787e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,0.0270271632305827,0.0030805857788987,0.0209892151039413,0.0330651113572242,1.98073077844749e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNGR2,Interferon gamma receptor 2,42016,0.0480647848021008,0.00548126810493856,0.0373214993164212,0.0588080702877804,2.01893225379628e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.0218863474255047,0.00249797955680381,0.0169903074941693,0.0267823873568402,2.15108644466482e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD1C,T-cell surface glycoprotein CD1c,42181,0.0224457631575663,0.00256431405613699,0.0174197076075378,0.0274718187075948,2.31758196498694e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX9,Sorting nexin-9,42145,0.0616431960556236,0.00704528377159716,0.0478344398632932,0.0754519522479541,2.39207711061044e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,39736,0.0324156260947375,0.00370438719689199,0.0251550271888292,0.0396762250006458,2.42749703418824e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCDC134,Coiled-coil domain-containing protein 134,39919,0.0438417519176196,0.00501332231650435,0.0340156401772711,0.0536678636579682,2.54359104156666e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS27,Serine protease 27,42107,0.0363487661401256,0.00416570840795969,0.0281839776605246,0.0445135546197266,2.95179514758678e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB6A,Ras-related protein Rab-6A,42119,0.0400044915502319,0.00459974624500431,0.0309889889100234,0.0490199941904403,3.79344786935993e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C5,Complement C5,39979,0.0135453012079981,0.0015579333588479,0.0104917518246562,0.01659885059134,3.9637822775204e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,0.0549122677476611,0.00632158892544318,0.0425219534537925,0.0673025820415298,4.16388680461986e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FADD,FAS-associated death domain protein,42145,0.0686618756201851,0.00791059950671809,0.0531571005870177,0.0841666506533526,4.41564035478689e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,42062,0.0408195160209586,0.00470848078828577,0.0315908936759185,0.0500481383659987,4.83766223812449e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL1A1,Collagen alpha-1(I) chain,42310,-0.0211068115088191,0.00243486525845556,-0.025879147415392,-0.0163344756022462,4.86155288537402e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAP18,Chromatin complexes subunit BAP18,39929,0.0611677546236769,0.00706551513377108,0.0473193449614856,0.0750161642858683,5.4867528523659e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUSD2,Sushi domain-containing protein 2,42137,-0.0254546596269577,0.00294146501692217,-0.0312199310601251,-0.0196893881937902,5.54101869038651e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPXM1,Probable carboxypeptidase X1,42181,0.0616798674609211,0.00712992150989997,0.0477052213015172,0.075654513620325,5.68030188392025e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP1,Rho GTPase-activating protein 1,41843,0.0417774856176824,0.00483001289376137,0.0323106603459101,0.0512443108894546,5.75984457081581e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,0.0931590484643847,0.0107781421274031,0.0720338898946746,0.114284207034095,6.19214103262211e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL10RB,Interleukin-10 receptor subunit beta,42185,0.0266324855091001,0.00308850398607414,0.0205790176963948,0.0326859533218055,7.23130024521019e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARF2,Scavenger receptor class F member 2,42249,-0.0254046574990496,0.00294930300310866,-0.0311852913851426,-0.0196240236129566,7.83702030456481e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS3BP,Galectin-3-binding protein,39979,0.0278968088929702,0.00323789974959128,0.0215505253837713,0.0342430924021691,7.86667691479653e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCEMP1,Mast cell-expressed membrane protein 1,39657,0.0790830266699293,0.00918647263739384,0.0610775403006373,0.0970885130392212,8.3940199084804e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,0.0475342760002641,0.00553144260949942,0.0366926484856452,0.058375903514883,9.5740938555207e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL7,C-C motif chemokine 7,42119,0.0499738962670769,0.00582367573652709,0.0385594918234838,0.06138830071067,1.04069576286103e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPM1F,Protein phosphatase 1F,39958,0.0474620498410817,0.00553222504942098,0.0366188887442166,0.0583052109379468,1.07927226486812e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INSL3,Insulin-like 3,39929,0.0800666208173784,0.00933465335829942,0.0617707002351115,0.0983625413996453,1.09693575143458e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOLR2,Folate receptor beta,42249,-0.0258308662257395,0.00301262678606263,-0.0317356147264222,-0.0199261177250567,1.10415720300963e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD276,CD276 antigen,42123,-0.0319216589937924,0.00372396974875643,-0.039220639701355,-0.0246226782862298,1.1269575617046e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARF1,Scavenger receptor class F member 1,42310,0.0377206244684217,0.00440529639300319,0.0290862435381354,0.0463550053987079,1.22035271708377e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PER3,Period circadian protein homolog 3,39657,0.109069253760658,0.0127380515389682,0.0841026727442804,0.134035834777036,1.25088822027398e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,0.0388201091698336,0.00453531088397404,0.0299308998372445,0.0477093185024227,1.2792805341737e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMG3,Proteasome assembly chaperone 3,42119,0.0437691361942162,0.00512225916762407,0.033729508225673,0.0538087641627594,1.42320610259351e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,-0.0350085760937302,0.00409720144056515,-0.0430390909172379,-0.0269780612702225,1.42786726069158e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBCA,Tubulin-specific chaperone A,39736,0.0744400717042991,0.00871028282123602,0.0573679173746765,0.0915122260339217,1.43747021604085e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAG3,Lymphocyte activation gene 3 protein,42070,-0.0359990174189975,0.00421385697569907,-0.0442581770913677,-0.0277398577466273,1.44696576167501e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,0.0674041341744061,0.0079011143284607,0.0519179500906232,0.0828903182581891,1.63513974271467e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMPD1,Sphingomyelin phosphodiesterase,42176,-0.0452409220481874,0.00530734573427655,-0.0556433196873694,-0.0348385244090053,1.69960224859991e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMOTL2,Angiomotin-like protein 2,39882,0.0431716225755334,0.00506339538741541,0.0332473676161991,0.0530958775348676,1.70451591481435e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAP3,Cytosol aminopeptidase,41913,0.0423995394428771,0.004977222876576,0.0326441826047882,0.0521548962809661,1.78522387778877e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG3A,Regenerating islet-derived protein 3-alpha,42310,-0.0558986095935864,0.00656271967165841,-0.0687615401500368,-0.0430356790371359,1.79715660243646e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMIGO2,Amphoterin-induced protein 2,42070,0.0206397542444219,0.00242825944938502,0.0158803657236272,0.0253991427652165,2.09695252306674e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP3R1,Calcineurin subunit B type 1,42016,0.0356198329636322,0.00419219259410171,0.0274031354791929,0.0438365304480716,2.15437404445679e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD72,B-cell differentiation antigen CD72,39736,0.0382379060177546,0.00450119723799029,0.0294155594312936,0.0470602526042155,2.22984197869315e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,0.0853460188254434,0.0100538945289686,0.0656403855486651,0.105051652102222,2.35374797973917e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM4,Intercellular adhesion molecule 4,42119,-0.0461799930466556,0.00544477237411637,-0.0568517468999237,-0.0355082391933876,2.45136797398118e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,0.0782262703841415,0.0092240941014026,0.0601470459453924,0.0963054948228906,2.47392653976507e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA2,Annexin A2,39492,0.0620218770878317,0.00731663551018465,0.0476812714878698,0.0763624826877936,2.61245938045829e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NGRN,Neugrin,39929,0.0197027409645141,0.00232445935142901,0.0151468006357132,0.0242586812933149,2.61282508910576e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABCA2,ATP-binding cassette sub-family A member 2,39575,0.0315597568987316,0.00373234213167508,0.0242443663206484,0.0388751474768148,3.12392351139219e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD93,Complement component C1q receptor,41654,-0.0275777276486981,0.00326238228322899,-0.033971996923827,-0.0211834583735693,3.13149706107282e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHGA,Chromogranin-A,39966,-0.0745124470149693,0.00881704304572358,-0.0917938513845875,-0.0572310426453511,3.24084828144549e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLF4,Krueppel-like factor 4,39586,0.0355280888702888,0.00420601638281471,0.0272842967599719,0.0437718809806056,3.36598793480768e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,40518,-0.0273564247572008,0.00324043900984783,-0.0337076852165026,-0.0210051642978991,3.47323908934529e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPDC1,Neural proliferation differentiation and control protein 1,42145,0.0290822452633585,0.00344951054531019,0.0223212045945506,0.0358432859321665,3.77617302898685e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENO2,Gamma-enolase,42249,0.0568143323974389,0.00675129474711741,0.0435817946930888,0.070046870101789,4.30476326603059e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD84,SLAM family member 5,42119,0.0277943777054552,0.00330318583603106,0.0213201334668344,0.0342686219440761,4.34199646480392e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,0.07582343204974,0.00902483493602001,0.0581347555751408,0.0935121085243393,4.9359704523384e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,0.0232521326086719,0.00278111323489611,0.0178011506682756,0.0287031145490683,6.98113881038862e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL19,C-C motif chemokine 19,42249,0.097856851195344,0.0117098230935359,0.0749055979320137,0.120808104458674,7.06112246101769e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,0.0348154850105276,0.00416619743083275,0.0266497380460954,0.0429812319749597,7.22945786929712e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,0.0423879951693433,0.00508060842643505,0.0324300026535306,0.052345987685156,8.07475986805188e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,0.0712992084273829,0.00857228574711724,0.0544975283630331,0.0881008884917327,9.84462298707518e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,39958,0.0278972771424115,0.00335865945538025,0.0213143046098662,0.0344802496749568,1.10129978434498e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,0.0539644682654968,0.00650654712295275,0.0412116359045094,0.0667173006264842,1.19890840453398e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PECAM1,Platelet endothelial cell adhesion molecule,42137,0.0260024671273003,0.00313612499479821,0.0198556621374958,0.0321492721171048,1.22533430607257e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSS,Cathepsin S,39358,0.0208870628031651,0.00252546110738984,0.0159371590326811,0.0258369665736492,1.49004240093974e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL26,C-C motif chemokine 26,42119,0.0768997033604044,0.00930891354816431,0.0586542328060024,0.0951451739148065,1.57972667290679e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL6R,Interleukin-6 receptor subunit alpha,42114,0.0291535529163479,0.00353872991439246,0.0222176422841387,0.0360894635485572,1.90437200758349e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,0.0308315754395827,0.00375216122392181,0.0234773394406959,0.0381858114384694,2.31916883278683e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CORO1A,Coronin-1A,41883,0.0755557634278836,0.00920039673424914,0.0575229858287553,0.0935885410270119,2.37052010408086e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,0.0406599403923276,0.00495566580105629,0.0309468354222573,0.050373045362398,2.56050364320585e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFRA1,GDNF family receptor alpha-1,42247,0.0242711093719037,0.00295942959595786,0.0184706273638263,0.0300715913799811,2.58954469362119e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL12A_IL12B,Interleukin-12,42070,0.0653744920264182,0.00798311032323452,0.0497275957928786,0.0810213882599579,2.86723583246125e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTN2,Dynactin subunit 2,42070,0.0804964173801177,0.00983922085629311,0.0612115445017832,0.0997812902584522,3.06120786604831e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,0.0261330275427609,0.00320211331805627,0.0198568854393706,0.0324091696461512,3.66811045882466e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGH,Gamma-glutamyl hydrolase,41933,0.028757551883413,0.0035246850543067,0.0218491691769718,0.0356659345898541,3.6818983174262e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAGED1,Melanoma-associated antigen D1,41843,0.0408232727592324,0.00500533769907621,0.031012810869043,0.0506337346494218,3.77468179947762e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYOM3,Myomesin-3,39736,-0.0820252660260843,0.0100555421871879,-0.101734128712973,-0.0623164033391959,3.7962431632452e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCOF1,Treacle protein,39958,0.027394587594382,0.00336648140868583,0.0207962840333577,0.0339928911554062,4.4569827322046e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIF22,Kinesin-like protein KIF22,39575,0.10480153456396,0.0128861387525483,0.0795447026089655,0.130058366518955,4.64305015392844e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS9,Galectin-9,42129,0.0264064899250336,0.00325650461449589,0.0200237408806217,0.0327892389694456,5.54728124102139e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.0264014254072414,0.00326117961220544,-0.032793337447164,-0.0200095133673187,6.18748797127854e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,39929,0.0283075520617884,0.00350329730363325,0.0214410893466672,0.0351740147769095,7.1181036836354e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SWAP70,Switch-associated protein 70,39930,0.0306858849589995,0.003800056475883,0.0232377742662689,0.0381339956517302,7.42301058710972e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,0.0604438866951097,0.0074943210294906,0.0457550174773081,0.0751327559129113,7.92341609226304e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,0.0312557543899981,0.00387433409776597,0.0236620595583768,0.0388494492216194,7.92376142697739e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSHB,Thyrotropin subunit beta,42145,0.0567425657442701,0.00706255093093318,0.0428999659196411,0.0705851655688991,1.01863742182546e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL15,C-C motif chemokine 15,42310,0.0362203265259362,0.00451591623393179,0.0273691307074299,0.0450715223444425,1.13721759337784e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSZ,Cathepsin Z,42168,0.0268099468058675,0.00334486294847382,0.0202540154268588,0.0333658781848762,1.18838305840472e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STK4,Serine/threonine-protein kinase 4,42145,0.0726197805958291,0.00906479427420825,0.0548527838183809,0.0903867773732773,1.22836725150894e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENTR1,Endosome-associated-trafficking regulator 1,39638,0.0514455817458457,0.00642118103662567,0.0388600669140594,0.064031096577632,1.24354446089043e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,0.0493453659170076,0.00616049732071085,0.0372707911684143,0.0614199406656009,1.25957063803392e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LONP1,"Lon protease homolog, mitochondrial",39638,0.0728926686971729,0.00910894455969956,0.0550391373601617,0.090746200034184,1.34319763476745e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FRZB,Secreted frizzled-related protein 3,41973,0.0205040738741054,0.00256452184592119,0.0154776110560999,0.0255305366921109,1.39837888617781e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMSB10,Thymosin beta-10,42137,0.0629733793687044,0.00788561345092906,0.0475175770048835,0.0784291817325254,1.50751102168257e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNAR1,Interferon alpha/beta receptor 1,39930,0.0203473717570163,0.00255004801147032,0.0153492776545345,0.0253454658594981,1.61445736475312e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABHD14B,Protein ABHD14B,41976,0.0462949714126978,0.00580796624018142,0.0349113575819422,0.0576785852434534,1.70167237173734e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDZD2,PDZ domain-containing protein 2,39575,0.0486593382858307,0.00611190668416877,0.03668000118486,0.0606386753868015,1.86872175551191e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH5,Cadherin-5,42310,-0.0250525434488117,0.00315149373303874,-0.0312294711655676,-0.0188756157320557,2.01958773578039e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARAF,Serine/threonine-protein kinase A-Raf,39757,0.0563081450297752,0.00709514471890881,0.042401661380714,0.0702146286788365,2.2849867260482e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLU,Clusterin,39979,0.024763448237877,0.00312242184427953,0.0186435014230892,0.0308833950526649,2.37996948746596e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERI1,3'-5' exoribonuclease 1,39757,0.028240950164495,0.00356094060897777,0.0212615065708985,0.0352203937580914,2.38592096483817e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEK7,Serine/threonine-protein kinase Nek7,39757,0.0609769013947609,0.00769210638977122,0.0459003728708094,0.0760534299187125,2.45472859802197e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,0.0299213856849383,0.00378067280880939,0.0225112669796719,0.0373315043902047,2.72380713820745e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPMT,Thiopurine S-methyltransferase,41843,0.0587150788555046,0.00742160044909299,0.0441687419752824,0.0732614157357269,2.74675162653529e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DGKZ,Diacylglycerol kinase zeta,41913,0.0296077452790338,0.00374564077539847,0.0222662893592528,0.0369492011988148,2.89877794892106e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1RL,Complement C1r subcomponent-like protein,39958,0.0161620036379421,0.00204613657409281,0.0121515759527202,0.020172431323164,3.07556149481995e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLAMF6,SLAM family member 6,41843,0.0316637297283737,0.00401086208074288,0.0238024400501177,0.0395250194066298,3.14330344446749e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,0.0723332645332436,0.00916318973469418,0.054373412653243,0.0902931164132442,3.19868422639854e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADM,Pro-adrenomedullin,42262,0.021412425504306,0.00271344908232525,0.0160940653029485,0.0267307857056635,3.21907240563886e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOF,Apolipoprotein F,39990,-0.021147559022497,0.00268522635102043,-0.0264106026704971,-0.015884515374497,3.70102966678171e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK6,Kallikrein-6,42158,0.0252064873026826,0.00320392832211841,0.0189267877913306,0.0314861868140347,3.89482908371651e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LACRT,Extracellular glycoprotein lacritin,39895,0.0370460415623869,0.00471547223602482,0.0278037159797783,0.0462883671449956,4.31577573650972e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOD,Apolipoprotein D,39468,-0.0346069422245243,0.00440488770100316,-0.0432405221184905,-0.0259733623305581,4.32314024097507e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FST,Follistatin,42166,0.0396562173744299,0.00505303228761672,0.0297522740907011,0.0495601606581586,4.54243733027712e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NID2,Nidogen-2,42137,0.0590892932254596,0.00756631629477878,0.0442593132876932,0.073919273163226,6.16132283769258e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,0.0305950407984873,0.00392112839200208,0.0229096291501632,0.0382804524468113,6.59633801074956e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGA6,Integrin alpha-6,42119,0.0411749160661704,0.00528078755087591,0.0308245724664536,0.0515252596658872,6.79554977174848e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IMPA1,Inositol monophosphatase 1,42016,0.0494084110636326,0.00635108936155739,0.0369602759149801,0.0618565462122851,7.81024984798967e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DENR,Density-regulated protein,39657,0.0463321857593363,0.00596354096895464,0.0346436454601852,0.0580207260584874,8.5944180661207e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,0.035887491618788,0.00461995922124168,0.0268323715451543,0.0449426116924217,8.68373057842177e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSCAM,Down syndrome cell adhesion molecule,39934,0.0292188816977831,0.00376687815275197,0.0218358005183892,0.0366019628771769,9.45686540541544e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPK1,Thiamin pyrophosphokinase 1,39958,0.0224815438564064,0.00290288010654695,0.0167918988475744,0.0281711888652384,1.04055470497265e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACRBP,Acrosin-binding protein,39919,0.0320589565326257,0.00413961631043468,0.0239453085641737,0.0401726045010776,1.04197111246057e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,42123,0.0433473993784268,0.0056026226433329,0.0323662589974943,0.0543285397593592,1.08993028674025e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EBI3_IL27,Interleukin-27,42247,-0.0245657330464493,0.00317647613240504,-0.0307916262659632,-0.0183398398269355,1.11810815523492e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC27A4,Long-chain fatty acid transport protein 4,41839,0.0547285135708063,0.00708430833256069,0.0408432692389874,0.0686137579026253,1.19582339148656e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPT,Dermatopontin,42310,0.0202965630150474,0.00263447809749141,0.0151329859439642,0.0254601400861305,1.40669746788527e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TREML2,Trem-like transcript 2 protein,42137,0.0274174698118525,0.00357744488173844,0.0204056778436452,0.0344292617800599,1.92492978901115e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLO1,Lactoylglutathione lyase,41900,0.0448980335145451,0.00586047218490613,0.0334115080321291,0.0563845589969611,1.96975383599087e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA9,Carbonic anhydrase 9,42262,-0.0370675080604956,0.00484313599523511,-0.0465600546111564,-0.0275749615098347,2.08471438166663e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,0.0706376391173058,0.00925519661300525,0.0524974537558155,0.0887778244787961,2.49600539312461e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,-0.0267800680574974,0.00351043678883566,-0.0336605241636153,-0.0198996119513795,2.5663971382354e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL7,Angiopoietin-related protein 7,42262,0.0290705135884477,0.00381201054919273,0.0215989729120299,0.0365420542648654,2.58044737653256e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DHPS,Deoxyhypusine synthase,39919,0.0317884929259319,0.00417861718678027,0.0235984032398426,0.0399785826120212,3.0177937996064e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ROBO2,Roundabout homolog 2,42249,0.0178600026915569,0.00234832701831747,0.0132572817356547,0.0224627236474592,3.02519758053054e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD27,CD27 antigen,42181,-0.0336552943181948,0.00443038505808259,-0.0423388490320367,-0.0249717396043529,3.24177196443001e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBP1,Guanylate-binding protein 1,39911,0.0509448553789039,0.00670687338115943,0.0377993835518314,0.0640903272059764,3.29704568387144e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,0.0364333624335567,0.00479818556471948,0.0270289187267065,0.0458378061404069,3.37363147468231e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCRN1,Secernin-1,42119,0.0435497793225118,0.0057408406918699,0.0322977315664467,0.0548018270785768,3.5156075637846e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,0.045056482169001,0.00594010033178964,0.0334138855186933,0.0566990788193087,3.54149612823515e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCT,Secretin,39649,0.0379038083310093,0.00499639067266115,0.0281108826125935,0.0476967340494252,3.55780082061268e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,42145,-0.0223838678461271,0.00295693079296199,-0.0281794522003326,-0.0165882834919216,3.97409974986502e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMS,Spermine synthase,39586,0.0504424788289005,0.00666457247793403,0.0373799167721498,0.0635050408856512,4.06997200494306e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,39803,0.0440246433334976,0.00582000231334503,0.0326174387993414,0.0554318478676539,4.20252347419722e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN5,CCN family member 5,42137,0.0297565674182532,0.00394036945078144,0.0220334432947216,0.0374796915417848,4.57012251256563e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MENT,Protein MENT,39736,-0.0186018964841801,0.00246584075057259,-0.0234349443553024,-0.0137688486130578,4.91884662287314e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFCAB2,Dynein regulatory complex protein 8,39757,0.0275990459674041,0.00366308297465508,0.0204194033370801,0.034778688597728,5.2861545000033e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,0.0274732470737288,0.00364751463873055,0.0203241183818169,0.0346223757656406,5.30741194122271e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,0.0563684258827034,0.00748502906588931,0.0416977689135603,0.0710390828518464,5.36648635365604e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCDC80,Coiled-coil domain-containing protein 80,42145,0.0274582823072769,0.00364945022448878,0.0203053598672789,0.0346112047472749,5.64913512076133e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,0.0513424461794127,0.00682498930714452,0.0379654671374095,0.064719425221416,5.77063933219792e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XRCC4,DNA repair protein XRCC4,41839,0.0287584348292844,0.00383032523131743,0.0212509973759022,0.0362658722826665,6.38292140493849e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LXN,Latexin,41960,-0.0534733091278933,0.00712751595256312,-0.067443240394917,-0.0395033778608696,6.6626420545238e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,0.034362522884047,0.0045834400730582,0.0253789803408529,0.0433460654272411,7.02428701635355e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17D,Interleukin-17D,41913,0.026503610118815,0.00353659426385153,0.019571885361666,0.033435334875964,7.09615345731251e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA9,Serpin A9,42025,0.0562115140305789,0.00750143103698776,0.0415087091980829,0.0709143188630749,7.12852656078378e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDF1,Endothelial differentiation-related factor 1,39934,0.0514883039902678,0.00688672376462575,0.0379903254116013,0.0649862825689343,8.19813588508992e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDHB,Succinate dehydrogenase,39930,0.0508729063373142,0.00680710065108959,0.0375309890611786,0.0642148236134498,8.38357400886127e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSR,"Glutathione reductase, mitochondrial",39949,0.0177647557081323,0.00237928709196788,0.0131013530078753,0.0224281584083894,8.84403729928605e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNF,Tumor necrosis factor,41880,0.0281316493929485,0.00377385565861107,0.0207348923020708,0.0355284064838262,9.58984728497592e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,39966,-0.0255091940224913,0.00342335613857293,-0.0322189720540942,-0.0187994159908884,9.89650793019246e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,0.0541355150435215,0.00726512018361862,0.039895879483629,0.068375150603414,9.91743469728308e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLRX,Glutaredoxin-1,42057,0.0428567478042088,0.00576580175476927,0.031555776364861,0.0541577192435566,1.126344921205e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGAM,Integrin alpha-M,42137,-0.0243423210552019,0.00327840011076302,-0.0307679852722974,-0.0179166568381064,1.19459079140303e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH1,Protocadherin-1,42264,0.0158548562842671,0.00213648654284827,0.0116673426602845,0.0200423699082497,1.23103288181385e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB8,DnaJ homolog subfamily B member 8,41900,0.043303287856283,0.00583548437989745,0.031865738471684,0.054740837240882,1.2358455591741e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MOG,Myelin-oligodendrocyte glycoprotein,42262,0.0255135376871523,0.0034488695921086,0.0187537532866195,0.0322733220876852,1.46690931395308e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMARCA2,Probable global transcription activator SNF2L2,41839,0.056463182025868,0.00763841935991671,0.0414918800804313,0.0714344839713048,1.53316862883149e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPL14,60S ribosomal protein L14,39638,0.0298993870235422,0.00405497480833779,0.0219516363992001,0.0378471376478843,1.78098607024303e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDK2,Protein sidekick-2,39736,0.0300895427693177,0.00408142306637359,0.0220899535592255,0.0380891319794099,1.79580553405159e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAA4,Serum amyloid A-4 protein,39979,0.0252072100632034,0.0034193777739168,0.0185052296263265,0.0319091905000804,1.79917105659555e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0245182246510738,0.00333469135331544,-0.0310542197035721,-0.0179822295985756,2.05740915649096e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SBSN,Suprabasin,39954,-0.0270727149961037,0.00368646352762797,-0.0342981835102545,-0.0198472464819529,2.21791834323044e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BPIFA2,BPI fold-containing family A member 2,39281,-0.0844789345197797,0.0115135229429324,-0.107045439487927,-0.0619124295516321,2.33657934256083e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGAL,Integrin alpha-L,39657,0.0332580019943891,0.0045350846917768,0.0243692359985066,0.0421467679902716,2.39913798322771e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TLR3,Toll-like receptor 3,42296,0.0464730509238111,0.00634063321323601,0.0340454098258685,0.0589006920217537,2.44126067510901e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.0362422265586109,0.00495051736268104,-0.0459452405894658,-0.0265392125277561,2.6007158181877e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAA10,N-alpha-acetyltransferase 10,39575,0.0383600839818612,0.00526158981223964,0.0280473679498715,0.0486728000138509,3.29839575465024e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WAS,Wiskott-Aldrich syndrome protein,41913,0.0495154744061724,0.00680857770489273,0.0361706621045826,0.0628602867077621,3.72570020043028e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,0.0697583060971726,0.00961017254265398,0.0509223679135708,0.0885942442807744,4.16084336340675e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RABEPK,Rab9 effector protein with kelch motifs,41843,0.0434054177084001,0.00599204769586763,0.0316610042244995,0.0551498311923006,4.60274874038866e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRP2,Neuropilin-2,42137,-0.0211481327116711,0.00291974889183123,-0.0268708405396603,-0.0154254248836819,4.62120018117858e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTN,Pleiotrophin,41900,0.0374045945687026,0.00516740568657339,0.0272764794230187,0.0475327097143864,4.78344374710196e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAPK2,Death-associated protein kinase 2,39657,0.0415836166152876,0.00574530504986624,0.0303228187175498,0.0528444145130255,4.86102560362391e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFHR2,Complement factor H-related protein 2,39904,0.0427401823529431,0.005922048744677,0.0311329668133762,0.05434739789251,5.64988271967803e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GC,Vitamin D-binding protein,39979,0.0193334509497139,0.00268042741776749,0.0140798132108896,0.0245870886885382,5.82821230637392e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB6,Integrin beta-6,41913,0.0229893769883502,0.00318802649726334,0.0167408450537141,0.0292379089229863,5.84712204641799e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGXT,Serine--pyruvate aminotransferase,42145,0.0574150467631039,0.00796420790901893,0.0418051992614268,0.073024894264781,5.9291852606035e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,0.0471182625086689,0.00654013805361222,0.034299591923589,0.0599369330937488,6.19536509375648e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PMM2,Phosphomannomutase 2,39575,0.0447592677904235,0.0062278411815035,0.0325526990746766,0.0569658365061703,7.05497538203592e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C7orf50,Uncharacterized protein C7orf50,39929,0.0170001665221334,0.00236563969954783,0.0123635127110197,0.0216368203332472,7.07594988727273e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGT,Angiotensinogen,39990,0.0161823420170336,0.00225831182179198,0.0117560508463213,0.0206086331877458,8.21809345308052e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INSL5,Insulin-like peptide INSL5,39930,0.0760115662731437,0.0106225914224701,0.0551912870851024,0.096831845461185,8.84179850004161e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACTN2,Alpha-actinin-2,39575,-0.0479704677451104,0.00670421994195387,-0.06111073883134,-0.0348301966588809,8.88382661452013e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,0.0721854898665417,0.0101082500417417,0.052373319784728,0.0919976599483553,9.72598421345783e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFC1,Cryptic protein,41843,0.0353428076189985,0.00496716448145374,0.0256071652353492,0.0450784500026478,1.17423204171882e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.0810263997511644,0.0113904062606128,0.0587012034803633,0.103351596021966,1.18745712079545e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARSA,Arylsulfatase A,42137,0.0332970416028416,0.00468383615283545,0.0241167227432841,0.0424773604623991,1.22810541781177e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDA,Cytidine deaminase,39946,0.0350909071765419,0.00494604871309995,0.025396651698866,0.0447851626542178,1.37318447254799e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG1A,Lithostathine-1-alpha,42105,-0.0367018001388615,0.00517512925111204,-0.0468450534710411,-0.0265585468066819,1.38806252955889e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,0.036559006030029,0.00515810062934845,0.026449128796506,0.0466688832635519,1.43110818111575e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSNK1D,Casein kinase I isoform delta,39657,0.0473095325984338,0.00667590066580321,0.0342247672934595,0.0603942979034081,1.4579963115612e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C2orf69,UPF0565 protein C2orf69,39649,0.0433358541115911,0.00612163291722231,0.0313374535938354,0.0553342546293469,1.53859127830049e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,0.045310788304277,0.00640222453232382,0.0327624282209223,0.0578591483876316,1.54293530255083e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,0.0345341339964392,0.00488127735791838,0.0249668303749192,0.0441014376179592,1.57170947103792e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRDT,Bromodomain testis-specific protein,39575,0.0268640439523494,0.00379673493361913,0.0194224434824559,0.0343056444222429,1.57914906234171e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXNB2,Plexin-B2,42255,0.0179557932493755,0.00253916291701402,0.012979033932028,0.022932552566723,1.606742098179e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,0.0505570647672224,0.00718317866062114,0.0364780345924049,0.0646360949420398,2.04076813097384e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,-0.0298204984590439,0.0042387123607222,-0.0381283746860594,-0.0215126222320284,2.10300857465938e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HPCAL1,Hippocalcin-like protein 1,42296,0.0536756048668456,0.00763648426661674,0.0387080957042768,0.0686431140294144,2.18115975374121e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA4,Annexin A4,42088,0.0528339469900097,0.00752224183510325,0.0380903529932073,0.0675775409868121,2.26427611217626e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TEK,Angiopoietin-1 receptor,42181,0.0161251276042635,0.00229704084240014,0.0116229275531592,0.0206273276553678,2.32475262565181e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,-0.0276677696316617,0.00394160931561991,-0.0353933238902767,-0.0199422153730467,2.35534060068746e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,0.0456207343380896,0.00650830552365311,0.0328644555117295,0.0583770131644497,2.52915988843219e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASAH1,Acid ceramidase,39876,0.0343852329645069,0.00490714050555306,0.024767237573623,0.0440032283553909,2.57027922229991e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,0.0392391297191193,0.00560234480841504,0.0282585338946258,0.0502197255436128,2.63109197680913e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REN,Renin,42145,-0.0589585209337923,0.0084237388404086,-0.0754690490609932,-0.0424479928065915,2.69748022918689e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OMD,Osteomodulin,42185,-0.0297920598038703,0.0042583414040695,-0.0381384089558465,-0.0214457106518941,2.75382186065263e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD101,Immunoglobulin superfamily member 2,39930,0.0313661627145509,0.00448435437628463,0.022576828137033,0.0401554972920687,2.81046751797843e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DMD,Dystrophin,39638,0.0373433085837482,0.00534229543704124,0.0268724095271474,0.0478142076403491,2.90492040090264e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLITRK6,SLIT and NTRK-like protein 6,41900,-0.0250705774751934,0.00359052442033601,-0.0321080053390519,-0.0180331496113348,3.03896291459897e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,0.0321097051910617,0.00460009035781461,0.0230935280897451,0.0411258822923784,3.11153888931676e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM3,Intercellular adhesion molecule 3,42310,-0.0196082139878314,0.00281058094804478,-0.0251169526459992,-0.0140994753296636,3.16349956361984e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HGFAC,Hepatocyte growth factor activator,39897,0.0195663217016827,0.00280711969083251,0.014064367107651,0.0250682762957144,3.34007324954346e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,0.0314445068134884,0.00451358071561252,0.0225978886108879,0.0402911250160889,3.3993092983544e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL11,C-X-C motif chemokine 11,42249,0.056310804518975,0.00810187130004415,0.0404311367708885,0.0721904722670616,3.8093373778649e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BGN,Biglycan,41820,-0.0850282115440295,0.0122498418808788,-0.109037901630552,-0.061018521457507,4.07011465938308e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,0.0175494007469704,0.00252849952444828,0.0125935416790517,0.022505259814889,4.08190558169648e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPM1A,Protein phosphatase 1A,41843,0.0225904626263094,0.00325501935665553,0.0162106246872645,0.0289703005653542,4.09788069484626e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMP1,Metalloproteinase inhibitor 1,42032,0.0207171915565434,0.00298907491730408,0.0148586047186274,0.0265757783944594,4.370327293639e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,39911,0.0289467612685792,0.00417750690195087,0.0207588477407555,0.0371346747964029,4.46237071557223e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL4,Angiopoietin-related protein 4,42166,-0.0320329611014683,0.00462754790093472,-0.0411029549873004,-0.0229629672156363,4.64561792081205e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKD2,Serine/threonine-protein kinase D2,39575,0.0313881892454794,0.00453770992447142,0.0224942777935154,0.0402821006974434,4.86335772485951e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELOB,Elongin-B,39575,0.0281239562270552,0.00407153053110586,0.0201437563860877,0.0361041560680227,5.20690348027372e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,0.024669025454018,0.00357301822096319,0.0176659097409301,0.0316721411671058,5.2728839770325e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FES,Tyrosine-protein kinase Fes/Fps,41843,0.0339597461413505,0.00492468296282802,0.0243073675342076,0.0436121247484935,5.59827188916313e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FXN,"Frataxin, mitochondrial",42262,0.0519339738455211,0.00754144123949755,0.0371527490161059,0.0667151986749363,5.96898150881131e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSE,Cathepsin E,39736,0.0379193234355258,0.00550599163756908,0.0271275798258904,0.0487110670451612,6.00843683487332e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,0.0519742261228091,0.00755930608822716,0.0371579861898838,0.0667904660557343,6.44925635400231e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL12B,Interleukin-12 subunit beta,42296,0.0390146787279142,0.00568564901913131,0.0278708066504168,0.0501585508054115,7.08426401681243e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFDC1,WAP four-disulfide core domain protein 1,39699,0.0385832098854438,0.00562804171206627,0.0275522481297939,0.0496141716410936,7.48188286513942e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYM,Ketimine reductase mu-crystallin,39586,0.0537567584764149,0.00784996296059587,0.038370831073647,0.0691426858791828,7.88730272541671e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP9,Caspase-9,39657,0.0452620166079888,0.00662592831522317,0.0322751971101514,0.0582488361058262,8.87248509349701e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.0183958276799721,0.00269623258689293,0.013111211809662,0.0236804435502822,9.30985341604665e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,0.0286928910032256,0.00420488589609481,0.0204513146468798,0.0369344673595714,9.33625110627872e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,0.0596666346363906,0.00877568126244139,0.0424662993620055,0.0768669699107757,1.10575104916519e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,41839,0.0292557756730201,0.0043141426772174,0.020800056025674,0.0377114953203662,1.24097626583475e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,0.0340487031012039,0.00502482226694576,0.0242000514579902,0.0438973547444176,1.28693087466035e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,41839,0.0445507702043965,0.00657679298627338,0.0316602559513007,0.0574412844574923,1.30620835040971e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPAN1,Tetraspanin-1,41900,0.0512004153393977,0.00756109248933529,0.0363806740603005,0.0660201566184948,1.32748361812339e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VIT,Vitrin,39958,0.0270161077723121,0.0039907082815432,0.0191943195404875,0.0348378960041368,1.35359660967094e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAS2,Growth arrest-specific protein 2,39757,0.0365918953852044,0.00540851495044575,0.0259912060823307,0.047192584688078,1.39395567174338e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGR,Tyrosine-protein kinase Fgr,41839,0.0411963016767233,0.00609407400958321,0.0292519166179402,0.0531406867355064,1.43715601272539e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMA4,Laminin subunit alpha-4,42185,0.0239872878162102,0.00354932409952451,0.0170306125811421,0.0309439630512782,1.45344304849498e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NXPH1,Neurexophilin-1,41839,0.0272410568035618,0.00403180015830092,0.019338728493292,0.0351433851138316,1.4722661135918e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGF1R,Insulin-like growth factor 1 receptor,42070,0.0150239131295055,0.00222480958047073,0.0106632863517828,0.0193845399072281,1.50862222927554e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,0.0261764092829412,0.00388087164120801,0.0185699008661735,0.0337829176997089,1.60503863608459e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPA2,Carboxypeptidase A2,42205,0.0465468603294587,0.00690514582852356,0.0330127745055526,0.0600809461533649,1.63758058310915e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNC,Tenascin,42217,-0.0337561352814232,0.00501259924725516,-0.0435808298060434,-0.0239314407568031,1.71376986887781e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPM3,Tropomyosin alpha-3 chain,39575,-0.0323040692667905,0.00480566834914392,-0.0417231792311126,-0.0228849593024684,1.88040778328222e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDGF,Hepatoma-derived growth factor,42243,0.0636578737026016,0.00948214529010555,0.0450728689339948,0.0822428784712085,1.97595614970308e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTGDS,Prostaglandin-H2 D-isomerase,42083,0.0220355502295913,0.00328520864410611,0.0155965412871434,0.0284745591720393,2.05875535166722e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP1,Interstitial collagenase,41693,0.0627629462221985,0.00935801952239686,0.0444212279583007,0.0811046644860964,2.07020185326995e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,0.0300616933519007,0.00448541846991919,0.0212702731508591,0.0388531135529423,2.15467633104738e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECE1,Endothelin-converting enzyme 1,41839,0.0245819318229097,0.00366862765779399,0.0173914216136335,0.0317724420321859,2.15992331440668e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAFA5,Chemokine-like protein TAFA-5,42070,0.0254909544946703,0.00381358284201618,0.0180163321243186,0.032965576865022,2.41241023755946e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,0.0342271494596172,0.00512144476355422,0.0241891177230509,0.0442651811961834,2.43083115350295e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,0.020862706358329,0.0031336655223849,0.0147207219344546,0.0270046907822034,2.8905446779588e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTNB,Dystrobrevin beta,39900,0.0313585897018122,0.00471800883491804,0.0221112923853729,0.0406058870182516,3.13803117517444e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IMMT,MICOS complex subunit MIC60,39919,0.0307430995113448,0.00462654953408339,0.0216750624245414,0.0398111365981483,3.17284865378169e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA4,Carbonic anhydrase 4,42310,-0.0167296203524901,0.00251855869941395,-0.0216659954033414,-0.0117932453016387,3.19955344470961e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBLIF,Cobalamin binding intrinsic factor,42129,0.0524237988656504,0.00792393985576597,0.0368928767483491,0.0679547209829517,3.8325283740993e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.0182014742477685,0.00275375634536281,0.0128041118108574,0.0235988366846796,3.99417032481063e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD274,Programmed cell death 1 ligand 1,42016,0.0231876387040068,0.00350838325628909,0.0163112075216802,0.0300640698863334,4.00977900301465e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,0.0474753337416439,0.0071867516345875,0.0333893005378524,0.0615613669454354,4.13107929548962e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6V1F,V-type proton ATPase subunit F,41820,0.045727682562761,0.00693074189160546,0.0321434284552143,0.0593119366703077,4.33185308055221e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHB4,Ephrin type-B receptor 4,42310,-0.0173713417446152,0.00263328868166082,-0.0225325875606704,-0.01221009592856,4.3546981864857e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIMAP8,GTPase IMAP family member 8,39560,0.034348194014839,0.00520572624004097,0.0241449705843586,0.0445514174453193,4.35500341102165e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.0167752911755221,0.0025434636186442,0.0117901024829795,0.0217604798680647,4.4274937440086e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFHR4,Complement factor H-related protein 4,39945,0.0499754724096747,0.00759292345769594,0.0350933424325907,0.0648576023867588,4.85116196115511e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADA2,Adenosine deaminase 2,42096,-0.0299287054208953,0.00455404435768048,-0.038854632361949,-0.0210027784798415,5.15028147012196e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPCAM,Epithelial cell adhesion molecule,42125,-0.0638001003992162,0.00970973165979503,-0.0828311744524144,-0.0447690263460179,5.18997472718785e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NADK,NAD kinase,42145,0.0372728800145275,0.0056741843669879,0.0261514786552312,0.0483942813738238,5.25561212787348e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OCLN,Occludin,39934,0.0301653666816869,0.00459271761692638,0.0211636401525112,0.0391670932108626,5.31960558344161e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOB,Apolipoprotein B-100,39990,0.0155069186291822,0.00236583078021498,0.0108698902999608,0.0201439469584035,5.82260056366393e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL2A1,Collagen alpha-1(II) chain,39638,0.0536070454770177,0.00818351174679445,0.0375673624533006,0.0696467285007348,5.98487026019869e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,0.0414195780098439,0.00634619274881827,0.0289810402221601,0.0538581157975277,6.96498854753175e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDCP1,CUB domain-containing protein 1,42016,0.0379600423490524,0.00582168376178083,0.026549542175962,0.0493705425221428,7.26029546809612e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PALM2,Paralemmin-2,39929,0.0262312525259899,0.00402419554564983,0.0183438292565163,0.0341186757954636,7.4087073851998e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS7_LGALS7B,Galectin-7,42076,0.0296864389791356,0.00456804285976441,0.0207330749739973,0.0386398029842738,8.38546696434119e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SF3B4,Splicing factor 3B subunit 4,42070,0.048751037879422,0.00751700755501671,0.0340177030715893,0.0634843726872548,9.15664769728722e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.0291178084726291,0.00449178816402146,-0.0379217132741112,-0.020313903671147,9.33768296621398e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGB3A1,Secretoglobin family 3A member 1,39736,-0.0175731432038094,0.00272191178888105,-0.0229080903100163,-0.0122381960976026,1.11848180304752e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QA,Complement C1q subcomponent subunit A,42230,-0.0149625256737887,0.00232192815985852,-0.0195135048671115,-0.010411546480466,1.20270493290687e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS22,Brain-specific serine protease 4,39657,0.0231627823393776,0.00359466274645778,0.0161172433563204,0.0302083213224349,1.21475791405242e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL15A1,Collagen alpha-1(XV) chain,39966,0.0180637157495144,0.00280457545764716,0.012566747852526,0.0235606836465028,1.23639815808778e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,41930,0.0304642141264453,0.00473464865760526,0.021184302757539,0.0397441254953516,1.28272632324903e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC10A,C-type lectin domain family 10 member A,42016,-0.0244134376600821,0.00379936658205914,-0.0318601961609181,-0.0169666791592462,1.35734122689115e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,0.0330467901855969,0.00514900341847953,0.0229547434853771,0.0431388368858168,1.43769271766968e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRD1,Natural killer cells antigen CD94,42296,0.0313326733937347,0.00489517807014246,0.0217381243762555,0.0409272224112139,1.5968151170084e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST5,Cystatin-D,41846,0.0374244364333114,0.00584867645128342,0.0259610305887959,0.0488878422778269,1.6188708327623e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,39930,0.0761061452893193,0.0118971898888523,0.0527876531071687,0.0994246374714699,1.64719058105258e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSDE1,Cold shock domain-containing protein E1,39575,0.0800908866914285,0.0125202972081913,0.0555511041633735,0.104630669219483,1.65033452704478e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGER,Advanced glycosylation end product-specific receptor,42093,0.0271402166013445,0.00426150398121031,0.0187876687981723,0.0354927644045167,1.96824703364608e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,0.0255261524689114,0.00402779209381086,0.0176316799650421,0.0334206249727807,2.40828762619885e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.0272609138982796,0.00430786622751357,-0.0357043317042062,-0.018817496092353,2.558278037352e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GDF15,Growth/differentiation factor 15,42310,-0.0300275665551252,0.00475234850965211,-0.0393421696340433,-0.0207129634762071,2.72333873438763e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECI2,Enoyl-CoA delta isomerase 2,39575,0.0398259209373191,0.00631677892461724,0.0274450342450693,0.0522068076295689,2.99684084832941e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD46,Membrane cofactor protein,42107,0.0187513588114625,0.00297538282221094,0.012919608479929,0.0245831091429959,3.02631196841637e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGMN,Legumain,42185,0.0237454847324718,0.00376883250376566,0.0163585730250911,0.0311323964398525,3.0586373845048e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,0.0382947156578745,0.00608163891282412,0.0263747033887392,0.0502147279270098,3.15428456863701e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,41843,0.0233442859618069,0.00370858171070882,0.0160754658088176,0.0306131061147962,3.17778472870018e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MILR1,Allergin-1,41913,-0.0334078088566571,0.00530975308583679,-0.0438149249048972,-0.023000692808417,3.23671280108116e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX7,Syntaxin-7,39657,0.0320291821235275,0.0050941103740783,0.022044725790334,0.042013638456721,3.34800892168773e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MNDA,Myeloid cell nuclear differentiation antigen,42119,0.0639833244376383,0.0101795996288389,0.0440313091651141,0.0839353397101625,3.36954031529924e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFTPD,Pulmonary surfactant-associated protein D,42145,0.0440891538027819,0.00701690447119777,0.0303360210392343,0.0578422865663295,3.41657675994171e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,39807,0.0365911381188118,0.00582778874464448,0.0251686721793086,0.048013604058315,3.53967063629997e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APRT,Adenine phosphoribosyltransferase,42002,0.0306818984795276,0.00489200482647794,0.0210935690196309,0.0402702279394244,3.67754094367137e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYOM2,Myomesin-2,39575,-0.0362793763259929,0.00578710430253075,-0.0476221007589532,-0.0249366518930326,3.77012631739187e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCAM2,Neural cell adhesion molecule 2,42137,-0.0175292471260176,0.00279858225322496,-0.0230144683423385,-0.0120440259096967,3.87528011191838e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGHMBP2,DNA-binding protein SMUBP-2,39575,0.0364308532392644,0.00582625079316599,0.0250114016846591,0.0478503047938697,4.17927914345844e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BOLA1,BolA-like protein 1,39586,0.0353549293657608,0.00565900307945384,0.0242632833300313,0.0464465754014903,4.32359706394827e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYZL2,Lysozyme-like protein 2,39560,0.0235896325360418,0.00377647086260556,0.0161877496453349,0.0309915154267487,4.35382153323394e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.0291035030537439,0.00466141836506704,-0.0382398830492753,-0.0199671230582125,4.40598231068113e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASGR2,Asialoglycoprotein receptor 2,39990,0.0171256360849808,0.00274285901902977,0.0117496324076824,0.0225016397622791,4.42499603833159e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,0.0661961238489859,0.0106174948806581,0.0453858338828959,0.0870064138150758,4.66439302158283e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.0295310572335608,0.00473796547644455,-0.0388174695673921,-0.0202446448997295,4.7143503412188e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AOC3,Membrane primary amine oxidase,42217,-0.019191490818486,0.00307930338709876,-0.0252269254571996,-0.0131560561797725,4.72845947346241e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,41843,0.0335588795888421,0.00538477636102623,0.0230047179212307,0.0441130412564535,4.73945199453185e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.0263426983255234,0.00423270894214755,-0.0346388078521326,-0.0180465887989142,5.00300616265709e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPA,Apolipoprotein(a),39775,-0.117856661495323,0.0189597094424857,-0.155017692002595,-0.0806956309880509,5.27620152556533e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.0331138410343345,0.00532925893173769,-0.0435591885405404,-0.0226684935281287,5.33016169973009e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,42129,0.0201588480063512,0.00324781656131028,0.013793127546183,0.0265245684665193,5.56205685701151e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH15,Cadherin-15,42230,0.0445690011068686,0.00718318531047149,0.0304899578983445,0.0586480443153927,5.64126062306199e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SV2A,Synaptic vesicle glycoprotein 2A,39649,0.0401292484091424,0.00648232184182957,0.0274238975991565,0.0528345992191284,6.2075186663415e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,39958,0.0381692971521042,0.00618054693231612,0.0260554251647646,0.0502831691394438,6.81155784897022e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APLP1,Amyloid-like protein 1,42145,-0.0324844857362098,0.00527716928304816,-0.0428277375309842,-0.0221412339414354,7.68732826709443e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSL,Cathepsin L1,42145,0.0156294276874022,0.00254076123563029,0.0106495356655669,0.0206093197092376,7.89267489981426e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESAM,Endothelial cell-selective adhesion molecule,42310,0.0207574683838992,0.00337909386920119,0.0141344444002648,0.0273804923675335,8.32638920482822e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX58,Antiviral innate immune response receptor RIG-I,41843,0.0361355139369896,0.00588388138138808,0.0246031064294689,0.0476679214445102,8.41157315571049e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,0.0283049292816488,0.00460844176797015,0.0192723834164273,0.0373374751468703,8.43030365734785e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXADR,Coxsackievirus and adenovirus receptor,42119,0.0311531415125738,0.00508190977165696,0.0211925983601262,0.0411136846650214,9.02083298583048e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,0.0763354980766794,0.0124544172947115,0.0519248401790448,0.100746155974314,9.12640572793992e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENAH,Protein enabled homolog,41913,0.0306485976920823,0.00500235650193167,0.0208439789482962,0.0404532164358683,9.21735411545277e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,0.0318236211762461,0.00520185506567003,0.0216279852475329,0.0420192571049594,9.75834112589059e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,0.0146991773988447,0.00240994015427724,0.00997569469646126,0.0194226601012281,1.09931817492021e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,0.024464001338497,0.00401339234756734,0.0165977523372651,0.032330250339729,1.11995540498609e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNLIP,Pancreatic triacylglycerol lipase,39990,0.0419710135445651,0.00689489166904818,0.0284570258732306,0.0554850012158995,1.1855449097446e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL14,C-C motif chemokine 14,42152,0.0255102559603586,0.00419772383979238,0.0172827172343655,0.0337377946863517,1.25606865748811e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIMAP7,GTPase IMAP family member 7,39736,-0.0203014050249337,0.00334071758001348,-0.0268492114817602,-0.0137535985681073,1.26489129224244e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX5,Sorting nexin-5,39638,0.0187532045761437,0.00309469494496983,0.0126876024840028,0.0248188066682845,1.40746844781034e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC16A1,Monocarboxylate transporter 1,41839,0.0346588432972307,0.00572698368478543,0.0234339552750513,0.0458837313194101,1.47059505246214e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTSL4,ADAMTS-like protein 4,39638,0.015534606618159,0.00256759744397797,0.0105021156279622,0.0205670976083558,1.49311763421422e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CX3CL1,Fractalkine,42016,-0.0209932385552968,0.00347485721655148,-0.0278039586997377,-0.0141825184108559,1.56760376329388e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AFAP1,Actin filament-associated protein 1,39736,0.0522880030911567,0.0086781449967371,0.035278838897552,0.0692971672847615,1.7418655600876e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,-0.01382441801181,0.00229548398416821,-0.0183235666207797,-0.00932526940284033,1.76336080302524e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPHS1,Nephrin,39657,0.0208078783845316,0.0034566068057142,0.0140329290453318,0.0275828277237314,1.80240358916375e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MDM1,Nuclear protein MDM1,39649,0.0196555964250982,0.00326749994845542,0.0132512965261256,0.0260598963240708,1.85029211117717e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCTS1,Malignant T-cell-amplified sequence 1,39930,0.0162808793669192,0.00271514062217746,0.0109592037474514,0.021602554986387,2.0797993735802e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TREML1,Trem-like transcript 1 protein,39990,0.0329535324359097,0.00550079189580831,0.0221719803201254,0.043735084551694,2.15267276211492e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.0228976781747701,0.00383602761818715,-0.0304162923064169,-0.0153790640431233,2.44514823024051e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F3,Tissue factor,42174,-0.0161775517468964,0.00271264121750174,-0.0214943285331998,-0.010860774960593,2.52619263529493e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,0.0295072971944872,0.00494877924499679,0.0198076898742935,0.0392069045146809,2.55747766854234e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPL,Periplakin,39657,0.0199634459505596,0.00335195512754208,0.0133936139005771,0.026533278000542,2.66738956807422e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,0.0403858445369993,0.00679426588697688,0.0270690833985246,0.053702605675474,2.8642293810929e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD74,HLA class II histocompatibility antigen gamma chain,42249,0.0213591102670116,0.00359867937662757,0.0143056986888216,0.0284125218452016,3.0048956942858e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,41820,0.0251400174082326,0.00424025415159324,0.0168291192711098,0.0334509155453553,3.12589353866885e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRC38,Leucine-rich repeat-containing protein 38,39649,0.0289900457514851,0.00489139247693081,0.0194029164967007,0.0385771750062695,3.18222502064253e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,-0.0262626451354484,0.00443544505666276,-0.0349561174465074,-0.0175691728243894,3.27613004443167e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX6,Syntaxin-6,41843,0.0401928816863056,0.0068127646497803,0.0268398629727362,0.053545900399875,3.73184055966138e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEPE,Matrix extracellular phosphoglycoprotein,42123,0.0144017249751577,0.00244174663089211,0.00961590157860912,0.0191875483717062,3.7643861302731e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPAN8,Tetraspanin-8,39930,0.0583392492839009,0.00990113400311684,0.0389330266377919,0.0777454719300099,3.91980667309252e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,0.0241179756088808,0.00410360750232989,0.0160749049043142,0.0321610463134473,4.29041659746213e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,42230,-0.011720430458302,0.001997536025395,-0.0156356010680762,-0.00780525984852776,4.52838650244948e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA6,Carbonic anhydrase 6,42103,-0.038145728943847,0.00650432328937485,-0.0508942025910217,-0.0253972552966723,4.60545297300689e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RCOR1,REST corepressor 1,41900,0.0271771751410363,0.00463561809297409,0.0180913636788071,0.0362629866032655,4.66241001466843e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCN2,Transcobalamin-2,42286,-0.0183961971800286,0.00314234574340776,-0.0245551948371079,-0.0122371995229494,4.90035351689684e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BST2,Bone marrow stromal antigen 2,42249,0.0309962521861956,0.00529494978339091,0.0206181506107494,0.0413743537616418,4.91126918016262e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,41843,0.0243392953252905,0.00417071043024391,0.0161647028820125,0.0325138877685686,5.47963020220433e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,-0.0252972836588098,0.0043422291498676,-0.0338080527925503,-0.0167865145250693,5.83873070608958e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP6,Gastrotropin,41881,0.0343522208220877,0.00590181614619461,0.0227846611755463,0.0459197804686292,5.99840607233185e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPR,Nucleoprotein TPR,39575,0.0295203642765789,0.00507437813022525,0.0195745831413374,0.0394661454118204,6.1391082263886e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,0.0266477335567402,0.00458584596203515,0.0176594754711513,0.035635991642329,6.38795018646939e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCD6,Programmed cell death protein 6,42145,-0.0424671611476487,0.00732851145522321,-0.0568310435998862,-0.0281032786954112,6.99297444542379e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSR1,Macrophage scavenger receptor types I and II,42249,0.0284216834553463,0.00491073252393794,0.0187966477084279,0.0380467192022646,7.29386202334036e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA1,Alpha-1-antitrypsin,39795,-0.00491411732766321,0.000849860708934856,-0.00657984431717553,-0.00324839033815089,7.56734629277331e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFF3,Trefoil factor 3,42143,-0.0216539153496351,0.00374734964673152,-0.0289987206572289,-0.0143091100420413,7.70455279081228e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWC2,Brorin,41973,0.0245788271215286,0.00425786982192235,0.0162334022705608,0.0329242519724964,7.98070647151724e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,0.0257983333187496,0.00446920337653113,0.0170386947007486,0.0345579719367506,7.98604708950828e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,0.0310790307358325,0.00538986021535549,0.0205149047137357,0.0416431567579292,8.28278519579627e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,-0.0186694127245257,0.00323940926434246,-0.0250186548826369,-0.0123201705664145,8.47518311035839e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOA1,Apolipoprotein A-I,39979,-0.0163851574491003,0.0028494697825999,-0.0219701182229961,-0.0108001966752045,9.14058371128745e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYL3,Myosin light chain 3,39638,-0.0468235924103357,0.00816303344125321,-0.062823137955192,-0.0308240468654795,9.94550776167793e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTSL2,ADAMTS-like protein 2,39966,0.0206657406830532,0.00360371711573405,0.0136024551362145,0.027729026229892,1.00256163840404e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,42247,0.0401778057608055,0.00702115112950477,0.0264163495469761,0.0539392619746348,1.0723933372078e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSF,Cathepsin F,42181,0.0239351808495403,0.00418547174813032,0.0157316562232048,0.0321387054758757,1.09645549734802e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,-0.0138950521150098,0.00243262925063994,-0.0186630054462641,-0.00912709878375554,1.14031759426965e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RANBP1,Ran-specific GTPase-activating protein,39638,0.0305467352594018,0.00535775145713867,0.02004554240341,0.0410479281153936,1.21869843394341e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,42070,0.0122915713487347,0.00215814971384882,0.00806159790959102,0.0165215447878784,1.25640016081053e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LIPF,Gastric triacylglycerol lipase,39638,0.0371842682586366,0.00653046775278973,0.0243845514631688,0.0499839850541045,1.27289792679773e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA14,Carbonic anhydrase 14,42262,-0.021679213781671,0.00381078951378228,-0.0291483612286842,-0.0142100663346577,1.30480325890733e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM3C,Protein FAM3C,42129,0.0179081540183454,0.00315662598030146,0.0117211670969545,0.0240951409397362,1.43030853599204e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPT2,Angiopoietin-2,42262,-0.0218715659937649,0.00387654559656364,-0.0294695953630296,-0.0142735366245002,1.71399237484876e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.0147703650415328,0.00261840197005568,0.00963829718022369,0.019902432902842,1.72464818035021e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGB2A2,Mammaglobin-A,39575,-0.0182314986713758,0.00323417817543242,-0.0245704878952233,-0.0118925094475282,1.77170784943378e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,0.0314928938617723,0.00559718749431982,0.0205224063729054,0.0424633813506391,1.88208716612575e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD248,Endosialin,39966,-0.0236404392345139,0.00420616382629694,-0.0318845203340559,-0.0153963581349719,1.94971614368189e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,42310,0.00941029354960772,0.00167578692828002,0.00612575117017888,0.0126948359290366,1.99862397245693e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CABP2,Calcium-binding protein 2,39649,0.0381779437026789,0.00679798914856408,0.0248538849714933,0.0515020024338645,2.00075902496601e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEO1,RNA polymerase-associated protein LEO1,39934,0.0169671388089766,0.00302301986865103,0.0110420198664206,0.0228922577515327,2.03937191664224e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTGES2,Prostaglandin E synthase 2,39579,0.0324915238497693,0.00579072596879903,0.0211417009509232,0.0438413467486154,2.0608397763591e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,42293,0.0350152933647642,0.00625111938376412,0.0227630993725866,0.0472674873569419,2.16667870710604e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,0.0219695604149212,0.00392639919492868,0.014273817992861,0.0296653028369815,2.25431047006178e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100P,Protein S100-P,41900,0.0310294120042835,0.00555814988823956,0.020135438223334,0.0419233857852331,2.41466336050161e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,0.0234843508040154,0.00421254653587213,0.015227759593706,0.0317409420143247,2.53398277279178e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LY75,Lymphocyte antigen 75,42119,0.0223618935988573,0.00401650381149091,0.0144895461283352,0.0302342410693795,2.63339854528862e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSV,Cathepsin L2,42200,0.0231251641785281,0.00415935383112733,0.0149728306695185,0.0312774976875377,2.75174922635269e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,0.0368570419023806,0.00663636008188123,0.0238497761418934,0.0498643076628678,2.85989888203815e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBS,Cystathionine beta-synthase,39638,0.0297497897288782,0.00537440764919626,0.0192159507364535,0.0402836287213029,3.17515508296308e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA12,Carbonic anhydrase 12,42070,-0.0187967116110337,0.00339926364862949,-0.0254592683623476,-0.0121341548597199,3.26858383578685e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ODAM,Odontogenic ameloblast-associated protein,41814,0.0309303583901957,0.00559384567425448,0.0199664208686569,0.0418942959117344,3.27509500076537e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,0.0216312966840551,0.00392892221592639,0.0139306091408394,0.0293319842272709,3.74501752246955e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM1,Intercellular adhesion molecule 1,42126,0.0166448386331119,0.00302326146393847,0.0107192461637925,0.0225704311024313,3.74639252546778e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINI2,Serpin I2,39930,0.0330152824590332,0.00599948120932482,0.0212562992887566,0.0447742656293099,3.81453913339735e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA7,Carbonic anhydrase 7,39757,-0.019137190469334,0.00348280641198455,-0.0259634910368237,-0.0123108899018443,3.99830738589101e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLIC5,Chloride intracellular channel protein 5,39649,-0.0179736450454257,0.00327305649802325,-0.0243888357815513,-0.0115584543093001,4.0759457550665e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPE,Ribulose-phosphate 3-epimerase,39757,0.0408034267499681,0.00743321203134941,0.0262343311685233,0.055372522331413,4.12264399612415e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLSTN2,Calsyntenin-2,42296,-0.0227830468566903,0.00415639910088419,-0.0309295890944233,-0.0146365046189573,4.29344275950741e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCAM,Basal cell adhesion molecule,42137,-0.0139362807861418,0.00255078324835805,-0.0189358159529236,-0.00893674561936,4.75007139698747e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA2,Carbonic anhydrase 2,42103,0.0375023395962643,0.00689270395764011,0.0239926398392897,0.051012039353239,5.39437871272578e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAGA,Alpha-N-acetylgalactosaminidase,39636,0.0323737337107665,0.00597409361286573,0.0206645102295496,0.0440829571919833,6.11867762546064e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB37,Ras-related protein Rab-37,41913,0.0456477981454133,0.00843375317161104,0.0291176419290556,0.0621779543617709,6.32230613335118e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MUC2,Mucin-2,39966,0.0520857274088847,0.00963710207196922,0.033197007347825,0.0709744474699444,6.62253700322646e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A13,Protein S100-A13,39657,0.0199561196410674,0.00369772243218058,0.0127085836739935,0.0272036556081413,6.92149962322129e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,0.0273580734025176,0.00508347796830856,0.0173944565846328,0.0373216902204024,7.52694076635635e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,0.0172927844557593,0.00321634965486911,0.0109887391322158,0.0235968297793027,7.74413739483549e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEL1L,Protein sel-1 homolog 1,39638,0.0175232840668776,0.0032661081617052,0.0111217120699354,0.0239248560638198,8.2500109318617e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA1,Carbonic anhydrase 1,41890,0.0313763177788983,0.00585207159344625,0.0199062574557437,0.042846378102053,8.38796118022333e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,39575,0.0543931161301915,0.0101460943511399,0.0345067712019573,0.0742794610584257,8.44449691037383e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFNA4,Ephrin-A4,41992,0.0179492206035622,0.00336225097996763,0.0113592086828256,0.0245392325242987,9.52726690350912e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,0.0228281672709114,0.00427826440881642,0.0144427690296313,0.0312135655121916,9.66336838963601e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,0.0203046842479045,0.003822292264441,0.0128129914096002,0.0277963770862089,1.10020174333323e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,0.024678719018985,0.00464834323665173,0.0155679662751476,0.0337894717628224,1.12226014910519e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL34,Interleukin-34,41814,0.0201359100017982,0.00379675796392397,0.0126942643925073,0.0275775556110892,1.15467468180093e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAT,Catalase,39827,0.0287672753600436,0.00543389362113492,0.0181168438626191,0.039417706857468,1.21897533725428e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENSA,Alpha-endosulfine,39919,0.0291265438500895,0.00550253923869268,0.0183415669422518,0.0399115207579272,1.22381064756898e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MUC16,Mucin-16,42070,0.104828795227939,0.0198275706235142,0.0659667568058516,0.143690833650027,1.26266430728244e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPR15L,Protein GPR15L,39930,0.0342137752575311,0.00647438026699909,0.0215239899342129,0.0469035605808493,1.28397888512969e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPC2,NPC intracellular cholesterol transporter 2,39820,0.018123758097716,0.003434421218742,0.0113922925089817,0.0248552236864503,1.33696820542756e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTB,Lymphotoxin-beta,39919,0.018820572773265,0.00357148820464604,0.0118204558921588,0.0258206896543713,1.39179298279e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRELP,Prolargin,42123,0.0127977825695245,0.00243129357484276,0.00803244716283271,0.0175631179762163,1.43286038279845e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK4,Kallikrein-4,42262,-0.0341956199607501,0.00650021880893421,-0.0469360488262612,-0.0214551910952391,1.45685852469171e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,0.0384574037910841,0.00731453507536458,0.0241209150433696,0.0527938925387987,1.48589383920269e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.0130900211169953,0.00249161744958522,0.00820645091580825,0.0179735913181823,1.51384875276956e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN4B,Sodium channel subunit beta-4,39638,0.0237570771236267,0.00452242103252679,0.0148931318998742,0.0326210223473792,1.52281799749746e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,0.0297809309766181,0.00567697815114172,0.0186540538003803,0.0409078081528559,1.5838801496893e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPO,Erythropoietin,42119,0.0397038891408849,0.00757130997740218,0.0248641215851766,0.0545436566965932,1.59508615840582e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GUCA2A,Guanylin,42083,-0.0191736710192649,0.00365778576052006,-0.0263429311098842,-0.0120044109286456,1.61349033811024e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,0.0218609623787379,0.0041719728023081,0.0136838956862141,0.0300380290712618,1.63497848812377e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,39872,0.0341177747704932,0.00651526159866733,0.0213478620371052,0.0468876875038811,1.66513269801532e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,-0.0136611161615964,0.00261210824091667,-0.0187808483137931,-0.00854138400939977,1.72078951878746e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP8,Caspase-8,42224,0.0330940578317903,0.00634269366250886,0.0206623782532729,0.0455257374103076,1.83850240943716e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALB2,Calretinin,41839,0.0159218482124768,0.00305644392896197,0.00993121811171136,0.0219124783132423,1.92428038846638e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PVALB,Parvalbumin alpha,42208,0.0603716360806041,0.0115992018640931,0.0376372004269817,0.0831060717342265,1.97021172082739e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSB,Cathepsin B,42153,-0.0274234745788903,0.00527285484212867,-0.0377582700694625,-0.0170886790883181,2.01238473263834e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,39638,0.0283714726216994,0.00545533740329607,0.0176790113112391,0.0390639339321597,2.02114539358154e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A12,Protein S100-A12,41910,0.0396115939987789,0.00762691525597467,0.0246628400970686,0.0545603479004893,2.09243335525977e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300LF,CMRF35-like molecule 1,42262,0.0323121475746581,0.00623577324077558,0.020090032022738,0.0445342631265782,2.22958106226198e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TDO2,"Tryptophan 2,3-dioxygenase",39649,0.0210963896708527,0.004082027912706,0.013095614961949,0.0290971643797565,2.40594588257232e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD83,CD83 antigen,42119,0.0185066390874111,0.00358354649868585,0.0114828879499868,0.0255303902248353,2.44721861776963e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,0.018972521889436,0.00367651172406004,0.0117665589102783,0.0261784848685937,2.49833861592739e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL7R,Interleukin-7 receptor subunit alpha,42137,-0.0278842129812555,0.00541647036833584,-0.0385004949031937,-0.0172679310593173,2.66909775294742e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRSF1,G-rich sequence factor 1,39486,0.0444810196443301,0.00864367426265885,0.0275394180895187,0.0614226211991414,2.70624614651616e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCAN,Neurocan core protein,42249,0.0200196344549666,0.00389221358730041,0.0123908958238578,0.0276483730860754,2.73389514042248e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTA,Lymphotoxin-alpha,42119,0.021346198031351,0.00415703818236601,0.0131984031939136,0.0294939928687884,2.86135380219159e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL1,Fc receptor-like protein 1,42145,0.0244097639621545,0.00475872779319179,0.0150826574874986,0.0337368704368104,2.94568125017491e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MDK,Midkine,42129,0.0272038372881983,0.00531545335741103,0.0167855487076726,0.0376221258687239,3.13229198224859e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WIF1,Wnt inhibitory factor 1,42262,-0.0178583696897259,0.00349480920349373,-0.0247081957285736,-0.0110085436508782,3.26557401873874e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PEPD,Xaa-Pro dipeptidase,39990,0.0139887860299416,0.00273821052045401,0.00862189340985171,0.0193556786500314,3.29575897092388e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTUS1,Microtubule-associated tumor suppressor 1,39757,0.0302389297984459,0.00592092311162315,0.0186339204996645,0.0418439390972273,3.32485790200886e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIF1C,Kinesin-like protein KIF1C,39575,0.0184746414711501,0.00362274286011328,0.011374065465328,0.0255752174769721,3.45999792265089e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP13,Collagenase 3,41839,-0.0170962776079306,0.0033538010690531,-0.0236697277032747,-0.0105228275125865,3.48764115840401e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,42262,0.0283561041430268,0.00556777313790335,0.0174432687927362,0.0392689394933173,3.57326448880026e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST1,Cystatin-SN,38503,0.0562043430760036,0.0110770568258187,0.034493311697399,0.0779153744546083,3.96728350096992e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN4,Contactin-4,42137,-0.0123843061627109,0.00244249544476537,-0.0171715972344511,-0.00759701509097083,4.02331429907111e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCF2,Neutrophil cytosol factor 2,42097,0.0437272904157701,0.00863104773615463,0.026810436852907,0.0606441439786332,4.11027332391739e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSC,Dipeptidyl peptidase 1,42123,0.0232840950241049,0.00460826907113144,0.0142518876446872,0.0323163024035225,4.41344563850223e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTP1,Glutathione S-transferase P,41759,-0.0366883383725295,0.00726366060502646,-0.0509251131583813,-0.0224515635866776,4.45521119513257e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,-0.0172435183779394,0.00341981132156531,-0.0239463485682074,-0.0105406881876714,4.66053327708464e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMBS,Porphobilinogen deaminase,42262,0.0210096737016254,0.00417522181386706,0.012826238946446,0.0291931084568048,4.91584621169244e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGSF21,Immunoglobulin superfamily member 21,39638,0.0210304807776788,0.00417963666893013,0.0128383929065757,0.0292225686487818,4.9392617859348e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM3B,Protein FAM3B,42070,0.0183714638927382,0.00365402053544821,0.0112095836432597,0.0255333441422166,5.02672399116343e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRH,Corticoliberin,41830,0.0447804063143342,0.00890791738087997,0.0273208882478094,0.0622399243808589,5.04637246080743e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL5,Fc receptor-like protein 5,42137,-0.0308795105540433,0.00614550749846058,-0.042924705251026,-0.0188343158570605,5.10574557258556e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHRDL1,Chordin-like protein 1,42166,0.0170384402649021,0.00339708097889639,0.0103801615462651,0.023696718983539,5.35330927185309e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGMB,RGM domain family member B,42249,0.0146052281296185,0.00291236412017718,0.00889699445407125,0.0203134618051658,5.37259811543207e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.0442190620901909,0.00883725930867176,0.0268980338451943,0.0615400903351876,5.69598093797298e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XG,Glycoprotein Xg,42261,0.0179815776189236,0.00359764210675004,0.0109301990896935,0.0250329561481537,5.85977771627399e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFIC,Nuclear factor 1 C-type,39934,0.0237300702543542,0.00475014279027203,0.0144197903854211,0.0330403501232874,5.9511022446143e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,41900,0.0264122737910743,0.00528946337261856,0.0160449255807419,0.0367796220014067,6.00851645481289e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADA,Adenosine deaminase,42296,0.0183900214420946,0.00368665113854805,0.0111641852105405,0.0256158576736488,6.16681961801499e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMOX1,Heme oxygenase 1,42007,-0.0255359633006005,0.00512104422876282,-0.0355732099889756,-0.0154987166122253,6.22595010790658e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,0.0476696628896679,0.00956823545343509,0.0289159214009351,0.0664234043784006,6.38593579843522e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,0.0259478179588211,0.00521218359526225,0.0157319381121071,0.0361636978055352,6.50888824816682e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.0292130869871227,0.00587695710644045,0.0176942510584994,0.0407319229157459,6.75023875214346e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,0.00947623875610449,0.00190694163880641,0.00573863314404394,0.013213844368165,6.81591850892869e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNU13,NHP2-like protein 1,39575,0.0325641635908855,0.00655463735317585,0.0197170743786608,0.0454112528031102,6.86275797937209e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICOSLG,ICOS ligand,42070,0.00984708428921578,0.00198617591517644,0.00595417949546996,0.0137399890829616,7.21596346730833e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,0.0231246034882672,0.00467086506585033,0.0139697079592005,0.0322794990173338,7.4796678478063e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXN,Thioredoxin,39854,0.0220458443648183,0.00446330825084455,0.0132977601931629,0.0307939285364736,7.95096702361006e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,0.0215514493416644,0.00436866031574973,0.0129888751227949,0.0301140235605339,8.18738516194222e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,0.0366918684589574,0.00743744928175289,0.0221144678667217,0.0512692690511931,8.19621919891751e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLYR1,Putative oxidoreductase GLYR1,39919,0.0295739862145953,0.00601892342189255,0.0177768963076859,0.0413710761215047,9.07168797201973e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UMOD,Uromodulin,42274,-0.0274552536271454,0.00559044335741908,-0.0384125226076868,-0.016497984646604,9.16112720044592e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PODXL,Podocalyxin,42070,0.0077165607682497,0.00157210880195477,0.00463522751641835,0.010797894020081,9.28908647104044e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEPTIN3,Neuronal-specific septin-3,39934,-0.0399004860869521,0.00813287021460462,-0.0558409117075771,-0.023960060466327,9.42077523198098e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,0.0243874006999766,0.00497573703777971,0.0146349561059284,0.0341398452940248,9.65840211513228e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA6,Corticosteroid-binding globulin,39979,0.00781477973921742,0.00160182973198587,0.00467519346452513,0.0109543660139097,1.08257067193306e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,39657,0.0153292940687546,0.00314286340017132,0.00916928180441884,0.0214893063330904,1.08939587121048e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,0.0139868256985945,0.0028681660615442,0.00836522021796787,0.0196084311792211,1.09165770107782e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELENOP,Selenoprotein P,39979,0.011448033829144,0.00234979996945915,0.00684242588900407,0.016053641769284,1.12009142840758e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,0.0183034902213562,0.00375865592683593,0.0109365246047578,0.0256704558379546,1.13332541696494e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDIA3,Protein disulfide-isomerase A3,39736,0.012428299998856,0.00255318232833091,0.00742406263532738,0.0174325373623846,1.14414761146235e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,0.017790786439862,0.00365646481497117,0.0106241154025185,0.0249574574772055,1.15397471261304e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RHOC,Rho-related GTP-binding protein RhoC,41963,0.059470358739886,0.0122264468131798,0.0355065229860536,0.0834341944937184,1.16303421163861e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COPB2,Coatomer subunit beta',39575,0.0217294805655184,0.00447115937504285,0.0129660081904344,0.0304929529406024,1.19058202028483e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFR4,Fibroblast growth factor receptor 4,39736,0.0264322271894508,0.00544734239442264,0.0157554360963824,0.0371090182825191,1.23682411724913e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA7,Thyroxine-binding globulin,39979,0.0092083385556905,0.00190760881512711,0.00546942527804137,0.0129472518333396,1.40292639237364e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFA,Protransforming growth factor alpha,42119,0.022675280292298,0.00469902776112577,0.0134651858804915,0.0318853747041045,1.41159322456945e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DKK3,Dickkopf-related protein 3,42310,-0.0147255833349219,0.00306299771279208,-0.0207290588519944,-0.00872210781784946,1.54395745771803e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AK1,Adenylate kinase isoenzyme 1,42145,0.0306588774689469,0.00638964261178686,0.0181351779498447,0.0431825769880492,1.61793253868493e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,0.0252782794041559,0.0052771259913459,0.0149351124611179,0.0356214463471939,1.68400274920815e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD302,CD302 antigen,42070,0.0154910049145346,0.00323462195530455,0.00915114588213771,0.0218308639469316,1.69294368123684e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LMOD1,Leiomodin-1,39934,-0.0172266394002662,0.003603016630785,-0.0242885519966048,-0.0101647268039276,1.76469356951071e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,0.0337069939224537,0.00705209818287202,0.0198848814840245,0.0475291063608828,1.77398341925108e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFYA,Nuclear transcription factor Y subunit alpha,39575,0.0191099462735174,0.00400724607590293,0.0112557439647477,0.0269641485822871,1.87666360300209e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSH3,Protein phosphatase Slingshot homolog 3,39560,0.0146562960677109,0.00307748761984535,0.00862442033281404,0.0206881718026078,1.93734213172037e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL8,Interleukin-8,42035,0.0335417778516618,0.00704533071505945,0.0197329296501453,0.0473506260531783,1.94788310700743e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MARCO,Macrophage receptor MARCO,42145,0.0127642139234164,0.00268433050988898,0.00750292612403395,0.0180255017227988,2.0040797046547e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DGCR6,Protein DGCR6,39586,0.0206829980517187,0.00434922467878199,0.012158517681306,0.0292074784221314,2.00413424719232e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX2,Sorting nexin-2,39919,0.0421176984084609,0.00887082019149834,0.0247308908331242,0.0595045059837977,2.0806790019837e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CILP,Cartilage intermediate layer protein 1,39966,0.0272182937611199,0.00574188529466916,0.0159641985835684,0.0384723889386715,2.1598533903023e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTF4,Neurotrophin-4,41843,0.0186335412735676,0.00393512953554558,0.0109206873838983,0.0263463951632369,2.21130840043867e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.02336741086475,0.00493984452530402,-0.0330495061343459,-0.0136853155951541,2.2634909039528e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1B,Interleukin-1 beta,41825,0.027671272337745,0.00586069726111394,0.0161843057059616,0.0391582389695283,2.3651657213544e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,0.0212469782508463,0.00450061880444507,0.012425765394134,0.0300681911075587,2.37153358378031e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CIT,Citron Rho-interacting kinase,39649,0.0223998406682671,0.00476155839219999,0.0130671862195551,0.0317324951169791,2.57815773742419e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,0.0194194282827037,0.00413209550493083,0.0113205210930393,0.0275183354723681,2.6316918221514e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPQ,Carboxypeptidase Q,39960,0.0182749554812367,0.00389069501229972,0.0106491932571292,0.0259007177053442,2.6698353656808e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARB2,Lysosome membrane protein 2,41777,0.0161205914296979,0.00343297088664456,0.00939196849187455,0.0228492143675212,2.68226292490094e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.023808732961496,0.00507284697936264,-0.0337515130410467,-0.0138659528819452,2.71369941441496e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HLA_E,,42119,0.0143025735454712,0.00304744921842461,0.00832957307735896,0.0202755740135834,2.71478966866483e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRTAP,Cartilage-associated protein,39649,0.0240346488167691,0.00512689309908883,0.013985938342555,0.0340833592909832,2.79248275359695e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD14,Monocyte differentiation antigen CD14,41932,0.020066438373402,0.0042847713535158,0.011668286520511,0.028464590226293,2.85218321454123e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,-0.0114910280351682,0.00245407725097841,-0.0163010194470858,-0.00668103662325046,2.86882723089698e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,0.0184702191035057,0.0039532720793731,0.0107218058279344,0.026218632379077,3.01602453381948e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,42115,0.0389959773068366,0.00837005728932903,0.0225906650197517,0.0554012895939216,3.20802891192587e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17A,Interleukin-17A,41877,-0.0207687740270509,0.00445850068134334,-0.0295074353624838,-0.012030112691618,3.22017007313506e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,0.0259324651332117,0.00557088324005113,0.0150135339827115,0.0368513962837119,3.27070698922722e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRD1,Bromodomain-containing protein 1,39757,-0.0147034919368228,0.00315917802213846,-0.0208954808602142,-0.00851150301343145,3.28964756470306e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPME1,Protein phosphatase methylesterase 1,42070,0.0280788788293517,0.00603961277031951,0.0162412377995255,0.0399165198591779,3.36520785968039e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWF,von Willebrand factor,42310,-0.0357028951153809,0.00769350207610926,-0.0507821591845551,-0.0206236310462068,3.5052207723906e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,0.0313518560355671,0.00677212918782237,0.0180784828274352,0.0446252292436989,3.70552279785234e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,0.0214595953473513,0.00464242085907202,0.0123604504635701,0.0305587402311324,3.83433661248869e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGA,Fibrinogen alpha chain,39735,0.0149501325503602,0.00323431647120414,0.00861087226680011,0.0212893928339203,3.8368812573727e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LUZP2,Leucine zipper protein 2,39919,0.021564376506071,0.00466708082329997,0.012416898092403,0.0307118549197389,3.8699124579188e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,-0.0246118155322753,0.00533653885274483,-0.0350714316836551,-0.0141521993808954,4.0260858823779e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG1B,Lithostathine-1-beta,42310,-0.0273117386092596,0.00592770133941475,-0.0389300332345125,-0.0156934439840067,4.11259642558868e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZBP1,Z-DNA-binding protein 1,39657,0.0197649518742642,0.00429534801052249,0.0113460697736401,0.0281838339748882,4.2416941343451e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSH,Pro-cathepsin H,41865,0.0356764703008037,0.00775623593608543,0.0204742478660763,0.0508786927355311,4.26985290343134e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BOC,Brother of CDO,41900,-0.0110861189141942,0.00241582465341722,-0.015821135234892,-0.00635110259349646,4.4953734130318e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CR2,Complement receptor type 2,42217,0.0221559783653989,0.00484717897058326,0.0126555075830557,0.0316564491477421,4.89902737356497e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CENPF,Centromere protein F,39757,0.0255100373056713,0.00559865757404677,0.0145366684605397,0.036483406150803,5.25761870376676e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,39934,0.0253933055820461,0.00557337881895241,0.0144694830968994,0.0363171280671928,5.26370205906482e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,0.0240248519024586,0.00528241596070273,0.0136713166194812,0.0343783871854359,5.47176438846509e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH6,Cadherin-6,42145,-0.0183486797305212,0.00404418955691884,-0.0262752912620821,-0.0104220681989602,5.75376519113074e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SRPX,Sushi repeat-containing protein SRPX,39958,-0.0181326285151393,0.00400549196873913,-0.025983392773868,-0.0102818642564106,6.0452045876461e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.0169605771970627,0.0037491519413593,-0.0243089150021269,-0.00961223939199845,6.12430772698506e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS53,Serine protease 53,39929,0.01792248062358,0.00396753830695599,0.0101461055419463,0.0256988557052137,6.32725561068557e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,0.0155025147036455,0.00343226398905468,0.00877527728509832,0.0222297521221927,6.33437298184886e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,0.0146759625003585,0.0032710859838877,0.00826463397193855,0.0210872910287784,7.31101616942771e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMEM25,Transmembrane protein 25,39934,-0.0218219099539012,0.00486767075163137,-0.0313625446270987,-0.0122812752807037,7.43132927132511e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DKK4,Dickkopf-related protein 4,41992,0.021509773774746,0.00479989142711874,0.0121019865775933,0.0309175609718987,7.48033747293554e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,0.0128591773893202,0.00287871672096845,0.007216892616222,0.0185014621624183,8.01193928432198e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,0.0364573762477064,0.00816256839024393,0.0204587422028283,0.0524560102925845,8.02016252270036e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,0.0160578220286965,0.00359637426229637,0.00900892847459558,0.0231067155827973,8.08425837379757e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G2A,"Phospholipase A2, membrane associated",42135,-0.0245389113250072,0.00550816754880555,-0.0353349197206661,-0.0137429029293484,8.45642489849727e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.0415594812978979,0.00933296672753767,0.023266866511924,0.0598520960838717,8.53645069384824e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",42145,0.0340448321560311,0.00764581491991028,0.019059034913007,0.0490306293990553,8.54592003267859e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,0.029084868600974,0.00654771464029523,0.0162513479059953,0.0419183892959526,8.99896947122637e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,-0.0133310224490202,0.00300325453076659,-0.0192174013293227,-0.00744464356871766,9.11588244674924e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,0.0157941667920663,0.00356279241909853,0.00881109365063316,0.0227772399334994,9.37652802432892e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RALY,RNA-binding protein Raly,39919,0.0221486527030794,0.00499644164247535,0.0123556270838277,0.0319416783223311,9.38556988654308e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAM,Signal transducing adapter molecule 1,39919,0.0165854204787943,0.0037560120128386,0.00922363693363066,0.023947204023958,1.01617727725285e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,0.0308295180728738,0.00698930659741401,0.0171304771419424,0.0445285590038053,1.03897518820724e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRN,Progranulin,42077,0.0115064613919504,0.00261259799673372,0.00638576931835229,0.0166271534655485,1.06982579326645e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUSP3,Dual specificity protein phosphatase 3,41839,0.0392878077010338,0.00892831729407447,0.0217883058046478,0.0567873095974197,1.08916817141664e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LY96,Lymphocyte antigen 96,42016,-0.0167343389632492,0.0038031157524175,-0.0241884458379875,-0.00928023208851089,1.09002977571551e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,0.0170767214675216,0.00388556546094257,0.00946101316407418,0.024692429770969,1.11850652068135e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHCHD6,MICOS complex subunit MIC25,39919,0.0132284700607248,0.0030150389874614,0.00731899364530042,0.0191379464761491,1.15701079564003e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17C,Interleukin-17C,41913,-0.0321073905373347,0.00736463696430775,-0.0465420789873779,-0.0176727020872915,1.31236107454947e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THBD,Thrombomodulin,42145,0.0133816076138511,0.00307100476052846,0.00736243828321532,0.0194007769444869,1.32583313593594e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF5,Fibroblast growth factor 5,41913,-0.0154186316398031,0.00354193520035951,-0.0223608246325077,-0.00847643864709845,1.35186924734531e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HLA_DRA,,42060,-0.0164354646260601,0.00377784442889059,-0.0238400397066857,-0.00903088954543458,1.36835521483487e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,0.0151197243025322,0.00348234829566211,0.00829432164303446,0.0219451269620299,1.42325585448925e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TK1,"Thymidine kinase, cytosolic",39757,0.0212558570560735,0.00489968067600273,0.0116524829311082,0.0308592311810389,1.44909204459088e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLL1,Delta-like protein 1,42181,-0.0138146118935212,0.00318865909907447,-0.0200643837277072,-0.00756484005933522,1.48538263562407e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB8,Serpin B8,42296,0.0262966068436326,0.00607028507878246,0.014398848089219,0.0381943655980462,1.48798281369821e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ROBO4,Roundabout homolog 4,39638,-0.00821146677411637,0.00189633002258093,-0.011928273618375,-0.00449465992985774,1.50296496582164e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL20,C-C motif chemokine 20,42296,0.0388663027963541,0.00898591189737297,0.0212539154775031,0.0564786901152051,1.53438242854363e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VIM,Vimentin,41900,0.0516087514167772,0.0119339637677062,0.0282181824320731,0.0749993204014812,1.53972735667966e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,0.0168881869340485,0.00391257123100528,0.00921954732127814,0.0245568265468188,1.59746829920203e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,41843,0.0230052989349044,0.00533187973144954,0.0125548146612633,0.0334557832085455,1.61000989136373e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD99,CD99 antigen,42137,-0.00891449692526534,0.00207183325073172,-0.0129752900966995,-0.00485370375383118,1.69906157542849e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,0.0124233309939793,0.00288796105424732,0.00676292732765456,0.0180837346603041,1.7065779365325e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BMP4,Bone morphogenetic protein 4,41992,-0.0211801470833523,0.00492536201520382,-0.0308338566331518,-0.0115264375335528,1.71835535333419e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SATB1,DNA-binding protein SATB1,39934,0.0130271581932562,0.00304063510176308,0.00706751339380053,0.0189868029927118,1.84782905058623e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,0.0167348185551014,0.00390876612130837,0.00907363695733695,0.0243960001528658,1.87336932530259e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYAR,Cell growth-regulating nucleolar protein,41843,0.0237266015571153,0.0055427289098164,0.0128628528938752,0.0345903502203555,1.87641240014561e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1R1,Interleukin-1 receptor type 1,42113,-0.0105963483687732,0.00248004451840555,-0.0154572356248481,-0.00573546111269835,1.94490726926271e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSTB,Cystatin-B,41959,0.0192315999077955,0.00450685703599496,0.0103981601172454,0.0280650396983456,1.99317691129322e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STC2,Stanniocalcin-2,42113,0.0106323863326719,0.00249459647979662,0.00574297723227055,0.0155217954330733,2.03827215388128e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NECTIN2,Nectin-2,42129,0.0136945231408094,0.00321358429064143,0.00739589793115216,0.0199931483504665,2.04481291675136e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COLEC12,Collectin-12,42123,0.0121171752841895,0.00284404312734674,0.00654285075458994,0.0176914998137892,2.05308478158386e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IDS,Iduronate 2-sulfatase,42296,0.00406853092717663,0.000955366105806448,0.00219601335979599,0.00594104849455727,2.07074647045e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTT2B,Glutathione S-transferase theta-2B,39929,0.106720925885561,0.0250653311176326,0.0575928768950011,0.155848974876121,2.08195870747273e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD28,T-cell-specific surface glycoprotein CD28,41843,0.016454948289093,0.00386780986218043,0.00887404095921933,0.0240358556189666,2.11114627072468e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THBS4,Thrombospondin-4,42189,0.0200821637153956,0.00472153636515326,0.0108279524396952,0.029336374991096,2.1204170511274e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.0162898173438401,0.00382989233476953,0.00878322836769187,0.0237964063199884,2.12047968028366e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRCAM,Neuronal cell adhesion molecule,42145,0.012677600688932,0.0029849523328048,0.00682709411663454,0.0185281072612294,2.17932580549354e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PALM,Paralemmin-1,39859,0.0134850905714831,0.00317962874162418,0.00725301823789969,0.0197171629050665,2.24214695416539e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH1,Cadherin-1,41697,0.0176619994345091,0.00417479872169001,0.00947939393999663,0.0258446049290215,2.34630171723778e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX3,Syntaxin-3,39929,0.0167161423449766,0.00396171706796248,0.00895117689177013,0.024481107798183,2.46840627987441e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNLY,Granulysin,42137,0.023616867154729,0.0056086150145092,0.012623981726291,0.034609752583167,2.56090312122106e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,0.0151110496565891,0.00359502232167538,0.00806480590610532,0.0221572934070728,2.64731063623481e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,0.0205155742850767,0.00488528376932302,0.0109404180972035,0.0300907304729498,2.69300099264549e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIL1,Nucleotide exchange factor SIL1,39638,0.0143067458639225,0.00341030671440405,0.00762254470369058,0.0209909470241544,2.74824155526543e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS3,Galectin-3,42196,0.012901143836108,0.00307806748517128,0.00686813156517229,0.0189341561070437,2.79098454075313e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTPN,Myotrophin,41900,0.0141444292055647,0.00337671758038901,0.00752606274800229,0.0207627956631272,2.82229179680261e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGLC2,Immunoglobulin lambda constant 2,39963,-0.0111180148247845,0.00265918334325237,-0.0163300141775591,-0.00590601547200981,2.92420794323282e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH3,Cadherin-3,42249,0.0159851013969251,0.00382732884088079,0.00848353686879879,0.0234866659250515,2.97778515783542e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VEGFD,Vascular endothelial growth factor D,42275,-0.0167113146787439,0.0040090874194377,-0.0245691260208418,-0.00885350333664604,3.08689392616881e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,0.0184531202713173,0.00442760796567049,0.00977500865860319,0.0271312318840315,3.09578361709947e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL25,C-C motif chemokine 25,42296,0.0212426123317168,0.0051010066959304,0.0112446392076932,0.0312405854557404,3.14089589010364e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PROCR,Endothelial protein C receptor,39575,-0.0149858217203548,0.00359979809583227,-0.0220414259881861,-0.00793021745252357,3.16545070382909e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLAUR,Urokinase plasminogen activator surface receptor,42040,-0.0122895555488633,0.00295860662595932,-0.0180884245357436,-0.00649068656198301,3.289738290473e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,0.0111269680943652,0.0026793367030219,0.00587546815644229,0.0163784680322881,3.30349454091154e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFHD1,EF-hand domain-containing protein D1,39934,0.0155059708934284,0.00373949538788254,0.00817655993317862,0.0228353818536782,3.39994268644965e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCAN,Brevican core protein,42016,0.0148933705683681,0.00359205330441777,0.0078529460917093,0.021933795045027,3.40117480928132e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,0.0129923583792427,0.00313984088326174,0.00683827024804968,0.0191464465104357,3.5266123332308e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMPRSS11D,Transmembrane protease serine 11D,39906,0.0163851521845151,0.00398286333064477,0.00857874005645138,0.0241915643125789,3.91764792566534e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PKD1,Polycystin-1,39958,0.0116203928272252,0.00282738952662987,0.00607870935503064,0.0171620762994197,3.98548092926951e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECM1,Extracellular matrix protein 1,39720,0.0155144690585841,0.00379076087029938,0.00808457775279736,0.0229443603643709,4.29380309161009e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,0.0147929640134612,0.00361500907658911,0.00770754622334653,0.0218783818035758,4.29968432697156e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LIFR,Leukemia inhibitory factor receptor,42119,-0.0102053908690372,0.00249394310978346,-0.0150935193642128,-0.00531726237386161,4.30020292131609e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL6A3,Collagen alpha-3(VI) chain,42310,0.0152271019410381,0.00372402393968716,0.00792801501925124,0.0225261888628249,4.35926939835561e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL31RA,Interleukin-31 receptor subunit alpha,39616,0.0158917136365326,0.00389999988468798,0.00824771386254411,0.023535713410521,4.63771746662517e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAST,Gastrin,39929,0.0552276462401804,0.0135987706317597,0.0285740558019313,0.0818812366784295,4.91448775212884e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASPN,Asporin,39958,0.0117460083299952,0.00289266142960525,0.00607639192796895,0.0174156247320215,4.92703634922995e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPP1,Tripeptidyl-peptidase 1,42057,0.0199168921610526,0.00492118443670564,0.0102713706651095,0.0295624136569956,5.21294652247385e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,0.0117554148268839,0.00290651102477174,0.00605865321833129,0.0174521764354365,5.2719882766934e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEG1,Protein LEG1 homolog,39398,-0.0295932969266755,0.00733766400085022,-0.0439751183683419,-0.0152114754850091,5.54321459389831e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,0.0130281706324654,0.00323335632094053,0.00669079224342196,0.0193655490215088,5.63171234631592e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C8B,Complement component C8 beta chain,39979,0.0126424240508491,0.00314268006546815,0.00648277112253153,0.0188020769791667,5.78781834628892e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.0163661245030059,0.00407248586420526,-0.0243481967968482,-0.00838405220916359,5.88446546884606e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGN,Secretagogin,41913,-0.0185317779560284,0.00461547884980656,-0.0275781165016493,-0.00948543941040756,5.97372079577777e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCC,Netrin receptor DCC,39649,0.00932904594213105,0.00232408569638331,0.00477383797721977,0.0138842539070423,6.00744070698248e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.0155247475770837,0.00389021628395604,-0.0231495714936376,-0.00789992366052989,6.62217970661353e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPTLC1,Serine palmitoyltransferase 1,39929,0.0160160303633241,0.00401811922428204,0.0081405166837313,0.0238915440429169,6.76315641689149e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERC2,ERC protein 2,39649,0.0305428891699097,0.00766472806384447,0.0155200221647745,0.0455657561750449,6.79528542351422e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD109,CD109 antigen,42137,-0.0141305212246829,0.00354721943646741,-0.0210830713201591,-0.00717797112920682,6.82491287686491e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,-0.0145149826290735,0.00366160828917662,-0.0216917348758597,-0.00733823038228736,7.40493723052828e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL24A1,Collagen alpha-1(XXIV) chain,39930,0.0231768315924971,0.0058558721427967,0.0116993221926156,0.0346543409923787,7.60799527609122e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.0317105627190666,0.00801215186095472,-0.0474143803665379,-0.0160067450715954,7.61011370226819e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTRK3,NT-3 growth factor receptor,42249,-0.00871358925109467,0.00220450274028353,-0.0130344146220504,-0.00439276388013894,7.76856705582817e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRR3,Small proline-rich protein 3,39929,0.0258716381065701,0.00654650663746879,0.0130404850971313,0.0387027911160089,7.79789888939557e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRISP3,Cysteine-rich secretory protein 3,39889,-0.011154451237398,0.002833973826005,-0.0167090399363678,-0.00559986253842821,8.33565559971221e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A14,Protein S100-A14,39934,0.0211754643608744,0.00538037501154439,0.0106299293382474,0.0317209993835014,8.34551012271833e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,0.0785015311347891,0.0199575718994325,0.0393846902119013,0.117618372057677,8.41648083984417e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRR4,Proline-rich protein 4,39652,-0.0290176127376966,0.00738176026300893,-0.0434858628531941,-0.0145493626221991,8.51133535175515e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIGR,Polymeric immunoglobulin receptor,41987,0.0151681547811115,0.00385945107727708,0.00760363066964843,0.0227326788925746,8.53259588475683e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4M,C-type lectin domain family 4 member M,39945,-0.0202427184925616,0.00515338155678312,-0.0303433463438565,-0.0101420906412667,8.61462593518628e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL1,Angiopoietin-related protein 1,41920,0.0117233948352002,0.00298614564026546,0.0058705493802799,0.0175762402901205,8.68306581283711e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CGA,Glycoprotein hormones alpha chain,42137,-0.0251878055165525,0.00643162341509224,-0.0377937874101332,-0.0125818236229717,9.03806162582904e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,0.0216876649658701,0.00554878981519024,0.0108120369280972,0.032563293003643,9.33102232254008e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,39649,0.0333161462149677,0.00853749807395321,0.0165826499900194,0.0500496424399159,9.58359370495341e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FSTL1,Follistatin-related protein 1,39638,-0.00943213096852296,0.00241707563777249,-0.014169599218557,-0.00469466271848887,9.58527054237123e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,-0.00784171588312613,0.0020131010729266,-0.0117873939860623,-0.00389603778019,9.86216637125346e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL9A2,Collagen alpha-2(IX) chain,39757,0.0180428652998398,0.00463346779111698,0.00896126842925056,0.0271244621704291,9.91669085166901e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS4,Galectin-4,42123,-0.0228144051897352,0.00586092071955761,-0.0343018098000681,-0.0113270005794023,9.96387530309035e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,41843,0.0229177315768367,0.00591360085628176,0.0113270738985245,0.034508389255149,0.000106950811865617
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL3,Fc receptor-like protein 3,41913,0.0215620733458004,0.00556415857300812,0.0106563225427045,0.0324678241488963,0.000107060131138027
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,0.011220790067301,0.00289674400117394,0.00554317182500013,0.016898408309602,0.000107748181433972
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC1A,C-type lectin domain family 1 member A,41900,-0.013686333662828,0.00354195201044515,-0.0206285596033005,-0.00674410772235546,0.000112044837569817
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UROS,Uroporphyrinogen-III synthase,39649,0.0265084767397502,0.00687276416428902,0.0130378589777438,0.0399790945017567,0.000115423379627358
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,39904,0.0182848874399948,0.00474475812018079,0.00898516152444043,0.0275846133555491,0.000116988337400754
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MST1,Hepatocyte growth factor-like protein,39854,0.0269836824623455,0.00700624041127079,0.0132514512562548,0.0407159136684362,0.000118105935529387
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOS1,"Nitric oxide synthase, brain",41839,-0.0235024572825473,0.00611027131287252,-0.0354785890557775,-0.0115263255093172,0.000120435154585134
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRUNE2,Protein prune homolog 2,39757,0.0115327140256045,0.00299942710562456,0.00565383689858036,0.0174115911526286,0.000121235966954461
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOSB,Protein fosB,41839,0.0153770093426761,0.00399965785589511,0.00753767994512173,0.0232163387402305,0.00012132355847788
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMPD3,AMP deaminase 3,39929,0.0275194131186272,0.0071586455875561,0.0134884677670173,0.0415503584702372,0.000121597400967059
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDHR1,Cadherin-related family member 1,41839,0.0165214980892313,0.00430069368433786,0.00809213846792911,0.0249508577105335,0.00012281064563011
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRG3,Proteoglycan 3,39966,-0.0198093954000827,0.00517243310339588,-0.0299473642827387,-0.00967142651742681,0.000128935401514088
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITM2A,Integral membrane protein 2A,42119,-0.0246592414643921,0.00644695551743273,-0.0372952742785602,-0.0120232086502239,0.000131389888810598
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AREG,Amphiregulin,42070,-0.0155431799490135,0.00406899811288469,-0.0235184162502675,-0.00756794364775956,0.000134103139405558
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX25,ATP-dependent RNA helicase DDX25,39649,-0.014209393849652,0.0037262814477601,-0.0215129054872618,-0.00690588221204223,0.000137874451012385
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSG3,Desmoglein-3,42196,0.0139089975619125,0.00365001739783085,0.00675496346216403,0.0210630316616609,0.000139203538339651
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JAM2,Junctional adhesion molecule B,42249,0.0107920311365953,0.002839131181998,0.0052273340198792,0.0163567282533113,0.000144638400269507
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSAP,Prosaposin,39886,0.0112753856032218,0.00296641990775532,0.00546120258402137,0.0170895686224222,0.000144866585991667
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,0.0281292655186717,0.00742147629098123,0.0135831719883485,0.0426753590489949,0.000151295204641529
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLPS,Colipase,42115,0.0290615554529515,0.00766907374749343,0.0140301709078643,0.0440929399980386,0.000151637790239568
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CENPJ,Centromere protein J,39757,0.0275191290583776,0.0072983781987471,0.0132143077888333,0.0418239503279219,0.000163708278236013
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF16,Fibroblast growth factor 16,39657,0.018204780169452,0.00483163147699879,0.00873478247453439,0.0276747778643696,0.00016552610967952
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOD3,Extracellular superoxide dismutase,39990,-0.0237187244706852,0.00630906846273899,-0.0360844986576536,-0.0113529502837167,0.000171128152513382
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,0.0169342208064924,0.0045055500944307,0.00810334262140828,0.0257650989915766,0.000171648469157542
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT19,"Keratin, type I cytoskeletal 19",42094,-0.0264662509295849,0.00704486199068173,-0.0402741804313211,-0.0126583214278487,0.000172812971570491
NMR metabolomics,X23508.Triglycerides in Medium VLDL,METAP1,Methionine aminopeptidase 1,41839,0.0113410746068974,0.00301923530631809,0.00542337340651394,0.0172587758072809,0.000173201251268038
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MET,Hepatocyte growth factor receptor,42158,-0.00748043005104145,0.00199350281747453,-0.0113876955732915,-0.00357316452879137,0.000175876422836598
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NECTIN1,Nectin-1,39657,0.0128356535023856,0.00342893502444787,0.0061149408544678,0.0195563661503034,0.000182513908500814
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ROBO1,Roundabout homolog 1,42144,0.00931071569460535,0.00248885451121287,0.00443256085262813,0.0141888705365826,0.000184071970120391
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYGD,Gamma-crystallin D,39929,0.0380723279474577,0.0101872134826948,0.0181053895213759,0.0580392663735395,0.000186946459546675
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FBLN2,Fibulin-2,39966,-0.0124573971323628,0.00334018569785723,-0.019004161100163,-0.00591063316456263,0.000192752886004932
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLAU,Urokinase-type plasminogen activator,42137,-0.011062876527106,0.00296917845775569,-0.0168824663043071,-0.00524328674990483,0.000195407076181636
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD209,CD209 antigen,42171,-0.0150670118675349,0.00405214327405227,-0.0230092126846773,-0.00712481105039244,0.000201389452744567
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300A,CMRF35-like molecule 8,39736,0.0118152537712439,0.00317750451435767,0.00558734492310281,0.0180431626193849,0.00020146709453246
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPARCL1,SPARC-like protein 1,42169,-0.0105400334138765,0.00284189828103752,-0.01611015404471,-0.00496991278304293,0.00020907372703148
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,-0.0120395544461444,0.00325587106534734,-0.0184210617342252,-0.0056580471580636,0.000218537961389124
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.0126760126578649,0.00342976683380083,-0.0193983556521145,-0.0059536696636153,0.000220175826293042
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1RAP,Interleukin-1 receptor accessory protein,42137,-0.0171668844236454,0.00465197628248356,-0.0262847579373131,-0.00804901090997757,0.000224925813327236
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEO1,Neogenin,39934,0.0086399468728669,0.00234709113482192,0.00403964824861593,0.0132402454971179,0.000233280630488177
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGB1A1,Uteroglobin,42165,0.0203818628100837,0.00556768205667834,0.00946920597899411,0.0312945196411732,0.000252438128696482
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLASP1,CLIP-associating protein 1,39560,0.0285074341225778,0.00781145761730936,0.0131969771926514,0.0438178910525041,0.000264035397169975
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP9,Fatty acid-binding protein 9,42119,0.0213467020784495,0.00585570399980846,0.00986952223882494,0.0328238819180741,0.000267920850763443
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH12,Protocadherin-12,39934,0.00962229402570236,0.00264921514824731,0.00442983233513764,0.0148147557162671,0.000282332029252776
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACE,Angiotensin-converting enzyme,39990,-0.010184636404928,0.00280687512290501,-0.0156861116458219,-0.0046831611640342,0.000286363509232331
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,0.0208761077798598,0.00575875051303023,0.00958895677432053,0.032163258785399,0.000290123513432147
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PMS1,PMS1 protein homolog 1,39649,0.0186011842600209,0.00513934780452303,0.00852806256315581,0.0286743059568861,0.000296644525727406
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAPG,Macrophage-capping protein,42015,0.022110547389218,0.00611628408933085,0.0101226305741296,0.0340984642043065,0.000301413427002941
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAYN,Layilin,41997,-0.0134488209060241,0.0037259072806263,-0.0207515991760517,-0.0061460426359966,0.000307856098515033
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOBR,Apolipoprotein B receptor,39638,-0.0160772366020151,0.00446542982035732,-0.0248294790499154,-0.00732499415411474,0.000319148043938867
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATXN2,Ataxin-2,39586,0.0396510753497677,0.0110151970986719,0.0180612890363708,0.0612408616631647,0.000320024081792237
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,0.010121559944464,0.00281895633304463,0.0045964055316965,0.0156467143572315,0.000331395532700137
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAFB2,Scaffold attachment factor B2,39934,0.0101566593818121,0.00283114815664821,0.00460760899478162,0.0157057097688426,0.000335308959729654
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM2,Intercellular adhesion molecule 2,42310,-0.0121935413448314,0.00340271132215284,-0.018862855536251,-0.00552422715341187,0.000340225129237044
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,0.0323850127864605,0.00907495338848149,0.0145981041450368,0.0501719214278843,0.000360404825575181
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,0.0384616562516449,0.0107855511833241,0.0173219759323296,0.0596013365709601,0.000363954391071383
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPA2,Heat shock-related 70 kDa protein 2,39919,0.0130009425229295,0.00365315387974715,0.00584076091862504,0.0201611241272339,0.000374040115076808
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM26,Tripartite motif-containing protein 26,39560,0.0211738387905824,0.00596920605819595,0.00947419491651837,0.0328734826646465,0.000391007366136483
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,0.0153666887912678,0.0043324495963481,0.0068750875824255,0.02385829000011,0.000391393476326896
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JCHAIN,Immunoglobulin J chain,41913,-0.0225878477586095,0.00636891416418861,-0.0350709195204192,-0.0101047759967998,0.000391610862086815
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEZ6L2,Seizure 6-like protein 2,42070,-0.00888934948753959,0.00251416575110423,-0.0138171143597039,-0.00396158461537529,0.000408053199720845
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,0.0234243525778046,0.00663289431756727,0.0104238797153727,0.0364248254402364,0.000414784588705954
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA11,Serpin A11,42310,-0.0153212984790721,0.00434142079846853,-0.0238304832440705,-0.00681211371407381,0.000418344765642513
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNG,Interferon gamma,41913,0.0418255045622382,0.0118668276941212,0.0185665222817606,0.0650844868427158,0.000425589265741295
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,41843,0.0190059342427164,0.00539440900961076,0.00843289258387933,0.0295789759015535,0.000427700908754883
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPR1,Atrial natriuretic peptide receptor 1,39575,-0.015629318032052,0.00443760138827938,-0.0243270167530796,-0.0069316193110244,0.000430012482709964
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,0.0380144993855449,0.0108057604341828,0.0168352089345465,0.0591937898365432,0.000436541075076683
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL5A1,Collagen alpha-1(V) chain,39736,-0.014963520166641,0.00426419309701189,-0.0233213386367843,-0.00660570169649765,0.000451385221570676
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHCY,Adenosylhomocysteinase,42145,0.0244803827036305,0.00698932488754517,0.010781305924042,0.0381794594832191,0.000462331681644399
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NELL1,Protein kinase C-binding protein NELL1,42181,0.0153117986064286,0.00437816617988499,0.00673059289385404,0.0238930043190032,0.000471479973653947
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN3,CCN family member 3,42299,0.0123466876781781,0.00353038663804365,0.00542712986761251,0.0192662454887436,0.000471549145039836
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRTG,Protogenin,42262,0.00892545179064015,0.00255267600489283,0.00392220682105021,0.0139286967602301,0.000472887148429035
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLSTN3,Calsyntenin-3,39929,0.0109066109798364,0.00314422193835593,0.00474393598065877,0.017069285979014,0.000524772901969803
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRD3,Bromodomain-containing protein 3,39575,0.0171030617734565,0.00493758353040409,0.00742539805386444,0.0267807254930485,0.000534530708805626
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,0.0121982126930073,0.00352370409161666,0.0052917526734387,0.019104672712576,0.00053831409774748
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ART3,Ecto-ADP-ribosyltransferase 3,42217,-0.0128924050034668,0.00372702623479896,-0.0201973764236728,-0.00558743358326083,0.000543507668330334
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC1,Sialoadhesin,42185,-0.0149075861221973,0.00432003897277854,-0.0233748625088432,-0.00644030973555135,0.000560628794411523
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QL2,Complement C1q-like protein 2,39657,0.0154324167432981,0.00447466960957551,0.00666206430853009,0.0242027691780661,0.000565100291345738
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFBR3,Transforming growth factor beta receptor type 3,42310,-0.0107250645567801,0.00312114817017603,-0.0168425149703251,-0.00460761414323508,0.000591561958149605
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CREBZF,CREB/ATF bZIP transcription factor,39560,-0.00931337369604134,0.00271121125963857,-0.0146273477649329,-0.00399939962714975,0.000594455747770397
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYOC,Myocilin,42137,-0.0159698079950557,0.0046502093392804,-0.0250842183000453,-0.00685539769006615,0.000596058384963862
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX18,Sorting nexin-18,39930,0.0155974934878474,0.00454409594090521,0.00669106544367315,0.0245039215320216,0.000600237733959659
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE3,Eosinophil cationic protein,42081,0.0387573838554275,0.0113209524888188,0.0165683169773426,0.0609464507335123,0.000620020376951258
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTF3,Neurotrophin-3,42119,0.0121650843143834,0.00357619433659328,0.00515574341466057,0.0191744252141062,0.000671658932927513
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HCG22,Protein PBMUCL2,39575,-0.0204887314582621,0.00603817269757412,-0.0323235499455073,-0.00865391297101678,0.000693252248894579
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,39757,0.0249783032013277,0.00736624005697977,0.0105404726896473,0.039416133713008,0.000699010039295745
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP5,Rho GTPase-activating protein 5,39560,0.0268142272252176,0.0079099671065821,0.0113106916963167,0.0423177627541186,0.000701573074099824
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,42249,0.00834105543669413,0.00246251546541951,0.00351452512447189,0.0131675857489164,0.000708068287860456
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALB1,Calbindin,42070,0.0159282000806494,0.00470263317561254,0.00671103905644881,0.0251453611048499,0.000708425575969959
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,-0.0218112195800909,0.00644238685975208,-0.034438297825205,-0.00918414133497687,0.000712733888608905
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPEP1,Dipeptidase 1,41997,-0.016169586282246,0.00478156413332238,-0.0255414519835578,-0.00679772058093409,0.00072257328212423
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTSL5,ADAMTS-like protein 5,39958,-0.0140969474824423,0.00417126883114458,-0.0222726343914857,-0.00592126057339894,0.000728529761113226
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.0195990399923386,0.00580571840030302,0.00821983192774469,0.0309782480569325,0.000738519788885217
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBP4,Guanylate-binding protein 4,41839,0.0171085500512802,0.00509975264292855,0.00711303487114021,0.0271040652314201,0.000796511004436874
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.0134927951863788,0.00403664769374024,0.00558096570664797,0.0214046246661097,0.000832350995484301
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPE,Carboxypeptidase E,42134,-0.0135582129653643,0.00406174773826614,-0.0215192385323659,-0.00559718739836262,0.000846038876496431
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MB,Myoglobin,42310,-0.0194296056917308,0.00583081430480422,-0.0308580017291471,-0.00800120965431457,0.000863813574024818
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FMR1,Synaptic functional regulator FMR1,41843,0.0124945421764924,0.00375614437031433,0.00513249921067635,0.0198565851423085,0.000882062107561833
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.0140026335124598,0.00421430888729756,-0.022262678931563,-0.0057425880933566,0.000894612971310921
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AZU1,Azurocidin,41751,0.0259095867052695,0.00783094829207168,0.010560928052809,0.04125824535773,0.000940107519157319
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBC1D17,TBC1 domain family member 17,41839,0.0147394185048579,0.00447829098808448,0.00596196816821237,0.0235168688415035,0.000999848986039666
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BSG,Basigin,42284,0.00713472314303759,0.00216971085319069,0.00288208987078384,0.0113873564152913,0.00101038255158805
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGBL1,Integrin beta-like protein 1,39966,0.0134563218807488,0.00409464684698425,0.0054308140606597,0.021481829700838,0.00101813112846731
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAX,Apoptosis regulator BAX,41814,0.0312904460768688,0.00954140373281247,0.0125892947605564,0.0499915973931813,0.0010428295477971
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INSR,Insulin receptor,39657,0.00583362897276746,0.00178091202150104,0.00234304141062542,0.00932421653490949,0.00105746907806537
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PADI4,Protein-arginine deiminase type-4,41814,0.0248829593634987,0.00759791349237684,0.00999104891844011,0.0397748698085573,0.00105944145260031
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,0.0196721534892223,0.00600817759732909,0.00789612539845727,0.0314481815799873,0.00106216555333521
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPNMB,Transmembrane glycoprotein NMB,41802,0.00991259210208633,0.00302959958140847,0.00397457692252573,0.0158506072816469,0.001070959371642
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOH,Beta-2-glycoprotein 1,42137,-0.0124181734959627,0.00380515485753802,-0.0198762770167372,-0.00496006997518814,0.00110312900723618
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,-0.024498319535479,0.00751036600168089,-0.0392186368987735,-0.00977800217218444,0.00110982154630998
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,39649,0.0102053288123443,0.00313245581917643,0.00406571540675849,0.0163449422179301,0.00112566078356761
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GZMB,Granzyme B,42119,0.0229279363571174,0.00704756414483563,0.0091147106332396,0.0367411620809953,0.00114347517891444
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,0.0225057799764855,0.00695189075488188,0.00888007409691698,0.036131485856054,0.00120937641993912
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,-0.0124965809321349,0.00386408936631629,-0.0200701960901148,-0.00492296577415494,0.00122417717588058
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACAN,Aggrecan core protein,41994,0.00918367389492535,0.00284248939510935,0.00361239468051103,0.0147549531093397,0.00123718151587175
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPESP1,Sperm equatorial segment protein 1,39958,0.0112506477542129,0.00348728529946184,0.00441556856726774,0.0180857269411581,0.00125805093041074
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP152,Centrosomal protein of 152 kDa,39560,0.0140717066916029,0.00437208774235521,0.00550241471658667,0.0226409986666191,0.00129223333938774
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSM,Oncostatin-M,42051,0.0229986664659401,0.00717600111437047,0.00893370428177401,0.0370636286501063,0.00135405088146076
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PON1,Serum paraoxonase/arylesterase 1,39990,-0.00902686232411419,0.00281652508342178,-0.0145472514876209,-0.0035064731606075,0.00135451651330804
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPA2,Replication protein A 32 kDa subunit,39657,0.0102882396056988,0.00321749007097682,0.00398195906658424,0.0165945201448134,0.00138967594966182
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,-0.0218175792229452,0.00683793154295062,-0.0352199250471284,-0.00841523339876196,0.00142266830994688
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BABAM1,BRISC and BRCA1-A complex member 1,39657,0.00977340009929747,0.00307052038583881,0.00375518014305339,0.0157916200555415,0.0014617210403855
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NLGN2,Neuroligin-2,39586,-0.0154513150646263,0.00485875166682505,-0.0249744683316035,-0.00592816179764924,0.0014763327706924
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANPEP,Aminopeptidase N,42187,0.00899703601781513,0.00283491706528166,0.00344059856986308,0.0145534734657672,0.00150870332452667
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NECTIN4,Nectin-4,42181,-0.0110825449008595,0.00349346138097561,-0.0179297292075717,-0.00423536059414736,0.00151537945735953
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,0.012941336123028,0.00409151725502824,0.00492196230317265,0.0209607099428833,0.00156592061897058
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL2,Apoptosis regulator Bcl-2,39930,0.0174882174365073,0.00554522462574423,0.00661957717004862,0.028356857702966,0.00161611568835402
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFPI2,Tissue factor pathway inhibitor 2,42142,0.0124725765347771,0.00396558502240587,0.00470002989086162,0.0202451231786926,0.00166329713119517
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,0.0150380469198281,0.00480000949629117,0.00563002830709746,0.0244460655325588,0.00173531913787973
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPA4,Carboxypeptidase A4,39518,0.0142900602778567,0.00457190174288863,0.00532913286179499,0.0232509876939184,0.00177891671214676
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFB2,Transforming growth factor beta-2 proprotein,39919,0.0168372359024767,0.00540203599043929,0.00624924536121568,0.0274252264437377,0.00183263706767158
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,39638,0.0102355779311585,0.00329024583191833,0.00378669610059857,0.0166844597617184,0.00187002816606521
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PFDN2,Prefoldin subunit 2,41839,0.0178332526529816,0.00573862156909983,0.00658555437754598,0.0290809509284173,0.00189022250073261
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,-0.0173618108218082,0.00559052376850452,-0.0283192374080771,-0.00640438423553934,0.00190392651173876
NMR metabolomics,X23508.Triglycerides in Medium VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,0.0125141228519285,0.00403151198461854,0.00461235936207618,0.0204158863417809,0.00191356497291942
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,0.0171630045949667,0.00553303844017585,0.00631824925222202,0.0280077599377114,0.00192669806543504
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TTN,Titin,39575,-0.0223068079904609,0.00720006161563894,-0.0364189287571132,-0.00819468722380857,0.00195230438572277
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OPTC,Opticin,42070,-0.0145952907540858,0.00471679373916889,-0.0238402064828568,-0.00535037502531476,0.001976656176286
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,39586,-0.0106574627437806,0.00345593416939318,-0.0174310937157913,-0.00388383177177001,0.00204871372167941
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,42070,-0.0256996636831275,0.00834993631980259,-0.0420655388699406,-0.00933378849631443,0.00208934393985511
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMOD4,Tropomodulin-4,39560,-0.0127909048056637,0.00416368559238003,-0.0209517285667285,-0.0046300810445988,0.00213140311625505
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GUK1,Guanylate kinase,39575,-0.0128512795628645,0.00418477383447971,-0.0210534362784448,-0.00464912284728431,0.00213892400232985
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TERF1,Telomeric repeat-binding factor 1,39657,-0.00927950511584521,0.00302174072529545,-0.0152021169374243,-0.00335689329426612,0.00213922752108669
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB2,Integrin beta-2,42079,-0.00916936216951243,0.0029884980065049,-0.015026818262262,-0.00331190607676281,0.00215767067107354
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,39966,0.0205165475284636,0.00668692954251747,0.00741016562512934,0.0336229294317978,0.0021589052946284
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G15,Phospholipase A2 group XV,42181,0.00871497748951941,0.0028563201786836,0.00311658993929956,0.0143133650397393,0.00228428855275418
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBPMS,RNA-binding protein with multiple splicing,39657,0.0204082828870467,0.00670205429608759,0.00727225646671507,0.0335443093073784,0.00233166807864411
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMP2,Metalloproteinase inhibitor 2,39958,-0.00898118647826188,0.00296702694308669,-0.0147965592867118,-0.00316581366981195,0.00247548690170955
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCUN1D2,DCN1-like protein 2,39560,-0.0251036083479559,0.00829818467581858,-0.0413680503125604,-0.00883916638335151,0.00249050600906653
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,0.0114239356921383,0.00378108552786075,0.00401300805753126,0.0188348633267454,0.00252223333543926
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,0.0162723533547801,0.00539559453098559,0.00569698807404833,0.0268477186355118,0.00256839487100973
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VAMP5,Vesicle-associated membrane protein 5,41900,0.0162348595164077,0.0053882422565306,0.00567390469360773,0.0267958143392077,0.00259152135832965
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATXN10,Ataxin-10,41839,0.0229732777071649,0.00762853410006091,0.00802135087104548,0.0379252045432842,0.00260456877310325
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,39757,0.0178971250809187,0.00595243189048286,0.00623035857557232,0.0295638915862651,0.00264695819188294
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,-0.00871155567218738,0.00290484672699032,-0.0144050552570884,-0.00301805608728635,0.00271380009185996
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.0174656072596309,0.00584213065274488,-0.0289161833390109,-0.00601503118025099,0.00279962202932472
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EXTL1,Exostosin-like 1,39575,0.0147832054383746,0.00494872133351992,0.0050837116246756,0.0244826992520737,0.00282095968625451
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC12A2,Solute carrier family 12 member 2,39575,-0.00817402212915314,0.00274623419483015,-0.0135566411510202,-0.00279140310728604,0.00292245000307164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNPY2,Protein canopy homolog 2,41900,0.018805285045111,0.00633017723038704,0.00639813767355245,0.0312124324166696,0.00297618051194835
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,39929,0.0118423355736914,0.00399194176855525,0.00401812970732314,0.0196665414400597,0.00301780073227286
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSRP3,Cysteine and glycine-rich protein 3,39575,-0.031210294898504,0.0105221474619531,-0.0518337039239321,-0.010586885873076,0.00302200339455869
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP112,Centrosomal protein of 112 kDa,39575,0.0136451286569414,0.00461637707042136,0.0045970295989155,0.0226932277149672,0.00312513381776712
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHX2,Bifunctional epoxide hydrolase 2,41900,0.0187199528200737,0.00633601170471463,0.00630136987883299,0.0311385357613143,0.00313691723047968
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,0.0322694731289497,0.0109415360478459,0.0108240624751718,0.0537148837827277,0.00319081876487082
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRTN,Neurturin,41913,0.0151697962518556,0.00515018030682607,0.0050754428504765,0.0252641496532347,0.00323003342191058
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEB,Nebulin,39575,-0.0121516485500425,0.00413846330312718,-0.0202630366241717,-0.00404026047591319,0.00332873873798164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFRAL,GDNF family receptor alpha-like,39574,-0.0192473225006316,0.00657337929916059,-0.0321311459269863,-0.00636349907427681,0.00341772867588268
NMR metabolomics,X23508.Triglycerides in Medium VLDL,L1CAM,Neural cell adhesion molecule L1,42181,0.00902287200943409,0.00308510867922393,0.00297605899815519,0.015069685020713,0.00345410780624842
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK14,Kallikrein-14,42262,-0.0140605128602441,0.00481340744283757,-0.0234947914482057,-0.00462623427228246,0.00349352668377311
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDHB15,Protocadherin beta-15,39919,-0.0120828925622506,0.0041393924989237,-0.0201961018601411,-0.00396968326436015,0.00351846412266838
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG4,Regenerating islet-derived protein 4,42144,0.0153797292665279,0.00529932625778997,0.00499304980125961,0.0257664087317963,0.00371143748045073
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,0.0122439061353031,0.0042322638331602,0.00394866902230914,0.0205391432482971,0.00382204711017262
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF5,Eukaryotic translation initiation factor 5,39575,0.0127997918791154,0.00442498807088782,0.00412681526017531,0.0214727684980556,0.00382798969094795
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL6,Interleukin-6,42070,-0.0224335930240502,0.00776204062310695,-0.0376471926453398,-0.00721999340276057,0.00385652100818776
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIT,Mast/stem cell growth factor receptor Kit,42199,-0.00873137066730729,0.0030244713596527,-0.0146593345322266,-0.002803406802388,0.00389660701803249
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTRL,Chymotrypsin-like protease CTRL-1,39929,-0.0213289989164118,0.00739274084098507,-0.0358187709647425,-0.00683922686808109,0.00391993469050779
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINI1,Neuroserpin,39713,0.00867437695157182,0.00300913221746578,0.00277647780533888,0.0145722760978048,0.00395058939148671
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFAP,Glial fibrillary acidic protein,41820,0.0136286214281435,0.00473572799744617,0.00434659455314897,0.022910648303138,0.0040106190765276
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A16,Protein S100-A16,41814,-0.0181875454377586,0.00633087799555563,-0.0305960663090477,-0.00577902456646958,0.00407458926996947
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA7A,Semaphorin-7A,42272,0.008519385945816,0.00296880455146665,0.00270052902494136,0.0143382428666906,0.00411575594377805
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINT1,Kunitz-type protease inhibitor 1,42081,-0.00795818909150693,0.00277835592690943,-0.0134037667082494,-0.00251261147476444,0.00418508803556906
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,0.00660651840197523,0.00230782346825826,0.00208318440418903,0.0111298523997614,0.00420743740211857
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.0196212085378055,0.00685443486692808,-0.0330559008769846,-0.00618651619862652,0.00420883724320561
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LCP1,Plastin-2,39966,0.0142505954925782,0.00498059079206087,0.0044886375401389,0.0240125534450175,0.00422776180416043
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNMA2,Paraneoplastic antigen Ma2,39586,0.0132122057780417,0.00462443020118674,0.00414832258371568,0.0222760889723677,0.00428407959864808
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK8,Kallikrein-8,41668,0.0108612098202635,0.00381309204706862,0.00338754940800905,0.018334870232518,0.00440083158182202
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ART5,Ecto-ADP-ribosyltransferase 5,39586,-0.0183390393384807,0.00644175056008205,-0.0309648704362415,-0.00571320824071992,0.00442286389918511
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.00897381252827286,0.00315564693163701,-0.0151588805142814,-0.00278874454226433,0.00446684274298775
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCND2,G1/S-specific cyclin-D2,39757,0.0109573903126073,0.00385754635019377,0.00339659946622754,0.0185181811589871,0.00451233249506659
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLL4,Delta-like protein 4,39638,0.0260433294501118,0.00917105450449943,0.00806806262129292,0.0440185962789307,0.00452341106186655
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHB6,Ephrin type-B receptor 6,41997,0.00967224373703873,0.00341254357583611,0.00298365832839995,0.0163608291456775,0.00459918766613906
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,0.0167180862340536,0.00590718365633749,0.00514000626763216,0.0282961662004751,0.00466140024517668
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,0.0225151005415737,0.00796172895318785,0.00691011179332555,0.0381200892898219,0.00469364733634544
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,0.0130223062094708,0.00460583001663679,0.00399487937686265,0.0220497330420789,0.0047018908379262
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100G,Protein S100-G,39934,-0.0143583653513216,0.00508362110223814,-0.0243222627117083,-0.00439446799093482,0.00474465182720326
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A11,Protein S100-A11,42027,0.013544658277446,0.0048130720160172,0.00411103712605223,0.0229782794288397,0.00489790613297717
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,-0.00828429632922591,0.00295032748523437,-0.0140669382002853,-0.00250165445816654,0.00499323980047202
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FRMD7,FERM domain-containing protein 7,39649,0.00988916919617788,0.00353465596854876,0.0029612434978223,0.0168170948945335,0.00515451297713798
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,0.0133970194122828,0.00479480348459487,0.00399920458247686,0.0227948342420887,0.00521366280068729
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUCA1,Tissue alpha-L-fucosidase,42212,0.0241731872932139,0.00869595529867289,0.00712911490781501,0.0412172596786128,0.00544637456851215
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF3,Granulocyte colony-stimulating factor,41913,0.0138382100389582,0.00498863624240444,0.00406048300384551,0.0236159370740709,0.00554579115000699
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UPK3BL1,Uroplakin-3b-like protein 1,39738,-0.0151992720608496,0.00549404572131327,-0.0259676016746236,-0.00443094244707556,0.00567551730653286
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,0.00821718512789281,0.00298948758300168,0.00235778946520953,0.0140765807905761,0.00599278155760557
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.0154671250626603,0.00562911844692519,0.00443405290668689,0.0265001972186336,0.00600962087561198
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,0.0246592004221382,0.00898061870213733,0.00705718776594904,0.0422612130783274,0.00604566633480789
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDRG1,p53 and DNA damage-regulated protein 1,39649,0.0144117133462551,0.00525240874452482,0.00411699220698648,0.0247064344855238,0.00608250751507408
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,-0.0113740723849192,0.00415208276349985,-0.0195121546013789,-0.00323599016845948,0.00616567308201803
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP12,Macrophage metalloelastase,42146,0.0154288561134463,0.00567976672808662,0.00429651332639656,0.0265611989004961,0.00660680334117741
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL14,C-X-C motif chemokine 14,41913,0.0161297735114919,0.00594159038332752,0.00448425636016994,0.0277752906628138,0.00664166547042186
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB44,Ras-related protein Rab-44,39919,0.0126471798042137,0.00466265640198214,0.00350837325632868,0.0217859863520987,0.00668906262292295
NMR metabolomics,X23508.Triglycerides in Medium VLDL,QSOX1,Sulfhydryl oxidase 1,39767,0.0112295591459627,0.00414481678593774,0.00310571824552477,0.0193534000464007,0.00675278476960028
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.00758996718218019,0.00280776679430363,0.00208674426534508,0.0130931900990153,0.00687601925699018
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP164,Centrosomal protein of 164 kDa,41913,0.0174458842493174,0.00646900551618607,0.00476663343759268,0.0301251350610421,0.00700886175811022
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.0246676355572319,0.00915079185930965,-0.0426031876014788,-0.00673208351298499,0.00703509076871949
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACHE,Acetylcholinesterase,39736,0.00959077739650376,0.00356020389298968,0.00261277776624399,0.0165687770267635,0.00707305164479852
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIAA1549L,UPF0606 protein KIAA1549L,39757,-0.00765209822115924,0.00284144082998649,-0.0132213222479328,-0.00208287419438572,0.00709107317711374
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA1,Annexin A1,39699,0.0124388708074554,0.00462182747233213,0.0033800889616844,0.0214976526532264,0.00712740434123721
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.00970558002957439,0.00361230881819626,0.00262545474590971,0.0167857053132391,0.00722254018219214
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,0.0110431507970472,0.0041270055421191,0.00295421993449377,0.0191320816596006,0.00746338921924922
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSME2,Proteasome activator complex subunit 2,41955,0.00982225054649194,0.00367132118467285,0.00262646102453315,0.0170180400684507,0.00747312635541735
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REXO2,"Oligoribonuclease, mitochondrial",39575,-0.0129440770523958,0.00484197315641344,-0.0224343444389661,-0.00345380966582543,0.00752187683897885
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WNT9A,Protein Wnt-9a,41913,-0.00808086058334593,0.00302915125210748,-0.0140179970374766,-0.00214372412921526,0.00764653285140703
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDK1,Cyclin-dependent kinase 1,39560,0.0100854066378863,0.00379398243400589,0.00264920106723472,0.0175216122085378,0.00786583923929019
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,0.00755012073854262,0.0028486751001307,0.00196671754228645,0.0131335239347988,0.0080490371102021
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSAP,Gamma-secretase-activating protein,41843,0.0231204099915595,0.00875986931357111,0.00595106613696017,0.0402897538461589,0.00831610935375245
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,41839,0.0408135110640456,0.0154706364138607,0.0104910636928786,0.0711359584352125,0.00834627453200158
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,0.00837077118360748,0.00317597536759124,0.00214585946312865,0.0145956829040863,0.00840704107254728
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LMNB1,Lamin-B1,39908,0.016714883098076,0.00634875917579143,0.00427131511352476,0.0291584510826272,0.00848044464449442
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.0119241744088202,0.00453997140706658,0.0030258304509697,0.0208225183666707,0.00863681676255242
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLP1R,Glucagon-like peptide 1 receptor,39586,-0.0101991095039632,0.00389277427773948,-0.0178289470883326,-0.00256927191959383,0.00880479901106567
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDIA5,Protein disulfide-isomerase A5,39560,0.0167819706450221,0.00640941179627398,0.00421952352432514,0.0293444177657191,0.00884822213844611
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHAD,Chondroadherin,39736,0.0127551901499875,0.00487545529713445,0.00319929776760395,0.022311082532371,0.00890331947767199
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOLH1,Glutamate carboxypeptidase 2,39657,0.0284144018524909,0.0108759377155453,0.00709756393002204,0.0497312397749597,0.00899797249999924
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SYT1,Synaptotagmin-1,39929,0.0108074969088258,0.00416346217902048,0.00264711103794567,0.018967882779706,0.00944939506813872
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VEGFB,Vascular endothelial growth factor B,39657,0.00795071923924944,0.00306978820594813,0.0019339343555911,0.0139675041229078,0.00961047412685692
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPC1,Glypican-1,42262,0.00794124035201228,0.00307117059987738,0.00192174597625263,0.0139607347277719,0.00972735007720192
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AXL,Tyrosine-protein kinase receptor UFO,42217,-0.00731259130795465,0.00283199177368383,-0.0128632951843749,-0.00176188743153435,0.00982939852738156
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RCC1,Regulator of chromosome condensation,39919,0.0139780277352743,0.00541655281727471,0.0033615842134159,0.0245944712571327,0.00987497540099717
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CR1,Complement receptor type 1,39970,0.00948861537883522,0.00368755566619686,0.00226100627308936,0.0167162244845811,0.0100904571449311
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,42070,-0.00844220822625396,0.00329547579110035,-0.0149013407768106,-0.00198307567569726,0.0104251987959659
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VCAN,Versican core protein,42249,-0.00798840021577047,0.00312752127965153,-0.0141183419238875,-0.00185845850765347,0.010653137945125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,39657,0.00961650190365111,0.00377284760605502,0.00222172059578327,0.0170112832115189,0.0108206175896038
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTA4H,Leukotriene A-4 hydrolase,42262,-0.0157479506592608,0.00619003601861397,-0.0278804212557441,-0.00361548006277737,0.0109674934579832
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,0.0137963350945541,0.00542334139411904,0.00316658596208075,0.0244260842270274,0.0109741055675147
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SULT1A1,Sulfotransferase 1A1,42249,-0.0339385099870608,0.0133606623510689,-0.0601254081951558,-0.00775161177896581,0.0110904763937509
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCN,Decorin,41900,-0.00607456092414701,0.00239159447109991,-0.0107620860875028,-0.00138703576079118,0.0110977059961481
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,0.0184877449341449,0.00728566300051423,0.00420784545313699,0.0327676444151528,0.011174075258039
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAMDC2,MAM domain-containing protein 2,39958,-0.00934337828948484,0.00369913279850727,-0.0165936785745591,-0.00209307800441058,0.0115560349102159
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,0.0146805010034112,0.00581751895273127,0.00327816385605794,0.0260828381507645,0.0116329144057058
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEBP1,Heme-binding protein 1,41900,-0.0135817812889287,0.00540769634118435,-0.0241808661176501,-0.00298269646020743,0.0120314636670878
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD200,OX-2 membrane glycoprotein,42119,-0.00708723295896778,0.0028257186171141,-0.0126256414485114,-0.00154882446942414,0.012149264338532
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,39657,0.0094652604375369,0.00377539652166582,0.00206548325507189,0.0168650376200019,0.0121871831367473
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,0.0144739454638549,0.00578502454670001,0.00313529735232287,0.0258125935753869,0.012364499444166
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,0.00818128732098369,0.00327394077693913,0.00176436339818299,0.0145982112437844,0.0124695159401117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,-0.00825912306369143,0.00330673578854482,-0.0147403252092393,-0.00177792091814359,0.0125134124596953
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPR158,Probable G-protein coupled receptor 158,39934,0.00898602569675658,0.00360362325415462,0.00192292411861352,0.0160491272748996,0.0126593367853165
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,0.0101377309410059,0.00407150778669108,0.00215757567909141,0.0181178862029205,0.0127913831662968
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGFLAM,Pikachurin,39930,0.00799408901118429,0.00321210812929638,0.00169835707776338,0.0142898209446052,0.0128340601116135
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF2RB,Cytokine receptor common subunit beta,39657,-0.0110010782463521,0.00442100288440639,-0.0196662438997886,-0.00233591259291555,0.0128477240502369
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSG4,Desmoglein-4,42018,0.0123264454081184,0.00498093937135552,0.00256380424026157,0.0220890865759752,0.0133462184858504
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK15,Kallikrein-15,39900,0.0135142757564876,0.00546343307938904,0.00280594692088506,0.0242226045920901,0.0133910189941675
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDI2,Protein DDI1 homolog 2,39736,0.0192589472840182,0.00778635071432953,0.00399769988393235,0.0345201946841041,0.0133973290930929
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAPRT,Nicotinate phosphoribosyltransferase,39929,0.00860325569814136,0.00348179592621002,0.00177893568276972,0.015427575713513,0.0134910206483627
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.0176561223865485,0.00715505614839263,0.00363221233569895,0.0316800324373981,0.0136129350821335
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,0.01434249421505,0.00581843272095549,0.00293836608197721,0.0257466223481227,0.0137161433165608
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MERTK,Tyrosine-protein kinase Mer,42296,0.00629933356094407,0.0025639463621711,0.00127399869108871,0.0113246684307994,0.0140268802654379
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA3,Carbonic anhydrase 3,42287,-0.0149967402735102,0.00611186410685449,-0.026975993922945,-0.00301748662407541,0.0141514799647589
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHA2,Ephrin type-A receptor 2,41614,-0.00821570655561367,0.00335968813819853,-0.0148006953064828,-0.00163071780474456,0.0144832092681292
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,-0.015217756563112,0.00624335034450644,-0.0274547232383446,-0.00298078988787938,0.0148048600935791
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPHA2,Glycoprotein hormone alpha-2,39930,-0.011022777217251,0.00453513597791823,-0.0199116437339707,-0.00213391070053124,0.0150922360439567
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX2,Peroxiredoxin-2,39819,0.015260604252963,0.00627903036455362,0.00295370473843793,0.0275675037674881,0.0150974141135573
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA8,Carbonic anhydrase-related protein,39657,0.00672277278222563,0.00276887112269343,0.00129578538174651,0.0121497601827047,0.0151988924293873
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G1B,Phospholipase A2,42299,-0.0112333574968755,0.00463247462113499,-0.0203130077543001,-0.00215370723945093,0.0153248120857409
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOA4,Apolipoprotein A-IV,39979,0.00866630685222894,0.00357787819742407,0.00165366558527777,0.0156789481191801,0.0154427277467273
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,42137,-0.0106150045351282,0.00439081557192622,-0.0192210030561036,-0.0020090060141528,0.0156386235135149
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYO6,Unconventional myosin-VI,39934,0.00939898669272205,0.00388915969299792,0.00177623369444613,0.017021739690998,0.0156770074921824
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPS10,40S ribosomal protein S10,39575,-0.0104414088211032,0.00434190686168255,-0.018951546270001,-0.00193127137220538,0.0161978628829186
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,0.0289279694101392,0.0120385396847566,0.00533243162801621,0.0525235071922622,0.0162771533759609
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,-0.00866884008244121,0.0036104965390395,-0.0157454132989586,-0.00159226686592379,0.0163632651134729
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300C,CMRF35-like molecule 6,42249,0.00878940140920278,0.00366268127796459,0.00161054610439218,0.0159682567140134,0.0164210325709562
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,-0.00519083592784492,0.00216502268511077,-0.00943428039066202,-0.000947391465027813,0.0165199492858566
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIF20B,Kinesin-like protein KIF20B,39586,0.0186301751803243,0.00777093257974354,0.00339914732402691,0.0338612030366216,0.0165276604436661
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ID4,DNA-binding protein inhibitor ID-4,39757,-0.0104415559924656,0.00436168717943363,-0.0189904628641556,-0.00189264912077573,0.0166855264500732
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKCQ,Protein kinase C theta type,41913,0.0106310154757642,0.0044456999371542,0.00191744359894192,0.0193445873525864,0.0168024910937619
NMR metabolomics,X23508.Triglycerides in Medium VLDL,QPCT,Glutaminyl-peptide cyclotransferase,42170,0.00668877997811953,0.00280614537038288,0.00118873505216908,0.01218882490407,0.0171570334499098
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX5,Syntaxin-5,39657,0.00985095346384127,0.00413432145820453,0.00174768340576038,0.0179542235219222,0.0172017943609353
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HRAS,GTPase Hras,39750,0.0244959867586617,0.0102971747751426,0.00431352419938216,0.0446784493179412,0.0173809474258722
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.00974281697896017,0.00409602505957915,-0.0177710260957353,-0.00171460786218504,0.017395394148496
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,39586,-0.017474281995649,0.00735362845087452,-0.031887393759363,-0.00306117023193491,0.0175052142453717
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17RA,Interleukin-17 receptor A,42137,0.0109124094339663,0.00461461642362012,0.00186776124367085,0.0199570576242617,0.0180563213580626
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NELL2,Protein kinase C-binding protein NELL2,42185,0.00709784863963084,0.00300943459052398,0.00119935684220384,0.0129963404370578,0.0183614462490435
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASET2,Ribonuclease T2,42258,0.00656653547885624,0.00278734919052957,0.00110333106541828,0.0120297398922942,0.0184951652653937
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RYR1,Ryanodine receptor 1,39575,-0.0082692547268913,0.00351082146112175,-0.0151504647906899,-0.00138804466309268,0.0185221784150421
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,-0.0102488285702145,0.00435801142455549,-0.0187905309623433,-0.00170712617808576,0.0187037865103259
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL36G,Interleukin-36 gamma,39624,0.0164191943561558,0.00698507960580817,0.00272843832877176,0.0301099503835398,0.0187602145756686
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHNAK2,Protein AHNAK2,39638,0.00761189048581012,0.00323993821174098,0.0012616115907978,0.0139621693808224,0.0188215365127893
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIPC2,PDZ domain-containing protein GIPC2,39929,-0.00744847228798365,0.00317294288189112,-0.0136674403364902,-0.00122950423947706,0.0189171648317211
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.0155443863991394,0.00663157360254352,-0.0285422706601247,-0.00254650213815407,0.0190927796963258
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.0131154281425288,0.00559796733603938,0.00214341216389157,0.024087444121166,0.0191496081305518
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHEK2,Serine/threonine-protein kinase Chk2,41900,0.00805669281499156,0.0034413521655251,0.00131164257056236,0.0148017430594208,0.0192395611012441
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,0.0127798886417176,0.00546325355807173,0.00207191166789704,0.0234878656155382,0.019339995786272
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPR101,Probable G-protein coupled receptor 101,39586,-0.0141103380244468,0.00604030050072696,-0.0259493270058717,-0.00227134904302197,0.0195074409276381
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,0.0122501721977451,0.00524410493580371,0.00197172652356979,0.0225286178719203,0.0195091559429218
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD55,Complement decay-accelerating factor,41714,0.00639539255524351,0.00273989870472891,0.00102519109397485,0.0117655940165122,0.019601781547398
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,42248,-0.00755515417025186,0.00324105379540473,-0.0139076196092451,-0.00120268873125858,0.0197636517003069
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NXPH3,Neurexophilin-3,39657,0.00726836891513393,0.00311900464033086,0.00115511982008544,0.0133816180101824,0.0198056158945018
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,0.0167479736853185,0.00718886694777666,0.00265779446767623,0.0308381529029607,0.0198394170396974
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,0.0087680278087486,0.00376400605804027,0.00139057593498968,0.0161454796825075,0.0198536921441565
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGR2,Anterior gradient protein 2 homolog,41740,0.0241572311072083,0.010429607729346,0.00371519995769007,0.0445992622567266,0.0205617510833304
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.0113789045666718,0.00492529756610297,-0.0210324877962336,-0.00172532133710998,0.0208900168495815
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LIF,Leukemia inhibitory factor,41839,0.0120211262490581,0.00520749234307857,0.00181444125662409,0.0222278112414921,0.0209906195792108
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB5,Serpin B5,41900,0.0116635971056662,0.0050623305200389,0.00174142928638999,0.0215857649249425,0.0212381193563299
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC11A,C-type lectin domain family 11 member A,42118,-0.01161518730348,0.00504724155871016,-0.0215077807585519,-0.00172259384840808,0.0213901493163988
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYTL1,Cytokine-like protein 1,39966,0.00610508396035474,0.00265464643608331,0.000901976945631446,0.011308190975078,0.0214791236644898
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHPK,Sedoheptulokinase,39757,-0.00954021607146754,0.00415320210640489,-0.0176804922000211,-0.00139993994291396,0.0216329294255854
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,-0.0129141010245099,0.00562643886490757,-0.0239419211997288,-0.00188628084929108,0.0217372731499496
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,0.00803959414223476,0.00351269668525928,0.00115470863912657,0.014924479645343,0.0221107723006864
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL2,Fc receptor-like protein 2,42229,0.0118963642840687,0.00520179510721945,0.00170084587391862,0.0220918826942189,0.0222126645541468
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPB6,Heat shock protein beta-6,42262,0.00966559115347298,0.00422732050677611,0.00138004296019181,0.0179511393467541,0.0222427032569802
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLMP,CXADR-like membrane protein,42262,0.00523907064762873,0.00230021299222871,0.000730653182860456,0.009747488112397,0.0227630637564174
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HBQ1,Hemoglobin subunit theta-1,42262,-0.0145427307340232,0.00638939698106437,-0.0270659488169093,-0.00201951265113701,0.0228570768133847
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD58,Lymphocyte function-associated antigen 3,42100,-0.00411954609069762,0.00181037098986879,-0.00766787323084045,-0.000571218950554791,0.0228900004395752
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,-0.0208650199332826,0.00926691120297959,-0.0390281658911226,-0.00270187397544262,0.0243690953521073
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN5,Contactin-5,42170,0.00865715858731822,0.00384972082169054,0.00111170577680476,0.0162026113978317,0.0245427455887248
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAP1A,Ras-related protein Rap-1A,39657,-0.0161467513474285,0.00718829122613971,-0.0302358021506623,-0.00205770054419462,0.0247071926290985
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,-0.00750577568394312,0.00335098900429037,-0.0140737141323523,-0.000937837235533983,0.025115597614969
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRTN3,Myeloblastin,41800,-0.0112061934660462,0.00500700720921234,-0.0210199275961024,-0.00139245933599002,0.0252310044382464
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST7,Cystatin-F,42148,0.0219535746818767,0.00981271622045134,0.00272065088979209,0.0411864984739614,0.0252856995937606
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.00728623685322002,0.00326342264604189,-0.0136825452394621,-0.000889928466977921,0.025588827637881
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,41839,0.0116632788046824,0.00523138144437033,0.00140977117371656,0.0219167864356483,0.0257984578699549
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,0.00703177474749619,0.00315580490959931,0.000846397124681538,0.0132171523703109,0.0258832222785069
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,0.00725462354163745,0.00326471076788006,0.000855790436592542,0.0136534566466824,0.0262939421985906
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARTN,Artemin,41913,0.0104181703497963,0.00469876763171049,0.00120858579164377,0.0196277549079489,0.0266253411296266
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,0.0143500223561134,0.00647521820507332,0.00165859467416974,0.0270414500380572,0.0267018553510542
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OLFM4,Olfactomedin-4,39347,0.0285181990309768,0.0128991833912288,0.00323579958416827,0.0538005984777853,0.0270669925039851
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCAM1,Neural cell adhesion molecule 1,42217,0.00751948000227589,0.00340200091696119,0.000851558205031951,0.0141874017995198,0.0271001520460294
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRHR1,Corticotropin-releasing factor receptor 1,41900,0.0133785589495855,0.00606444222505127,0.00149225218848504,0.025264865710686,0.0273964213597539
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL19,Interleukin-19,41756,-0.0168360505489001,0.00763315307081027,-0.0317970305676882,-0.00187507053011193,0.0274258657201704
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DBH,Dopamine beta-hydroxylase,39978,0.0261183145800264,0.0118481590701276,0.00289592280257637,0.0493407063574764,0.0275147884235374
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOP1,DNA topoisomerase 1,39930,0.0274983235238943,0.0125352607745932,0.00292921240569158,0.0520674346420971,0.0282788210675001
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EVI2B,Protein EVI2B,39560,-0.00906053846188941,0.00415555557013508,-0.0172054273793542,-0.000915649544424654,0.0292532091616051
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLSTN1,Calsyntenin-1,41839,0.0114647235987613,0.00527146893041671,0.00113264449514451,0.021796802702378,0.0296580133919491
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.00822673806581267,0.0038223450602685,0.000734941747686406,0.0157185343839389,0.0313971173833229
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA6C,Semaphorin-6C,39657,0.00576388304871265,0.00268241274309239,0.000506354072251568,0.0110214120251737,0.0316744297294208
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,0.00747154012030971,0.0034825191419785,0.000645802602031854,0.0142972776385876,0.0319351579880876
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP290,Centrosomal protein of 290 kDa,39757,0.0118105971923692,0.00551085249324759,0.00100932630560393,0.0226118680791345,0.0321224187194939
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA4C,Semaphorin-4C,42070,-0.00619555556017663,0.00289472901516809,-0.0118692244299061,-0.000521886690447171,0.0323493552373089
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCP2,Non-specific lipid-transfer protein,41843,0.0164979522312017,0.0077183970153751,0.00136989408106649,0.0316260103813369,0.0325768826172024
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NMRK2,Nicotinamide riboside kinase 2,39560,-0.00865526070648016,0.00406199584586764,-0.0166167725643807,-0.000693748848579588,0.0331286304609455
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD59,CD59 glycoprotein,41638,0.00522907741875868,0.00245491601110757,0.000417442036987842,0.0100407128005295,0.0331867084309008
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PREB,Prolactin regulatory element-binding protein,41913,0.00625796472937849,0.00294762295268076,0.000480623742124197,0.0120353057166328,0.0337676675409661
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1A,Interleukin-1 alpha,41913,0.012754558222992,0.00601534385938074,0.000964484258605789,0.0245446321873783,0.0339960486290525
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GKN1,Gastrokine-1,41538,0.00623454232970287,0.00295067206602469,0.000451225080294473,0.0120178595791113,0.0346264744293521
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC44A4,Choline transporter-like protein 4,39649,-0.0151154030842507,0.00715710419232732,-0.0291433273012122,-0.00108747886728915,0.034713639177347
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD48,CD48 antigen,42166,-0.00674352157661056,0.00319511779184238,-0.0130059524486216,-0.00048109070459949,0.0348274921450387
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL15,Interleukin-15,42119,0.00720913453051179,0.0034227717120699,0.000500501974854784,0.0139177670861688,0.0352030149196914
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,-0.00755402151844502,0.0035885342878651,-0.0145875487226606,-0.000520494314229423,0.0353101503066419
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB39B,Ras-related protein Rab-39B,39575,0.0201824110189248,0.00960174201188198,0.00136299667563615,0.0390018253622135,0.0355801168292836
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,-0.00594377921124763,0.0028301509443031,-0.0114908750620817,-0.000396683360413556,0.0357364570528177
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,0.00650135287758923,0.0030962689537838,0.000432665728172976,0.0125700400270055,0.0357707865791326
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOX9,Transcription factor SOX-9,39649,0.00603524889874076,0.0028743956407543,0.000401433442862337,0.0116690643546192,0.0357815239883728
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIAA1549,UPF0606 protein KIAA1549,39757,0.0148893083885946,0.00711133365693195,0.00095109442100799,0.0288275223561812,0.0363053523399626
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMIGO1,Amphoterin-induced protein 1,39649,0.0110375881405183,0.00527616354889743,0.000696307584679322,0.0213788686963572,0.0364637587578676
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.0067100158356702,0.00321274795294332,0.000413029847901297,0.0130070018234391,0.0367663272225997
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH17,Cadherin-17,42145,-0.0147826970764321,0.00709231251134105,-0.0286836295986606,-0.000881764554203657,0.0371491408098898
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,42185,-0.00618847693132038,0.002983254587329,-0.0120356559224852,-0.000341297940155538,0.0380605405567366
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDRG1,Protein NDRG1,41839,0.0142295190301989,0.0068675086296283,0.000769202116127379,0.0276898359442703,0.0382841975546137
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COMMD9,COMM domain-containing protein 9,39919,0.00857771355109309,0.00414206626313422,0.000459263675350012,0.0166961634268362,0.0383928186736437
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANK2,Ankyrin-2,39575,-0.0150503191599714,0.00726896230951856,-0.0292974852866277,-0.000803153033315011,0.0384297404975865
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,-0.00731348604835283,0.00353805766800537,-0.0142480790776434,-0.000378893019062299,0.0387490016395353
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TEX101,Testis-expressed protein 101,39649,0.0132086716877037,0.00640658500807215,0.000651765071882244,0.0257655783035251,0.0392564385418119
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC13A1,Solute carrier family 13 member 1,39919,0.0128632135530348,0.00624017832923445,0.000632464027735322,0.0250939630783343,0.0392921105630739
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FSHB,Follitropin subunit beta,39638,-0.00879138446130017,0.00426695599710714,-0.0171546182156302,-0.000428150706970176,0.0393893347048204
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.0180708316629204,0.00877110689579126,-0.0352622011786713,-0.000879462147169548,0.0393926208201748
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,0.0270306521617077,0.0131318167810452,0.00129229127085913,0.0527690130525562,0.0395703911433166
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARG1,Arginase-1,42015,0.0108041843371205,0.00525687627426262,0.000500706839565788,0.0211076618346753,0.0398743761687747
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.00754112542489902,0.00367189458958635,0.000344212029309776,0.0147380388204883,0.0400202262325871
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,39575,0.0069308790074385,0.00339415458780687,0.000278336015337033,0.01358342199954,0.0411749375652138
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,39757,0.00957232634172836,0.00468929788264781,0.000381302491738655,0.0187633501917181,0.0412431692815095
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPTXR,Neuronal pentraxin receptor,42145,0.00722897580646789,0.00354936797554993,0.000272214574390022,0.0141857370385458,0.0417001408300311
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPLX2,Complexin-2,39560,-0.00649158012797438,0.00318818437853434,-0.0127404215099017,-0.000242738746047071,0.0417605953953571
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,0.0148497503478902,0.00729376508172255,0.000553970787713992,0.0291455299080664,0.041774516949836
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,42185,0.00575511655171654,0.00282932704816052,0.000209635537321931,0.0113005975661112,0.0419615278845027
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPSAB1,Tryptase alpha/beta-1,42281,0.0109908927833802,0.00541398808299637,0.000379476140707305,0.0216023094260531,0.0423665180103741
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,-0.00639597922296405,0.00315066737205136,-0.0125712872721847,-0.000220671173743374,0.0423765705314088
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,0.00944652318909333,0.00466767710530777,0.000297876062690102,0.0185951703154966,0.043009054461937
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLVRB,Flavin reductase,42137,0.0133577050198489,0.00662641584487885,0.000369929963886351,0.0263454800758115,0.0438378351631415
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,0.0156567463757678,0.00778431481764355,0.000399489333186426,0.0309140034183491,0.0443152694252097
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF7,Fibroblast growth factor 7,39560,-0.0162456904716587,0.00808305052446481,-0.0320884694996097,-0.000402911443707649,0.0444719030234802
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL12,Stromal cell-derived factor 1,41913,0.00824661253860107,0.00410479764260242,0.000201209159100329,0.0162920159181018,0.0445553694479915
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,0.0140588484954851,0.00700392474279547,0.000331155999605945,0.0277865409913642,0.0447433960391578
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.0108952245644289,0.00543179176963549,-0.0215415364329145,-0.000248912695943342,0.0448993790020545
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSC1,Hamartin,39657,0.0153938797095536,0.0076917611831771,0.000318027790526533,0.0304697316285808,0.0453794493092778
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD82,CD82 antigen,39757,-0.00861300589365797,0.00430600077166598,-0.0170527674061233,-0.000173244381192653,0.045499276680147
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,39657,0.00510158794172388,0.00255231417158044,9.90521654262097e-05,0.0101041237180215,0.0456534851036403
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMCN2,Hemicentin-2,39721,-0.0120218800836029,0.00603076698466437,-0.0238421833735451,-0.000201576793660778,0.0462393440285902
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB7,Integrin beta-7,42262,-0.0095228379668791,0.00479464893674377,-0.0189203498828969,-0.000125326050861305,0.0470378714277444
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,0.0254691785308361,0.0128713159441315,0.000241399280338294,0.0506969577813339,0.0478643007692664
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,0.0141007220219389,0.0071410234736916,0.00010431601350337,0.0280971280303744,0.0483333986297445
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSBP1,Heat shock factor-binding protein 1,39638,0.0197203370413613,0.0100125812038718,9.56778817725601e-05,0.03934499620095,0.0489142727265765
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAD51,DNA repair protein RAD51 homolog 1,39757,0.0106846681117339,0.0054566295897326,-1.03258841419786e-05,0.0213796621076098,0.05024226720967
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD177,CD177 antigen,42123,-0.026228724193028,0.0133971070219423,-0.0524870539560349,2.96055699788682e-05,0.0502751759668927
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,-0.00603366522939704,0.00308771502263894,-0.0120855866737694,1.82562149752801e-05,0.0507115484215078
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,-0.0138909989292751,0.00711604871212035,-0.027838454405031,5.64565464808188e-05,0.0509507889893262
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUSD5,Sushi domain-containing protein 5,39695,-0.0069763361883609,0.00358098867998833,-0.013995074001138,4.24016244162185e-05,0.0514210926908849
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYH7B,Myosin-7B,39560,-0.00868849266041984,0.00446066657151282,-0.017431399140585,5.44138197452922e-05,0.0514642257865218
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,-0.00637733957013007,0.00327738799702423,-0.0128010200442976,4.63409040374193e-05,0.0516969756817703
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MATN3,Matrilin-3,41992,-0.00667912438065619,0.00343560473866318,-0.013412909668436,5.46609071236381e-05,0.05190552831731
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.0140716412195045,0.00725030873135414,-0.000138963893949596,0.0282822463329586,0.0522994088749105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.00881206998462254,0.00454282393621077,-0.0177160048995957,9.18649303505766e-05,0.0524322359200828
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.00786241078252531,0.00406022206557501,-9.5624466001705e-05,0.0158204460310523,0.0528382986273612
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPO,Myeloperoxidase,42137,0.00904831563833484,0.00467823578139806,-0.000121026493205357,0.018217657769875,0.0531179760752036
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGLYRP1,Peptidoglycan recognition protein 1,42248,-0.00843421289796616,0.00436216448553609,-0.0169840552896169,0.000115629493684582,0.0531961941393418
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH3GL3,Endophilin-A3,39690,0.0171055641995607,0.00885339449578305,-0.000247089012174025,0.0344582174112955,0.0533737097959289
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN2B,Sodium channel subunit beta-2,39649,-0.00566566059894843,0.00293420455394606,-0.0114167015246827,8.53803267858401e-05,0.0535207609176187
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,-0.0151736239702672,0.00787291976511213,-0.030604546709887,0.000257298769352585,0.0539657023368173
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG3G,Regenerating islet-derived protein 3-gamma,39919,0.00793970595945761,0.00412413505849988,-0.000143598755202154,0.0160230106741174,0.0542317609069254
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,-0.00583474614232479,0.0030308132002738,-0.0117751400148614,0.000105647730211853,0.0542325083886948
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BMP10,Bone morphogenetic protein 10,39736,0.00565407705350016,0.00293961506512732,-0.000107568474149398,0.0114157225811497,0.0544543845767947
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGA4,Pepsin A-4,39990,0.014882894702256,0.00779075406223049,-0.000386983259715739,0.0301527726642278,0.0561160954333711
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MUCL3,Mucin-like protein 3,39560,-0.00838119277044213,0.00443194367219821,-0.0170678023679506,0.000305416827066356,0.058639027252747
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,42310,-0.00610314638036145,0.00323201516802417,-0.0124378961096888,0.000231603348965927,0.0590012950792726
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.00578143626226986,0.00306192132693137,-0.000219929538515616,0.0117828020630553,0.0590245146582965
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDC1,Syndecan-1,42145,0.00793734911750342,0.0042083352742869,-0.00031098802009891,0.0161856862551057,0.0593026009650979
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,-0.0159910653409846,0.00848743357351564,-0.0326264351450753,0.000644304463106048,0.0595796202661053
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THY1,Thy-1 membrane glycoprotein,42249,0.00570229931656899,0.00303882845327452,-0.000253804451849064,0.011658403084987,0.0606107852141262
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACRV1,Acrosomal protein SP-10,39657,0.0206739649826042,0.0110488947069798,-0.000981868643076186,0.0423297986082846,0.0613528679905329
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPT1,Palmitoyl-protein thioesterase 1,39649,0.0150624634508853,0.00805459578919645,-0.000724544295939744,0.0308494711977103,0.0615038728488124
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGMA,Repulsive guidance molecule A,42249,-0.00625091528241199,0.00334388122403655,-0.0128049224815236,0.000303091916699642,0.0615942468644491
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUSP29,Dual specificity phosphatase 29,39649,-0.0130876553964953,0.00700521552917633,-0.0268178778336809,0.000642567040690253,0.061750466483491
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLB1,"Phospholipase B1, membrane-associated",39929,0.0115170546571438,0.00616717904811643,-0.000570616277164414,0.023604725591452,0.0618610427132803
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDDC2,5'-deoxynucleotidase HDDC2,39930,-0.00843651748155367,0.00454951468438226,-0.0173535662629429,0.000480531299835562,0.0637111432855735
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAPS,Calcyphosin,39929,0.0182843225937283,0.0098744906656987,-0.00106967911104117,0.0376383242984978,0.064098870326549
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NME1,Nucleoside diphosphate kinase A,39657,-0.00421954977475711,0.00228061217046893,-0.00868954962887621,0.000250450079361985,0.0643138444650013
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,0.00555677516881651,0.00300842958557128,-0.000339746818903191,0.0114532971565362,0.0647633115230497
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PMCH,Pro-MCH,39575,-0.0158319517792636,0.00858211363538548,-0.0326528945046192,0.000988990946091891,0.065099185751452
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA3,Alpha-1-antichymotrypsin,39951,-0.00285032929159902,0.00154680203284769,-0.0058820612759805,0.000181402692782451,0.0653953725890678
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PFDN4,Prefoldin subunit 4,39560,-0.0101025855159248,0.00548923576956087,-0.0208614876242641,0.000656316592414493,0.0657313137503422
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP1,"Fatty acid-binding protein, liver",42123,-0.0181535786571303,0.00988370145108227,-0.0375256335012515,0.00121847618699097,0.0662733772924047
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST6,Cystatin-M,41864,0.00949977399404595,0.00517565985795594,-0.0006445193275477,0.0196440673156396,0.0664582958570933
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYL4,Myosin light chain 4,39638,-0.00983229451771475,0.0053628679934344,-0.0203435157848462,0.000678926749416671,0.0667696788706865
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIRREL1,Kin of IRRE-like protein 1,39586,-0.0106115002383062,0.0058026574788377,-0.021984708896828,0.000761708420215734,0.0674669965501478
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRTAC1,Cartilage acidic protein 1,42310,0.00588366389317169,0.00321929656099718,-0.000426157366382787,0.0121934851527262,0.0676277137118002
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENDOU,Poly(U)-specific endoribonuclease,39090,0.0107048547702194,0.00588104124066425,-0.000821986061482573,0.0222316956019213,0.0687522857888712
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP1,Caspase-1,41839,0.0130349985302797,0.0071670130698461,-0.00101234708661864,0.0270823441471781,0.0689723004428656
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTO1,Protein LTO1 homolog,41913,0.00775817625010102,0.00429370867370961,-0.000657492750369822,0.0161738452505719,0.0708050152667103
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,0.0151726117028526,0.0084211358796497,-0.00133281462126081,0.031678038026966,0.071615171307545
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,-0.015698201382677,0.00871341506564523,-0.0327764949113416,0.00138009214598768,0.071633756665477
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCN1,Transcobalamin-1,39806,-0.00667426935604933,0.0037050414527038,-0.0139361506033488,0.000587611891250121,0.0716663998722154
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RALB,Ras-related protein Ral-B,39657,0.00554905392039959,0.00308256644067012,-0.000492776303313847,0.011590884144113,0.071865639266453
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD2,T-cell surface antigen CD2,39575,-0.00727762075620389,0.00404717333181196,-0.0152100804865553,0.000654838974147562,0.0721730379367715
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBM19,Probable RNA-binding protein 19,39575,-0.00898955325769247,0.00500121861328657,-0.0187919417397342,0.000812835224349209,0.0722881079231368
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUP50,Nuclear pore complex protein Nup50,39575,-0.00592484344287472,0.00329877646162424,-0.0123904453076582,0.000540758421908795,0.0725103961624187
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAD2,Glutamate decarboxylase 2,39657,-0.00845246124506908,0.00470939485505814,-0.017682875160983,0.000777952670844862,0.0727115417360221
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PZP,Pregnancy zone protein,39979,0.00618640668357914,0.00345182283854142,-0.000579166079962042,0.0129519794471203,0.0731251817226097
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCG3,Secretogranin-3,42144,-0.00619039776732618,0.00345951775592504,-0.0129710525689393,0.000590257034286913,0.0735757000967776
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GZMH,Granzyme H,41900,0.0146038482930453,0.00818265277896996,-0.00143415115373583,0.0306418477398264,0.0743274634426028
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.00475395482445264,0.00266443505715695,-0.00997624753648026,0.000468337887574974,0.0744143772381671
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ULBP2,UL16-binding protein 2,42016,0.00730818033033464,0.00409835076134951,-0.000724587161910409,0.0153409478225797,0.0745763038502332
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,42137,-0.00657421362887772,0.00368979559636328,-0.0138062129977498,0.000657785739994313,0.0748159433834841
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OTOA,Otoancorin,39586,-0.00972278312461284,0.00546269088327074,-0.0204296572558235,0.000984091006597812,0.0751277642178526
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLAMF1,Signaling lymphocytic activation molecule,41913,-0.011032197772028,0.0062023707295384,-0.0231888444019233,0.00112444885786726,0.0753106894639753
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHRM1,Muscarinic acetylcholine receptor M1,39649,-0.00668506175696651,0.00376549946837882,-0.014065440714989,0.000695317201055971,0.0758684123285061
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,0.0049153315340207,0.00279373270954073,-0.000560384576679137,0.0103910476447205,0.0785299663948556
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KEL,Kell blood group glycoprotein,41839,0.00661526320002344,0.00376484247047321,-0.00076382804210405,0.0139943544421509,0.0789212304312807
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,0.0137501085758654,0.00787061746731746,-0.00167630166007682,0.0291765188118076,0.0806574430915772
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RTKN2,Rhotekin-2,39575,-0.00923005203101935,0.00529603509877195,-0.0196102808246124,0.00115017676257367,0.081392535998078
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB118,Beta-defensin 118,39586,0.0103224745300949,0.00592453355759751,-0.00128961124279621,0.021934560302986,0.0814792319456607
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,0.00950662424323991,0.00545809968516755,-0.00119125113968849,0.0202044996261683,0.0815760940677116
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AIF1L,Allograft inflammatory factor 1-like,39638,0.0102761775478287,0.00590226386081418,-0.0012922596193671,0.0218446147150245,0.0817014574620759
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF9,Fibroblast growth factor 9,39539,0.00745565119079976,0.00428524329667598,-0.000943425670685161,0.0158547280522847,0.0819146879920285
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,-0.00747739065736183,0.00430012777805418,-0.015905641102348,0.000950859787624363,0.0820843407719003
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLAMF8,SLAM family member 8,41843,-0.00971479088324456,0.00560164952383293,-0.0206940239499571,0.00126444218346798,0.0828928825401266
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,-0.0104357375649797,0.00601858688431337,-0.0222321678582339,0.00136069272827453,0.0829552877365242
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM5,Intercellular adhesion molecule 5,42145,0.00829787966300557,0.00478595717185844,-0.00108259639383697,0.0176783557198481,0.0829768075172057
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD80,T-lymphocyte activation antigen CD80,39958,0.0061565134704998,0.00356228937328225,-0.000825573701133414,0.013138600642133,0.0839712527118606
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX1,ATP-dependent RNA helicase DDX1,39930,0.00863930780057443,0.00500573214797325,-0.00117192720945314,0.018450542810602,0.0843957354182041
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,0.00568889076736116,0.00329832176503615,-0.000775819892109681,0.012153601426832,0.0845946330623248
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFF1,Trefoil factor 1,42084,-0.0144360744945938,0.00837207225596822,-0.0308453361162915,0.00197318712710393,0.0846742407651504
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,-0.00526771808811874,0.00305802307497656,-0.0112614433150728,0.000726007138835308,0.0849909491903141
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,39657,-0.0105208458772734,0.00611562741449936,-0.0225074756096922,0.00146578385514534,0.085401980846007
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,-0.0110113226737384,0.0064009583652542,-0.0235572010696367,0.00153455572215979,0.0854130953219299
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFBR2,TGF-beta receptor type-2,42181,0.00611601411936446,0.00356090072948903,-0.00086335131043403,0.013095379549163,0.0859020839573624
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.009775202311304,0.00570845595748418,-0.020963775987973,0.001413371365365,0.0868498329155738
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,-0.007841694938045,0.00457974239741226,-0.016817990036973,0.00113460016088304,0.0868767493602212
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INHBB,Inhibin beta B chain,39736,0.00929404054212222,0.00542966999908359,-0.00134811265608163,0.0199361937403261,0.086977286297379
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL10RA,Interleukin-10 receptor subunit alpha,41913,0.00995388342331309,0.00582583074098414,-0.00146474482901582,0.021372511675642,0.0875525458021678
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POF1B,Protein POF1B,39657,-0.00804014352398648,0.00472422724946533,-0.0172996289329385,0.00121934188496556,0.0888029748990949
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOS2,"Nitric oxide synthase, inducible",39575,-0.00712818511431206,0.00419261108897538,-0.0153457028487038,0.00108933262007968,0.0891257834836935
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,0.00703891329160285,0.00415550832622952,-0.001105883027807,0.0151837096110127,0.0903171490838963
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBM25,RNA-binding protein 25,39560,-0.00822997372407365,0.00486983127355081,-0.0177748430202332,0.00131489557208593,0.0910580090584633
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,0.00514586721117553,0.00305980886276547,-0.000851358159844792,0.0111430925821959,0.0926434333056955
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,-0.0100352041304987,0.00597321724544832,-0.0217427099315774,0.00167230167058002,0.0929792605562
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCAR,Immunoglobulin alpha Fc receptor,42119,-0.00840935372075216,0.00506250762226029,-0.0183318686603823,0.00151316121887801,0.096715667710228
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,0.00615724611056966,0.00370843898081411,-0.00111129429182599,0.0134257865129653,0.0968709185267361
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPM1B,Protein phosphatase 1B,39657,0.0106162849557414,0.00641260022254158,-0.00195241148044007,0.0231849813919229,0.0978443743590193
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.0238142238090671,0.0144178630120599,-0.0520732353127044,0.00444478769457026,0.0986199590957608
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL6ST,Interleukin-6 receptor subunit beta,42145,0.00300736139817417,0.00182468900255604,-0.00056902904683566,0.006583751843184,0.0993450626792505
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP1B4,Protein ATP1B4,39560,-0.00715612911685606,0.00435593903814197,-0.0156937696316143,0.0013815113979022,0.100443861890499
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4D,C-type lectin domain family 4 member D,42119,0.0105233876670556,0.00643180201406816,-0.00208294428051803,0.0231297196146291,0.101831645091223
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBP6,Guanylate-binding protein 6,39575,-0.00760850120441001,0.0046503550711728,-0.0167231971439087,0.00150619473508869,0.101844847130832
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPA33,Cell surface A33 antigen,42070,0.0227410080562446,0.013903091247894,-0.00450905078962765,0.0499910669021168,0.101929945188897
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLITRK1,SLIT and NTRK-like protein 1,39657,0.00551985604640605,0.00337854607289179,-0.00110209425646185,0.012141806349274,0.102330101325088
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TLR2,Toll-like receptor 2,39757,-0.00391638380660623,0.00240536488468537,-0.00863089898058955,0.000798131367377087,0.103513477996187
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TEX33,Testis-expressed protein 33,39757,-0.00652407034614407,0.00400799564176126,-0.0143797418039961,0.001331601111708,0.10360320868003
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK3,Prostate-specific antigen,39966,0.0192471649406445,0.0119095357530212,-0.00409552513527701,0.0425898550165659,0.106097467064888
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.00824069836009263,0.00510145531870612,-0.0182395507847566,0.00175815406457136,0.106256098266231
NMR metabolomics,X23508.Triglycerides in Medium VLDL,H2AP,Huntingtin-interacting protein M,39560,-0.00839894588864738,0.00523985549761886,-0.0186690626639804,0.00187117088668559,0.108986329159478
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTNAP2,Contactin-associated protein-like 2,42119,-0.00714624000435882,0.00446079776572023,-0.0158894036251705,0.00159692361645284,0.109176891698858
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,39586,-0.0114706788843957,0.00720633710272928,-0.0255950996057451,0.00265374183695365,0.111469915656204
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJA1,DnaJ homolog subfamily A member 1,39560,-0.00773539230044809,0.00487045658597447,-0.0172814872089581,0.00181070260806188,0.112263786713451
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00491255277330059,0.00310612013272152,-0.00117544268683359,0.0110005482334348,0.113771849839664
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFDC2,WAP four-disulfide core domain protein 2,41430,-0.00690196436346209,0.00437467340086711,-0.0154763242291616,0.00167239550223745,0.114656986026698
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.00415649630800448,0.00263585689528463,-0.00932277582276235,0.00100978320675339,0.114845272692643
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,39657,-0.00751459691144039,0.00476871928329241,-0.0168612867066935,0.00183209288381273,0.115098139410611
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYH4,Myosin-4,39575,-0.00749028367623511,0.00476562487673049,-0.0168309084346269,0.00185034108215665,0.116041614347164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,0.00766404680903628,0.00489795054762474,-0.00193593626430822,0.0172640298823808,0.117670515367371
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMPRSS5,Transmembrane protease serine 5,41946,-0.00625629979586099,0.0040131964440079,-0.0141221648261165,0.00160956523439449,0.11903621985213
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TG,Thyroglobulin,39919,-0.016945665425293,0.0108856312301896,-0.0382815026364645,0.00439017178587859,0.119569614586685
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6V1D,V-type proton ATPase subunit D,42070,0.00419505617702229,0.00269810279402055,-0.00109322529925799,0.00948333765330257,0.120013145048292
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.0108205438147863,0.00697988803146538,-0.0245011243564584,0.00286003672688587,0.121111305933348
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C9orf40,Uncharacterized protein C9orf40,39930,0.0125214102442732,0.00808107905223153,-0.00331750469810057,0.028360325186647,0.121296093231929
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHL1,Neural cell adhesion molecule L1-like protein,42189,-0.0047903084441469,0.00311387598004521,-0.0108935053650355,0.00131288847674171,0.123980274893662
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL5,Interleukin-5,41913,0.0220379775880663,0.0143609435693543,-0.00610947180786808,0.0501854269840007,0.124911462482781
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLNS1A,Methylosome subunit pICln,39649,-0.00534541007979206,0.003494087432685,-0.0121938214478547,0.00150300128827055,0.126083876777268
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.0097510921131319,0.00638008842951609,-0.0222560654349834,0.00275388120871963,0.126450744861738
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPN1,Epsin-1,39757,0.0068642491872994,0.00449565096997292,-0.00194722671384752,0.0156757250884463,0.126823093251505
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPSG1,Tryptase gamma,39657,0.00415828640058696,0.00272372605894015,-0.00118021667493573,0.00949678947610966,0.126866620937153
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN1,Contactin-1,42310,-0.00423638396764394,0.00277685108782256,-0.00967901209977616,0.00120624416448828,0.127130788908811
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AIDA,"Axin interactor, dorsalization-associated protein",39649,0.0135597663558758,0.00891124946444748,-0.00390628259444126,0.0310258153061929,0.128126442390655
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC7A,C-type lectin domain family 7 member A,42296,-0.00939825919159187,0.00618227481702882,-0.0215155178329684,0.00271899944978462,0.128485223318721
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNL1,Thioredoxin-like protein 1,39570,0.0160607005516464,0.0105765569969054,-0.00466935116228817,0.036790752265581,0.128912483372067
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,-0.00585724911579644,0.00386120305071087,-0.0134252070951897,0.00171070886359686,0.129307826671543
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EP300,Histone acetyltransferase p300,39657,0.0048552591282944,0.00320077064862192,-0.00141825134300455,0.0111287695995934,0.129319722313542
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A3,Protein S100-A3,39919,0.00671567172661974,0.00443612140716867,-0.00197912623143087,0.0154104696846703,0.130088987507076
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.00641579176054778,0.00424252872703892,-0.00189956454444851,0.0147311480655441,0.130496533419659
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,0.0135755803508719,0.00898474853054614,-0.00403452676899854,0.0311856874707423,0.130827960920805
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.00723735662089183,0.00482102193915503,-0.00221184637985202,0.0166865596216357,0.133330543709262
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPHS2,Podocin,39657,-0.0158689370087544,0.0105922738058896,-0.036629793668298,0.00489191965078927,0.13411983761577
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,-0.00460461124145325,0.00308256314800588,-0.0106464350115448,0.00143721252863828,0.135266061536819
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NXPE4,NXPE family member 4,39575,-0.00496008450643576,0.00332764715069072,-0.0114822729217896,0.00156210390891806,0.136103677549749
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,-0.00333860000991048,0.00224889996664706,-0.00774644394453872,0.00106924392471776,0.137692146854119
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTR,Methionine synthase,39575,0.0100561423051398,0.00679438340461503,-0.00326084916790566,0.0233731337781853,0.138884084991852
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,39575,-0.0162705838475772,0.0110194748525084,-0.0378687545584936,0.00532758686333918,0.139830391698276
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPEP2,Dipeptidase 2,42070,-0.00461398225605507,0.00312738151002199,-0.0107436500156982,0.00151568550358803,0.140141848197965
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.00532675602062972,0.0036136587424533,-0.00175601511457875,0.0124095271558382,0.140493187842746
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMC3,26S proteasome regulatory subunit 6A,39560,-0.0046688563182436,0.00316735925975642,-0.0108768804673662,0.00153916783087897,0.140495966055588
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DOC2B,Double C2-like domain-containing protein beta,39649,0.00561802591204135,0.00381779907948378,-0.00186486028374687,0.0131009121078296,0.141174902339789
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",39560,0.0145211354540547,0.00989904838554469,-0.0048809993816129,0.0339232702897223,0.142425868400007
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAPN3,Calpain-3,39919,-0.00593835045708127,0.00405419604822121,-0.0138845747115948,0.0020078737974323,0.143019146584984
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADRA2A,Alpha-2A adrenergic receptor,39575,-0.0105574738320293,0.0072270758704467,-0.0247225425381049,0.00360759487404621,0.144092832010224
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNDC15,Thioredoxin domain-containing protein 15,42181,-0.00418844030027478,0.00287178893623953,-0.00981714661530425,0.00144026601475469,0.144732025552403
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,0.0062097672044716,0.00425823921120493,-0.00213638164949006,0.0145559160584333,0.144782675814934
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGS8,Regulator of G-protein signaling 8,41913,-0.0096435203740161,0.00664292016479556,-0.0226636438970154,0.0033766031489832,0.14660888947494
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UNG,Uracil-DNA glycosylase,39919,0.00530303245343273,0.00366022427256245,-0.00187100712078968,0.0124770720276551,0.147413549476039
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGM2,Phosphoglucomutase-2,39649,0.00914805765693009,0.00631410317254186,-0.00322758456125195,0.0215236998751121,0.147413638453144
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.00988333281498825,0.00682837191364235,-0.0232669417657272,0.00350027613575075,0.147815182258719
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENOPH1,Enolase-phosphatase E1,39919,0.00801109478789324,0.00554022963013118,-0.00284775528716386,0.0188699448629503,0.148208800435736
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.00507519100431203,0.00351234139103647,-0.0119593801307435,0.00180899812211945,0.148492663554784
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,-0.00401531001127347,0.00278145830704626,-0.00946696829308414,0.00143634827053719,0.148875104713492
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DIPK2B,Divergent protein kinase domain 2B,39736,0.00448766921377089,0.00311037105584283,-0.00160865805568106,0.0105839964832228,0.14910260281193
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTK7,Inactive tyrosine-protein kinase 7,41839,0.00573579664222684,0.00398163892263596,-0.00206821564613965,0.0135398089305933,0.149732187764801
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE1,Ribonuclease pancreatic,39990,0.00369818560805936,0.0025692151708676,-0.00133747612684114,0.00873384734295986,0.150058391188811
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPTX2,Neuronal pentraxin-2,39966,-0.00512212101232231,0.00356033135746184,-0.0121003704729475,0.00185612844830291,0.150273242173532
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,-0.00753135734273558,0.00524183029276574,-0.0178053447165564,0.00274263003108526,0.150808588397966
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,39586,-0.00744947708075268,0.00519684403397622,-0.0176352913873461,0.00273633722584071,0.151754383936415
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNPEP,Aspartyl aminopeptidase,39929,0.00846977065477471,0.00591837208758036,-0.00313023863688278,0.0200697799464322,0.152429703999118
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,-0.00521604136924127,0.00364913755396659,-0.0123683509750158,0.00193626823653325,0.15291512172479
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSMB,Beta-microseminoprotein,42103,-0.0103566099662,0.00725915454168484,-0.0245845528679023,0.0038713329355023,0.153690532122797
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRR5,Proline-rich protein 5,39657,0.00699298972878268,0.00490509115079323,-0.00262098892677205,0.0166069683843374,0.15399488554743
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,39560,0.00880046538785633,0.00618867800549873,-0.00332934350292118,0.0209302742786339,0.155046955127658
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,0.00861135417695112,0.00610797810876295,-0.00336028291622426,0.0205829912701265,0.158611260777683
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM171B,Protein FAM171B,39919,0.0038883987815526,0.00275931588311364,-0.00151986034935013,0.00929665791245533,0.15880663325839
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TLR4,Toll-like receptor 4,39657,0.00415695408774478,0.00295108046305133,-0.00162716361983582,0.00994107179532538,0.158975366795615
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EXOSC10,Exosome component 10,39575,-0.00847510781239362,0.00606290294694247,-0.0203583975884009,0.00340818196361363,0.162182456944773
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL9,C-X-C motif chemokine 9,42185,0.00942444145727739,0.00675335238050565,-0.00381212920851368,0.0226610121230685,0.162881756934069
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,39586,0.00703478121323682,0.00504265870051603,-0.0028488298397746,0.0169183922662482,0.163027756488662
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TJP3,Tight junction protein ZO-3,39586,-0.00601704439544186,0.00432449581236183,-0.014493056187671,0.00245896739678732,0.164136478478968
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRISP2,Cysteine-rich secretory protein 2,42262,0.00767324035344213,0.00551931906874827,-0.00314462502130447,0.0184911057281887,0.164475237253089
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGBL2,Cytosolic carboxypeptidase 2,39586,0.0132520302531962,0.00955687934222489,-0.00547945325756455,0.031983513763957,0.165577176466
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB6B,Ras-related protein Rab-6B,41839,0.00682663138543141,0.0049271092357051,-0.00283050271655058,0.0164837654874134,0.165915435812508
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP3,"Fatty acid-binding protein, heart",39958,0.0078262868969495,0.00565566007818158,-0.00325880685628639,0.0189113806501854,0.166447736065522
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFF2,Trefoil factor 2,42166,-0.00840270375625255,0.0060730101908887,-0.0203058037303944,0.00350039621788929,0.166499352270134
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,0.00722250179834234,0.00524574415353159,-0.00305915674257958,0.0175041603392643,0.168592480601293
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,0.00595836444289853,0.00432910277641644,-0.00252667699887768,0.0144434058846748,0.168740216060106
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,0.0088716951837717,0.0064472002146859,-0.00376481723701268,0.0215082076045561,0.168832161658574
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,-0.0111931696285674,0.00814612423871842,-0.0271595731364555,0.00477323387932072,0.169449886913288
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,0.011945426634204,0.00870972673484217,-0.00512563776608665,0.0290164910344946,0.170245917593331
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAEP,Glycodelin,42016,-0.0149170482431778,0.0109039268006051,-0.0362887447723638,0.00645464828600814,0.171321313283609
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YY1,Transcriptional repressor protein YY1,39657,0.00394817666678024,0.00289970652190408,-0.00173524811615177,0.00963160144971225,0.173358838043215
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,-0.00807618005584497,0.00594126121638552,-0.0197210520399606,0.00356869192827065,0.174067520099447
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DHODH,Dihydroorotate dehydrogenase,39575,0.00653477563004075,0.00483193516353465,-0.00293581729048716,0.0160053685505687,0.176270852253611
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDNRB,Endothelin receptor type B,39657,0.00613726620823408,0.00455569005072878,-0.00279188629119432,0.0150664187076625,0.177954703034863
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,0.00756291125349314,0.00563454292456269,-0.00348079287864974,0.018606615385636,0.179545857508663
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GUCY2C,Heat-stable enterotoxin receptor,39757,-0.0114194554117589,0.00850935477884075,-0.0280977907782867,0.005258879954769,0.179627065640976
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP4,Caspase-4,39757,-0.0231223228989253,0.0172486860500389,-0.0569297475570016,0.0106851017591509,0.180101488742985
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAG,S-arrestin,39586,-0.00725210516820983,0.00543609869051524,-0.0179068586016197,0.00340264826520004,0.182210439318061
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NMI,N-myc-interactor,39875,-0.0100976824489913,0.00757400012271135,-0.0249427226895055,0.004747357791523,0.182492011173924
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCUN1D1,DCN1-like protein 1,39586,-0.0104389990727843,0.0078385874354639,-0.0258026304462936,0.00492463230072491,0.182971648836221
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NGF,Beta-nerve growth factor,42016,0.00168818972551483,0.00126821278660542,-0.000797507336231784,0.00417388678726145,0.183160132951653
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LCN15,Lipocalin-15,39934,-0.00838685780130671,0.00630426445587128,-0.0207432161348144,0.003969500532201,0.183430813432847
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL13,Interleukin-13,41913,-0.00665191033474843,0.00505210131479317,-0.016554028911743,0.00325020824224619,0.187974577549793
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OFD1,Oral-facial-digital syndrome 1 protein,39757,-0.00904938753516393,0.00687411109409837,-0.0225226452795967,0.00442387020926887,0.188051849823986
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPP10,Inactive dipeptidyl peptidase 10,42119,0.00501707062185976,0.00381258529979627,-0.00245559656574094,0.0124897378094605,0.188222030769441
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OMP,Olfactory marker protein,39586,-0.00655049829293697,0.00498514179452662,-0.0163213762102092,0.00322037962433522,0.188872156860626
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMA1,Laminin subunit alpha-1,39575,-0.00706002075225986,0.00537567346939466,-0.0175963407522734,0.00347629924775368,0.189100011954478
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDAN1,Codanin-1,39929,0.00298160267914815,0.00227259106475555,-0.00147267580777274,0.00743588116606903,0.189552181148296
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,-0.0103411966939125,0.007925280353585,-0.0258747461869391,0.00519235279911405,0.191975370032966
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.00619473246641063,0.00475322793828775,-0.00312159429263335,0.0155110592254546,0.1925051892387
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TUBB3,Tubulin beta-3 chain,39586,-0.00387086149197248,0.00297593612057283,-0.00970369628829524,0.00196197330435027,0.193381382148562
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALMS1,Alstrom syndrome protein 1,39757,-0.00594725563668135,0.00461484825847006,-0.0149923582232827,0.00309784694991996,0.197521535812027
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,0.00454674147989417,0.00352902687106728,-0.0023701511873977,0.011463634147186,0.197634571289922
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMBN,Ameloblastin,41913,-0.00365066664271404,0.00284402442055663,-0.00922495450700504,0.00192362122157695,0.199294825971114
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHA10,Ephrin type-A receptor 10,41839,0.0087645874291266,0.0068403580672903,-0.00464251438276239,0.0221716892410156,0.200108874224344
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,-0.0064729607964426,0.00506323061162999,-0.0163968927952374,0.00345097120235217,0.201121450040995
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOS,Proto-oncogene c-Fos,39539,-0.00479976588149915,0.00375459087691805,-0.0121587640002585,0.00255923223726023,0.2011452238138
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,41843,0.00518274969207005,0.00406139988409042,-0.00277759408074718,0.0131430934648873,0.201942786424673
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,0.00909307778132504,0.00716700653442212,-0.00495425502614233,0.0231404105887924,0.204559787014564
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL22,Interleukin-22,39919,-0.0092803164664116,0.00731666032902309,-0.0236209707112969,0.00506033777847366,0.204687837554719
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFRA2,GDNF family receptor alpha-2,42070,0.00273501102788118,0.00217038048757779,-0.00151893472777129,0.00698895678353364,0.207636079974102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL2L15,Bcl-2-like protein 15,39657,0.00740803157266308,0.0058862499694587,-0.00412901836747597,0.0189450815128021,0.208226140116674
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LY6D,Lymphocyte antigen 6D,42041,0.00518828478248703,0.00413000983980993,-0.00290653450354043,0.0132831040685145,0.209050694948639
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BEX3,Protein BEX3,39560,-0.00611144854349913,0.00486524909041189,-0.0156473367607064,0.00342443967370818,0.209090906570343
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HYAL1,Hyaluronidase-1,42077,-0.00301404177799122,0.00239955482317358,-0.00771716923141144,0.00168908567542899,0.209107387317595
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,-0.00743335452025286,0.00596277094946896,-0.019120385581212,0.0042536765407063,0.212560701885134
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.00983400138200213,0.0079015669043719,-0.00565306975056679,0.0253210725145711,0.213314192360253
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNR,Tenascin-R,42016,0.00541116139596408,0.00435992288074708,-0.0031342874503002,0.0139566102422283,0.214585333042223
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,-0.00507396180692792,0.00410721024034205,-0.0131240938779983,0.0029761702641425,0.216715880692724
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MORF4L2,Mortality factor 4-like protein 2,39560,-0.00485108734896448,0.00392827752137058,-0.0125505112908508,0.00284833659292185,0.21688875433938
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GH2,Growth hormone variant,41843,0.0208049011017977,0.0168584281553298,-0.0122376180826488,0.0538474202862442,0.217189423571501
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDN1,Endothelin-1,39638,0.00375138925980047,0.00305683658481143,-0.00224001044642994,0.00974278896603089,0.219768758916624
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPAN7,Tetraspanin-7,39586,-0.0124453096736886,0.0101430753981901,-0.0323257374541412,0.00743511810676391,0.219857919965395
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STEAP4,Metalloreductase STEAP4,39586,0.00926178018853961,0.00756919234052689,-0.00557383679889309,0.0240973971759723,0.221123596608897
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEZ6L,Seizure 6-like protein,42181,0.00349260733689888,0.00286100358346423,-0.00211495968669102,0.00910017436048877,0.222196957933755
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FZD8,Frizzled-8,39586,0.00543086947219726,0.00447737991850827,-0.00334479516807894,0.0142065341124735,0.225172327881681
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DOCK9,Dedicator of cytokinesis protein 9,39586,0.0147886776413308,0.0122172986987652,-0.00915722780824897,0.0387345830909106,0.226124509145658
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD160,CD160 antigen,42296,-0.00609012439952797,0.00503462578422754,-0.0159579909366139,0.00377774213755801,0.226434916555707
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,42123,0.0375581659419337,0.0311294351560963,-0.0234555269640151,0.0985718588478825,0.227639645711961
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,-0.0148630141777816,0.0123561516944259,-0.0390810714988563,0.00935504314329312,0.229042344286252
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PEAR1,Platelet endothelial aggregation receptor 1,42310,0.00285743333662538,0.00237586933872919,-0.00179927056728383,0.00751413724053458,0.229117230977492
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALPP,"Alkaline phosphatase, placental type",42070,0.0130254176312464,0.0108343000063687,-0.00820981038123632,0.0342606456437291,0.229292090469944
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTNNA1,Catenin alpha-1,39586,-0.00419505688361312,0.00351604690751476,-0.011086508822342,0.0026963950551158,0.232849148346171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OGN,Mimecan,42137,0.00535868489240773,0.00449840392279197,-0.00345818679626454,0.01417555658108,0.233579725300656
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.00378137453214138,0.00318285197864923,-0.00245701534601111,0.0100197644102939,0.234840196540542
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAT1,Diamine acetyltransferase 1,39575,-0.00597371853551416,0.00503095146484803,-0.0158343834066163,0.00388694633558797,0.235098182625204
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MN1,Transcriptional activator MN1,39649,-0.00726367343053011,0.00612739034964574,-0.0192733585158358,0.00474601165477555,0.235867740592234
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHI3L1,Chitinase-3-like protein 1,41907,0.0102930578983609,0.00870313150184271,-0.00676507984525085,0.0273511956419726,0.236955377757231
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LMNB2,Lamin-B2,39929,0.00351989934671158,0.00298184669664712,-0.00232452017871678,0.00936431887213995,0.237848946911792
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNPO1,Transportin-1,39757,0.00434673482784116,0.0036874124734265,-0.00288059362007477,0.0115740632757571,0.238501558371025
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FH,"Fumarate hydratase, mitochondrial",39586,0.0100195585341166,0.00855563159887548,-0.00674947939967931,0.0267885964679126,0.241581241878376
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.00604665927275584,0.00517762212384936,-0.0161947986355006,0.0041014800899889,0.242894727514842
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,0.00503389052196617,0.00433633142331507,-0.00346531906773137,0.0135331001116637,0.245718190908983
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,0.00740956879560749,0.00643057683424312,-0.00519436179950902,0.020013499390724,0.249247476865024
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSP90B1,Endoplasmin,41774,0.00759131079971359,0.00661080171998958,-0.00536586057146598,0.0205484821708932,0.250857649956006
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL36A,Interleukin-36 alpha,39657,-0.00684774234023894,0.00597188374929033,-0.018552634488848,0.00485714980837011,0.25154544963377
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL4A4,Collagen alpha-4(IV) chain,39743,-0.00638087855170888,0.0055674092580487,-0.0172930006974843,0.00453124359406658,0.251773127904637
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,39560,-0.00581250897180105,0.00508480857552893,-0.0157787337798378,0.00415371583623565,0.253016794027808
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,0.00425019749785075,0.00372133952736062,-0.00304362797577607,0.0115440229714776,0.25342644400213
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD7,T-cell antigen CD7,39636,0.00531491595129793,0.00465470534925122,-0.00380830653323446,0.0144381384358303,0.253546449659735
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RSPO1,R-spondin-1,42016,0.00402792427078924,0.00354869814292014,-0.00292752408933423,0.0109833726309127,0.256377664499407
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMC3,Structural maintenance of chromosomes protein 3,39560,0.0061333760528029,0.00542123349213449,-0.0044922415917807,0.0167589936973865,0.257927630183706
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MKI67,Proliferation marker protein Ki-67,39657,0.00478334383083165,0.00423115465660824,-0.0035097192961205,0.0130764069577838,0.25828778160022
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGLON5,IgLON family member 5,39560,-0.0108713492600403,0.00963720964801888,-0.0297602801701573,0.00801758165007671,0.259319337403927
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARB1,Scavenger receptor class B member 1,41839,0.00649858612071625,0.00577984330071122,-0.00482990674867774,0.0178270789901103,0.260883543486339
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP53BP1,TP53-binding protein 1,39657,-0.0100440295738965,0.00893954717923818,-0.0275655420452033,0.00747748289741036,0.26122830728171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MANSC4,MANSC domain-containing protein 4,39575,0.00794026414099562,0.00706885180015546,-0.00591468538730907,0.0217952136693003,0.261345310271726
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEDD9,Enhancer of filamentation 1,39657,0.00394692781600391,0.00351999228091142,-0.00295225705458246,0.0108461126865903,0.262189315232437
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,0.00561311562988597,0.00502363013969001,-0.00423319944390646,0.0154594307036784,0.263871611343963
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUOX2,Dual oxidase 2,41900,0.00815817410155596,0.00730855914103556,-0.00616660181487373,0.0224829500179857,0.264335598791768
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRK1,NKG2-D type II integral membrane protein,39929,0.00545621044785499,0.00489851228794989,-0.00414487363652679,0.0150572945322368,0.265366951106445
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HTR1A,5-hydroxytryptamine receptor 1A,39586,-0.00831647203811811,0.00752330804196651,-0.0230621558003725,0.00642921172413624,0.268998575596768
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.00673872834810909,0.00611441127019374,-0.00524551774147063,0.0187229744376888,0.270439863074074
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,39930,-0.00623706021286834,0.00565944504139005,-0.0173295724939928,0.00485545206825616,0.270458059478661
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL2RB,Interleukin-2 receptor subunit beta,41913,-0.00416630049926939,0.00378317291359731,-0.0115813194099201,0.00324871841138133,0.27079842257009
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,0.00495740127500244,0.00450997154360764,-0.00388214295046853,0.0137969455004734,0.271700199529426
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,-0.0167711543131619,0.0152615612056943,-0.0466838142763227,0.0131415056499988,0.271829402668771
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCARE,Photoreceptor cilium actin regulator,39586,-0.00945737998980351,0.00865500101032528,-0.0264211819700411,0.00750642199043405,0.274546435998078
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIRREL2,Kin of IRRE-like protein 2,41839,0.00452479074317757,0.00414739115622819,-0.00360409592302968,0.0126536774093848,0.275294117882175
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANKRA2,Ankyrin repeat family A protein 2,39560,-0.00620890837884895,0.0057248232119474,-0.0174295618742659,0.00501174511656795,0.278140890862585
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNXB,Tenascin-X,42137,-0.00294657413682955,0.0027192229061712,-0.00827625103292511,0.002383102759266,0.278557543445599
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL4,Interleukin-4,41913,0.0106289258858673,0.00981235194618782,-0.00860328392866087,0.0298611357003954,0.27873085409315
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MORF4L1,Mortality factor 4-like protein 1,39757,-0.00443396357833927,0.00409533042749623,-0.0124608112162319,0.00359288405955335,0.278970496573444
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RETN,Resistin,42105,-0.00479521026593337,0.00446837878406044,-0.0135532326826918,0.0039628121508251,0.283226049621458
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,-0.00736117685492945,0.00686169524737272,-0.02081009953978,0.00608774582992108,0.283387706054962
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,39657,-0.00636593199733859,0.00593604289862153,-0.0180005760786368,0.00526871208395961,0.283554768183195
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,0.00656184944072339,0.00611939473356782,-0.00543216423706954,0.0185558631185163,0.283602795034958
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,39934,-0.00443293513141268,0.00413456291734761,-0.012536678449414,0.00367080818658863,0.283668595319594
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCD1,Programmed cell death protein 1,42232,0.00464818317290396,0.00435777983976261,-0.00389306531303074,0.0131894316588387,0.286153228714715
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,-0.00237976648085104,0.0022351236476066,-0.00676060883015997,0.00200107586845789,0.287028256464494
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBX2,Chromobox protein homolog 2,39575,-0.00436036274213404,0.00410554604656818,-0.0124072329934077,0.0036865075091396,0.288228885978069
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXDC2,Plexin domain-containing protein 2,39929,0.00301021590836617,0.00284925587552097,-0.00257432560765494,0.00859475742438728,0.290766042693986
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA10,Annexin A10,41839,-0.00895864670185825,0.00850529304813983,-0.0256290210762123,0.00771172767249583,0.292221582058951
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFL4,Insulin growth factor-like family member 4,39657,0.00781488057774105,0.00743114502442182,-0.00675016367012572,0.0223799248256078,0.292988272814404
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPTX1,Neuronal pentraxin-1,42137,0.00456559560359722,0.00434370407275112,-0.00394806437899497,0.0130792555861894,0.293239012179758
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTNL10,Butyrophilin-like protein 10,39560,-0.00435302750007299,0.00414822471407372,-0.0124835479396575,0.0037774929395115,0.294030451483388
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPO,Lactoperoxidase,41647,-0.00670423980619128,0.00641487995055675,-0.0192774045092825,0.00586892489689994,0.29599260296531
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAG,Myelin-associated glycoprotein,39649,0.00527980925712534,0.00506080171128397,-0.00463936209699123,0.0151989806112419,0.29684364786314
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RELB,Transcription factor RelB,39657,0.00501925847274242,0.00487647371753861,-0.00453863001363326,0.0145771469591181,0.303370478574872
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,0.00406415825983799,0.00396743343990135,-0.00371201128236865,0.0118403278020446,0.305675001475375
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK11,Kallikrein-11,42062,0.00342458771517046,0.00335196531869283,-0.00314526430946748,0.0099944397398084,0.306957548873084
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,-0.00365930419819017,0.00359046522288216,-0.0106966160350392,0.00337800763865886,0.308143421558897
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAPPA,Pappalysin-1,41913,-0.00501482585014794,0.00493165271280942,-0.0146808651672544,0.00465121346695852,0.309236055875567
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLSPN,Claspin,41820,0.00375330617750106,0.0036982685123015,-0.00349530010660987,0.011001912461612,0.310180648524811
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,0.00517227836139417,0.00512195836988299,-0.0048667600435765,0.0152113167663648,0.312601001663431
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,-0.0064438075944474,0.00639732012046375,-0.0189825550305563,0.00609493984166155,0.313828806901798
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK1,Kallikrein-1,42016,-0.0133813646874847,0.013287348934801,-0.0394245685996946,0.0126618392247252,0.313916616214726
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL24,Interleukin-24,41913,-0.00504602163409025,0.00501318015482401,-0.0148718547375453,0.00477981146936481,0.31416887247756
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THBS2,Thrombospondin-2,42137,-0.00401672142007049,0.00401798597175774,-0.0118919739247157,0.00385853108457467,0.317480708035915
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFAP3,Microfibril-associated glycoprotein 3,41900,0.0049662791182992,0.00497293761822244,-0.00478067861341679,0.0147132368500152,0.317977082186178
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH17,Protocadherin-17,42145,0.00388766336276116,0.00389514541194567,-0.00374682164465235,0.0115221483701747,0.318258816478628
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL9,Interleukin-9,39757,-0.00571772326829814,0.0058357524957639,-0.0171557981599954,0.0057203516233991,0.327218535416884
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.00596464563211784,0.00612021814443621,-0.00603098193097712,0.0179602731952128,0.329789839648903
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MBL2,Mannose-binding protein C,39826,-0.0111550395691238,0.0114690106602463,-0.0336343004632066,0.011324221324959,0.330760969209379
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,-0.00366308016171407,0.00376654018538823,-0.011045498925075,0.00371933860164687,0.330806799843773
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.00346892300074028,0.00357038861149831,-0.00352903867779641,0.010466884679277,0.331280115554505
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PFDN6,Prefoldin subunit 6,39649,0.0065314718844675,0.00674626684671206,-0.00669121113508815,0.0197541549040231,0.332985202750311
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.00474519014312397,0.00494213890861471,-0.0144317824040088,0.00494140211776086,0.337001198451794
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRK1,Protein BRICK1,41839,0.00452943844909325,0.00472533145377359,-0.00473221120030298,0.0137910880984895,0.337805983787224
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REST,RE1-silencing transcription factor,39560,-0.0034111819858562,0.00356060968997308,-0.0103899769782034,0.00356761300649103,0.338067193650202
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEPTIN8,Septin-8,39906,0.00324782677187366,0.00339143773540286,-0.00339939118951594,0.00989504473326326,0.338257311638605
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA11,Carbonic anhydrase-related protein 11,41843,-0.00300671949412905,0.00317407688979371,-0.00922791019812472,0.00321447120986663,0.343516623561067
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP9,Matrix metalloproteinase-9,42125,-0.00588483571209061,0.00622373920826952,-0.0180833645602989,0.00631369313611765,0.344396761690169
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HIP1,Huntingtin-interacting protein 1,39575,0.003237021402311,0.0034267327138005,-0.00347937471673797,0.00995341752135998,0.344864594721036
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB1,Integrin beta-1,42167,0.00206520865611048,0.00219293514035385,-0.00223294421898307,0.00636336153120402,0.346334618386545
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPVL,Probable serine carboxypeptidase CPVL,42223,0.00401819644415976,0.00426898736309829,-0.00434901878751289,0.0123854116758324,0.346591998278615
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,0.00295368615676061,0.00314227950015502,-0.00320518166354322,0.00911255397706445,0.347243719065342
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,0.00710507503575029,0.00760427323095196,-0.00779930049691556,0.0220094505684161,0.350138552223144
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KCNIP4,Kv channel-interacting protein 4,41839,0.00492281769651801,0.00529838866509959,-0.00546202408707719,0.0153076594801132,0.352845911814163
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLK,STE20-like serine/threonine-protein kinase,39757,-0.00761003916939359,0.00820909446546229,-0.0236998643216997,0.00847978598291249,0.353933393621077
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFAP2A,Transcription factor AP-2-alpha,39586,0.00572082256995725,0.00618732964012241,-0.00640634352468268,0.0178479886645972,0.355192842182127
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH23,Cadherin-23,39929,-0.00257114506081239,0.00278208003251691,-0.00802402192454553,0.00288173180292076,0.355411853214821
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,-0.00400793430304631,0.00434783596992604,-0.0125296928041014,0.00451382419800873,0.356641143025133
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,-0.0040708196695425,0.00443196462561319,-0.0127574703357444,0.00461583099665935,0.358370240896993
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXDC1,Plexin domain-containing protein 1,41843,-0.00307075437896262,0.00334999568515577,-0.00963674592186793,0.0034952371639427,0.35934576546536
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,0.00352241384838366,0.00384847657010282,-0.00402060022901787,0.0110654279257852,0.36006393178082
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YAP1,Transcriptional coactivator YAP1,39929,0.00261374227262206,0.00286905639161485,-0.00300960825494305,0.00823709280018718,0.362308898354651
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABO,Histo-blood group ABO system transferase,39990,0.013711435467282,0.0150678719505491,-0.0158215935557942,0.0432444644903582,0.362853245819918
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,0.00483705602742185,0.00535834013406678,-0.00566529063534904,0.0153394026901927,0.366696462184732
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,-0.00577233518949796,0.00640540112321302,-0.0183269213909955,0.00678225101199956,0.367515787380603
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDIA2,Protein disulfide-isomerase A2,39560,0.00374581031496883,0.00415711783865958,-0.00440214064880395,0.0118937612787416,0.367576510400487
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,0.00456555652091097,0.00507955860450342,-0.00539037834391573,0.0145214913857377,0.368773753599499
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZP4,Zona pellucida sperm-binding protein 4,39560,0.00291400157607311,0.00324525996477041,-0.00344670795487689,0.00927471110702311,0.369245009752833
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARG2,"Arginase-2, mitochondrial",39919,-0.0039347301524996,0.00438268013652736,-0.0125247832200932,0.00465532291509402,0.369316156080629
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMA1,Proteasome subunit alpha type-1,41843,0.00431443330673498,0.00481512100539371,-0.00512320386383669,0.0137520704773067,0.370259634314298
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAP18,Histone deacetylase complex subunit SAP18,39757,-0.00667274715182793,0.00751262816658039,-0.0213974983583255,0.00805200405466964,0.37445012050285
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,-0.00285669999553574,0.00322535067192437,-0.0091783873125075,0.00346498732143601,0.375793786964661
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUMF1,Formylglycine-generating enzyme,39657,0.00607580268044174,0.00686870634234638,-0.00738686175055717,0.0195384671114407,0.376411667366646
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMG4,Proteasome assembly chaperone 4,39657,-0.00514005855120938,0.00581659284452797,-0.0165405805264842,0.00626046342406545,0.37688338555447
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXK,Tyrosine-protein kinase TXK,39757,-0.00666319812433894,0.00761031177720242,-0.0215794092076557,0.00825301295897779,0.38129430551053
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAD1,Glutamate decarboxylase 1,39560,0.00238750410462913,0.00273934027899864,-0.00298160284220819,0.00775661105146646,0.383466616588601
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,-0.0045704512670971,0.00525433746299775,-0.0148689526945727,0.00572805016037849,0.38440496120224
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP8,Neutrophil collagenase,42224,0.00642554489444358,0.00744224689171025,-0.00816125901330851,0.0210123488021957,0.387939504089771
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,0.00250729700226617,0.00290962815835596,-0.00319557418811152,0.00821016819264386,0.388857991592008
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF20,Fibroblast growth factor 20,39657,-0.00386574583436754,0.00448683923835766,-0.0126599507415485,0.00492845907281346,0.388940445857667
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,-0.00778227463932856,0.00908361182419328,-0.0255861538147474,0.0100216045360903,0.391608312358832
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,0.00620808982081421,0.00727589762206387,-0.00805266951843099,0.0204688491600594,0.39354403299084
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRXN3,Neurexin-3,39649,0.00318892269886919,0.00374120058112782,-0.00414383044014134,0.0105216758378797,0.394021967023395
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELL,L-selectin,39979,0.00206363109464297,0.00242268263392599,-0.00268482686785198,0.00681208905713791,0.394345317362696
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPK13,Mitogen-activated protein kinase 13,39560,0.00385822981733033,0.00453848885512903,-0.00503720833872255,0.0127536679733832,0.395280658261088
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OBP2B,Odorant-binding protein 2b,41979,-0.00506810691759902,0.00596393435989459,-0.0167574182629924,0.00662120442779437,0.39545564506301
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,0.00610811734699363,0.00719059343302833,-0.0079854457817419,0.0202016804757292,0.395643926454418
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSLN,Mesothelin,42048,-0.00512922351952599,0.00604231453067522,-0.0169721599996494,0.00671371296059744,0.395961008904768
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFRA3,GDNF family receptor alpha-3,41989,0.00245175402949932,0.0028961328584904,-0.00322466637314186,0.0081281744321405,0.397254816613354
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FBN2,Fibrillin-2,39649,0.00527863810736416,0.00624992819394111,-0.00697122115276042,0.0175284973674887,0.398357075413236
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,0.0042336773051443,0.00501441697814092,-0.00559457997201191,0.0140619345823005,0.398519651665339
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,-0.00320995664023977,0.00383251864815584,-0.0107216931906252,0.00430177991014567,0.402296565421748
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD164L2,CD164 sialomucin-like 2 protein,39649,-0.00317626624530054,0.00380380892140809,-0.0106317317312604,0.00427919924065932,0.403723063544367
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PALM3,Paralemmin-3,39575,0.00658077625021138,0.00788822701099619,-0.00888014869134115,0.0220417011917639,0.404156645223258
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNNI3,"Troponin I, cardiac muscle",41900,0.00727372352441365,0.00873113339239027,-0.00983929792467127,0.0243867449734986,0.40481515862033
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FSTL3,Follistatin-related protein 3,42084,-0.00282354601754678,0.00340218100358541,-0.0094918207845742,0.00384472874948063,0.406597386091837
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNW1,Interferon omega-1,39575,-0.00302975165668812,0.00367004708045124,-0.0102230439343725,0.00416354062099632,0.409085966322882
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CORO6,Coronin-6,39586,-0.00334118418505637,0.00405960045088979,-0.0112980010688004,0.00461563269868762,0.410507225500279
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNF75D,Zinc finger protein 75D,39757,-0.00519906035095486,0.00635694859768671,-0.0176586796024208,0.0072605589005111,0.413457619404668
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL28,C-C motif chemokine 28,42075,0.00499931278397249,0.00612333284592463,-0.00700241959403978,0.0170010451619848,0.414264928181501
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRP2BP,LRP2-binding protein,39649,-0.00659758393300261,0.00808344730031614,-0.0224411406416222,0.00924597277561702,0.41441224846578
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HBZ,Hemoglobin subunit zeta,39958,-0.00911621327464573,0.0111696940737452,-0.0310088136591864,0.0127763871098949,0.414428012181028
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH4,Cadherin-4,39586,0.00393380063214193,0.00483688525677109,-0.00554649447112942,0.0134140957354133,0.416068222924039
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB5,Integrin beta-5,42181,0.00324543820513145,0.00399442728539621,-0.00458363927424512,0.011074515684508,0.416523905195485
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,0.00346239853278207,0.0042678955146513,-0.00490267667593448,0.0118274737414986,0.417230235439319
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHA4,Ephrin type-A receptor 4,39736,0.00246214634097098,0.00303749273958133,-0.00349133942860843,0.00841563211055039,0.417621301289949
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRC1,Macrophage mannose receptor 1,39990,-0.00239075585746711,0.00295364509719743,-0.00817990024797408,0.00339838853303985,0.41828730918802
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNLZ,DNL-type zinc finger protein,39586,-0.00707531628568438,0.00878212856638981,-0.0242882882758084,0.0101376557044396,0.420462491429934
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,0.00223289076236708,0.00277414206978618,-0.00320442769441383,0.00767020921914798,0.420898216155092
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JUN,Transcription factor AP-1,41913,-0.00403765393736752,0.00501925382395148,-0.0138753914323124,0.00580008355757738,0.421161253205793
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,-0.00329606990079321,0.00412343536769531,-0.011378003221476,0.0047858634198896,0.42410127516111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.00283111546973167,0.00355929470555039,-0.00980733309261043,0.00414510215314709,0.426386304733212
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZP3,Zona pellucida sperm-binding protein 3,39638,-0.022025037535453,0.0277322679705059,-0.0763802827576445,0.0323302076867385,0.427094606715264
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAGE2A,G antigen 2A,39560,-0.00539436703341579,0.00679824846808953,-0.0187189340308713,0.00793019996403969,0.427507441774219
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,0.00384878960072422,0.0048549849371285,-0.00566698087604764,0.0133645600774961,0.427937236797733
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,0.00319348070623556,0.00403236456285616,-0.00470995383696251,0.0110969152494336,0.428399776540284
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRRT3,Proline-rich transmembrane protein 3,39638,0.00317683058631652,0.0040271650463079,-0.00471641290444697,0.01107007407708,0.430216415529643
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,-0.00197745258801391,0.00251079194051358,-0.00689860479142053,0.00294369961539271,0.430958170855687
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC51B,Organic solute transporter subunit beta,39575,-0.00593386593568397,0.00754646979360155,-0.020724946731143,0.00885721485977506,0.431702773486716
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PI3,Elafin,41966,0.00457328089557833,0.00584625325956863,-0.00688537549317619,0.0160319372843329,0.434076569562936
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,-0.00550185076349966,0.00709307963000807,-0.0194042868383155,0.00840058531131616,0.437963488334611
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,-0.00480492605371009,0.0062004300379039,-0.0169577689280017,0.00734791682058155,0.438395052709695
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCIN,Adseverin,39586,-0.00594040874416208,0.00767207232600496,-0.0209776705031318,0.00909685301480765,0.438775989073417
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,0.00616686903761797,0.00802445855012815,-0.00956106972063319,0.0218948077958691,0.44220123986296
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHC1,SHC-transforming protein 1,39560,-0.00934623855488681,0.0121690898834484,-0.0331976547264457,0.0145051776166721,0.442485300909698
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCDC50,Coiled-coil domain-containing protein 50,39934,0.0059147274974409,0.00773144764370101,-0.00923890988421307,0.0210683648790949,0.444274376146809
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,39649,0.00514687599622748,0.00673691652527834,-0.00805748039331805,0.018351232385773,0.444894899159688
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNF174,Zinc finger protein 174,39657,0.00289170248407208,0.00382307514293912,-0.00460152479608859,0.0103849297642328,0.449436741126589
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD70,CD70 antigen,42119,-0.00345026102138436,0.0045941277854055,-0.0124547514807791,0.00555422943801041,0.452656419907331
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALCAM,CD166 antigen,42310,0.00152052905034052,0.00204660321240408,-0.00249081324597148,0.00553187134665253,0.457523145872737
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GID8,Glucose-induced degradation protein 8 homolog,39934,0.00262371759416484,0.00353191668345566,-0.00429883910540825,0.00954627429373792,0.457582189815932
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDA1,DET1- and DDB1-associated protein 1,39575,0.00302504650276388,0.00407336636720582,-0.00495875157695952,0.0110088445824873,0.457715305505191
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FDX2,"Ferredoxin-2, mitochondrial",39575,0.00425867577903202,0.0057420935177379,-0.00699582751573427,0.0155131790737983,0.458309790054892
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALY,Neuron-specific vesicular protein calcyon,39575,-0.00299541272378375,0.00404276693163834,-0.0109192359097949,0.0049284104622274,0.458750923302555
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC123,Cell division cycle protein 123 homolog,39560,0.00483577844673421,0.00652936485645465,-0.00796177667191691,0.0176333335653853,0.458939720891809
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMMR,Hyaluronan mediated motility receptor,39541,0.0036686506875506,0.00502999438684675,-0.00619013831066902,0.0135274396857702,0.465800255406945
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,39657,0.00473813879681967,0.00650903303506827,-0.00801956595191414,0.0174958435455535,0.466670123285499
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYOM1,Myomesin-1,39586,0.00369800667808796,0.00509163643635944,-0.00628160073717655,0.0136776140933525,0.467676234728034
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBP2,Guanylate-binding protein 2,41913,0.00457239268846753,0.00630516985693953,-0.00778574023113395,0.016930525608069,0.468353421690289
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLI2,Zinc finger protein GLI2,39657,-0.00250154299673917,0.00345063507484291,-0.00926478774343128,0.00426170174995295,0.468497139318949
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERCC1,DNA excision repair protein ERCC-1,39560,0.00252030023476009,0.00347677874058415,-0.00429418609678485,0.00933478656630502,0.468531798509226
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,-0.00598617462885753,0.0083211354654422,-0.0222956001411242,0.0103232508834092,0.471913282509989
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHH,Sonic hedgehog protein,39657,-0.00318755011901822,0.00443507850891697,-0.0118803039964955,0.00550520375845905,0.472332745220505
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,-0.0027199657752938,0.00379053620913839,-0.010149416745205,0.00470948519461744,0.473039245160072
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL31,Interleukin-31,39657,-0.00413479431794099,0.00577986803860566,-0.0154633356736081,0.0071937470377261,0.474390193365833
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL15RA,Interleukin-15 receptor subunit alpha,41913,-0.00258065041412451,0.00360794524701451,-0.00965222309827295,0.00449092227002394,0.47445555026356
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCNE1,G1/S-specific cyclin-E1,39657,0.00676223765763618,0.00952353390632588,-0.0119038887987625,0.0254283641140349,0.477684692622922
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TEF,Thyrotroph embryonic factor,39575,0.00315769161728327,0.00445464077149378,-0.00557340429484454,0.0118887875294111,0.478429904640663
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B2M,Beta-2-microglobulin,39979,0.0022427292858223,0.00316603901101186,-0.00396270717576095,0.00844816574740555,0.478729590074413
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTNAP4,Contactin-associated protein-like 4,39649,-0.00777208163395042,0.0109795991027379,-0.0292920958753166,0.0137479326074158,0.479043591387973
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASQ2,Calsequestrin-2,39575,0.00349840825288838,0.00494936211385229,-0.00620234149026211,0.0131991579960389,0.479680777628715
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,0.00623385974042901,0.00884786473391844,-0.0111079551380511,0.0235756746189092,0.481095661044657
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.00477678673715539,0.0067884972800754,-0.0180822414061032,0.00852866793179239,0.481659886516105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DENND2B,DENN domain-containing protein 2B,39575,-0.00356010642063386,0.00509646272358182,-0.0135491733588542,0.00642896051758651,0.484851488674919
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PXDNL,Peroxidasin-like protein,39919,-0.00414281311926235,0.00594662653489925,-0.0157982011276649,0.00751257488914019,0.486026084633024
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACTN4,Alpha-actinin-4,41913,0.00226776610009129,0.00327970835428913,-0.0041604622743154,0.00869599447449798,0.489292596728168
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.00384743856011452,0.00560904641547125,-0.0148411695344382,0.00714629241420914,0.492768910008107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGAV,Integrin alpha-V,42262,0.0011823686978611,0.00172764872702399,-0.00220382280710593,0.00456856020282813,0.493746681844411
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTRC,Chymotrypsin-C,42122,0.00464529671562535,0.00679363619365057,-0.00867023022392976,0.0179608236551805,0.494131005587979
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,0.00241418414495351,0.00359201168352893,-0.00462615875476319,0.00945452704467021,0.501532746314649
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPON1,Spondin-1,42144,0.00226906416186371,0.00339073292790631,-0.00437677237683266,0.00891490070056008,0.503382005207606
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,0.00388099236338531,0.00584124745605741,-0.00756785265048721,0.0153298373772578,0.506440910753073
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PADI2,Protein-arginine deiminase type-2,41913,-0.00391432235038896,0.00592799797700592,-0.0155331983853206,0.00770455368454264,0.509065688280811
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHGB,Secretogranin-1,42210,0.00287209222308149,0.00439544795108858,-0.00574298576105213,0.0114871702072151,0.51349385643002
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL21,C-C motif chemokine 21,42185,0.00259019857987882,0.00397841276957536,-0.00520749044848888,0.0103878876082465,0.515016632630438
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACTA2,"Actin, aortic smooth muscle",41900,-0.00295230114412585,0.00453540860811709,-0.0118417020160353,0.00593709972778364,0.515093295659731
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELAVL4,ELAV-like protein 4,39586,0.00554430657304501,0.0085232617720651,-0.0111612865002026,0.0222498996462926,0.515388602877001
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INSL4,Early placenta insulin-like peptide,39919,-0.00324811562080579,0.00500254483710071,-0.0130531035015232,0.00655687225991161,0.516162406602543
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PALLD,Palladin,39657,-0.00257106066272018,0.00396392357255998,-0.0103403508649377,0.00519822953949738,0.516600666583441
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MLLT1,Protein ENL,39560,-0.00447024483187428,0.00690150777026942,-0.0179972000616023,0.00905671039785377,0.51717961299042
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TET2,Methylcytosine dioxygenase TET2,39750,-0.00676251011863771,0.0104411087568878,-0.0272270832821379,0.0137020630448625,0.517204484753713
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUSD4,Sushi domain-containing protein 4,39919,-0.00258779778272957,0.00400464224286079,-0.0104368965787367,0.00526130101327758,0.518163269471417
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,0.00185091709818781,0.0028674669185044,-0.00376931806208082,0.00747115225845644,0.518621763358707
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,-0.00287056857033706,0.00446773240785103,-0.0116273240897251,0.00588618694905096,0.52055223216201
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17F,Interleukin-17F,41913,-0.00486262707355394,0.00762993569909904,-0.0198173010437881,0.0100920468966802,0.523934516463388
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTM4,Glutathione S-transferase Mu 4,39575,-0.00494192219236095,0.00777234709676785,-0.0201757225020259,0.010291878117304,0.524897911666806
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOLR3,Folate receptor gamma,42132,-0.0126558713565487,0.0199618527783918,-0.0517811028021967,0.0264693600890993,0.52608968512272
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTPP1,dCTP pyrophosphatase 1,42145,0.00208727134348552,0.00329325434946501,-0.0043675071814659,0.00854204986843694,0.526220720306581
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NINJ1,Ninjurin-1,41843,0.00356061823826075,0.0056503839044105,-0.00751413421438383,0.0146353706909053,0.52860398468044
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,-0.00214964320906368,0.0034117005567704,-0.00883657630033367,0.00453728988220631,0.52865556850388
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF1,Macrophage colony-stimulating factor 1,42185,-0.00176426117874794,0.00280621322718003,-0.0072644391040208,0.00373591674652492,0.529557233021943
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDAC8,Histone deacetylase 8,39657,0.0039334248370779,0.00625937789932314,-0.00833495584559545,0.0162018055197512,0.52975159323027
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPGN,Epigen,39919,-0.00301853610537497,0.00481282755600947,-0.0124516781151535,0.00641460590440359,0.530550236303714
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RANGAP1,Ran GTPase-activating protein 1,41843,-0.00313584296622131,0.00500829098124208,-0.0129520932894558,0.00668040735701317,0.531240240508779
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.00238563328017273,0.0038188146882108,-0.00987051006906589,0.00509924350872042,0.532177478745122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC12A,C-type lectin domain family 12 member A,39657,0.00132371580023708,0.00212154554494973,-0.00283451346786439,0.00548194506833854,0.532680272329358
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFNA1,Ephrin-A1,42113,0.00191070290228717,0.00306258600645291,-0.00409196567036053,0.00791337147493487,0.532713336224704
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COPE,Coatomer subunit epsilon,41839,0.00299934597131425,0.00482639658954558,-0.00646039134419509,0.0124590832868236,0.534316761782216
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGR,Progesterone receptor,39657,0.00647096167326823,0.0104188150658263,-0.0139499158557513,0.0268918392022878,0.534557011287594
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA3G,Semaphorin-3G,39736,0.00293449239424043,0.00473326829281455,-0.00634271345967608,0.0122116982481569,0.535289103688969
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBP7,Retinoid-binding protein 7,39930,0.00401372331001763,0.00649111854398189,-0.00870886903618686,0.0167363156562221,0.536363154828033
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DIPK1C,Divergent protein kinase domain 1C,39649,0.00270272447847999,0.00437107455906376,-0.00586458165728497,0.0112700306142449,0.536376916283886
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZPR1,Zinc finger protein ZPR1,39586,-0.00616975315682102,0.0100195535676184,-0.025808078149353,0.013468571835711,0.538058252758817
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,39575,-0.00228240676024358,0.00371940504798192,-0.00957244065428815,0.00500762713380099,0.53946044576329
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,-0.00234843313773476,0.00384058498611219,-0.00987597971051466,0.00517911343504513,0.540895423347365
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,0.00219234964782265,0.00359758609421154,-0.00485891909683196,0.00924361839247727,0.542273174470126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAL,Galanin peptides,42185,0.0042087890953824,0.00692150700214999,-0.00935736462883158,0.0177749428195964,0.543148498896832
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,0.00271972919607766,0.00449199597794806,-0.00608458292070054,0.0115240413128559,0.544882699840984
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.00378200849213692,0.00629908757043433,-0.00856420314591437,0.0161282201301882,0.548248231546099
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPBGL,Trophoblast glycoprotein-like,39649,-0.00253478591306045,0.00422820590536696,-0.0108220694875797,0.00575249766145878,0.548855512029284
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRC1,Protein regulator of cytokinesis 1,39919,0.00274543455731273,0.00458360667522565,-0.00623843452612955,0.011729303640755,0.549206089507073
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PYDC1,Pyrin domain-containing protein 1,39638,-0.00255178357848566,0.00429098589932776,-0.0109621159411681,0.00585854878419675,0.552066453334481
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCL2,Phosducin-like protein 2,39560,-0.00322939388467814,0.00543164460837393,-0.013875417317091,0.00741662954773476,0.552155404004702
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,39586,-0.00436531479091931,0.00737193675300491,-0.0188143108268089,0.0100836812449703,0.553760295458312
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX1B,Syntaxin-1B,39649,0.00246432785204556,0.00417729289466498,-0.00572316622149779,0.0106518219255889,0.555246842512662
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,-0.00327807424192194,0.00563239817143259,-0.0143175746579298,0.00776142617408594,0.560576333616885
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENG,Endoglin,42310,-0.00104123002757485,0.00179679017843898,-0.00456293877731525,0.00248047872216555,0.562265077749543
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PKLR,Pyruvate kinase PKLR,42143,-0.00374753085673784,0.00647646489799336,-0.0164414020568048,0.00894634034332914,0.562842855785261
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DKKL1,Dickkopf-like protein 1,42070,-0.00500195719201031,0.00870791765142822,-0.0220694757888096,0.012065561404789,0.56569670007412
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYTH3,Cytohesin-3,39560,0.00432580332254276,0.00760337102266272,-0.0105768038818762,0.0192284105269617,0.569413746001623
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,-0.00346411059580018,0.00611665296020322,-0.0154527503977985,0.00852452920619813,0.571173646921597
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESPL1,Separin,39560,-0.0031362027979528,0.00555153418503047,-0.0140172098006125,0.00774480420470691,0.572136053017237
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.00989651219142033,0.0176021558813389,-0.024603713336004,0.0443967377188447,0.573966757731044
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4C,C-type lectin domain family 4 member C,42119,0.00282630621451631,0.00503955002659215,-0.00705121183760431,0.0127038242666369,0.574926059500441
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TLR1,Toll-like receptor 1,39657,0.0015604292692103,0.00278240687867095,-0.00389308821298475,0.00701394675140536,0.574931653370751
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,-0.00176035981251124,0.00314444784478291,-0.00792347758828575,0.00440275796326327,0.575604091787281
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIPR,Gastric inhibitory polypeptide receptor,39657,0.002619532212932,0.00469524023517677,-0.00658313864801446,0.0118222030738785,0.576915576965668
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KDM3A,Lysine-specific demethylase 3A,39657,-0.00507481727157203,0.0092178165392361,-0.0231417376884748,0.0129921031453307,0.581957154701504
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,0.00207735657672532,0.00379253354550401,-0.00535600917246253,0.00951072232591317,0.583875031077255
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,-0.00302838957642814,0.00559679097839109,-0.0139980998940747,0.0079413207412184,0.588453819170876
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,-0.00146104763965013,0.00270876716861951,-0.00677023129014437,0.0038481360108441,0.589637076342185
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,-0.00378875951973326,0.00709912444806535,-0.0177030434379413,0.0101255243984748,0.593564142914047
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFNB2,Ephrin-B2,39649,-0.00320581590807102,0.00601838031862683,-0.0150018413325796,0.00859020951643757,0.594272143085245
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBA,Lysosomal acid glucosylceramidase,39649,0.00306774870863479,0.00576860394743136,-0.00823871502833068,0.0143742124456003,0.594874598662612
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300E,CMRF35-like molecule 2,42232,0.0023055497263811,0.00434366130592977,-0.00620802643324124,0.0108191258860034,0.59557650864024
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,0.00273631301015254,0.00516370879685964,-0.00738455623169235,0.0128571822519974,0.596183350334638
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSB,Lupus La protein,41839,0.00322880302113081,0.00612508731389683,-0.00877636811410698,0.0152339741563686,0.598102427006267
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL10,Interleukin-10,41913,-0.00421326745140676,0.00799557617963402,-0.0198845967634894,0.0114580618606759,0.598237213695962
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,-0.0017670070859652,0.0033712269591498,-0.00837461192589881,0.00484059775396842,0.600189228926346
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEPTIN7,Septin-7,39757,-0.00288474842840625,0.00552995897157703,-0.0137234680126972,0.00795397115588473,0.601918690079848
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLHL41,Kelch-like protein 41,39934,-0.00283056690354731,0.00545270774645869,-0.0135178740866063,0.00785674027951173,0.603692663977398
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,-0.00227557524336747,0.00443830942730221,-0.0109746617208798,0.00642351123414486,0.608162919701782
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,-0.00140325584661577,0.00274359553149728,-0.00678070308835044,0.0039741913951189,0.609034701296241
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFBR1,TGF-beta receptor type-1,39657,-0.00116543347297027,0.00228547436261389,-0.00564496322369349,0.00331409627775296,0.610110212164115
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.00408945740281471,0.00803174702664885,-0.011652766769417,0.0198316815750465,0.610649103849879
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ISM2,Isthmin-2,39966,0.00229595967827334,0.00451513556434953,-0.00655370602785173,0.0111456253843984,0.61111055196458
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL3A1,Collagen alpha-1(III) chain,39966,0.00124416399608835,0.00245307239018071,-0.00356385788866584,0.00605218588084254,0.612034150631594
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOX2,Transcription factor SOX-2,39915,0.00129431992070602,0.00255287350939265,-0.00370931215770358,0.00629795199911562,0.612161111640752
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00238317028954366,0.00472633597231683,-0.0116467887952846,0.00688044821619732,0.614108343460554
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCNA,Proliferating cell nuclear antigen,39560,0.00338165143083919,0.00670664101266818,-0.00976336495399044,0.0165266678156688,0.61411389568718
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFAP3L,Microfibrillar-associated protein 3-like,39649,-0.0033790124505043,0.00670203165208996,-0.0165149944886006,0.00975696958759201,0.614146819888379
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,-0.0019939321356349,0.00396139999059687,-0.00975827611720476,0.00577041184593496,0.614733249008718
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL21R,Interleukin-21 receptor,39657,-0.002805787104975,0.00562875020090704,-0.0138381374987528,0.00822656328880281,0.618159720745226
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,-0.00389366408857141,0.00785656552778373,-0.0192925325230275,0.0115052043458847,0.620190746125109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VNN2,Vascular non-inflammatory molecule 2,42070,-0.00242839153542047,0.00491676912184004,-0.0120652590142269,0.007208475943386,0.621384963307341
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COMP,Cartilage oligomeric matrix protein,42042,0.00169569956454148,0.00346336678539612,-0.00509249933483493,0.00848389846391788,0.624417775591139
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMPRSS11B,Transmembrane protease serine 11B,39586,0.00384666212940166,0.00789274728950557,-0.0116231225580293,0.0193164468168326,0.626008218466149
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CKAP4,Cytoskeleton-associated protein 4,42247,0.00141828597919037,0.00294821565337231,-0.00436021670141935,0.00719678865980009,0.630477384361532
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,-0.00748399587578898,0.0155917049240749,-0.0380437375269758,0.0230757457753978,0.63123618439087
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD5L,CD5 antigen-like,39925,0.00239302245132718,0.00499358429268564,-0.00739440276233668,0.012180447664991,0.631791809854111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,0.00323723654530508,0.00675845302432575,-0.0100093313823734,0.0164838044729836,0.63195473596408
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRL,Prolactin,42249,0.00362607515411629,0.00765152605500139,-0.0113709159136864,0.018623066221919,0.635577219083419
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,39966,0.00106524550786786,0.00228816100544722,-0.00341955006280868,0.0055500410785444,0.641549015093278
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.00227950021735624,0.00492798141793022,-0.0119383437964995,0.007379343361787,0.643687045469432
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,41879,0.00257540590131292,0.00557694255639711,-0.00835540150922542,0.0135062133118512,0.644235681380494
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL2,Interleukin-2,41913,-0.00153518399785022,0.00332479463457844,-0.00805178148162397,0.00498141348592353,0.64427676739553
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH22,Cadherin-22,39757,0.00131919715331953,0.00286496379164661,-0.00429613187830783,0.00693452618494689,0.645196070932509
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GJA8,Gap junction alpha-8 protein,39560,-0.002976438677898,0.0064912641648963,-0.0156993164410948,0.00974643908529875,0.646580881426143
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,-0.00297360723117628,0.00648537764708829,-0.0156849474194693,0.00973773295711678,0.646594070707579
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDDM3B,Epididymal secretory protein E3-beta,39919,0.00291253854540866,0.00638491281423787,-0.00960189057049756,0.0154269676613149,0.648284048505529
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNN,Tenascin-N,39966,0.00204576234898985,0.0044967866777477,-0.00676793953939564,0.0108594642373754,0.649162019048899
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.00125273718795254,0.00276625008523902,-0.00416911297911594,0.00667458735502102,0.650655105885653
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRN1,Neuritin,39934,0.00163382656141157,0.00361519306862437,-0.0054519518530922,0.00871960497591533,0.651325597121981
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HK2,Hexokinase-2,41900,0.00127083861702889,0.00283855257863457,-0.00429272443709486,0.00683440167115264,0.654372276747627
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC2L,C-type lectin domain family 2 member L,39649,-0.00237359274947337,0.0053272403387175,-0.0128149838133597,0.00806779831441292,0.655925528725965
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL25,Interleukin-25,39510,0.00157664948729919,0.00357372307045859,-0.00542784773079966,0.00858114670539803,0.659092579377027
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.00166042664121541,0.00376768085199134,-0.00572422782868762,0.00904508111111843,0.659436956463839
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHIT1,Chitotriosidase-1,42207,-0.0071128763781713,0.0162839873423479,-0.0390294915691733,0.0248037388128307,0.662261962453386
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYPLA2,Acyl-protein thioesterase 2,39586,0.00485557803083301,0.011296960220583,-0.0172864640015097,0.0269976200631757,0.667340255623944
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BSND,Barttin,39560,0.00149561886008807,0.00349034240539256,-0.00534545225448134,0.00833668997465749,0.668294065506789
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC1A4,Neutral amino acid transporter A,39649,0.00225244129979293,0.0052854306917787,-0.00810700285609332,0.0126118854556792,0.669999266584119
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IKZF2,Zinc finger protein Helios,41843,-0.0039208669172735,0.0092452468256767,-0.0220415506955998,0.0141998168610528,0.67150310761514
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSCA,Prostate stem cell antigen,39930,0.0114384682855285,0.0270059320651744,-0.0414931585622133,0.0643700951332704,0.67189921002393
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,-0.0014394131307782,0.00340434500691157,-0.00811192934432487,0.00523310308276847,0.672435891834846
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GM2A,Ganglioside GM2 activator,39733,0.00167965933402658,0.00400391664974233,-0.00616801729946838,0.00952733596752153,0.674855874619615
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL3RA,Interleukin-3 receptor subunit alpha,41913,0.00136943038077136,0.00326734168950041,-0.00503455933064943,0.00777342009219216,0.675130246712053
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP350,Centrosome-associated protein 350,39560,-0.00159252017828622,0.00380241881839352,-0.00904526106233752,0.00586022070576508,0.675357599313562
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBLN1,Cerebellin-1,39586,-0.00402466614485465,0.00963361211076436,-0.0229065458819528,0.0148572135922435,0.676121021855848
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP30,Rho GTPase-activating protein 30,39757,-0.0017417894968673,0.0041804467658638,-0.00993546515796035,0.00645188616422575,0.676941335303345
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,0.00118347999939772,0.00285772944412596,-0.00441766971108916,0.00678462970988459,0.678783202383655
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYBB2,Beta-crystallin B2,39929,0.00295759680809547,0.00727095091849522,-0.0112934669921552,0.0172086606083461,0.684185404544078
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOP56,Nucleolar protein 56,39575,0.00472500609059205,0.011651485130137,-0.0181119047644764,0.0275619169456605,0.685097180255879
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTTG1,Securin,39757,0.00174622036148868,0.00432528105213366,-0.0067313305006933,0.0102237712236707,0.686423325395192
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RLN1,Prorelaxin H1,39934,0.00184371977598912,0.00460704359811164,-0.00718608567630969,0.0108735252282879,0.689019805749348
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPT,Microtubule-associated protein tau,41839,0.00219912503535117,0.00549698303380998,-0.00857496171091639,0.0129732117816187,0.689118511114927
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.00167410178626286,0.00418826893219971,-0.00653490532084858,0.00988310889337429,0.689376346821879
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MORC3,MORC family CW-type zinc finger protein 3,39929,0.00116189385881845,0.00291858753438081,-0.00455853770856794,0.00688232542620483,0.69056292499341
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,-0.00143064645409669,0.00359883631106371,-0.00848436562378156,0.00562307271558818,0.690982669225231
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPAN15,Tetraspanin-15,39575,-0.00207539854621157,0.00523092175433503,-0.0123280051847082,0.00817720809228508,0.691555261871844
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOLR1,Folate receptor alpha,42110,0.00120106466078572,0.00306706338767313,-0.00481037957905362,0.00721250890062505,0.69535932850902
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPP7,Dipeptidyl peptidase 2,42054,0.00255756814796233,0.00653963012824164,-0.0102601069033913,0.015375243199316,0.695738690621767
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,0.00193796812447789,0.00498720530914536,-0.00783695428144702,0.0117128905304028,0.697588361763705
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRNN,Cornulin,41749,0.00271697852847898,0.007007733002785,-0.0110181781569796,0.0164521352139376,0.698235835632737
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,-0.00274683614886556,0.00709719219100395,-0.0166573328432333,0.0111636605455022,0.69874047482989
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRND,Prion-like protein doppel,39929,-0.001955345884758,0.00508218385010697,-0.0119164262309677,0.00800573446145166,0.70043341929013
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRLB,Fc receptor-like B,41843,0.00244584310219923,0.00641131575973524,-0.0101203357868818,0.0150120219912803,0.702846938282828
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,39575,-0.00218297407221636,0.00576239958127349,-0.0134772772515124,0.00911132910707968,0.704820889964507
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCP11,T-complex protein 11 homolog,39757,-0.0022721639848294,0.00601127047034867,-0.0140542541067128,0.009509926137054,0.705449679663177
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MELTF,Melanotransferrin,39958,0.00117866558560532,0.00312875647194464,-0.00495369709940617,0.00731102827061682,0.706388629263969
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHP1,Calcineurin B homologous protein 1,39586,0.00287492311625737,0.0076741308696578,-0.0121663733882719,0.0179162196207867,0.707946430216715
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEPACAM2,HEPACAM family member 2,39929,-0.00169839287304885,0.00454219868400767,-0.0106011022937039,0.00720431654760617,0.708475101883465
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL20,Interleukin-20,41913,-0.0018037492652772,0.00485053223085519,-0.0113107924377534,0.00770329390719898,0.709998347817392
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,0.00187861292999188,0.00505603719271252,-0.00803121996772467,0.0117884458277084,0.71022760931822
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLGN,Calmegin,39649,0.00175047569411778,0.0047522248924016,-0.00756388509498936,0.0110648364832249,0.712620326823334
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,0.00195095638789651,0.0052983892122877,-0.00843388646818738,0.0123357992439804,0.712717405816613
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RUVBL1,RuvB-like 1,41843,0.00371559999637577,0.0102934449644258,-0.0164595521338989,0.0238907521266504,0.71812943499079
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,0.00186363815690287,0.00520583149143108,-0.00833979156630205,0.0120670678801078,0.720357309586015
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF12,Fibroblast growth factor 12,39657,0.00168684612251525,0.00471328858783786,-0.00755119950964695,0.0109248917546775,0.720431311789941
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSN,Gelsolin,39943,0.000693540869956714,0.00197001994596454,-0.00316769822413378,0.00455477996404721,0.72480907602019
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNL2,Interferon lambda-2,39586,-0.00213443056412934,0.00608622611796716,-0.014063433755345,0.00979457262708629,0.725821251253257
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,39575,0.00167855378707743,0.00484879469718426,-0.00782508381940371,0.0111821913935586,0.729214384179378
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,-0.00120767109124586,0.00350879564391773,-0.00808491055332462,0.00566956837083289,0.730714519737127
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFDC12,WAP four-disulfide core domain protein 12,42223,-0.00226698335866168,0.00662452285955206,-0.0152510481633837,0.0107170814460604,0.732197526899627
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRPB1,Signal-regulatory protein beta-1,42100,0.00168239404727139,0.00496513909182825,-0.00804927857271197,0.0114140666672548,0.734734577665898
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSH1,Chorionic somatomammotropin hormone 1,39990,-0.00100262770326811,0.00296342840390638,-0.00681094737492461,0.0048056919683884,0.735117964946152
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,39757,0.00147383917678415,0.00438388731742247,-0.00711857996536389,0.0100662583189322,0.736730458525636
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EVPL,Envoplakin,39757,0.00116570912420842,0.00347051116799779,-0.00563649276506726,0.00796791101348409,0.736960323862413
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRX,Cone-rod homeobox protein,41900,-0.00366985426080586,0.0111827001568054,-0.0255879465681444,0.0182482380465327,0.742786432843179
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,-0.00153329570420268,0.00471133397607533,-0.0107675102973103,0.00770091888890496,0.74484799163729
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,0.00572103646135003,0.0178884404829757,-0.0293403068852824,0.0407823798079825,0.749112571479882
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RSPO3,R-spondin-3,42262,0.000933782998570461,0.00292086226710876,-0.0047911070449627,0.00665867304210363,0.749204974542282
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE6,Ribonuclease K6,39937,-0.00106455765749855,0.00335512251647358,-0.00764059778978676,0.00551148247478967,0.751026957485196
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB116,Beta-defensin 116,39586,-0.00242797581835804,0.00780656500831485,-0.0177288432346551,0.0128728915979391,0.755793463558336
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMEM132A,Transmembrane protein 132A,39638,0.00202517866207396,0.00652922552527934,-0.0107721033674735,0.0148224606916215,0.756436515969423
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAND5,DAN domain family member 5,39657,-0.0017426602109307,0.00568556219625653,-0.0128863621155935,0.00940104169373211,0.759225011504662
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,0.0022209865127479,0.00726861339610673,-0.0120254957436213,0.0164674687691171,0.759946588265361
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.00120850063026938,0.00397476636301813,-0.00899904270178493,0.00658204144124616,0.761100753682293
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,39894,-0.00119092429805807,0.00397908500479792,-0.00898993090746199,0.00660808231134585,0.764719699688998
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL3,Interleukin-3,39560,0.00189107020574041,0.00637046921500938,-0.010595049455678,0.0143771898671588,0.766587084937988
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,-0.00147702123114597,0.00503255119331252,-0.0113408215700385,0.00838677910774657,0.769150498713277
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL6,Fc receptor-like protein 6,42119,-0.00208526285899131,0.00713327318678007,-0.0160664783050803,0.0118959525870976,0.770039548019023
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UNC5D,Netrin receptor UNC5D,39657,-0.000788288741479974,0.00271473609145633,-0.00610917148073438,0.00453259399777443,0.771535588022649
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM171A2,Protein FAM171A2,39934,-0.00468787465695405,0.0162363467435705,-0.0365111142743523,0.0271353649604442,0.772795439408346
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIAA2013,Uncharacterized protein KIAA2013,39919,-0.00160525655234188,0.00558259715840296,-0.0125471469828117,0.00933663387812792,0.773699128508617
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC39A14,Zinc transporter ZIP14,41839,0.00100387151321439,0.00350956901241478,-0.00587488375111857,0.00788262677754735,0.774853184349025
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,0.00149995527867838,0.00528215929560917,-0.0088530769407156,0.0118529874980723,0.776441556608638
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PODXL2,Podocalyxin-like protein 2,42181,-0.000840292016433368,0.00296997155329941,-0.00666143626090022,0.00498085222803348,0.777235334414487
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBR1,T-box brain protein 1,39649,0.00139548535490981,0.00499094330949665,-0.00838676353170362,0.0111777342415232,0.779786934153484
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,-0.00129513649372291,0.00464562631154334,-0.0104005640643479,0.00781029107690204,0.780414074470507
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,-0.000820677956330751,0.00294478368791663,-0.00659245398464734,0.00495109807198584,0.780487984711971
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,-0.00123036579249464,0.00443583596614668,-0.00992460428614213,0.00746387270115285,0.781500601454517
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,-0.000864978124645258,0.00312001085267851,-0.00698019939589514,0.00525024314660462,0.781604250913006
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.00141494124811354,0.00514742047449065,-0.00867400288188813,0.0115038853781152,0.78341087474332
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NLGN1,Neuroligin-1,39649,-0.00191350584106324,0.00698835940368785,-0.0156106902722914,0.0117836785901649,0.784233210431441
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENO1,Alpha-enolase,42119,-0.00223783690854032,0.00818322434646373,-0.0182769566276092,0.0138012828105286,0.784498894147529
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,-0.00163941788349868,0.00600230444698244,-0.0134039345995843,0.0101250988325869,0.784756365857677
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINT3,Kunitz-type protease inhibitor 3,39930,-0.00467613796091019,0.0172607556324734,-0.0385072190005581,0.0291549430787378,0.786464001105696
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,0.00093902621241935,0.00349008726920735,-0.00590154483522705,0.00777959726006575,0.787892250747908
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SKIV2L,Helicase SKI2W,39575,-0.00110376854971533,0.0041163178587789,-0.00917175155292198,0.00696421445349131,0.788593029082994
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAP1,Antigen peptide transporter 1,39757,-0.0015795786876013,0.00606361380623147,-0.013464261747815,0.0103051043726124,0.794481995382047
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBQLN3,Ubiquilin-3,39575,0.00151887761227454,0.00584909185120541,-0.00994534241608807,0.0129830976406372,0.795117412297582
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PITHD1,PITH domain-containing protein 1,39539,-0.00208526555151405,0.00803254379540209,-0.0178290513905021,0.013658520287474,0.795175571495014
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,-0.00144741293835776,0.00557838139300622,-0.01238104046865,0.00948621459193443,0.795278826859334
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RRP15,RRP15-like protein,39586,0.00244993757008531,0.00948197926297674,-0.0161347417853491,0.0210346169255197,0.796119811579225
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,0.00245267789747322,0.00952080073760512,-0.0162080915482328,0.0211134473431792,0.796710768037365
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,0.00136846427099238,0.0053663827828299,-0.00914964598335423,0.011886574525339,0.798722707271398
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESR1,Estrogen receptor,39657,0.00151458993060588,0.00594201049376301,-0.0101317506371696,0.0131609304983814,0.798808787184134
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEFL,Neurofilament light polypeptide,41797,-0.00124308270697842,0.00492148270621912,-0.0108891888111679,0.00840302339721106,0.800594426989391
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFD,Complement factor D,39979,0.000531752262906977,0.00210600306517972,-0.00359601374484528,0.00465951827065923,0.800664132890747
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MORN4,MORN repeat-containing protein 4,39560,0.00201034035826266,0.00814142132763709,-0.013946845443906,0.0179675261604314,0.804969001525816
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPSD1,Tryptase delta,39934,0.000935496576607907,0.0038013131079752,-0.00651507711502349,0.0083860702682393,0.805610619273277
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDSN,Corneodesmosin,42246,0.00111785053391323,0.00455251894914202,-0.00780508660640513,0.0100407876742316,0.806037776261846
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,-0.000652031109972436,0.00266946636905064,-0.0058841851933117,0.00458012297336683,0.807037579484606
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,-0.000856586627601978,0.00351800768570973,-0.00775188169159304,0.00603870843638908,0.807633224237638
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAMT,Guanidinoacetate N-methyltransferase,39575,-0.000890000683866357,0.00367987447914648,-0.00810255466299346,0.00632255329526075,0.808896061135032
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALCB,Calcitonin gene-related peptide 2,39929,0.00101950458142643,0.00422330129817903,-0.00725816596300446,0.00929717512585733,0.809249546159488
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,39657,0.00101482169433103,0.00424068672740453,-0.00729692429138185,0.0093265676800439,0.810872764006292
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM3D,Protein FAM3D,39930,-0.00215475414888664,0.00909595274796866,-0.0199828215349052,0.0156733132371319,0.812745225037191
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRC25,Leucine-rich repeat-containing protein 25,42070,-0.000951656594544831,0.00409020522337488,-0.00896845883235959,0.00706514564326993,0.816023376247019
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,0.00153573085657335,0.00667767517610063,-0.0115525124885839,0.0146239742017306,0.818111705275546
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,-0.00144176610633518,0.00628207976710407,-0.0137546424498592,0.0108711102371888,0.818480303269961
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPB41L5,Band 4.1-like protein 5,39649,0.00147764198017839,0.00646964707348878,-0.0112028662838596,0.0141581502442164,0.81934256934565
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UPK3A,Uroplakin-3a,39586,-0.00112401488283555,0.00503685527574864,-0.0109962512233029,0.00874822145763179,0.823416636309282
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL33,Interleukin-33,41913,-0.000912690649764422,0.00410104572119059,-0.00895074026329797,0.00712535896376913,0.823888613613997
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPT1,Translationally-controlled tumor protein,41913,-0.00147568535179479,0.00666082940600775,-0.01453091098757,0.0115795402839804,0.824670108951172
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCLRE1C,Protein artemis,39560,-0.000685581601083298,0.00316676566021065,-0.00689244229509618,0.00552127909292958,0.828607755596015
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSLNL,Mesothelin-like protein,39649,-0.000842027950845548,0.0039449932971691,-0.00857421481329698,0.00689015891160588,0.830986025315477
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF6,Fibroblast growth factor 6,39657,0.00084396437635522,0.00406215801867326,-0.00711786534024438,0.00880579409295482,0.835418188581536
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PI16,Peptidase inhibitor 16,39990,0.000521283678390274,0.0025094385825191,-0.00439721594334716,0.00543978330012771,0.835444127675808
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.000643598279596181,0.00310563127175119,-0.00544343901303616,0.00673063557222852,0.835829450985482
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHISA5,Protein shisa-5,39966,0.000556866934746722,0.00270001585998096,-0.00473516415081595,0.0058488980203094,0.836602606602246
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC6A,C-type lectin domain family 6 member A,41843,-0.000982751752812417,0.00492900248766812,-0.0106435966286419,0.00867809312301709,0.841967416749026
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL2RG,Cytokine receptor common subunit gamma,39919,-0.000732017268646569,0.00369736498674495,-0.00797885264266666,0.00651481810537353,0.84306152699973
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,0.00058444176977214,0.00295822358819275,-0.00521367646308564,0.00638256000262992,0.843388867467709
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLT1,Vascular endothelial growth factor receptor 1,42042,0.000437239984373188,0.00226058276150546,-0.00399350222817752,0.0048679821969239,0.846633645573249
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSAPL1,Proactivator polypeptide-like 1,39930,0.00100016472080485,0.00522541938736169,-0.00924165727842407,0.0112419867200338,0.848212733864015
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,42017,-0.00114930930902303,0.00609626739253564,-0.0130979933983929,0.0107993747803468,0.850466621110329
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC25A,M-phase inducer phosphatase 1,39560,-0.000780208119071428,0.00416664768256475,-0.00894683757689835,0.00738642133875549,0.851467461260414
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL9A1,Collagen alpha-1(IX) chain,42119,-0.000862017766078081,0.00463429227229646,-0.00994523061977914,0.00822119508762298,0.85244088436452
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,-0.000782594323350398,0.00424204752428323,-0.00909700747094553,0.00753181882424473,0.853636243509316
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA5,Annexin A5,41780,0.000567078590805256,0.00316180027692456,-0.00563004995196688,0.00676420713357739,0.857663234408517
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRD2,Bromodomain-containing protein 2,39586,0.000653264455438218,0.00364245640951393,-0.00648595010720909,0.00779247901808552,0.857668373871162
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL18BP,Interleukin-18-binding protein,42217,-0.000581894363666107,0.00326305789552786,-0.00697748783890072,0.0058136991115685,0.85846809729234
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMY2B,Alpha-amylase 2B,41300,-0.000929521175642043,0.00521438952304377,-0.0111497246408078,0.00929068228952375,0.858521016882817
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMY2A,Pancreatic alpha-amylase,41665,-0.000896386127951992,0.00508772954241634,-0.010868336031088,0.00907556377518404,0.860150640797024
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HLA_A,,39934,-0.000589008806486048,0.003411856073538,-0.00727624671062052,0.00609822909764843,0.862940722575241
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLINT1,Clathrin interactor 1,39560,0.000862025289039937,0.00519838661617773,-0.00932681247866841,0.0110508630567483,0.868297301768637
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00102007289275302,0.00616309423716797,-0.0110595918120962,0.0130997375976022,0.868543087956777
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL20RB,Interleukin-20 receptor subunit beta,39657,-0.000717491249491939,0.00435830268963617,-0.00925976452117883,0.00782478202219496,0.869241137929089
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LHB,Lutropin subunit beta,41843,-0.0015127292341334,0.00920228678489233,-0.0195492113325224,0.0165237528642556,0.86942961160106
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNL1,Interferon lambda-1,41839,0.000774690361656246,0.0047295842697921,-0.00849529480713628,0.0100446755304488,0.869893678979508
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRR1B,Cornifin-B,39757,-0.00144674627756694,0.00897984530022471,-0.0190472430660074,0.0161537505108735,0.872009383010742
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,0.000677471762575343,0.00420871372850501,-0.00757160714529448,0.00892655067044516,0.87212088633498
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LY9,T-lymphocyte surface antigen Ly-9,41960,-0.000507486351677827,0.00315963567161108,-0.00670037226803555,0.00568539956467989,0.872398702352123
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,-0.000564569948730443,0.00357742431629895,-0.00757632160867639,0.00644718171121551,0.874605761490219
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NENF,Neudesin,39919,-0.00179089827988427,0.0116814863638843,-0.0246866115530974,0.0211048149933289,0.878155899535743
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALPI,Intestinal-type alkaline phosphatase,39657,-0.0019930134590115,0.0130337406269584,-0.0275391450878499,0.0235531181698269,0.878470577015859
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYB5A,Cytochrome b5,39560,-0.00112832504112785,0.00740505073100339,-0.0156422244738945,0.0133855743916388,0.878896062360345
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,39560,0.000399233524339177,0.00264321332387397,-0.0047814645904538,0.00557993163913215,0.879946170986823
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSTN,Osteocrin,39649,0.000629400014987609,0.0042093439966328,-0.00762091421841267,0.00887971424838789,0.881142515290763
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCLN,Nicalin,41913,-0.000768229306747747,0.00532415024276903,-0.0112035637825751,0.00966710516907956,0.885272521332108
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,0.00149974451233332,0.0104209070161514,-0.0189252332393235,0.0219247222639901,0.885568661517792
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFRC,Transferrin receptor protein 1,42200,0.000548787716288625,0.00389656126930435,-0.0070884723715479,0.00818604780412515,0.887999233897787
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,0.000429627532100519,0.00306033113556807,-0.00556862149361291,0.00642787655781395,0.888357139153171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT17,"Keratin, type I cytoskeletal 17",39575,-0.000576527827221408,0.00419954240272568,-0.00880763093656375,0.00765457528212093,0.890809240155861
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TYMP,Thymidine phosphorylase,42070,0.000945908327890906,0.00691594450353966,-0.0126093428990468,0.0145011595548286,0.891212972861826
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,39757,0.000723890598570228,0.00558898087595328,-0.0102305119182982,0.0116782931154387,0.89694771487399
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL20RA,Interleukin-20 receptor subunit alpha,41913,0.000590966111644198,0.00460977577326596,-0.00844419440395709,0.00962612662724549,0.897993862606149
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTLA,B- and T-lymphocyte attenuator,39560,0.00112010964800146,0.00891307346041723,-0.0163495143344163,0.0185897336304192,0.899995125936278
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,-0.00151967628515986,0.0122567449757794,-0.0255428964376876,0.0225035438673678,0.901327815496636
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,-0.00080597279919315,0.00653821383775787,-0.0136208719211986,0.0120089263228123,0.901894683912199
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNF830,Zinc finger protein 830,39919,0.000977083204806515,0.00806636404609219,-0.0148329903255342,0.0167871567351472,0.903589773064755
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD33,Myeloid cell surface antigen CD33,42181,0.000990208551477232,0.0082598425215968,-0.0151990827908525,0.017179499893807,0.904578194431649
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERVV_1,,39575,0.000541106363287604,0.00453291937052774,-0.00834341560294676,0.00942562832952197,0.904982354278414
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,0.000507964369445171,0.00429982698777911,-0.00791969652660189,0.00893562526549223,0.905962057500419
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.000658195645442717,0.00572266953415347,-0.0105582366414981,0.0118746279323835,0.90843494557651
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJA4,DnaJ homolog subfamily A member 4,39929,-0.000798096572714918,0.00718357423415163,-0.0148779020716521,0.0132817089262223,0.911538853983097
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,-0.000342468361824031,0.00313096261131337,-0.00647915507999823,0.00579421835635016,0.912902098560013
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLIN3,Perilipin-3,42145,-0.000483792721693286,0.00445400679950673,-0.00921364604872648,0.00824606060533991,0.913505772407317
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VASN,Vasorin,41975,0.000298000313100113,0.00284895733488925,-0.00528595606328282,0.00588195668948304,0.916694956970235
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FZD10,Frizzled-10,39649,0.000636860788251958,0.00620567486132223,-0.0115262619399396,0.0127999835164435,0.91826202728525
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAGLN3,Transgelin-3,39560,-0.000639658289909273,0.00624270074217617,-0.0128753517445746,0.011596035164756,0.918389472385798
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAGEA3,Melanoma-associated antigen 3,39757,0.000913071992431887,0.0089557747160247,-0.0166402464509765,0.0184663904358403,0.918795468318416
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,0.000492239814545674,0.00503139425138217,-0.00936929291816337,0.0103537725472547,0.922066149541133
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP73,Tumor protein p73,39649,-0.000346055907347667,0.00356516381453708,-0.00733377698384034,0.006641665169145,0.922675805078767
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,0.000491798185038069,0.00507965899271142,-0.00946433344067631,0.0104479298107524,0.922873357986479
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,-0.000770845630169009,0.00802610241171254,-0.0165020063571256,0.0149603150967876,0.923488704085388
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LMOD2,Leiomodin-2,39586,-0.000612819739593369,0.0063935081047583,-0.0131440956249196,0.0119184561457329,0.9236412072084
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FDX1,"Adrenodoxin, mitochondrial",39575,-0.000613114238517811,0.00655168150297019,-0.0134544099843394,0.0122281815073038,0.925443549914721
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPEP,Glutamyl aminopeptidase,39575,0.000402361765266025,0.00441397796415194,-0.00824903504447177,0.00905375857500382,0.927370085629853
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,-0.000283195908585932,0.00314752153818735,-0.00645233812343313,0.00588594630626127,0.928309257952235
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,0.000590317035049556,0.00658139450095996,-0.012309216186832,0.0134898502569311,0.928531337578538
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHD,SH2 domain-containing adapter protein D,39554,-0.000754804961223838,0.00857940120648569,-0.0175704313259358,0.0160608214034881,0.929895176939231
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,0.000357468980507388,0.00423954848925077,-0.00795204605842412,0.0086669840194389,0.932805070505118
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,39649,0.00030271765458397,0.00381685305417417,-0.0071783143315974,0.00778374964076534,0.93678685554204
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLGAP5,Disks large-associated protein 5,39934,0.000402931103345955,0.00513710927399795,-0.00966580307369003,0.0104716652803819,0.93748311793262
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CGN,Cingulin,39649,-0.000302682205061828,0.00389387353871802,-0.00793467434094915,0.00732930993082549,0.938041905343378
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBP1,Retinol-binding protein 1,39649,0.000522233549379027,0.00730743503685005,-0.0138003391228471,0.0148448062216051,0.943028133639481
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD86,T-lymphocyte activation antigen CD86,39930,0.000217861849999143,0.00315758814445777,-0.00597101091313808,0.00640673461313637,0.944993794566636
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPTN,Neuroplastin,41843,-0.000556486540091555,0.00814483192541898,-0.0165203571139127,0.0154073840337296,0.945528844504314
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,0.000265107925934186,0.00398491043233249,-0.0075453165214375,0.00807553237330588,0.946958477232795
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGAX,Integrin alpha-X,39757,-0.00033098644105787,0.00536756604821739,-0.010851415895564,0.0101894430134482,0.950831387915329
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF3,Fibroblast growth factor 3,39657,-0.000183539891906746,0.00307947872621759,-0.00621931819529323,0.00585223841147974,0.9524745299581
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,0.00028159307530008,0.00477853496074685,-0.00908433544776374,0.0096475215983639,0.95300990033518
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,-0.000314529257846469,0.00544267817759775,-0.0109821784859381,0.0103531199702451,0.953917379550637
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UGDH,UDP-glucose 6-dehydrogenase,39575,0.000587700268764588,0.0103798211678231,-0.0197567492201687,0.0209321497576979,0.954849332619926
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKAP12,A-kinase anchor protein 12,39736,0.000122405528303177,0.00221007924778038,-0.00420934979734636,0.00445416085395272,0.955832635106685
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTF,Ciliary neurotrophic factor,39586,-0.000186260806419386,0.00359277501563932,-0.00722809983707245,0.00685557822423368,0.958654608413528
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCDC2C,Doublecortin domain-containing protein 2C,39560,-0.000326297790312298,0.0066053477479391,-0.0132727793762729,0.0126201837956483,0.960602199048715
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GHRHR,Growth hormone-releasing hormone receptor,41839,-0.000255155278313049,0.00562587760746506,-0.0112818753889446,0.0107715648323185,0.963825939708026
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDAC9,Histone deacetylase 9,39586,-0.000314605026247657,0.00693714298779291,-0.0139114052823218,0.0132821952298264,0.963828515951563
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRING1,SREBP regulating gene protein,39560,-0.000271200536564784,0.00645726082605168,-0.0129274317556261,0.0123850306824965,0.966500008607432
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT8,"Keratin, type II cytoskeletal 8",39586,-0.000366277097337506,0.00872349983841454,-0.01746433678063,0.016731782585955,0.966509503776825
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEZ6,Seizure protein 6 homolog,39649,-0.000133273426911751,0.00325768379444305,-0.00651833366402014,0.00625178681019663,0.967367997093592
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK12,Kallikrein-12,41843,-0.000555002870394823,0.0138752579630428,-0.0277505084779588,0.0266405027371691,0.968094157212799
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KHDC3L,KH domain-containing protein 3,39560,0.00026557703477082,0.00698020855007609,-0.0134156317233783,0.0139467857929199,0.969650782701652
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,0.000172622765377723,0.00457650370979806,-0.00879732450582648,0.00914257003658193,0.969912131360324
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CADPS,Calcium-dependent secretion activator 1,39649,-0.000158894362407423,0.00424400620048809,-0.00847714651536407,0.00815935779054923,0.970135087035581
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCR1,Natural cytotoxicity triggering receptor 1,42095,-0.000148195415819119,0.00398715059186308,-0.00796301057587076,0.00766661974423253,0.970351402536917
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN2,Contactin-2,42262,0.00016603780280366,0.00457511243551776,-0.00880118257081114,0.00913325817641846,0.971050438564971
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,-0.000281126650945909,0.0077699938451131,-0.0155103145873676,0.0149480612854758,0.971138641545674
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNGR1,Interferon gamma receptor 1,42185,-7.89261714067362e-05,0.00224844927584613,-0.00448588675206515,0.00432803440925168,0.971998530503768
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP15,Matrix metalloproteinase-15,39958,0.000176496884592208,0.00505939623499022,-0.00973991973598861,0.010092913505173,0.972172078745313
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,-0.00017931376407985,0.00615617330664176,-0.0122454134450977,0.011886785916938,0.976763455412646
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGT5,Glutathione hydrolase 5 proenzyme,42016,7.20531673317277e-05,0.00249313653687319,-0.00481449444493972,0.00495860077960317,0.976944288797799
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL11,Interleukin-11,41913,-0.000162912036839249,0.00633375076970217,-0.0125770635454555,0.012251239471777,0.979480053646083
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NME3,Nucleoside diphosphate kinase 3,42144,-6.11345509811603e-05,0.00248426749942396,-0.00493029884985212,0.0048080297478898,0.980367456028054
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYL6B,Myosin light chain 6B,39649,0.000220931568015993,0.00949346605265876,-0.0183862618951952,0.0188281250312272,0.981433758092751
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN3B,Sodium channel subunit beta-3,39586,-9.43758614319618e-05,0.00484395408853222,-0.00958852587495511,0.00939977415209119,0.984455970520702
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,9.16741111066638e-05,0.00510949193295293,-0.00992293007748108,0.0101062782996944,0.985685506722119
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,-5.79514269266004e-05,0.00516768742808606,-0.0101866187859753,0.0100707159321221,0.991052762572454
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSLP,Thymic stromal lymphopoietin,41900,-6.1469074128593e-05,0.0062625889167169,-0.0123361433508937,0.0122132052026365,0.992168811263465
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,2.66341960259301e-05,0.00273435028170869,-0.0053326923561231,0.00538596074817496,0.992228430350062
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RASA1,Ras GTPase-activating protein 1,41839,3.26482301657525e-05,0.00339134055192682,-0.00661437925161082,0.00667967571194233,0.992319077339102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC4A1,Band 3 anion transport protein,39966,4.30988600333609e-05,0.00495388658184703,-0.00966651884038683,0.00975271656045355,0.993058637043053
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DRAXIN,Draxin,42016,2.30078879732893e-05,0.00442840493723414,-0.00865666578900562,0.0087026815649522,0.99585466682125
